data_2jn4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jn4 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.508 ' HB3' ' HB3' ' A' ' 63' ' ' ALA . 64.8 mtt . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -130.33 130.25 44.22 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.871 0.367 . . . . 0.0 111.722 -174.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.459 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 14.5 p -144.58 138.7 23.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 172.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 52.3 ttm -113.45 110.64 20.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.703 0.287 . . . . 0.0 110.378 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.1 mm -84.51 110.98 19.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -99.17 134.18 42.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.129 0.49 . . . . 0.0 109.725 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.604 ' HZ2' ' HB3' ' A' ' 7' ' ' LYS . 4.4 mmmp? -128.46 149.02 50.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.973 0.892 . . . . 0.0 113.292 -165.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 9' ' ' ALA . 8.7 m -136.81 174.41 10.65 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 165.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.482 ' H ' HG22 ' A' ' 8' ' ' THR . . . -57.12 -50.65 72.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.472 0.578 . . . . 0.0 110.64 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 51.7 p -101.33 -31.27 11.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.7 136.36 19.79 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.865 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.518 ' HB3' HD13 ' A' ' 25' ' ' ILE . 72.8 m80 -134.99 112.76 10.86 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 176.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.4 m -130.66 145.27 51.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.417 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.471 ' HB3' HD12 ' A' ' 40' ' ' LEU . . . -126.68 126.25 43.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.463 177.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -107.46 103.56 12.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.766 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.45 98.17 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.716 174.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.64 -46.64 77.4 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.306 -173.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.833 ' HZ1' ' HB2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -62.66 -17.09 59.82 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -174.659 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -117.48 -10.07 10.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.919 0.39 . . . . 0.0 110.205 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.2 t70 60.86 30.2 19.5 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.663 0.744 . . . . 0.0 109.511 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.5 tp -99.06 114.38 27.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.601 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -110.44 118.49 36.4 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 172.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 9.8 tp10 -134.48 158.75 43.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.993 0.425 . . . . 0.0 110.798 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.3 mt -77.19 141.19 40.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.594 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.601 HG22 ' HE3' ' A' ' 28' ' ' MET . 71.9 mt -83.08 110.19 17.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.4 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.7 m -102.89 -23.61 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.507 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.629 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 8.0 tp10 -133.9 133.66 41.73 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.601 ' HE3' HG22 ' A' ' 25' ' ' ILE . 0.8 OUTLIER -128.74 153.01 47.79 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.391 -174.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -66.75 -51.77 52.08 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 169.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.497 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 40.3 t30 -114.57 135.52 22.31 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.625 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.497 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 2.0 Cg_endo -38.39 -31.49 0.21 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 124.184 3.256 . . . . 0.0 113.436 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.472 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . . . -72.28 -69.52 0.39 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.155 174.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 3.4 tt 176.65 -71.74 0.01 OUTLIER 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.831 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.722 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 41.2 m95 -68.14 160.32 29.27 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.621 -173.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.21 -46.22 0.73 Allowed Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.598 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.63 -85.83 0.05 OUTLIER Glycine 0 C--O 1.225 -0.456 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.055 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.63 157.38 29.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.291 0.567 . . . . 0.0 111.743 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 46' ' ' LEU . 9.8 p -135.23 149.04 28.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 174.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.629 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 18.7 m -125.79 126.34 44.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.013 0.435 . . . . 0.0 110.316 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.471 HD12 ' HB3' ' A' ' 14' ' ' ALA . 2.6 mm? -82.44 166.68 19.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.602 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.7 -10.09 33.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.298 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -89.19 -13.33 38.55 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.981 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.53 -13.08 56.79 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.681 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -69.56 141.8 53.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.882 0.373 . . . . 0.0 110.952 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 39.6 mt-30 -113.23 135.19 54.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.799 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -127.39 137.08 52.67 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.613 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.46 ' N ' HD13 ' A' ' 46' ' ' LEU . 32.3 tt0 -89.97 137.59 32.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.012 0.434 . . . . 0.0 111.268 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.465 ' HB3' ' CE3' ' A' ' 34' ' ' TRP . 3.0 mm? -107.01 122.93 39.99 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.096 177.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.461 ' HD2' ' HZ3' ' A' ' 34' ' ' TRP . 37.8 Cg_exo -59.38 -4.65 2.52 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.864 2.376 . . . . 0.0 113.43 176.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 71.07 89.77 0.1 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.224 0.61 . . . . 0.0 112.075 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 22.2 ptm -162.09 127.14 3.38 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 56.53 79.0 0.19 Allowed 'General case' 0 C--O 1.234 0.268 0 O-C-N 123.328 0.392 . . . . 0.0 109.986 -173.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.722 ' HA ' ' HB2' ' A' ' 34' ' ' TRP . . . -46.5 -40.76 13.02 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.323 -171.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.472 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 16.3 t70 -125.2 94.49 4.18 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 170.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.538 ' HB ' ' HG3' ' A' ' 7' ' ' LYS . 1.3 m -63.61 131.59 94.91 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.638 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -83.13 0.34 9.62 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.689 2.259 . . . . 0.0 112.838 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.407 ' HB2' ' HD2' ' A' ' 58' ' ' PRO . 2.9 pp -146.54 161.87 36.47 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.387 -178.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 57' ' ' LEU . 39.3 Cg_endo -66.25 112.39 2.31 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.259 1.972 . . . . 0.0 111.362 175.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.3 tt -108.7 142.16 22.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.503 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.7 m -109.97 115.08 29.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.279 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.491 HG13 ' HH2' ' A' ' 34' ' ' TRP . 21.3 m -125.49 178.52 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.883 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -74.33 146.59 42.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.892 0.377 . . . . 0.0 110.905 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 1' ' ' MET . . . -90.73 129.39 36.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.595 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -145.42 99.6 3.32 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 174.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.79 155.02 19.81 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.924 -173.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 4.7 mp . . . . . 0 C--O 1.248 0.979 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptt? . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 120.494 0.188 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -129.55 142.97 50.64 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 122.545 0.338 . . . . 0.0 110.367 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.603 HG11 HD23 ' A' ' 46' ' ' LEU . 10.7 p -151.3 138.83 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 175.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.463 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 47.3 ttm -103.7 122.45 45.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.734 0.302 . . . . 0.0 110.609 -176.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 58' ' ' PRO . 45.0 mm -96.09 128.79 46.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.5 mtp180 -97.4 123.63 41.31 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.997 0.427 . . . . 0.0 110.747 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -95.17 116.68 29.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.806 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.8 t -159.68 143.67 14.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.474 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.35 -26.63 46.8 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.79 0.329 . . . . 0.0 111.513 -175.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.5 p -64.89 -27.43 68.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.294 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 167.89 113.66 0.28 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.082 -0.58 . . . . 0.0 111.803 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -53.84 137.38 38.65 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.4 t -138.86 162.65 34.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.904 0.383 . . . . 0.0 110.705 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.49 ' HB2' HD13 ' A' ' 40' ' ' LEU . . . -145.18 139.43 27.23 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.925 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -115.05 109.35 17.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.099 0.476 . . . . 0.0 110.994 -177.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 46.6 t -84.41 97.09 4.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.075 174.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.22 -55.34 28.96 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -170.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.528 ' H ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -55.17 -32.39 62.11 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.844 0.354 . . . . 0.0 111.587 -176.353 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -96.57 -9.98 28.23 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.565 -176.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.8 t70 58.49 27.89 16.19 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.798 0.808 . . . . 0.0 109.744 -176.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.409 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 48.3 tp -91.82 110.42 21.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.928 -177.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -109.49 108.89 19.54 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 171.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.445 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 8.3 tp10 -132.59 160.23 37.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.034 0.445 . . . . 0.0 111.204 -172.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.8 mt -82.62 137.02 34.64 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.828 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 72.3 mt -78.57 101.77 4.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.237 176.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.8 m -98.14 -9.95 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.591 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.53 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 6.1 tp10 -138.43 122.61 18.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.227 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -151.82 140.24 20.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -60.28 -54.24 48.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.32 -177.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.47 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 24.2 t-20 -85.34 137.87 36.65 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.751 -174.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -50.53 -37.79 53.01 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.454 2.769 . . . . 0.0 112.551 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -78.77 -62.7 1.61 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.224 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.605 ' HG ' HD23 ' A' ' 48' ' ' LEU . 23.2 tp 176.82 -76.37 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.57 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.463 ' HE3' ' O ' ' A' ' 49' ' ' PRO . 61.3 m95 -73.02 125.65 28.12 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.775 -174.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.528 ' HA2' ' HB2' ' A' ' 50' ' ' ALA . . . 179.54 -55.07 0.09 OUTLIER Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.107 -177.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.0 -137.4 2.34 Favored Glycine 0 C--O 1.226 -0.385 0 C-N-CA 121.232 -0.509 . . . . 0.0 112.045 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.76 155.53 39.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.301 0.572 . . . . 0.0 111.751 -176.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.02 151.8 13.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.106 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 62.6 m -142.55 132.63 24.52 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.964 0.411 . . . . 0.0 110.453 178.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.49 HD13 ' HB2' ' A' ' 14' ' ' ALA . 3.2 mm? -81.5 162.84 23.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.331 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.4 -22.73 65.25 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.199 0.523 . . . . 0.0 110.833 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.445 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 27.5 t-20 -73.93 -18.77 60.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.509 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.14 -15.88 30.38 Favored Glycine 0 C--N 1.331 0.258 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.396 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 12.7 t-105 -57.83 117.33 4.16 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.602 0.239 . . . . 0.0 110.418 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -92.37 134.16 35.19 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.603 HD23 HG11 ' A' ' 3' ' ' VAL . 37.4 tp -143.13 164.87 28.98 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -111.38 141.13 45.33 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.605 HD23 ' HG ' ' A' ' 33' ' ' LEU . 16.3 tp -123.12 95.94 45.26 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.235 -175.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.463 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 28.9 Cg_endo -60.89 131.37 36.97 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.147 2.564 . . . . 0.0 112.608 -175.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.528 ' HB2' ' HA2' ' A' ' 35' ' ' GLY . . . -70.29 82.21 0.54 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.853 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 37.4 mtm -98.75 -71.36 0.69 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.955 177.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.34 128.15 6.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.99 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -95.24 -12.13 26.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.586 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -78.83 -11.34 59.99 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.45 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.8 t -60.95 119.89 49.02 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 120.924 0.392 . . . . 0.0 110.667 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -90.98 9.71 2.99 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.326 2.684 . . . . 0.0 112.865 -175.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.3 pp -122.99 150.0 58.17 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.917 -174.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 58.2 Cg_endo -72.38 97.95 0.9 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.311 2.007 . . . . 0.0 111.54 175.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.9 tt -94.92 139.68 18.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.187 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 4' ' ' MET . 41.1 m -92.06 122.09 34.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.3 175.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.0 m -116.45 170.4 6.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.422 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.99 120.05 14.24 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.039 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.63 108.82 5.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.512 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -119.73 106.37 12.07 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 175.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.781 ' HB2' ' HZ3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -99.11 158.1 15.9 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.795 0.331 . . . . 0.0 111.278 -178.606 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.25 1.129 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 174.92 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.449 ' O ' ' HG2' ' A' ' 1' ' ' MET . 45.9 ttp . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 120.867 0.365 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.595 ' HD2' ' HB1' ' A' ' 17' ' ' ALA . 1.3 tmtp? -104.18 120.3 40.84 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -176.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.9 p -138.37 128.46 34.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.961 0.41 . . . . 0.0 110.101 175.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 51.0 ttm -103.1 110.12 21.94 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.4 mm -84.82 111.61 20.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.469 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 94.3 mtt180 -103.85 139.26 39.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.648 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -103.77 157.07 17.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.84 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.8 m -139.94 159.07 43.01 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -44.63 -50.19 9.9 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.091 0.472 . . . . 0.0 111.124 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.2 m -129.5 96.65 4.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.725 175.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.01 175.01 14.03 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 121.276 -0.487 . . . . 0.0 112.956 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.456 ' HB3' HD12 ' A' ' 25' ' ' ILE . 73.3 m80 -139.17 139.09 37.46 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.5 p -134.91 133.71 39.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.886 0.374 . . . . 0.0 110.624 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.496 ' HB2' HD13 ' A' ' 40' ' ' LEU . . . -105.23 123.08 47.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.533 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -93.94 103.84 15.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.638 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.4 HG11 ' HZ3' ' A' ' 44' ' ' TRP . 49.8 t -86.39 112.13 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.114 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.595 ' HB1' ' HD2' ' A' ' 2' ' ' LYS . . . -59.91 -46.53 89.07 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -173.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -59.3 -11.84 4.72 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -172.046 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -144.38 15.39 1.65 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 p30 42.03 29.98 0.16 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.516 0.727 . . . . 0.0 111.474 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.4 tt -88.72 117.55 27.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.372 -172.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -112.98 109.1 18.3 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 174.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 9.6 tp10 -117.29 163.24 16.63 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.034 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.0 mt -75.72 129.34 36.93 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.237 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.456 HD12 ' HB3' ' A' ' 12' ' ' HIS . 72.4 mt -78.06 98.11 2.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.119 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.471 HG23 ' HG2' ' A' ' 27' ' ' GLU . 16.7 m -91.38 -46.37 14.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.501 -177.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.548 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 20.9 mm-40 -113.11 107.35 15.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.413 -175.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.71 142.93 50.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.619 0.247 . . . . 0.0 110.346 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -62.57 -40.87 98.22 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.122 0.487 . . . . 0.0 110.643 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -91.79 139.82 24.85 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.868 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -48.17 -38.85 33.63 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.624 2.883 . . . . 0.0 112.828 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.691 ' HB1' ' HB1' ' A' ' 53' ' ' ALA . . . -89.05 -61.8 1.63 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.502 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.423 HD11 HD11 ' A' ' 25' ' ' ILE . 27.4 tp -175.25 -71.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -177.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.403 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 70.8 m95 -79.33 136.19 36.93 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -170.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 165.42 -45.97 0.28 Allowed Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.397 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.16 -134.59 1.71 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.38 -0.438 . . . . 0.0 112.245 -177.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.71 165.95 21.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.292 0.568 . . . . 0.0 111.931 -175.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.8 p -146.93 167.35 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.464 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 60.7 m -142.48 123.64 14.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.785 0.326 . . . . 0.0 110.202 175.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.496 HD13 ' HB2' ' A' ' 14' ' ' ALA . 3.4 mm? -73.09 159.81 32.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.824 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.84 -16.77 52.84 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.963 0.411 . . . . 0.0 110.999 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.403 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 25.0 t-20 -75.53 -31.43 60.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.966 178.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 126.38 -20.45 6.2 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.52 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.4 ' HZ3' HG11 ' A' ' 16' ' ' VAL . 29.6 m0 -61.15 132.81 54.91 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.753 0.311 . . . . 0.0 111.555 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -104.94 137.46 42.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.803 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.3 tp -134.41 141.41 46.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.909 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.507 ' HB3' ' HB2' ' A' ' 64' ' ' ARG . 27.2 tt0 -97.52 110.3 22.88 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 120.814 0.34 . . . . 0.0 111.042 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 3.9 mm? -93.32 144.48 28.37 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.365 176.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 48' ' ' LEU . 11.4 Cg_exo -70.83 158.63 55.02 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.42 2.08 . . . . 0.0 111.001 173.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.15 73.35 3.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.269 0.557 . . . . 0.0 110.293 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.4 mmt -95.74 -168.76 1.82 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.133 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.56 115.41 5.74 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 176.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.691 ' HB1' ' HB1' ' A' ' 32' ' ' ALA . . . -48.54 -35.8 14.06 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.583 0.552 . . . . 0.0 111.584 -174.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -119.96 86.47 2.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.18 0.514 . . . . 0.0 109.724 169.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 58.2 m -65.63 129.62 94.38 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.386 175.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.38 -34.21 40.28 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.171 2.581 . . . . 0.0 113.162 -175.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 pp -132.23 158.67 74.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.182 -176.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.469 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . 39.6 Cg_endo -66.54 105.3 0.88 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.393 2.062 . . . . 0.0 111.18 175.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.1 tt -104.56 145.39 13.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.184 -174.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 91.9 m -90.12 132.89 35.19 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.648 173.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.9 m -135.56 176.33 8.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 120.664 0.269 . . . . 0.0 111.096 -177.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.67 121.68 15.93 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.677 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.18 110.59 21.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.518 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.507 ' HB2' ' HB3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -113.38 100.71 8.75 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 172.265 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -82.79 119.17 24.01 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 75.8 mt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.629 -0.701 . . . . 0.0 110.14 -178.181 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.47 ' HE3' ' HD3' ' A' ' 18' ' ' LYS . 23.9 ptt? . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.42 ' HE3' HG23 ' A' ' 60' ' ' THR . 39.2 tptt -71.03 133.15 46.1 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -172.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.44 HG21 ' HA ' ' A' ' 16' ' ' VAL . 7.3 p -150.95 148.15 15.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.863 -178.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.9 ttt -102.96 124.82 49.19 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.732 0.301 . . . . 0.0 110.949 -176.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.456 HG13 HD11 ' A' ' 48' ' ' LEU . 42.4 mm -109.22 128.97 64.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.732 177.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.554 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 92.7 mtt180 -101.13 118.99 38.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.09 0.471 . . . . 0.0 111.34 -176.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.402 ' HD3' ' HG ' ' A' ' 33' ' ' LEU . 9.8 mmmm -107.68 116.53 32.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.233 171.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.1 m -139.96 72.84 1.41 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.349 0.595 . . . . 0.0 109.82 175.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 54.85 -93.79 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.945 -176.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.4 t -94.48 -25.94 16.67 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.225 0.536 . . . . 0.0 110.287 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.0 112.59 4.29 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -126.43 119.92 28.45 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.427 ' OG ' ' HD2' ' A' ' 6' ' ' ARG . 16.7 p -147.57 163.1 37.66 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.484 ' HB2' HD11 ' A' ' 40' ' ' LEU . . . -139.28 141.7 37.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.372 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -114.53 104.03 11.61 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.216 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.44 ' HA ' HG21 ' A' ' 3' ' ' VAL . 47.9 t -76.1 88.19 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.629 176.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.94 -29.18 41.38 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.239 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.47 ' HD3' ' HE3' ' A' ' 1' ' ' MET . 52.5 tptt -57.86 -38.05 75.03 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.419 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 19' ' ' LYS . 54.1 tttm -117.16 -1.81 11.79 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.472 -175.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.9 t70 64.71 23.73 12.8 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 122.033 0.921 . . . . 0.0 109.385 -174.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.3 tt -88.87 125.48 34.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.729 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -124.98 125.22 43.55 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.447 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 10.5 tp10 -154.44 162.26 41.25 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.893 0.378 . . . . 0.0 110.815 -176.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.1 mt -79.6 144.51 33.76 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.65 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.577 HG22 ' HE1' ' A' ' 28' ' ' MET . 67.3 mt -81.11 114.14 21.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.086 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.46 HG23 ' HG3' ' A' ' 27' ' ' GLU . 19.8 m -104.67 -26.15 3.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.488 -178.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.582 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 39.3 mt-10 -132.91 114.34 13.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.354 -176.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.577 ' HE1' HG22 ' A' ' 25' ' ' ILE . 0.6 OUTLIER -109.53 157.43 19.0 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 178.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.404 ' OE1' ' HG3' ' A' ' 37' ' ' LYS . 8.6 tp10 -72.32 -49.54 33.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.69 0.757 . . . . 0.0 109.428 171.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -95.57 138.48 21.82 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.717 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -50.29 -31.54 29.97 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.016 2.477 . . . . 0.0 111.562 173.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.92 -69.56 0.49 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.977 173.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.663 ' HB3' ' HD1' ' A' ' 34' ' ' TRP . 0.3 OUTLIER -178.43 -72.46 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.602 178.445 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.663 ' HD1' ' HB3' ' A' ' 33' ' ' LEU . 14.5 m95 -79.08 144.5 34.53 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.985 -174.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 176.83 -58.14 0.1 Allowed Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.08 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -146.47 -73.19 0.02 OUTLIER Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.242 -174.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.404 ' HG3' ' OE1' ' A' ' 29' ' ' GLU . 1.7 pptp? -132.97 167.7 19.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.169 0.509 . . . . 0.0 110.924 176.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.6 p -147.21 154.7 11.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.381 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 11.7 m -134.52 134.43 41.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.971 0.415 . . . . 0.0 110.624 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.484 HD11 ' HB2' ' A' ' 14' ' ' ALA . 2.9 mm? -87.08 169.76 12.12 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.582 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.52 -12.14 59.64 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.09 0.471 . . . . 0.0 110.884 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -80.83 -20.83 41.57 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.845 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.2 -8.92 59.26 Favored Glycine 0 C--N 1.332 0.335 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 -175.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -64.71 133.39 52.02 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -107.87 138.13 44.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.862 0.363 . . . . 0.0 110.465 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.437 HD12 HG12 ' A' ' 3' ' ' VAL . 3.4 tm? -138.27 132.41 31.64 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -84.07 113.33 20.96 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.456 HD11 HG13 ' A' ' 5' ' ' ILE . 18.2 tp -105.97 116.53 59.49 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.349 -173.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.415 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 3.0 Cg_exo -74.92 154.93 43.24 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.341 2.028 . . . . 0.0 111.419 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.57 74.09 5.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.294 0.568 . . . . 0.0 109.825 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.5 mmt -90.85 -54.89 3.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.997 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.439 ' O ' HG23 ' A' ' 55' ' ' THR . . . -163.21 95.08 0.84 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.237 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.481 ' HA ' ' CD1' ' A' ' 34' ' ' TRP . . . -71.48 -32.61 68.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.585 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.74 -52.93 54.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.861 -175.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 52' ' ' ALA . 9.8 t -28.51 120.82 0.27 Allowed Pre-proline 0 N--CA 1.477 0.897 0 O-C-N 124.224 0.952 . . . . 0.0 113.403 -169.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -85.66 10.43 3.7 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.205 2.604 . . . . 0.0 112.432 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.8 pp -131.76 153.18 81.39 Favored Pre-proline 0 C--O 1.236 0.395 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.568 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.554 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . 41.9 Cg_endo -66.63 149.9 83.89 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.826 2.35 . . . . 0.0 112.682 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.1 tt -152.03 146.93 15.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.252 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.42 HG23 ' HE3' ' A' ' 2' ' ' LYS . 17.0 m -102.02 128.27 48.54 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.315 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.401 HG12 ' HZ3' ' A' ' 34' ' ' TRP . 27.5 m -132.7 174.97 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 120.877 0.37 . . . . 0.0 111.393 -177.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -78.5 161.59 26.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.463 171.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -167.45 159.96 12.8 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.333 0.587 . . . . 0.0 112.543 -175.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -113.13 141.56 46.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.866 172.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.424 ' HZ2' ' C ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -96.51 126.16 41.5 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.489 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.424 ' C ' ' HZ2' ' A' ' 65' ' ' LYS . 2.8 mm? . . . . . 0 C--O 1.245 0.837 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.611 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -108.7 144.54 36.36 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 122.511 0.324 . . . . 0.0 110.57 -173.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.5 p -147.17 141.59 20.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.808 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.2 ttm -101.75 112.72 25.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.83 0.348 . . . . 0.0 110.268 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.458 HG13 HD12 ' A' ' 48' ' ' LEU . 41.0 mm -95.61 124.48 48.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.426 ' HB2' ' OG ' ' A' ' 13' ' ' SER . 97.4 mtt180 -97.39 118.32 33.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.148 0.499 . . . . 0.0 110.838 -175.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.54 ' HB3' ' HZ3' ' A' ' 7' ' ' LYS . 3.0 mmmp? -98.38 116.51 30.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.746 177.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.1 p -134.34 161.82 33.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.27 113.12 1.8 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.807 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.8 p 52.85 23.03 2.59 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.575 0.75 . . . . 0.0 111.688 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.85 134.84 7.84 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -133.81 117.9 17.4 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -178.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.426 ' OG ' ' HB2' ' A' ' 6' ' ' ARG . 15.3 p -135.88 161.8 34.61 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.516 ' HB1' HD12 ' A' ' 40' ' ' LEU . . . -146.24 146.24 30.69 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.66 -0.246 . . . . 0.0 110.523 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -129.7 110.25 11.63 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.94 0.4 . . . . 0.0 111.019 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.538 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 56.4 t -87.92 96.29 5.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 172.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.07 -37.88 84.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.251 -171.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.64 -22.76 66.68 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.621 0.248 . . . . 0.0 111.453 -174.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.469 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 6.4 tmtm? -119.36 -2.73 10.56 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.669 0.271 . . . . 0.0 110.586 -178.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 64.04 27.72 14.24 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.687 -177.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.538 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 54.2 tp -84.01 111.46 19.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.244 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -123.7 113.15 18.24 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -148.18 162.83 38.66 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.839 0.352 . . . . 0.0 110.825 -173.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.7 mt -84.14 151.63 24.78 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.332 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 78.6 mt -92.2 101.21 12.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.668 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.428 HG12 ' HB1' ' A' ' 41' ' ' ALA . 16.3 m -83.87 -37.34 13.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.934 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.537 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 47.2 mt-10 -125.26 139.96 53.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.021 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 16.1 ptt? -151.2 156.74 41.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.876 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.461 ' OE1' ' HG3' ' A' ' 37' ' ' LYS . 8.8 tp10 -67.1 -37.48 83.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.079 0.466 . . . . 0.0 111.273 -176.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -117.74 137.02 23.89 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.073 -172.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -47.61 -31.43 14.13 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.495 2.797 . . . . 0.0 112.099 175.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.16 -61.71 1.89 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.552 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 172.42 -67.25 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.973 0.796 . . . . 0.0 110.755 175.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.515 ' HZ3' HG21 ' A' ' 61' ' ' VAL . 44.4 m95 -74.06 133.38 42.89 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.461 -171.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.83 -56.63 0.05 OUTLIER Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.201 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.67 -67.3 0.01 OUTLIER Glycine 0 C--N 1.334 0.446 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.524 -174.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.461 ' HG3' ' OE1' ' A' ' 29' ' ' GLU . 1.9 pptp? -134.62 168.73 18.46 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.029 0.442 . . . . 0.0 111.152 175.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 46' ' ' LEU . 14.0 p -146.97 160.67 9.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.479 -177.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.537 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 33.0 m -138.89 126.3 21.68 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.83 0.348 . . . . 0.0 110.355 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.516 HD12 ' HB1' ' A' ' 14' ' ' ALA . 2.9 mm? -78.77 159.12 28.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.168 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.428 ' HB1' HG12 ' A' ' 26' ' ' VAL . . . -65.13 -12.06 46.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.087 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -85.3 2.78 42.6 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.48 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.26 -8.79 79.07 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.197 -0.525 . . . . 0.0 113.553 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 18.0 m0 -85.52 142.83 28.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.1 0.476 . . . . 0.0 111.274 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -101.69 159.8 15.01 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.756 -176.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.402 ' O ' HG13 ' A' ' 38' ' ' VAL . 3.2 tm? -159.37 136.33 9.53 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -176.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -82.84 122.8 28.69 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 122.247 -0.283 . . . . 0.0 110.28 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.458 HD12 HG13 ' A' ' 5' ' ' ILE . 22.7 tp -115.53 112.78 43.18 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.123 -174.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.415 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 60.0 Cg_endo -68.73 158.03 59.45 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.26 1.973 . . . . 0.0 111.961 -175.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.94 76.91 3.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.093 0.473 . . . . 0.0 110.514 178.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.443 ' HA ' ' HE2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -91.75 -164.8 1.23 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.627 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.3 109.66 17.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.743 0.306 . . . . 0.0 110.962 -178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.79 -7.49 54.57 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.714 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -60.86 -25.68 66.83 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.793 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.2 p -57.02 117.52 18.29 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.924 -176.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -92.14 10.88 2.41 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.145 2.563 . . . . 0.0 111.682 174.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 pp -139.5 160.85 59.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.212 -175.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -62.98 135.71 52.9 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.53 2.153 . . . . 0.0 112.726 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.9 tt -130.54 140.15 49.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.022 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.3 m -100.85 119.05 38.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.895 0.378 . . . . 0.0 110.786 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.515 HG21 ' HZ3' ' A' ' 34' ' ' TRP . 35.4 m -122.5 170.67 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.721 178.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 1' ' ' MET . 10.2 mt-10 -82.85 157.12 23.25 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 171.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -149.23 164.37 34.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.23 0.538 . . . . 0.0 111.923 -172.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.614 ' HG3' HH11 ' A' ' 64' ' ' ARG . 11.3 mmt85 -116.62 125.71 52.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.655 175.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -82.22 108.69 15.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.99 0.424 . . . . 0.0 110.354 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 78.0 mt . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.417 -0.802 . . . . 0.0 109.673 178.753 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.403 ' HZ3' HG23 ' A' ' 60' ' ' THR . 52.1 tptt -88.8 114.73 25.74 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.328 -172.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.506 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 9.5 p -147.38 141.98 19.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.092 174.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.448 ' SD ' ' HB2' ' A' ' 58' ' ' PRO . 51.0 ttm -117.18 120.28 37.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.676 0.274 . . . . 0.0 110.319 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.4 mm -88.62 115.1 28.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -111.03 118.97 37.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.784 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.458 ' O ' ' HD3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -127.74 138.44 52.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.023 0.44 . . . . 0.0 110.986 179.036 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.64 HG22 ' H ' ' A' ' 9' ' ' ALA . 3.0 m -147.19 -179.02 6.54 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.64 ' H ' HG22 ' A' ' 8' ' ' THR . . . -49.54 107.17 0.13 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 117.826 0.285 . . . . 0.0 110.729 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.2 p 67.79 -41.02 0.42 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.787 1.235 . . . . 0.0 112.746 -177.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.69 110.78 3.14 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.318 -0.467 . . . . 0.0 112.71 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -118.42 128.88 55.04 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.6 p -143.9 155.4 44.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.877 0.37 . . . . 0.0 110.648 -178.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.433 ' HB2' HD13 ' A' ' 40' ' ' LEU . . . -128.49 115.57 18.36 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -90.37 103.91 16.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.871 -176.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.1 t -80.25 99.59 4.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.39 175.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.28 -53.85 44.87 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -172.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -11.73 31.06 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -174.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -118.3 -8.98 10.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.723 0.297 . . . . 0.0 110.526 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.4 t70 57.65 26.65 13.19 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 122.032 0.92 . . . . 0.0 109.593 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.1 tt -86.98 123.54 32.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.127 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -133.16 104.48 6.52 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 171.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.32 165.16 19.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.904 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.7 mt -79.69 132.99 36.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.844 0.354 . . . . 0.0 110.63 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.431 HD12 HD11 ' A' ' 33' ' ' LEU . 69.5 mt -71.37 105.33 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.776 174.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.41 HG22 ' HG2' ' A' ' 27' ' ' GLU . 10.9 m -81.42 -49.25 18.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.173 -177.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.56 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 58.1 mm-40 -106.76 140.95 38.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.916 -177.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 59.5 mtt -132.96 156.73 46.75 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.408 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 10.6 tp10 -65.35 -49.13 70.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.551 0.691 . . . . 0.0 109.336 172.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -127.43 148.34 66.02 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.877 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.05 -23.08 11.68 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.337 2.691 . . . . 0.0 113.742 -174.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -71.25 -66.44 0.62 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.696 0.284 . . . . 0.0 110.547 176.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 18.7 tp 170.2 -70.48 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.008 -175.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 46.4 m95 -76.29 153.61 35.78 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.023 -176.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.485 ' HA2' ' HB1' ' A' ' 50' ' ' ALA . . . 159.62 -33.21 0.45 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.477 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.21 -78.24 0.05 OUTLIER Glycine 0 C--O 1.226 -0.393 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.421 ' HD3' ' C ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -129.73 161.3 30.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.919 0.39 . . . . 0.0 110.937 178.296 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.7 m -140.01 167.59 18.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 171.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.56 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 17.7 m -135.78 125.77 25.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.9 0.381 . . . . 0.0 110.671 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.433 HD13 ' HB2' ' A' ' 14' ' ' ALA . 3.7 mm? -77.88 161.45 27.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.558 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.8 -19.69 60.03 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.187 0.518 . . . . 0.0 110.395 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -63.08 -23.25 67.36 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.407 175.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.36 12.3 57.42 Favored Glycine 0 C--N 1.332 0.36 0 N-CA-C 111.621 -0.592 . . . . 0.0 111.621 -176.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.683 ' HZ2' ' HE2' ' A' ' 65' ' ' LYS . 45.8 t-105 -106.76 140.08 40.17 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 -178.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -94.41 149.04 21.63 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.954 -177.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.497 HD21 ' HB2' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -142.9 131.81 22.88 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.194 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 42.2 tt0 -89.9 120.88 31.5 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.79 0.329 . . . . 0.0 111.205 -175.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -121.03 113.32 32.85 Favored Pre-proline 0 C--O 1.235 0.332 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.371 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.51 152.89 79.83 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.384 2.056 . . . . 0.0 111.573 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.485 ' HB1' ' HA2' ' A' ' 35' ' ' GLY . . . -71.38 75.58 0.75 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.031 0.443 . . . . 0.0 110.434 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.6 mmt -87.99 -74.37 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.389 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.99 110.03 1.85 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.545 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.2 -30.87 70.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.238 0.542 . . . . 0.0 109.628 175.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -73.36 86.77 1.5 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.447 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.432 HG23 ' HB ' ' A' ' 59' ' ' ILE . 32.1 m -139.02 109.02 7.61 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.596 177.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -83.6 14.56 2.35 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.037 2.491 . . . . 0.0 113.22 -176.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.6 pp -145.66 159.98 45.87 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.648 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.448 ' HB2' ' SD ' ' A' ' 4' ' ' MET . 37.9 Cg_endo -66.62 106.27 1.05 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.258 1.972 . . . . 0.0 111.328 175.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.432 ' HB ' HG23 ' A' ' 55' ' ' THR . 8.7 tt -89.45 146.73 5.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.113 -174.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.403 HG23 ' HZ3' ' A' ' 2' ' ' LYS . 20.1 m -110.84 132.71 53.97 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.275 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.4 m -139.82 177.14 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 122.419 0.288 . . . . 0.0 110.505 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -86.01 118.17 25.31 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.224 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.506 ' HB1' ' HB ' ' A' ' 3' ' ' VAL . . . -70.28 109.83 4.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.945 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.544 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 1.4 tmm_? -93.59 101.73 13.9 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 174.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.683 ' HE2' ' HZ2' ' A' ' 44' ' ' TRP . 45.3 tttm -73.15 129.7 38.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.166 -176.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 66' ' ' LEU . 5.8 mp . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.553 -0.736 . . . . 0.0 109.485 176.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -101.61 121.56 42.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.008 -173.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.6 p -137.4 129.52 41.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 173.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.448 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 52.9 ttm -101.06 115.06 29.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.656 -175.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.1 mm -96.28 116.36 38.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.0 mtt85 -97.68 126.12 42.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.209 0.528 . . . . 0.0 110.853 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.585 ' HD3' ' HG ' ' A' ' 33' ' ' LEU . 16.1 mmmt -119.78 115.37 23.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.006 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.2 t -135.82 -167.46 2.04 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 175.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.21 -74.11 0.04 OUTLIER 'General case' 0 C--O 1.235 0.298 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -174.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.6 p -112.11 -28.51 7.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.985 0.421 . . . . 0.0 110.795 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.02 138.69 27.2 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.6 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -141.6 121.69 13.78 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 175.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.4 p -140.45 158.87 43.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.865 0.364 . . . . 0.0 111.277 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.477 ' HB3' HD13 ' A' ' 40' ' ' LEU . . . -131.05 137.88 49.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.792 176.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.448 ' HB3' ' HB3' ' A' ' 4' ' ' MET . 40.1 t80 -119.17 104.64 10.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.956 0.407 . . . . 0.0 111.207 -177.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 59.7 t -79.83 97.37 2.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.564 174.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.13 -40.64 77.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.778 -172.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.43 ' HE2' ' HB2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -69.32 -11.96 61.25 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -171.701 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -133.98 0.47 3.18 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.777 0.322 . . . . 0.0 111.008 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 59.32 24.06 12.56 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.782 -177.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.487 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 41.9 tp -83.07 108.26 16.23 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.17 -178.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -121.87 126.72 49.36 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.452 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 10.7 tp10 -147.61 162.63 38.74 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.556 -175.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.3 mt -78.29 139.59 38.86 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.576 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.67 HG23 ' HE2' ' A' ' 28' ' ' MET . 79.9 mt -82.16 104.84 11.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.852 176.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.6 m -94.84 -37.59 8.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 111.674 0.249 . . . . 0.0 111.674 -177.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.589 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 34.5 tt0 -127.95 134.39 49.3 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -176.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.67 ' HE2' HG23 ' A' ' 25' ' ' ILE . 0.9 OUTLIER -122.87 160.87 25.19 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.516 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -66.73 -49.06 67.21 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -106.88 142.92 26.01 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 173.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -54.91 -21.94 28.27 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.019 2.48 . . . . 0.0 113.135 -174.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.11 -71.83 0.2 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.623 0.249 . . . . 0.0 110.669 177.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.585 ' HG ' ' HD3' ' A' ' 7' ' ' LYS . 1.1 tm? -179.45 -63.23 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -178.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.407 ' HA ' HD21 ' A' ' 48' ' ' LEU . 58.1 m95 -83.57 165.28 19.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.464 -177.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 159.22 -70.39 0.24 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.718 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -147.57 -48.36 0.03 OUTLIER Glycine 0 C--N 1.33 0.198 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.138 -175.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.01 164.51 30.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.84 0.353 . . . . 0.0 110.315 178.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.8 p -143.41 137.24 25.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.725 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.589 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 30.5 m -112.31 116.12 29.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.81 0.338 . . . . 0.0 110.751 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.477 HD13 ' HB3' ' A' ' 14' ' ' ALA . 2.9 mm? -75.29 154.97 37.13 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.985 173.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.11 -16.5 52.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.079 0.466 . . . . 0.0 111.436 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -82.5 3.28 29.0 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.814 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.25 31.77 45.79 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.731 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 19.6 t-105 -113.7 113.91 25.65 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -98.93 121.08 40.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.276 0.56 . . . . 0.0 110.807 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.6 tp -110.62 147.85 33.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.026 178.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 35.6 tt0 -84.95 115.66 22.93 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.407 HD21 ' HA ' ' A' ' 34' ' ' TRP . 15.0 tp -112.54 116.68 48.04 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.631 -171.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.18 155.84 58.98 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.5 2.133 . . . . 0.0 112.27 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.09 79.6 5.49 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.955 0.407 . . . . 0.0 111.011 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.1 mmt -98.41 -169.16 1.76 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.122 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.37 116.79 2.62 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.971 178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.62 -46.69 28.88 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.75 0.657 . . . . 0.0 111.722 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.494 ' HA ' ' HE2' ' A' ' 7' ' ' LYS . 30.2 m-20 -116.37 79.47 1.32 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.085 0.469 . . . . 0.0 110.269 178.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.4 m -62.98 121.88 71.53 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.688 175.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.15 2.38 6.77 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.673 2.249 . . . . 0.0 113.184 -174.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 pp -151.86 156.88 34.47 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.631 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.21 110.24 1.95 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.462 2.108 . . . . 0.0 111.008 174.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.7 tt -105.36 137.18 36.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.101 0.476 . . . . 0.0 111.003 -175.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.9 m -95.81 118.84 33.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.303 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.9 178.11 2.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.832 -177.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -76.37 149.06 37.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.202 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.18 156.8 17.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.105 0.478 . . . . 0.0 111.47 -177.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.542 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -162.21 105.69 1.16 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.963 174.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -73.9 141.05 46.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.804 0.335 . . . . 0.0 111.118 -177.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.43 HD23 ' HB2' ' A' ' 47' ' ' GLU . 70.6 mt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.818 -0.61 . . . . 0.0 109.43 175.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptt? . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 121.286 0.565 . . . . 0.0 110.005 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.411 ' HG3' ' HB2' ' A' ' 17' ' ' ALA . 23.9 tptm -94.21 110.64 22.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.277 -169.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.471 HG22 ' HA ' ' A' ' 16' ' ' VAL . 11.7 p -146.98 141.67 20.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.051 174.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 47.5 ttp -125.05 129.02 49.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.49 -177.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.9 mm -96.94 123.81 49.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.635 ' HD3' ' HB3' ' A' ' 58' ' ' PRO . 22.2 mmt85 -99.1 131.53 45.07 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.205 0.526 . . . . 0.0 111.416 -177.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.417 ' NZ ' ' O ' ' A' ' 55' ' ' THR . 10.2 mmmm -93.55 120.25 33.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.968 176.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.5 p -123.32 146.43 47.93 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.75 -37.66 82.58 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.028 0.442 . . . . 0.0 110.514 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.6 m -110.27 76.27 0.98 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.076 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.54 -160.05 13.53 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.434 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -138.96 146.24 40.74 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.5 m -136.9 143.82 43.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.495 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -123.84 132.32 53.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.771 0.32 . . . . 0.0 110.151 177.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -104.93 102.39 11.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.158 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.471 ' HA ' HG22 ' A' ' 3' ' ' VAL . 47.8 t -76.36 90.75 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.295 174.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.411 ' HB2' ' HG3' ' A' ' 2' ' ' LYS . . . -62.48 -32.89 73.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.143 -172.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.784 ' HZ3' ' HB2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -69.05 -1.59 7.95 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.778 -0.192 . . . . 0.0 111.487 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -136.84 -1.74 2.19 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.342 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 56.49 29.9 16.19 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.053 0.454 . . . . 0.0 110.752 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.3 tp -98.12 117.21 31.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.874 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -109.33 125.08 51.96 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 169.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 8.0 tp10 -143.91 160.6 40.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.934 0.397 . . . . 0.0 110.767 -177.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.5 mt -76.45 134.79 39.45 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.231 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.438 HG22 HG12 ' A' ' 38' ' ' VAL . 64.5 mt -81.0 91.6 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.8 m -78.72 -32.78 16.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.79 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.561 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 8.5 tp10 -129.37 141.34 51.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.207 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.15 157.81 42.05 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.3 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -65.19 -67.03 0.47 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.776 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.473 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 56.5 t30 -90.39 130.98 39.72 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.839 -175.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.473 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 1.6 Cg_endo -40.55 -35.02 1.33 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.462 3.441 . . . . 0.0 113.567 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -67.91 -65.78 0.65 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.785 0.326 . . . . 0.0 110.535 176.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 29.6 tp 174.57 -69.21 0.01 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.161 -175.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.506 ' HE3' ' O ' ' A' ' 49' ' ' PRO . 49.1 m95 -75.26 130.9 39.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.407 -177.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.426 ' HA2' ' HB1' ' A' ' 50' ' ' ALA . . . -168.09 -57.44 0.03 OUTLIER Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.293 -178.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.37 -68.02 0.07 OUTLIER Glycine 0 C--O 1.225 -0.458 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 -177.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -101.3 146.57 27.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.648 0.261 . . . . 0.0 110.321 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.438 HG12 HG22 ' A' ' 25' ' ' ILE . 17.2 t -147.15 153.13 12.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 43.2 m -142.8 131.21 22.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.069 0.461 . . . . 0.0 111.025 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.495 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.2 mm? -86.21 165.33 16.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.622 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.32 -20.76 65.77 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.142 0.496 . . . . 0.0 110.908 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.408 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 8.0 t30 -77.34 -9.35 58.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.47 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.62 -10.61 68.77 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 121.252 -0.499 . . . . 0.0 111.992 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 27.1 t-105 -64.64 123.38 19.15 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.448 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 43.8 mt-30 -98.62 126.96 44.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.889 0.376 . . . . 0.0 110.378 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.7 tp -123.64 139.03 54.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.538 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 21.0 tt0 -95.67 101.97 13.72 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -178.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.7 tp -101.5 104.33 33.39 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.543 -173.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.506 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 59.2 Cg_endo -70.62 136.26 30.31 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.441 2.094 . . . . 0.0 111.639 -175.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.426 ' HB1' ' HA2' ' A' ' 35' ' ' GLY . . . -64.69 80.44 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.957 0.408 . . . . 0.0 111.578 -177.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.3 mmt -86.65 -59.87 2.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.282 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.45 116.96 5.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.775 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.74 -54.77 33.45 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.617 0.573 . . . . 0.0 111.516 -174.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -103.98 91.43 3.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.985 0.421 . . . . 0.0 110.295 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.417 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . 1.9 m -73.22 128.61 87.33 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.187 177.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.55 -44.09 11.96 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.403 2.069 . . . . 0.0 112.502 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.566 ' HB2' ' HD2' ' A' ' 58' ' ' PRO . 2.7 pp -132.56 165.99 32.26 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.405 -177.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.635 ' HB3' ' HD3' ' A' ' 6' ' ' ARG . 29.3 Cg_endo -60.73 110.23 0.79 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.382 2.054 . . . . 0.0 111.737 177.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.9 tt -101.63 147.81 8.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.019 -176.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 87.5 m -101.73 120.13 39.87 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.156 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.1 m -120.38 178.55 2.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.161 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.66 123.17 21.25 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.519 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.46 110.2 14.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.086 0.47 . . . . 0.0 110.782 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.409 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 3.5 tpm_? -122.14 105.16 10.01 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.203 176.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -83.58 151.28 25.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.893 0.378 . . . . 0.0 110.78 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 7.1 mp . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.331 -0.842 . . . . 0.0 109.34 174.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.738 ' SD ' ' HD3' ' A' ' 18' ' ' LYS . 24.2 ttt . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.453 ' HG3' HG23 ' A' ' 60' ' ' THR . 39.8 tttm -71.41 115.15 10.24 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.58 0.752 . . . . 0.0 110.678 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.528 HG21 ' HA ' ' A' ' 16' ' ' VAL . 8.2 p -134.24 136.31 53.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.954 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.7 ttm -104.28 116.53 32.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.967 0.413 . . . . 0.0 111.233 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.514 HG13 HD11 ' A' ' 48' ' ' LEU . 45.2 mm -91.18 115.55 30.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.489 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 74.3 mtp180 -97.46 118.78 34.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.127 0.489 . . . . 0.0 110.952 -171.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -100.03 116.59 32.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.857 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 t -149.16 -177.58 5.9 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.27 104.59 0.15 Allowed 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.386 0.429 . . . . 0.0 111.608 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.1 p 67.75 -52.96 0.51 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.005 1.322 . . . . 0.0 113.504 177.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.95 81.81 0.54 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.451 -0.404 . . . . 0.0 113.23 -174.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.413 ' HB3' HD12 ' A' ' 33' ' ' LEU . 61.2 m80 -70.84 110.42 5.59 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m -114.66 151.9 32.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.936 0.398 . . . . 0.0 111.546 -170.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.444 ' HB2' HD21 ' A' ' 40' ' ' LEU . . . -124.35 118.57 27.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.66 175.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -106.11 106.91 17.64 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.044 0.449 . . . . 0.0 110.912 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.528 ' HA ' HG21 ' A' ' 3' ' ' VAL . 29.9 t -93.71 96.51 6.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.666 176.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.82 -45.55 86.0 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.348 -173.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.738 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 49.2 pttt -63.79 -35.22 79.9 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.732 0.301 . . . . 0.0 111.054 -177.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.604 ' HZ2' HD11 ' A' ' 21' ' ' LEU . 48.0 tttm -90.42 -9.97 45.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.882 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 62.07 20.51 11.68 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.042 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.604 HD11 ' HZ2' ' A' ' 19' ' ' LYS . 4.2 tt -106.23 128.8 54.22 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -175.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.484 ' N ' HD22 ' A' ' 21' ' ' LEU . 45.3 tt0 -131.0 113.89 14.53 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 175.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.459 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 7.7 tp10 -136.4 160.36 38.99 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.941 0.401 . . . . 0.0 111.014 -175.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.2 mt -79.4 143.49 35.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.763 175.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 68.6 mt -90.0 123.13 42.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.2 m -110.59 -27.42 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -176.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.58 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 52.5 mm-40 -129.85 100.56 5.52 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.765 0.317 . . . . 0.0 110.988 -176.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.546 ' SD ' ' N ' ' A' ' 28' ' ' MET . 1.0 OUTLIER -99.97 155.37 17.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.399 -178.546 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -67.99 -53.54 25.22 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 170.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.519 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 59.3 t30 -97.42 131.16 27.77 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.042 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.519 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 2.8 Cg_endo -42.06 -39.98 6.07 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 124.185 3.257 . . . . 0.0 113.182 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.52 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -69.16 -66.39 0.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.462 177.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' A' ' 12' ' ' HIS . 4.5 mt 178.7 -72.63 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.255 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.592 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 41.1 m95 -72.66 140.41 47.91 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.053 -173.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.19 -23.83 0.88 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 121.278 -0.487 . . . . 0.0 112.287 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.86 -137.19 3.6 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.968 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.516 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -67.09 146.72 54.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.332 0.587 . . . . 0.0 111.941 -176.427 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.0 m -137.68 136.91 45.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 172.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 26.8 m -111.32 128.55 55.99 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.727 0.298 . . . . 0.0 110.765 -175.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.459 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . 80.6 mt -72.37 157.2 38.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.985 176.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.16 -17.74 58.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.306 0.574 . . . . 0.0 110.582 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -69.61 -28.55 66.03 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.49 176.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.78 -18.84 26.44 Favored Glycine 0 C--N 1.331 0.269 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -175.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.701 ' HZ2' ' HD2' ' A' ' 65' ' ' LYS . 41.2 t-105 -71.0 141.51 50.99 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -114.43 146.48 40.57 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.255 0.55 . . . . 0.0 111.735 -175.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.6 tp -135.3 141.9 45.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.659 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.579 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 38.5 tt0 -92.42 105.63 17.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.187 0.518 . . . . 0.0 110.049 -178.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.514 HD11 HG13 ' A' ' 5' ' ' ILE . 18.9 tp -83.22 126.44 72.05 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.537 -174.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.42 ' HB2' ' HE1' ' A' ' 51' ' ' MET . 75.2 Cg_exo -51.83 145.15 32.76 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.0 2.466 . . . . 0.0 113.203 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.7 88.2 7.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.967 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.42 ' HE1' ' HB2' ' A' ' 49' ' ' PRO . 23.5 ptp -135.37 -152.39 0.46 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.439 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.54 112.47 0.6 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.656 0.265 . . . . 0.0 110.562 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.592 ' HA ' ' HB2' ' A' ' 34' ' ' TRP . . . -63.91 -27.19 68.98 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.161 -173.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -135.66 93.51 2.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.148 0.499 . . . . 0.0 110.644 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.0 p -79.67 129.84 69.78 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.672 174.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.04 -8.43 23.58 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.398 2.065 . . . . 0.0 111.936 -178.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.2 pp -138.23 158.08 71.54 Favored Pre-proline 0 C--O 1.236 0.376 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.456 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.489 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . 38.2 Cg_endo -66.19 136.13 42.89 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.437 2.091 . . . . 0.0 111.058 174.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.5 tt -136.78 144.31 32.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.877 0.37 . . . . 0.0 110.944 -174.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.453 HG23 ' HG3' ' A' ' 2' ' ' LYS . 63.7 m -98.11 130.77 44.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.145 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 3' ' ' VAL . 26.3 m -140.14 179.41 2.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 120.968 0.413 . . . . 0.0 111.599 -174.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -64.03 138.67 58.57 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.212 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.434 ' HB3' ' HB ' ' A' ' 3' ' ' VAL . . . -108.37 123.41 48.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.022 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.579 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -122.89 102.04 7.79 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 175.047 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.701 ' HD2' ' HZ2' ' A' ' 44' ' ' TRP . 28.2 ttpt -65.16 145.3 56.45 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.691 -176.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.451 HD22 ' HB2' ' A' ' 47' ' ' GLU . 91.3 mt . . . . . 0 C--O 1.253 1.253 0 CA-C-O 118.821 -0.609 . . . . 0.0 109.847 175.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.671 ' SD ' ' NH1' ' A' ' 64' ' ' ARG . 59.1 mtt . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -114.32 115.33 27.21 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.99 -173.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.1 p -137.72 127.83 36.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.04 0.448 . . . . 0.0 110.002 174.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.459 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 23.2 ttt -101.71 111.87 24.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.349 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.1 mm -77.21 117.61 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -96.38 118.53 33.09 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.317 -172.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.448 ' NZ ' ' O ' ' A' ' 54' ' ' ASP . 14.3 mmmm -106.08 118.43 36.59 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.05 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 72.5 m -142.23 157.3 45.0 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.65 107.26 0.11 Allowed 'General case' 0 C--O 1.233 0.233 0 O-C-N 123.094 0.247 . . . . 0.0 110.675 178.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.5 p 66.92 -41.38 0.4 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.272 1.429 . . . . 0.0 112.916 -176.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.07 105.31 1.6 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.321 -0.466 . . . . 0.0 112.682 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -104.61 121.88 44.46 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 175.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.409 ' HB3' HD22 ' A' ' 24' ' ' LEU . 33.7 p -138.68 160.8 38.75 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.761 0.315 . . . . 0.0 110.177 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.495 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -128.0 115.81 19.07 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -87.22 103.19 15.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.59 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.1 t -74.34 89.04 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.207 175.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.3 -34.61 70.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.147 -172.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.43 -12.27 59.84 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -177.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.408 ' O ' ' HG2' ' A' ' 19' ' ' LYS . 39.1 tttm -127.2 -7.82 5.9 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.484 0.183 . . . . 0.0 110.973 178.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.3 t70 67.94 17.21 9.62 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.758 0.79 . . . . 0.0 110.332 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.45 HD22 ' HG2' ' A' ' 23' ' ' GLU . 7.6 tt -88.42 134.71 33.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.192 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -134.09 111.04 10.02 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 173.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.544 ' HB2' ' HB3' ' A' ' 40' ' ' LEU . 78.1 mm-40 -116.61 160.14 21.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.27 177.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.409 HD22 ' HB3' ' A' ' 13' ' ' SER . 83.1 mt -76.95 136.2 38.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.549 175.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.623 HG22 ' HE1' ' A' ' 28' ' ' MET . 85.9 mt -71.96 107.26 2.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.035 175.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.0 m -94.79 -22.77 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.179 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.565 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 32.7 tt0 -142.45 142.57 32.35 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.097 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.623 ' HE1' HG22 ' A' ' 25' ' ' ILE . 1.0 OUTLIER -123.72 177.24 5.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.096 -177.005 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.451 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 8.2 tp10 -84.2 -56.79 3.47 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 168.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.6 t-20 -95.59 137.63 21.93 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.819 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -44.64 -22.59 0.65 Allowed 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.642 2.895 . . . . 0.0 113.076 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.22 -69.25 0.62 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.169 173.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.4 tp -177.94 -75.55 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.922 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.475 ' HE3' ' O ' ' A' ' 49' ' ' PRO . 29.4 m95 -72.11 137.42 47.03 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.659 -176.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.506 ' HA2' ' HB3' ' A' ' 50' ' ' ALA . . . -179.67 -40.45 0.07 OUTLIER Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.419 -0.895 . . . . 0.0 113.356 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.49 -71.43 0.05 OUTLIER Glycine 0 C--O 1.225 -0.419 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.959 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.451 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -120.28 164.54 16.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.0 0.429 . . . . 0.0 111.143 176.348 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 46' ' ' LEU . 14.8 p -147.34 147.02 17.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 45.7 m -121.45 133.03 55.05 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.257 0.551 . . . . 0.0 111.126 -177.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.544 ' HB3' ' HB2' ' A' ' 23' ' ' GLU . 3.6 mm? -92.28 155.92 17.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.886 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.57 -34.68 51.64 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -90.03 -1.62 57.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.881 0.372 . . . . 0.0 111.442 -171.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.94 -27.61 8.15 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.518 174.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -59.4 140.23 56.34 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.872 0.336 . . . . 0.0 110.6 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.428 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 46.2 mt-30 -122.13 144.15 49.11 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.524 HD11 ' N ' ' A' ' 47' ' ' GLU . 1.6 tm? -133.67 140.49 47.09 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -176.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.524 ' N ' HD11 ' A' ' 46' ' ' LEU . 38.0 tt0 -81.69 112.13 18.59 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.9 tp -110.97 95.18 23.08 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.27 -175.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.475 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 21.7 Cg_exo -65.46 151.28 85.43 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.782 2.321 . . . . 0.0 112.298 -175.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.506 ' HB3' ' HA2' ' A' ' 35' ' ' GLY . . . -74.74 81.34 2.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.98 0.419 . . . . 0.0 110.491 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.2 mmt -95.08 -63.72 1.14 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.201 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.446 ' HB3' HG23 ' A' ' 55' ' ' THR . . . -144.73 112.67 6.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.003 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.12 99.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.5 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.448 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . 6.7 p-10 -70.74 -54.99 9.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.395 -176.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.446 HG23 ' HB3' ' A' ' 52' ' ' ALA . 1.2 p 41.63 88.38 0.1 Allowed Pre-proline 0 N--CA 1.471 0.6 0 C-N-CA 123.11 0.564 . . . . 0.0 112.0 -177.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.55 -20.94 30.47 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.783 2.322 . . . . 0.0 112.956 -173.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.4 pp -125.97 153.93 73.79 Favored Pre-proline 0 C--O 1.236 0.35 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.63 -177.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.67 94.7 0.39 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.511 2.141 . . . . 0.0 111.693 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.7 tt -89.19 143.36 11.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.968 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 4' ' ' MET . 28.0 m -97.76 130.6 44.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.917 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.7 m -126.57 177.05 5.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 121.028 0.442 . . . . 0.0 111.194 -177.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -78.11 125.18 28.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.249 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.17 122.95 28.01 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -173.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.671 ' NH1' ' SD ' ' A' ' 1' ' ' MET . 4.6 mpt_? -118.48 100.53 7.52 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 168.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -74.78 131.8 41.09 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 82.7 mt . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.554 -0.736 . . . . 0.0 109.698 178.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 49.0 ttm . . . . . 0 N--CA 1.484 1.229 0 CA-C-O 120.773 0.32 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -109.13 133.23 53.28 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 120.803 0.335 . . . . 0.0 111.416 -176.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.513 ' HB ' ' HB3' ' A' ' 63' ' ' ALA . 14.5 p -144.0 134.25 20.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.747 174.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.5 ttp -103.54 114.02 27.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.778 0.323 . . . . 0.0 110.224 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.4 mm -90.15 116.66 31.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.072 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -94.13 147.46 23.13 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.035 0.445 . . . . 0.0 110.198 -175.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 55' ' ' THR . 36.4 mmtm -121.3 151.58 39.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.446 -176.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.44 HG22 ' N ' ' A' ' 9' ' ' ALA . 59.9 m -159.59 164.01 34.57 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.44 ' N ' HG22 ' A' ' 8' ' ' THR . . . -39.37 -42.75 1.1 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.881 0.472 . . . . 0.0 112.002 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.6 t -146.75 -32.66 0.31 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.763 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.97 75.75 0.74 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.312 -0.471 . . . . 0.0 112.999 -177.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -68.33 138.0 55.08 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.8 p -145.08 162.8 36.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.697 0.284 . . . . 0.0 110.955 -178.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.483 ' HB1' HD11 ' A' ' 40' ' ' LEU . . . -139.61 143.88 37.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.655 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 59.7 t80 -126.37 112.44 15.66 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.0 t -85.6 123.01 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.281 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.49 -70.58 0.12 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.86 -15.88 60.0 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -172.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.764 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 57.9 tptt -101.41 -15.63 17.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.494 0.187 . . . . 0.0 110.712 -177.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 58.91 25.0 13.15 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.382 0.61 . . . . 0.0 110.188 -177.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.764 ' HB2' ' HG3' ' A' ' 19' ' ' LYS . 7.0 tt -90.96 124.33 35.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.181 -173.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -128.25 109.19 11.24 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -133.23 161.03 35.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.093 -176.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.4 mt -77.83 146.53 35.67 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.564 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.462 HG21 ' HE3' ' A' ' 28' ' ' MET . 72.2 mt -88.79 112.79 24.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.707 177.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.5 m -101.5 -37.46 5.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 116.805 -0.18 . . . . 0.0 111.482 -178.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.459 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 39.1 tt0 -127.43 119.5 26.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.896 0.379 . . . . 0.0 110.642 -178.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.517 ' SD ' ' N ' ' A' ' 28' ' ' MET . 1.2 mpt? -103.43 158.13 16.55 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 9.0 tp10 -60.12 -58.7 7.42 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.132 0.492 . . . . 0.0 109.924 174.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.461 HD21 ' N ' ' A' ' 30' ' ' ASN . 0.9 OUTLIER -96.98 153.4 38.55 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.248 175.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.8 -14.87 23.92 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.711 2.274 . . . . 0.0 112.741 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.82 -69.75 0.59 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.104 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.49 ' HA ' ' HG2' ' A' ' 28' ' ' MET . 1.3 tm? -176.05 -67.89 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -178.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 56.8 m95 -84.24 160.84 20.7 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.551 -177.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 168.89 -57.59 0.2 Allowed Glycine 0 C--N 1.337 0.596 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.338 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.42 -64.12 0.02 OUTLIER Glycine 0 C--N 1.33 0.226 0 C-N-CA 121.295 -0.479 . . . . 0.0 112.118 -175.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 1.7 pptp? -131.27 168.62 17.21 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.786 0.327 . . . . 0.0 110.901 175.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.0 p -147.08 152.35 13.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.589 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.459 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 44.9 m -123.26 127.82 49.11 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 120.982 0.42 . . . . 0.0 110.856 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.483 HD11 ' HB1' ' A' ' 14' ' ' ALA . 3.4 mm? -79.38 159.69 26.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.434 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.87 -29.0 66.66 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.021 -175.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -74.87 -31.68 61.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.891 0.377 . . . . 0.0 110.466 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 128.85 -10.32 6.32 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.494 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.524 ' CE3' HD11 ' A' ' 21' ' ' LEU . 3.2 m-90 -69.9 141.98 53.06 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.142 0.471 . . . . 0.0 110.985 178.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -103.48 137.35 41.68 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.602 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 58.3 tp -130.39 141.99 50.53 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 177.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 29.8 tt0 -80.88 122.45 27.24 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.0 tp -114.28 100.18 52.32 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.886 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.429 ' HB2' ' HE3' ' A' ' 51' ' ' MET . 20.9 Cg_endo -58.65 150.78 67.61 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.788 2.326 . . . . 0.0 112.687 -173.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.77 90.49 0.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.547 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.429 ' HE3' ' HB2' ' A' ' 49' ' ' PRO . 26.3 mmt -114.64 -173.09 2.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.427 176.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.62 114.21 2.16 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.672 0.273 . . . . 0.0 110.61 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.81 -50.48 73.82 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.213 -178.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -80.39 76.87 7.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.399 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.492 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 1.4 p -116.01 98.65 51.58 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.736 173.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -77.67 -7.12 16.57 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.65 2.233 . . . . 0.0 112.492 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.444 HD11 ' O ' ' A' ' 57' ' ' LEU . 2.5 pp -102.11 149.67 36.78 Favored Pre-proline 0 C--O 1.239 0.546 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.355 -177.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.57 92.56 0.68 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.54 2.16 . . . . 0.0 111.356 175.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.481 HG23 ' HZ3' ' A' ' 7' ' ' LYS . 8.7 tt -93.62 142.29 13.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.595 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.2 m -100.8 123.11 44.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.189 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.3 m -126.44 178.5 4.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 120.834 0.35 . . . . 0.0 110.736 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 1' ' ' MET . 6.7 mp0 -69.21 149.61 48.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.397 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.513 ' HB3' ' HB ' ' A' ' 3' ' ' VAL . . . -119.5 133.19 55.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.003 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.525 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 14.9 tpt180 -134.89 122.21 21.66 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 174.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -83.17 123.69 29.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.045 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.495 HD12 ' HB2' ' A' ' 47' ' ' GLU . 7.2 mp . . . . . 0 C--O 1.25 1.113 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.488 ' HE3' ' HG2' ' A' ' 18' ' ' LYS . 91.7 mmm . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.574 ' HZ1' ' HB2' ' A' ' 2' ' ' LYS . 4.3 ttmp? -113.25 137.8 50.95 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.618 0.247 . . . . 0.0 111.111 -174.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.457 HG23 ' HA ' ' A' ' 16' ' ' VAL . 14.5 p -145.91 138.78 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.306 175.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 47.0 ttm -111.2 114.79 28.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.301 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.2 mm -86.2 113.52 24.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -104.98 139.19 40.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.246 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -138.41 135.67 35.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.326 178.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.6 m -108.83 -53.8 2.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.366 0.603 . . . . 0.0 109.544 174.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -170.75 -91.03 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.576 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.5 t -76.84 -28.32 55.45 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 168.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.94 98.07 0.77 Allowed Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.798 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -107.5 121.86 45.47 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 175.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.3 p -135.17 161.04 36.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.918 0.389 . . . . 0.0 110.844 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.518 ' HB2' HD12 ' A' ' 40' ' ' LEU . . . -137.19 119.07 15.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.404 178.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -90.06 102.29 15.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.015 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.457 ' HA ' HG23 ' A' ' 3' ' ' VAL . 49.2 t -77.24 90.71 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.59 -31.54 57.11 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.184 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.488 ' HG2' ' HE3' ' A' ' 1' ' ' MET . 48.9 tptt -52.85 -54.64 31.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.136 176.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.552 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 9.3 tmtt? -94.92 -5.04 45.74 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.641 -176.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.7 t70 60.07 27.32 16.75 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 122.139 0.971 . . . . 0.0 109.06 -174.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.41 ' HB2' ' HD2' ' A' ' 19' ' ' LYS . 6.9 tt -106.31 118.5 36.8 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.686 -175.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -108.05 132.54 53.45 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 172.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -144.86 161.53 39.06 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -176.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.9 mt -78.23 140.16 38.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.427 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.671 HG23 ' HE2' ' A' ' 28' ' ' MET . 77.2 mt -84.6 122.86 38.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.036 178.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.9 m -112.3 -35.75 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -174.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.525 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 4.7 tm-20 -129.46 123.78 32.4 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -176.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.671 ' HE2' HG23 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -124.11 140.93 52.5 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.754 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.576 ' HB2' ' HD3' ' A' ' 37' ' ' LYS . 33.0 tt0 -58.22 -36.2 72.8 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.283 0.563 . . . . 0.0 110.362 176.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -109.05 140.36 21.85 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.898 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -49.54 -34.65 34.55 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.225 2.617 . . . . 0.0 112.637 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.78 -68.93 0.5 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.304 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.523 ' HB3' ' HD1' ' A' ' 34' ' ' TRP . 21.2 tp 178.89 -68.46 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.459 -178.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.523 ' HD1' ' HB3' ' A' ' 33' ' ' LEU . 13.6 m95 -78.14 135.23 37.62 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.516 -176.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 50' ' ' ALA . . . -172.17 -48.36 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.434 -177.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.34 -72.91 0.05 OUTLIER Glycine 0 C--O 1.226 -0.383 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -176.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.576 ' HD3' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -123.21 155.34 37.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.979 0.419 . . . . 0.0 111.004 176.456 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 46' ' ' LEU . 8.5 p -146.72 157.09 11.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.45 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 34.9 m -127.03 129.86 48.85 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.087 0.47 . . . . 0.0 111.111 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.518 HD12 ' HB2' ' A' ' 14' ' ' ALA . 3.7 mm? -81.23 163.75 22.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.086 175.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.1 -24.36 66.18 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.898 0.38 . . . . 0.0 111.432 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -83.99 5.59 25.11 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.67 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.34 8.39 87.21 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.589 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.447 ' HE1' HD21 ' A' ' 46' ' ' LEU . 33.3 t-105 -76.65 112.33 13.09 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -88.96 115.86 26.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.992 0.425 . . . . 0.0 110.48 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.49 HD23 ' HB1' ' A' ' 63' ' ' ALA . 2.3 tm? -118.9 136.27 54.14 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -176.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.468 ' N ' HD11 ' A' ' 46' ' ' LEU . 36.8 tt0 -79.8 111.85 16.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 0.0 110.366 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.5 tp -109.35 99.99 39.23 Favored Pre-proline 0 C--O 1.236 0.384 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.953 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.405 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 19.2 Cg_exo -65.36 153.33 78.74 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.612 2.208 . . . . 0.0 112.106 -174.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.433 ' HB3' ' HA2' ' A' ' 35' ' ' GLY . . . -79.53 83.76 5.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.785 0.326 . . . . 0.0 110.141 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 93.2 mmm -113.0 -79.6 0.58 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.309 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -127.84 101.12 6.21 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.481 ' HA ' ' CD1' ' A' ' 34' ' ' TRP . . . -79.14 -50.94 10.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.325 -175.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -95.25 27.07 3.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.929 -173.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.6 t -65.37 134.0 95.56 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -83.56 -1.62 10.2 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.613 2.209 . . . . 0.0 113.591 -175.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.421 HD13 ' O ' ' A' ' 57' ' ' LEU . 3.2 pp -120.9 149.36 50.71 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.441 0.163 . . . . 0.0 111.135 -175.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.35 95.71 0.46 Allowed 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.305 2.003 . . . . 0.0 111.244 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.6 tt -89.21 142.11 13.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.849 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.4 m -101.94 123.17 45.39 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.624 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.3 m -127.69 178.0 5.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.957 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -69.54 149.93 47.68 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.547 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.49 ' HB1' HD23 ' A' ' 46' ' ' LEU . . . -115.56 151.22 35.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.117 -177.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -153.3 121.47 6.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.616 175.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -87.19 121.31 29.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.816 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.419 HD22 ' N ' ' A' ' 66' ' ' LEU . 2.3 mm? . . . . . 0 C--O 1.248 1.026 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 172.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.623 ' SD ' ' HG2' ' A' ' 64' ' ' ARG . 59.9 mtt . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -130.52 111.76 12.57 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -169.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.555 HG12 HD12 ' A' ' 46' ' ' LEU . 7.4 p -142.09 130.45 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 171.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 46.8 ttm -101.06 112.05 24.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.0 mm -86.98 129.49 38.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -96.2 132.35 41.73 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 55' ' ' THR . 0.1 OUTLIER -107.98 116.58 32.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.368 0.604 . . . . 0.0 112.066 -166.038 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 t -177.41 131.35 0.16 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.783 171.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.55 -26.14 68.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.586 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.9 p -103.27 20.66 17.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.548 -176.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.87 49.43 0.12 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.82 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -57.4 123.74 16.51 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.469 ' HB3' HD22 ' A' ' 24' ' ' LEU . 10.7 p -151.03 162.48 40.77 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.367 -0.235 . . . . 0.0 110.367 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.415 ' HB3' HD21 ' A' ' 40' ' ' LEU . . . -145.57 136.11 24.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.233 -177.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -105.12 102.55 12.04 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 174.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.479 ' HA ' HG21 ' A' ' 3' ' ' VAL . 47.1 t -84.44 95.07 3.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.85 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.91 -26.4 64.29 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.562 -176.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -52.97 -39.44 63.0 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 175.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.515 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 2.6 tmtp? -116.05 -6.76 11.95 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 16' ' ' VAL . 19.1 m-20 59.69 26.01 15.05 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.614 -170.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.443 ' HB2' ' HB3' ' A' ' 19' ' ' LYS . 5.1 tt -84.33 125.95 32.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.67 -176.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.43 ' N ' HD22 ' A' ' 21' ' ' LEU . 43.0 tt0 -116.22 120.46 39.04 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.453 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 7.4 tp10 -147.81 161.97 40.18 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.986 0.422 . . . . 0.0 111.184 -176.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.469 HD22 ' HB3' ' A' ' 13' ' ' SER . 96.3 mt -82.05 137.86 34.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.689 174.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.2 mt -83.05 106.33 13.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.458 HG21 ' HG3' ' A' ' 27' ' ' GLU . 16.5 m -81.96 -34.4 12.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.398 -177.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.458 ' HG3' HG21 ' A' ' 26' ' ' VAL . 48.6 mt-10 -132.83 140.16 47.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.334 -177.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.462 ' HG2' ' HA ' ' A' ' 33' ' ' LEU . 2.5 mpp? -126.15 160.0 31.39 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.44 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 14.7 tp10 -64.53 -41.63 96.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.229 0.538 . . . . 0.0 109.702 174.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -118.8 152.2 51.18 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.543 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -49.62 -33.03 29.97 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.161 2.574 . . . . 0.0 113.21 -177.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.36 -68.67 0.48 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.744 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.462 ' HA ' ' HG2' ' A' ' 28' ' ' MET . 3.7 tt -178.39 -71.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.977 0.417 . . . . 0.0 110.227 -178.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.692 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 31.7 m95 -76.65 155.72 33.21 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.27 -173.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 162.34 -42.54 0.36 Allowed Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.836 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.0 -65.61 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.44 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -144.79 167.93 21.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.793 0.33 . . . . 0.0 111.205 178.153 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.4 m -139.41 172.43 12.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.339 174.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.2 m -132.79 122.39 24.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.319 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.545 HD11 ' HB3' ' A' ' 44' ' ' TRP . 85.9 mt -78.17 155.99 30.12 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.159 176.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.16 -9.31 22.04 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.022 0.439 . . . . 0.0 111.308 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.42 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 28.2 t-20 -86.54 -13.13 46.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.251 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.88 -1.32 59.55 Favored Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.785 -176.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.545 ' HB3' HD11 ' A' ' 40' ' ' LEU . 15.3 t-105 -80.16 121.02 25.06 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 178.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -94.84 131.11 41.07 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.555 HD12 HG12 ' A' ' 3' ' ' VAL . 1.0 OUTLIER -122.66 132.38 54.24 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.259 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.555 ' HB3' ' HB2' ' A' ' 64' ' ' ARG . 32.2 tt0 -90.6 122.69 33.62 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.774 0.321 . . . . 0.0 110.87 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.418 HD11 ' CZ3' ' A' ' 34' ' ' TRP . 3.2 mm? -109.6 100.76 43.58 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -65.34 71.22 0.29 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.344 2.696 . . . . 0.0 113.469 -173.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 36.9 89.05 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.375 1.07 . . . . 0.0 113.489 175.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.479 ' HB2' ' CE3' ' A' ' 34' ' ' TRP . 25.2 mmt -129.62 -169.02 2.03 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 174.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.64 108.72 0.37 Allowed 'General case' 0 CA--C 1.532 0.273 0 O-C-N 123.098 0.249 . . . . 0.0 110.794 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.692 ' HA ' ' HB2' ' A' ' 34' ' ' TRP . . . -50.57 -37.06 37.62 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.746 -175.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.428 ' CG ' ' HZ2' ' A' ' 7' ' ' LYS . 18.5 t70 -128.07 70.78 1.36 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 175.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.487 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 3.9 t -57.5 139.9 80.42 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.133 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.57 5.2 4.42 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.825 2.35 . . . . 0.0 113.352 -176.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.413 HD22 ' N ' ' A' ' 57' ' ' LEU . 2.5 pt? -152.07 147.69 20.2 Favored Pre-proline 0 C--O 1.234 0.267 0 O-C-N 122.512 -0.118 . . . . 0.0 110.966 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.99 94.33 0.28 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.622 2.215 . . . . 0.0 110.648 173.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.8 tt -96.35 150.56 4.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.08 0.467 . . . . 0.0 111.741 -172.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 90.3 m -98.93 127.75 44.93 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.14 175.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.408 ' O ' HG11 ' A' ' 3' ' ' VAL . 31.6 m -133.05 179.36 4.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 120.863 0.363 . . . . 0.0 111.02 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -55.97 108.87 0.5 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.042 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.482 ' HB3' ' HB ' ' A' ' 3' ' ' VAL . . . -72.56 109.59 6.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.531 173.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.623 ' HG2' ' SD ' ' A' ' 1' ' ' MET . 91.7 mtt180 -132.81 135.01 45.41 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -108.53 150.58 27.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.02 0.438 . . . . 0.0 110.947 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.7 mt . . . . . 0 C--O 1.252 1.22 0 CA-C-O 118.449 -0.786 . . . . 0.0 109.659 175.02 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.64 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 121.474 0.654 . . . . 0.0 110.748 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -100.84 118.97 37.96 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.469 -175.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.484 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 11.5 p -137.8 132.58 44.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 174.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 57.9 ttp -112.23 117.6 32.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.293 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 58' ' ' PRO . 43.0 mm -87.44 119.38 34.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 176.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 6' ' ' ARG . 41.7 mtm180 -96.28 125.65 40.94 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.948 0.404 . . . . 0.0 110.039 -179.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 55' ' ' THR . 32.3 mmtp -85.65 115.65 23.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.596 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.6 m -159.1 134.01 8.17 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.37 -74.73 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -173.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 42.1 m -74.58 -29.24 61.25 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.918 0.39 . . . . 0.0 110.584 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.06 40.57 2.38 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.144 -0.551 . . . . 0.0 113.674 -174.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -58.81 115.56 3.17 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 172.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.7 p -138.1 151.22 47.59 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.013 0.435 . . . . 0.0 111.364 -174.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -122.5 115.74 22.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.955 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -96.22 103.61 15.52 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.949 0.404 . . . . 0.0 111.166 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.9 t -79.93 101.74 5.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.846 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.13 -37.45 83.85 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -173.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.801 ' HZ1' ' HB2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -68.21 -3.96 12.4 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -175.677 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.681 ' HD2' ' HB2' ' A' ' 21' ' ' LEU . 7.4 tmtm? -131.75 -16.73 2.92 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.038 0.447 . . . . 0.0 109.836 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.6 t70 59.23 60.97 2.19 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.89 0.853 . . . . 0.0 109.265 -170.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.681 ' HB2' ' HD2' ' A' ' 19' ' ' LYS . 7.2 tt -132.18 119.86 21.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.995 -179.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -127.8 121.02 29.11 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.418 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 8.9 tp10 -130.31 162.28 29.38 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.4 mt -77.1 133.62 38.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.093 0.473 . . . . 0.0 110.857 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.455 HG23 ' HB ' ' A' ' 38' ' ' VAL . 73.9 mt -80.72 103.48 7.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.635 176.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.2 m -104.98 -1.0 9.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.976 0.417 . . . . 0.0 111.207 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.635 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 9.4 tp10 -147.61 137.85 23.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.935 -177.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 64.4 mtt -139.45 138.28 36.3 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -65.5 -45.56 83.1 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.07 143.65 27.02 Favored Pre-proline 0 N--CA 1.465 0.293 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 171.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.06 -21.88 67.23 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.892 2.395 . . . . 0.0 113.122 -174.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -75.24 -68.82 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.684 0.278 . . . . 0.0 110.55 178.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 3.8 tt 171.18 -60.29 0.01 OUTLIER 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.472 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 55.0 m95 -85.59 128.72 34.84 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.079 -178.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 148.1 50.55 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 -177.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 122.36 -95.22 0.54 Allowed Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 175.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.44 156.17 44.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.086 0.469 . . . . 0.0 111.039 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.455 ' HB ' HG23 ' A' ' 25' ' ' ILE . 20.4 m -125.78 149.35 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 172.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.635 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 22.6 m -109.91 121.07 44.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.084 0.468 . . . . 0.0 110.275 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.418 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . 3.1 mm? -67.01 157.03 34.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.831 177.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.71 -28.54 34.57 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -172.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -95.6 2.36 54.14 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -174.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.94 -14.49 28.94 Favored Glycine 0 N--CA 1.459 0.207 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.602 175.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -62.41 148.4 45.55 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.4 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 34.4 mt-30 -125.35 145.81 49.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.722 0.296 . . . . 0.0 110.369 177.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 52.9 tp -132.33 139.63 48.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -93.58 118.1 30.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.619 0.247 . . . . 0.0 110.891 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.415 ' N ' HD23 ' A' ' 48' ' ' LEU . 2.7 mm? -121.14 107.56 37.29 Favored Pre-proline 0 N--CA 1.465 0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.206 177.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.67 156.24 66.67 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.35 2.033 . . . . 0.0 111.017 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.56 74.25 0.78 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.006 0.431 . . . . 0.0 110.034 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 95.4 mmm -89.74 -65.2 1.04 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.878 -177.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.92 102.96 2.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.656 178.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.472 ' HA ' ' CD1' ' A' ' 34' ' ' TRP . . . -65.46 -37.65 87.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.873 -178.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.434 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . 5.3 p-10 -56.94 -69.28 0.16 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.176 -178.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.498 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 1.9 p 27.94 87.14 0.1 Allowed Pre-proline 0 N--CA 1.472 0.649 0 C-N-CA 123.837 0.855 . . . . 0.0 113.089 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -78.19 13.62 1.74 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.025 2.483 . . . . 0.0 112.829 -177.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -141.71 153.09 64.46 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.857 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 32.0 Cg_endo -63.91 97.36 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.453 2.102 . . . . 0.0 111.419 177.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.4 tt -89.43 148.35 4.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.811 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 63.2 m -111.54 120.54 42.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.688 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.8 m -125.04 177.66 4.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.089 0.471 . . . . 0.0 111.734 -176.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.43 ' HG3' ' HG3' ' A' ' 1' ' ' MET . 40.8 tt0 -61.43 108.96 1.03 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.731 177.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.484 ' HB1' ' HB ' ' A' ' 3' ' ' VAL . . . -74.47 123.57 24.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.484 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.7 ttm105 -138.44 102.77 4.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.876 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.42 ' C ' ' HD3' ' A' ' 65' ' ' LYS . 13.7 tmtt? -82.13 129.75 34.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.54 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 77.5 mt . . . . . 0 C--O 1.253 1.24 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.26 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.541 0.21 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.493 ' HE2' HG23 ' A' ' 60' ' ' THR . 15.4 tptm -125.3 142.65 51.38 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -178.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.58 HG12 HD21 ' A' ' 46' ' ' LEU . 12.3 p -147.62 147.07 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 116.662 -0.244 . . . . 0.0 110.78 -178.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.539 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 27.0 ttt -110.97 113.56 26.2 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 176.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.9 mm -92.41 128.43 44.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.085 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.418 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 81.1 mtp180 -97.02 118.89 34.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.067 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -121.1 124.98 46.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.534 -176.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 42.9 p -134.76 176.26 8.81 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 169.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.21 -33.43 73.46 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.893 0.378 . . . . 0.0 111.113 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.0 p -111.93 -56.58 2.37 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.315 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.58 137.48 20.28 Favored Glycine 0 C--O 1.237 0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 113.387 -174.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -128.2 118.72 23.85 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.418 ' HB3' ' HB2' ' A' ' 6' ' ' ARG . 23.1 t -142.22 162.37 35.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.739 0.304 . . . . 0.0 110.204 -176.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.465 ' HB2' HD11 ' A' ' 40' ' ' LEU . . . -140.74 134.97 31.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.277 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -118.91 107.68 13.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.222 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 37.1 t -75.85 104.51 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.35 -69.59 0.12 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -171.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -12.36 54.36 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -171.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.479 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 17.2 tppt? -100.17 -20.38 15.99 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.719 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 61.59 29.08 18.11 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.111 0.481 . . . . 0.0 110.732 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.479 ' HB2' ' HG3' ' A' ' 19' ' ' LYS . 7.4 tt -101.82 120.2 40.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.746 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -117.77 132.17 56.49 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 172.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 8.2 tp10 -147.03 165.6 29.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.419 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.409 HD13 ' N ' ' A' ' 25' ' ' ILE . 1.3 tp -86.71 140.66 29.56 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 122.988 0.515 . . . . 0.0 110.359 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.409 ' N ' HD13 ' A' ' 24' ' ' LEU . 79.4 mt -80.13 113.24 19.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.541 177.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.4 m -106.57 -27.52 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -177.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.483 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 4.0 tm-20 -138.17 133.32 33.14 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -177.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.447 ' SD ' ' O ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -142.59 147.0 35.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 0.0 111.082 -178.135 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -67.27 -65.0 0.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.956 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -75.36 138.37 71.44 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.17 -177.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -46.7 -26.11 4.21 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.63 2.887 . . . . 0.0 112.942 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -93.85 -68.44 0.8 Allowed 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 173.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 32.0 tp 174.44 -63.2 0.01 OUTLIER 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.553 -176.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.477 ' HZ3' HG21 ' A' ' 61' ' ' VAL . 63.9 m95 -75.47 134.82 40.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.241 -172.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.95 -13.45 5.0 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.17 -0.538 . . . . 0.0 112.041 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -168.85 -150.7 6.81 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.832 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.647 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -85.61 162.86 18.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.457 0.646 . . . . 0.0 112.696 -173.416 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 46' ' ' LEU . 8.7 p -146.7 158.82 10.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.2 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 31.4 m -133.29 128.27 35.4 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.083 0.468 . . . . 0.0 110.216 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' A' ' 14' ' ' ALA . 3.4 mm? -81.74 165.61 20.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.206 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.29 -19.61 63.45 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.104 0.478 . . . . 0.0 111.152 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.414 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 61.8 t30 -83.79 -4.39 58.61 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.522 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.33 0.36 82.62 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.971 -176.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 42.2 t-105 -66.06 121.7 15.73 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -100.5 120.2 39.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.902 0.382 . . . . 0.0 110.538 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.58 HD21 HG12 ' A' ' 3' ' ' VAL . 62.7 tp -130.25 135.26 47.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.588 -178.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.647 ' HA ' ' HA ' ' A' ' 37' ' ' LYS . 30.1 tt0 -104.63 126.36 51.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.792 0.329 . . . . 0.0 110.569 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.36 136.17 64.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.909 177.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -81.66 29.72 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.908 2.406 . . . . 0.0 112.834 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 62.52 104.97 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.559 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.5 mmt -139.36 -176.66 4.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.25 178.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.57 122.58 14.43 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.274 0.359 . . . . 0.0 110.47 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.16 -38.71 90.08 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.092 0.472 . . . . 0.0 109.794 176.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -69.95 94.82 0.88 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.957 177.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.6 p -131.67 90.17 37.54 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.272 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -86.33 12.9 2.88 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.142 2.561 . . . . 0.0 111.868 177.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.1 pp -145.84 154.87 51.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.332 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.8 125.24 10.87 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.387 2.058 . . . . 0.0 111.429 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.9 tt -126.08 137.08 58.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 120.883 0.373 . . . . 0.0 111.045 -177.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 4' ' ' MET . 26.1 m -90.66 120.02 31.38 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.169 177.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.477 HG21 ' HZ3' ' A' ' 34' ' ' TRP . 34.3 m -128.51 176.95 6.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.392 -175.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -70.28 149.31 47.55 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.935 176.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.443 ' HB2' HD11 ' A' ' 46' ' ' LEU . . . -120.14 121.07 37.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.61 0.243 . . . . 0.0 111.412 -174.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.538 ' HB2' ' HB3' ' A' ' 47' ' ' GLU . 31.3 mmt180 -113.83 100.75 8.68 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 174.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -79.95 148.34 31.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.898 0.38 . . . . 0.0 111.157 -175.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.477 HD11 ' HB2' ' A' ' 47' ' ' GLU . 5.5 mp . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.488 -0.768 . . . . 0.0 109.228 175.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.403 ' CG ' ' HB2' ' A' ' 63' ' ' ALA . 43.6 ttm . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.454 ' HZ1' HG23 ' A' ' 60' ' ' THR . 53.6 tttp -108.99 133.03 53.52 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 122.504 0.322 . . . . 0.0 110.626 -173.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' A' ' 63' ' ' ALA . 14.8 p -143.4 129.17 16.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.021 0.439 . . . . 0.0 110.499 174.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 47.7 ttm -105.55 120.9 42.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.216 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 46.9 mm -96.3 122.83 48.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -96.17 149.62 21.43 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.922 0.391 . . . . 0.0 109.964 -177.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -105.6 125.32 50.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.499 -178.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.0 m -158.84 144.05 16.2 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -177.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.405 ' C ' ' H ' ' A' ' 11' ' ' GLY . . . -54.45 100.52 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.233 0.333 . . . . 0.0 110.654 178.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.8 p 68.48 -32.9 0.22 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.935 1.294 . . . . 0.0 112.923 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 9' ' ' ALA . . . -82.12 54.05 4.82 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.699 -178.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -69.89 118.59 12.94 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.2 t -111.72 150.05 30.77 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.492 ' HB1' HD21 ' A' ' 40' ' ' LEU . . . -124.52 131.19 53.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.167 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -110.39 103.26 11.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.117 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.517 HG13 ' HG3' ' A' ' 18' ' ' LYS . 24.4 t -88.53 104.91 15.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.025 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.07 -26.76 68.38 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -171.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.517 ' HG3' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -65.07 -20.21 66.37 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.724 0.297 . . . . 0.0 111.22 -176.29 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.521 ' HD3' HD11 ' A' ' 21' ' ' LEU . 65.0 tttp -133.67 -3.01 2.96 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.779 -178.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 60.2 30.25 19.71 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.181 0.515 . . . . 0.0 109.69 -172.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.521 HD11 ' HD3' ' A' ' 19' ' ' LYS . 5.3 tt -82.99 121.18 26.67 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -176.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -123.15 111.48 16.56 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 7.5 tp10 -136.74 163.82 29.71 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.739 0.304 . . . . 0.0 110.474 -176.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.9 mt -85.55 142.45 29.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.209 176.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.484 HG22 ' HB ' ' A' ' 38' ' ' VAL . 74.7 mt -87.99 115.56 28.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.312 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.4 m -104.45 -45.4 9.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.314 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.591 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 36.9 tt0 -107.65 141.13 39.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 50.1 mtt -131.58 142.91 50.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.447 -178.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -66.75 -53.3 34.64 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 171.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.527 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 65.0 t30 -100.73 129.0 28.48 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.93 175.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.527 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 8.4 Cg_endo -45.91 -26.84 3.63 Favored 'Trans proline' 0 N--CA 1.476 0.491 0 C-N-CA 124.291 3.327 . . . . 0.0 113.646 -176.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -71.6 -70.88 0.3 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.865 0.364 . . . . 0.0 110.847 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 25.8 tp 173.35 -58.52 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.217 -175.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.431 ' CE3' ' HB2' ' A' ' 51' ' ' MET . 47.2 m95 -92.33 157.62 16.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.315 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.48 -38.24 1.91 Allowed Glycine 0 CA--C 1.507 -0.418 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.44 -149.51 5.33 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -77.76 149.37 34.52 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.14 0.495 . . . . 0.0 111.493 -177.788 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.484 ' HB ' HG22 ' A' ' 25' ' ' ILE . 35.8 m -124.62 139.39 51.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 170.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.591 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 22.1 m -100.61 117.06 33.98 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.994 0.426 . . . . 0.0 110.53 -178.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . 86.8 mt -65.56 152.16 44.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.989 174.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.67 -24.53 49.32 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.78 -177.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -79.27 -12.9 59.95 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.877 0.37 . . . . 0.0 111.263 -178.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.1 54.83 1.56 Allowed Glycine 0 CA--C 1.518 0.227 0 N-CA-C 111.541 -0.623 . . . . 0.0 111.541 -175.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.47 ' HB3' HD11 ' A' ' 40' ' ' LEU . 22.7 t-105 -136.62 115.83 12.55 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -93.75 120.19 33.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.892 0.377 . . . . 0.0 111.167 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.504 HD21 ' HB1' ' A' ' 63' ' ' ALA . 0.6 OUTLIER -116.82 126.41 53.02 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.788 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 37' ' ' LYS . 30.4 tt0 -86.84 128.42 35.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.987 0.422 . . . . 0.0 111.464 -176.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.426 HD11 ' CZ3' ' A' ' 34' ' ' TRP . 3.6 mm? -100.02 122.47 50.5 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.811 175.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.544 ' HB2' ' HE3' ' A' ' 51' ' ' MET . 7.6 Cg_exo -74.07 39.33 0.52 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.429 2.752 . . . . 0.0 113.234 -176.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 51.6 68.33 0.82 Allowed 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 176.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.544 ' HE3' ' HB2' ' A' ' 49' ' ' PRO . 25.5 mmt -104.06 176.61 5.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.761 176.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.412 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -62.75 117.3 6.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.856 0.36 . . . . 0.0 111.293 -178.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.6 -28.13 60.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.467 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -82.61 17.39 1.81 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.845 -177.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.412 HG21 ' HB3' ' A' ' 52' ' ' ALA . 1.2 p -59.79 115.74 14.04 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.491 174.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.79 10.37 1.67 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.934 2.423 . . . . 0.0 113.381 -172.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.9 pp -143.98 159.81 51.87 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 122.327 0.251 . . . . 0.0 110.359 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.43 97.83 0.45 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.242 1.961 . . . . 0.0 110.935 175.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.1 tt -89.19 141.03 14.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.92 -175.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.454 HG23 ' HZ1' ' A' ' 2' ' ' LYS . 67.3 m -107.58 127.02 53.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.398 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.15 177.18 5.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.462 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -72.1 130.65 41.41 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 176.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.54 ' HB3' ' HB ' ' A' ' 3' ' ' VAL . . . -87.64 146.73 25.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.83 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 64' ' ' ARG . 23.5 ttp180 -145.35 113.75 6.67 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 176.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -81.73 137.72 35.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.415 -175.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.519 HD13 ' HB2' ' A' ' 47' ' ' GLU . 5.0 mp . . . . . 0 C--O 1.245 0.827 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 171.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.543 ' HE2' ' HB3' ' A' ' 62' ' ' GLU . 26.8 ttt . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.425 ' HG3' HG23 ' A' ' 60' ' ' THR . 39.1 ttpt -129.62 132.0 46.62 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.95 0.405 . . . . 0.0 111.301 -174.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.0 p -138.4 120.11 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 169.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.4 ttt -107.56 110.46 22.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.222 -174.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 58' ' ' PRO . 45.7 mm -85.18 128.81 38.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.159 -178.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.551 ' HB2' ' HB2' ' A' ' 13' ' ' SER . 79.5 mtp180 -96.57 131.41 43.23 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.412 ' NZ ' ' O ' ' A' ' 54' ' ' ASP . 14.2 mmmm -121.82 118.81 29.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.025 -173.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.6 p -133.65 166.85 21.65 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.59 -24.21 39.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.1 0.476 . . . . 0.0 110.178 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.6 m -75.97 -31.82 59.19 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.259 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -176.34 -168.9 37.13 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.79 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.548 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 48.7 m80 -121.39 141.89 50.53 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.803 -0.444 . . . . 0.0 109.803 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.551 ' HB2' ' HB2' ' A' ' 6' ' ' ARG . 15.7 m -142.98 158.93 43.14 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.486 ' HB1' HD12 ' A' ' 40' ' ' LEU . . . -140.31 138.13 34.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.526 0.203 . . . . 0.0 110.831 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -111.12 103.57 12.02 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.403 HG11 ' HB3' ' A' ' 18' ' ' LYS . 41.3 t -88.24 96.32 5.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.004 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.05 -26.31 62.34 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.866 0.365 . . . . 0.0 111.533 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.403 ' HB3' HG11 ' A' ' 16' ' ' VAL . 18.2 tppt? -55.3 -26.84 42.85 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.139 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -133.5 0.24 3.3 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.372 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 57.75 28.39 15.82 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.467 0.651 . . . . 0.0 109.789 -172.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.3 tp -86.15 121.07 28.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.014 -175.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -112.72 115.82 29.14 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 173.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -139.37 161.59 37.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.955 0.407 . . . . 0.0 110.122 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.0 mt -80.46 141.63 35.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.317 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.548 ' HB ' ' HB2' ' A' ' 12' ' ' HIS . 74.6 mt -84.78 120.14 34.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.202 178.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.7 m -106.13 -27.15 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.042 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.615 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 8.0 tp10 -133.78 143.09 48.19 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.53 157.26 43.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.857 -178.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.461 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 10.8 tp10 -64.39 -37.88 89.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.842 0.353 . . . . 0.0 111.0 -177.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.477 ' OD1' ' HA3' ' A' ' 35' ' ' GLY . 12.9 m120 -125.91 148.81 64.0 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -45.63 -32.62 8.76 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.762 2.974 . . . . 0.0 113.614 -173.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -73.72 -69.71 0.42 Allowed 'General case' 0 C--O 1.234 0.284 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 176.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 3.4 tt 175.83 -66.82 0.01 OUTLIER 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.277 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -70.89 154.81 41.51 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.315 -175.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.477 ' HA3' ' OD1' ' A' ' 30' ' ' ASN . . . 128.89 0.62 6.01 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.858 -177.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 48' ' ' LEU . . . 155.43 -140.7 7.52 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.497 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.461 ' HE2' ' HA ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -71.28 166.23 22.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.285 0.564 . . . . 0.0 112.253 -174.654 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.7 p -144.33 163.54 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.13 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.615 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 37.2 m -142.11 126.18 17.34 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.008 0.432 . . . . 0.0 110.605 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.486 HD12 ' HB1' ' A' ' 14' ' ' ALA . 3.4 mm? -78.76 168.47 19.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.46 177.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.85 -22.52 65.57 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.565 -177.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -83.42 -13.97 53.65 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.094 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.79 -4.21 53.16 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.55 -178.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 49.3 t-105 -67.65 136.59 54.62 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -122.37 137.03 55.0 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -174.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -123.62 154.01 39.91 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.23 171.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.535 ' HB3' ' HB2' ' A' ' 64' ' ' ARG . 39.1 tt0 -105.91 113.02 26.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 3.3 mm? -96.07 135.15 22.9 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.403 -178.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.79 156.73 64.8 Favored 'Trans proline' 0 C--O 1.238 0.485 0 C-N-CA 122.181 1.92 . . . . 0.0 110.808 173.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.21 87.95 0.17 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.091 0.472 . . . . 0.0 110.8 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.5 mmt -104.87 179.65 4.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.628 176.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.29 125.48 23.77 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.794 177.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.0 -23.2 64.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.819 -174.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.412 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . 15.3 p-10 -74.31 -57.01 4.22 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.792 -0.185 . . . . 0.0 110.617 -177.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.4 p 33.48 81.63 0.23 Allowed Pre-proline 0 CA--C 1.537 0.458 0 O-C-N 123.809 0.693 . . . . 0.0 112.263 -178.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -76.33 -2.52 12.72 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.626 2.217 . . . . 0.0 112.21 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.408 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.5 pp -128.28 157.39 74.6 Favored Pre-proline 0 C--O 1.235 0.327 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.742 -177.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 59.1 Cg_endo -72.04 98.38 0.9 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.204 1.936 . . . . 0.0 111.504 176.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.6 tt -97.38 143.77 11.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.034 -177.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.425 HG23 ' HG3' ' A' ' 2' ' ' LYS . 38.4 m -100.86 136.05 41.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.26 176.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.9 m -137.42 177.4 5.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 120.703 0.287 . . . . 0.0 110.521 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.543 ' HB3' ' HE2' ' A' ' 1' ' ' MET . 4.8 mp0 -64.34 134.82 55.39 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.586 177.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.94 114.02 25.69 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.48 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.535 ' HB2' ' HB3' ' A' ' 47' ' ' GLU . 2.7 mmp_? -117.58 125.85 51.52 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 172.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -97.24 146.82 24.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.57 0.224 . . . . 0.0 110.625 -178.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.3 mp . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.56 175.304 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.618 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.17 0 CA-C-O 121.304 0.573 . . . . 0.0 110.212 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -119.2 137.65 53.49 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.948 -173.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 p -149.65 128.59 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.513 174.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 53.0 ttm -102.16 111.05 23.18 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.4 mm -79.24 111.83 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -102.67 118.96 37.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.995 -176.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -86.9 128.31 35.05 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 170.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.3 p -140.41 163.32 33.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.714 -173.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.21 -22.9 66.36 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.331 0.586 . . . . 0.0 109.992 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 m -67.17 -14.73 63.18 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.386 174.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.47 -99.78 0.61 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.969 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -130.84 128.57 40.91 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.4 p -139.33 150.95 45.97 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.289 -0.264 . . . . 0.0 110.289 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.49 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -141.5 131.34 24.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.755 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -99.37 103.36 15.15 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.1 t -91.54 105.0 16.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.216 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.24 -30.04 71.26 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.822 0.344 . . . . 0.0 111.233 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -55.2 -46.71 75.89 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.964 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.674 ' HD2' ' HB2' ' A' ' 21' ' ' LEU . 4.7 tmtm? -99.6 -11.63 20.8 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -178.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 60.52 31.55 20.29 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.218 -171.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.674 ' HB2' ' HD2' ' A' ' 19' ' ' LYS . 49.1 tp -106.31 121.89 45.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.055 -174.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -107.25 108.16 19.44 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.412 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 9.0 tp10 -137.09 163.68 30.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.76 0.314 . . . . 0.0 110.675 -175.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.3 mt -80.65 137.02 36.31 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.811 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.6 mt -82.07 85.2 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.37 0.605 . . . . 0.0 109.405 175.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.435 HG23 ' HG3' ' A' ' 27' ' ' GLU . 15.8 m -73.45 -27.98 24.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.086 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.464 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 44.3 mt-10 -127.21 126.42 42.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.901 -178.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -145.08 143.47 30.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 -174.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.417 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 10.2 tp10 -58.18 -54.36 47.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.484 -177.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -90.08 144.74 31.74 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.366 -173.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.7 -31.06 39.59 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.962 2.441 . . . . 0.0 112.35 176.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -84.4 -63.88 1.26 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.272 175.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 25.0 tp 176.94 -71.87 0.01 OUTLIER 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.603 -177.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -71.41 121.1 17.98 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.741 -176.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.03 -52.76 0.02 OUTLIER Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.011 -176.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.64 -66.64 0.02 OUTLIER Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.216 -176.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.417 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -134.05 162.02 33.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.673 0.273 . . . . 0.0 110.948 178.368 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.4 m -146.28 169.79 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 176.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.464 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 27.9 m -143.36 127.24 17.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.272 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.49 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.2 mm? -74.83 155.95 37.01 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.137 176.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.04 -18.3 33.48 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -176.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.629 HD21 HD13 ' A' ' 21' ' ' LEU . 91.4 m-20 -90.98 8.87 33.11 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.654 0.264 . . . . 0.0 111.34 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.83 32.58 44.81 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.817 176.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 24.9 t90 -107.82 116.67 32.37 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 175.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -86.83 139.99 30.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.084 0.469 . . . . 0.0 111.149 -177.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 59.7 tp -136.29 139.68 42.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.467 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 64' ' ' ARG . 34.5 tt0 -81.37 132.96 35.35 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.0 tp -133.09 98.38 15.76 Favored Pre-proline 0 C--O 1.236 0.391 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 -177.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.27 156.34 41.02 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.877 2.385 . . . . 0.0 112.598 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.34 82.01 3.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.104 0.478 . . . . 0.0 110.264 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.5 mmt -113.58 -174.31 2.44 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.58 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.16 101.78 0.32 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.644 -177.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.05 -18.25 40.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.178 176.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -73.77 -4.75 36.53 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.388 -178.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.0 t -56.74 135.14 78.53 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.544 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -87.22 12.47 2.94 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.973 2.448 . . . . 0.0 112.872 -176.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 pp -140.19 154.06 69.66 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.186 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.26 104.59 1.58 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.402 2.068 . . . . 0.0 111.214 176.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.5 tt -88.95 140.28 16.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.148 -176.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 65.3 m -95.89 130.28 42.9 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.346 177.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.5 m -127.95 175.01 10.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.699 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -73.03 123.33 23.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.202 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 1' ' ' MET . . . -83.02 109.83 17.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.381 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.545 ' HB2' ' HB3' ' A' ' 47' ' ' GLU . 4.1 mpt_? -102.79 114.78 29.33 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 172.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -78.47 125.86 29.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.051 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.063 179.444 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.518 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -121.1 129.95 53.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.787 0.327 . . . . 0.0 111.77 -172.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.6 p -145.27 143.04 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.055 174.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 49.6 ttm -112.52 119.87 39.68 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.9 mm -89.58 116.04 30.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -97.58 149.1 22.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.456 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -133.93 149.29 51.28 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.928 0.394 . . . . 0.0 110.849 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.4 p -142.54 -167.86 2.6 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 171.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.35 90.45 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.5 m 74.85 -41.39 0.47 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.79 0.836 . . . . 0.0 111.683 -177.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.24 118.76 15.39 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.421 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.512 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 26.2 m80 -110.34 147.94 32.94 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.7 p -150.67 160.95 43.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.797 0.332 . . . . 0.0 110.68 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.426 ' HB2' HD21 ' A' ' 40' ' ' LEU . . . -129.62 130.92 46.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.061 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -120.23 104.85 10.41 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.985 -177.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.3 t -79.83 90.41 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 173.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.19 -48.37 54.18 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.697 -172.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.07 -23.06 66.26 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.698 0.285 . . . . 0.0 111.636 -174.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -107.86 -16.02 14.41 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.69 -178.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.2 t70 70.01 22.17 5.87 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.726 0.774 . . . . 0.0 110.015 -175.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 22' ' ' GLU . 5.5 tt -83.98 123.06 29.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.222 178.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.414 ' N ' HD22 ' A' ' 21' ' ' LEU . 32.8 tt0 -134.31 116.91 15.81 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 174.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.502 ' HB3' HD11 ' A' ' 40' ' ' LEU . 7.2 tp10 -133.71 157.88 44.7 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.874 0.368 . . . . 0.0 110.219 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.9 mt -76.8 140.78 40.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.433 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.512 ' HB ' ' HB2' ' A' ' 12' ' ' HIS . 64.6 mt -83.45 114.96 24.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.806 176.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.4 m -102.23 -44.71 10.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -128.97 125.94 38.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.718 0.294 . . . . 0.0 111.034 -177.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.527 ' HG2' ' HA ' ' A' ' 33' ' ' LEU . 2.1 mpp? -111.51 167.85 10.0 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 174.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -84.86 -10.1 57.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.454 0.645 . . . . 0.0 109.38 173.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 28' ' ' MET . 15.5 m120 -127.61 142.4 44.0 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.292 177.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -56.83 -36.93 99.05 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.79 2.327 . . . . 0.0 112.733 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.16 -70.81 0.34 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.893 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.527 ' HA ' ' HG2' ' A' ' 28' ' ' MET . 2.5 tt 178.35 -65.55 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 71.0 m95 -83.6 158.51 21.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.238 -174.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.88 -63.98 0.52 Allowed Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -131.84 -127.68 2.86 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.444 -0.407 . . . . 0.0 112.228 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 8.3 ptpp? -90.25 166.26 13.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.139 0.495 . . . . 0.0 111.834 -173.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 46' ' ' LEU . 9.2 p -146.69 162.18 9.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.81 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 34.8 m -131.67 126.01 33.54 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.742 0.306 . . . . 0.0 110.414 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.502 HD11 ' HB3' ' A' ' 23' ' ' GLU . 59.8 mt -70.83 159.32 34.82 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.288 177.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.72 -24.46 57.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.13 -177.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -106.7 21.52 17.35 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.078 0.466 . . . . 0.0 111.382 -177.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.89 -33.71 6.2 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 114.774 0.67 . . . . 0.0 114.774 168.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.5 ' HB2' HD12 ' A' ' 40' ' ' LEU . 5.3 m-90 -53.9 128.51 30.43 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 117.418 0.609 . . . . 0.0 110.946 -177.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -103.71 138.52 40.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 110.982 -178.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 47' ' ' GLU . 2.8 tm? -137.72 144.56 41.77 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.594 ' HA ' ' HA ' ' A' ' 37' ' ' LYS . 29.7 tt0 -111.5 129.58 56.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.889 0.376 . . . . 0.0 110.955 -177.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -81.33 144.5 53.85 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.604 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -84.05 28.15 0.58 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.947 2.431 . . . . 0.0 112.65 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 57.73 96.0 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.094 0.557 . . . . 0.0 112.219 178.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.6 mmt -133.49 -173.74 3.31 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.96 145.4 25.14 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 173.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.14 -28.09 64.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.974 0.416 . . . . 0.0 110.78 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -79.26 50.69 1.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.395 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.9 p -74.59 123.1 88.84 Favored Pre-proline 0 N--CA 1.453 -0.308 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 172.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.16 -7.77 19.87 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.579 2.186 . . . . 0.0 112.632 -175.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.1 pp -152.16 163.75 22.54 Favored Pre-proline 0 C--O 1.235 0.336 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.471 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.64 99.15 0.43 Allowed 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.073 1.849 . . . . 0.0 110.283 172.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.3 tt -88.05 143.49 11.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.223 0.535 . . . . 0.0 111.406 -170.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.2 m -96.06 122.51 38.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.659 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.9 m -129.78 174.3 12.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 120.956 0.408 . . . . 0.0 111.508 -175.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -63.53 126.34 27.19 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.381 177.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.51 109.57 20.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.697 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.574 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 30.1 tpt180 -101.47 100.41 10.86 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -79.62 133.68 36.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.805 -176.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.511 HD12 ' HB2' ' A' ' 47' ' ' GLU . 6.4 mp . . . . . 0 C--O 1.252 1.192 0 CA-C-O 118.256 -0.878 . . . . 0.0 109.42 175.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.678 ' HG3' ' HB1' ' A' ' 63' ' ' ALA . 24.6 ptp . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -103.68 127.51 51.12 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.125 0.488 . . . . 0.0 112.024 -163.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.557 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 14.4 p -140.21 128.0 24.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.376 170.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 51.8 ttp -109.32 110.88 22.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.905 0.383 . . . . 0.0 110.465 -177.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.8 mm -84.01 131.49 33.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.423 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -96.46 121.74 38.6 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 176.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.852 ' HE2' ' HA ' ' A' ' 54' ' ' ASP . 27.1 mmmt -92.96 116.01 28.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.371 177.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 11' ' ' GLY . 84.8 m -152.33 127.18 9.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.303 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.57 3.9 4.46 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -172.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.465 ' H ' HG22 ' A' ' 8' ' ' THR . 5.6 p -127.75 -0.5 6.06 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.736 0.272 . . . . 0.0 111.736 177.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.474 ' O ' ' HB ' ' A' ' 8' ' ' THR . . . -179.3 102.0 0.16 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.543 -177.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.548 ' CD2' HD21 ' A' ' 33' ' ' LEU . 64.7 m80 -81.07 143.82 32.18 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.9 t -143.13 162.31 35.89 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.492 ' HB2' HD12 ' A' ' 40' ' ' LEU . . . -145.73 122.95 11.52 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.639 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.414 ' HD1' ' HB2' ' A' ' 22' ' ' GLU . 41.9 t80 -102.35 102.73 13.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.575 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.9 t -83.78 98.27 5.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.716 175.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.35 -39.82 91.98 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.004 -173.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.469 ' NZ ' ' SD ' ' A' ' 1' ' ' MET . 0.1 OUTLIER -70.06 -5.91 30.01 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -177.167 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -130.49 10.61 5.24 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 41.58 29.59 0.11 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.677 0.791 . . . . 0.0 111.407 -175.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.591 HD21 HD22 ' A' ' 42' ' ' ASN . 52.1 tp -100.64 132.29 46.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.73 -174.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.414 ' HB2' ' HD1' ' A' ' 15' ' ' TYR . 41.0 tt0 -134.24 112.46 11.08 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 170.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -129.77 163.41 26.27 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.023 -176.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.7 mt -79.23 132.2 36.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.574 178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.548 ' HB ' ' HB2' ' A' ' 12' ' ' HIS . 70.3 mt -77.03 98.03 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.582 175.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.2 m -88.38 -29.99 5.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.87 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.585 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 9.9 tp10 -123.25 139.56 53.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.792 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.43 ' HA ' HG22 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -150.48 147.92 28.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.225 -178.463 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -55.46 -42.82 74.81 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.703 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -131.92 144.92 55.24 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.356 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.89 -27.47 20.81 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.154 2.569 . . . . 0.0 112.784 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.568 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -64.59 -61.88 1.93 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.353 175.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.568 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 1.5 tm? 167.04 -62.82 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.469 -177.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.564 ' CD1' ' HB3' ' A' ' 33' ' ' LEU . 39.1 m95 -88.0 157.81 18.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.297 -171.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.81 -32.73 0.48 Allowed Glycine 0 C--N 1.331 0.294 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.153 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.17 -78.29 0.06 OUTLIER Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.384 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -130.21 162.29 29.24 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.269 0.557 . . . . 0.0 111.703 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.53 HG11 HG22 ' A' ' 25' ' ' ILE . 9.8 t -143.71 155.61 16.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.16 -177.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.585 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 20.1 m -134.03 127.27 31.92 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.782 0.325 . . . . 0.0 110.61 176.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.492 HD12 ' HB2' ' A' ' 14' ' ' ALA . 3.5 mm? -75.66 167.14 22.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.149 176.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.5 -21.98 64.7 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.791 0.329 . . . . 0.0 111.559 -178.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.591 HD22 HD21 ' A' ' 21' ' ' LEU . 27.4 p30 -90.81 1.26 57.08 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.627 -178.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.07 8.29 64.93 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.319 176.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.531 ' HE1' HD22 ' A' ' 46' ' ' LEU . 62.0 t-105 -76.35 117.86 18.45 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 176.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -92.53 116.49 29.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.74 0.305 . . . . 0.0 110.806 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.531 HD22 ' HE1' ' A' ' 44' ' ' TRP . 0.6 OUTLIER -115.23 134.72 54.88 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -178.221 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.579 ' HB3' ' HB2' ' A' ' 64' ' ' ARG . 31.6 tt0 -91.01 120.39 31.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.775 0.322 . . . . 0.0 110.636 -178.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.407 HD13 ' CZ3' ' A' ' 34' ' ' TRP . 3.6 mm? -110.07 106.34 58.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 175.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.8 44.33 1.53 Allowed 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.225 2.617 . . . . 0.0 113.878 -167.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 51.16 82.68 0.06 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.373 0.606 . . . . 0.0 111.848 176.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 97.0 mmm -119.16 -155.45 0.61 Allowed 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -50.12 107.77 0.18 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.828 0.347 . . . . 0.0 110.589 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.01 -34.9 77.05 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.593 -174.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.852 ' HA ' ' HE2' ' A' ' 7' ' ' LYS . 12.6 t70 -134.33 102.11 5.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.877 0.37 . . . . 0.0 110.479 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.4 p -97.14 139.98 21.8 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.08 175.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.52 7.63 3.36 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.693 2.262 . . . . 0.0 112.242 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 pp -147.4 161.01 37.63 Favored Pre-proline 0 C--O 1.236 0.374 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.89 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.28 108.26 1.33 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.017 1.811 . . . . 0.0 110.495 173.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.2 tt -88.02 137.81 20.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.15 -171.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.4 m -106.13 127.4 53.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.678 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.6 m -138.78 178.15 4.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 120.951 0.405 . . . . 0.0 111.056 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 1' ' ' MET . 41.1 tt0 -73.89 124.59 26.43 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.725 178.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.678 ' HB1' ' HG3' ' A' ' 1' ' ' MET . . . -80.74 109.96 15.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.132 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.579 ' HB2' ' HB3' ' A' ' 47' ' ' GLU . 89.5 mtt180 -110.2 137.72 47.55 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 176.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -111.65 124.39 52.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.088 -172.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 C--O 1.25 1.082 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 174.45 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.508 ' HB3' ' HB3' ' A' ' 63' ' ' ALA . 64.8 mtt . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -130.33 130.25 44.22 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.871 0.367 . . . . 0.0 111.722 -174.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.459 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 14.5 p -144.58 138.7 23.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 172.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 52.3 ttm -113.45 110.64 20.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.703 0.287 . . . . 0.0 110.378 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.1 mm -84.51 110.98 19.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -99.17 134.18 42.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.129 0.49 . . . . 0.0 109.725 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.604 ' HZ2' ' HB3' ' A' ' 7' ' ' LYS . 4.4 mmmp? -128.46 149.02 50.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.973 0.892 . . . . 0.0 113.292 -165.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 9' ' ' ALA . 8.7 m -136.81 174.41 10.65 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 165.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.482 ' H ' HG22 ' A' ' 8' ' ' THR . . . -57.12 -50.65 72.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.472 0.578 . . . . 0.0 110.64 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 51.7 p -101.33 -31.27 11.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.7 136.36 19.79 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.865 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.518 ' HB3' HD13 ' A' ' 25' ' ' ILE . 72.8 m80 -134.99 112.76 10.86 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 176.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.4 m -130.66 145.27 51.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.417 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.471 ' HB3' HD12 ' A' ' 40' ' ' LEU . . . -126.68 126.25 43.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.463 177.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -107.46 103.56 12.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.766 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.45 98.17 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.716 174.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.64 -46.64 77.4 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.306 -173.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.833 ' HZ1' ' HB2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -62.66 -17.09 59.82 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -174.659 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -117.48 -10.07 10.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.919 0.39 . . . . 0.0 110.205 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.2 t70 60.86 30.2 19.5 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.663 0.744 . . . . 0.0 109.511 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.5 tp -99.06 114.38 27.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.601 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -110.44 118.49 36.4 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 172.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 9.8 tp10 -134.48 158.75 43.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.993 0.425 . . . . 0.0 110.798 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.3 mt -77.19 141.19 40.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.594 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.601 HG22 ' HE3' ' A' ' 28' ' ' MET . 71.9 mt -83.08 110.19 17.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.4 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.7 m -102.89 -23.61 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.507 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.629 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 8.0 tp10 -133.9 133.66 41.73 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.601 ' HE3' HG22 ' A' ' 25' ' ' ILE . 0.8 OUTLIER -128.74 153.01 47.79 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.391 -174.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -66.75 -51.77 52.08 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 169.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.497 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 40.3 t30 -114.57 135.52 22.31 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.625 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.497 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 2.0 Cg_endo -38.39 -31.49 0.21 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 124.184 3.256 . . . . 0.0 113.436 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.472 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . . . -72.28 -69.52 0.39 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.155 174.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 3.4 tt 176.65 -71.74 0.01 OUTLIER 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.831 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.722 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 41.2 m95 -68.14 160.32 29.27 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.621 -173.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.21 -46.22 0.73 Allowed Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.598 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.63 -85.83 0.05 OUTLIER Glycine 0 C--O 1.225 -0.456 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.055 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.63 157.38 29.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.291 0.567 . . . . 0.0 111.743 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 46' ' ' LEU . 9.8 p -135.23 149.04 28.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 174.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.629 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 18.7 m -125.79 126.34 44.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.013 0.435 . . . . 0.0 110.316 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.471 HD12 ' HB3' ' A' ' 14' ' ' ALA . 2.6 mm? -82.44 166.68 19.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.602 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.7 -10.09 33.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.298 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -89.19 -13.33 38.55 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.981 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.53 -13.08 56.79 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.681 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -69.56 141.8 53.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.882 0.373 . . . . 0.0 110.952 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 39.6 mt-30 -113.23 135.19 54.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.799 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -127.39 137.08 52.67 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.613 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.46 ' N ' HD13 ' A' ' 46' ' ' LEU . 32.3 tt0 -89.97 137.59 32.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.012 0.434 . . . . 0.0 111.268 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.465 ' HB3' ' CE3' ' A' ' 34' ' ' TRP . 3.0 mm? -107.01 122.93 39.99 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.096 177.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.461 ' HD2' ' HZ3' ' A' ' 34' ' ' TRP . 37.8 Cg_exo -59.38 -4.65 2.52 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.864 2.376 . . . . 0.0 113.43 176.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 71.07 89.77 0.1 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.224 0.61 . . . . 0.0 112.075 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 22.2 ptm -162.09 127.14 3.38 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 56.53 79.0 0.19 Allowed 'General case' 0 C--O 1.234 0.268 0 O-C-N 123.328 0.392 . . . . 0.0 109.986 -173.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.722 ' HA ' ' HB2' ' A' ' 34' ' ' TRP . . . -46.5 -40.76 13.02 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.323 -171.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.472 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 16.3 t70 -125.2 94.49 4.18 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 170.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.538 ' HB ' ' HG3' ' A' ' 7' ' ' LYS . 1.3 m -63.61 131.59 94.91 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.638 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -83.13 0.34 9.62 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.689 2.259 . . . . 0.0 112.838 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.407 ' HB2' ' HD2' ' A' ' 58' ' ' PRO . 2.9 pp -146.54 161.87 36.47 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.387 -178.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 57' ' ' LEU . 39.3 Cg_endo -66.25 112.39 2.31 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.259 1.972 . . . . 0.0 111.362 175.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.3 tt -108.7 142.16 22.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.503 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.7 m -109.97 115.08 29.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.279 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.491 HG13 ' HH2' ' A' ' 34' ' ' TRP . 21.3 m -125.49 178.52 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.883 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -74.33 146.59 42.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.892 0.377 . . . . 0.0 110.905 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 1' ' ' MET . . . -90.73 129.39 36.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.595 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -145.42 99.6 3.32 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 174.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.79 155.02 19.81 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.924 -173.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 4.7 mp . . . . . 0 C--O 1.248 0.979 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptt? . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 120.494 0.188 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -129.55 142.97 50.64 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 122.545 0.338 . . . . 0.0 110.367 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.603 HG11 HD23 ' A' ' 46' ' ' LEU . 10.7 p -151.3 138.83 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 175.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.463 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 47.3 ttm -103.7 122.45 45.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.734 0.302 . . . . 0.0 110.609 -176.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 58' ' ' PRO . 45.0 mm -96.09 128.79 46.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.5 mtp180 -97.4 123.63 41.31 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.997 0.427 . . . . 0.0 110.747 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -95.17 116.68 29.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.806 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.8 t -159.68 143.67 14.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.474 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.35 -26.63 46.8 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.79 0.329 . . . . 0.0 111.513 -175.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.5 p -64.89 -27.43 68.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.294 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 167.89 113.66 0.28 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.082 -0.58 . . . . 0.0 111.803 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -53.84 137.38 38.65 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.4 t -138.86 162.65 34.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.904 0.383 . . . . 0.0 110.705 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.49 ' HB2' HD13 ' A' ' 40' ' ' LEU . . . -145.18 139.43 27.23 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.925 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -115.05 109.35 17.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.099 0.476 . . . . 0.0 110.994 -177.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 46.6 t -84.41 97.09 4.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.075 174.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.22 -55.34 28.96 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -170.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.528 ' H ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -55.17 -32.39 62.11 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.844 0.354 . . . . 0.0 111.587 -176.353 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -96.57 -9.98 28.23 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.565 -176.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.8 t70 58.49 27.89 16.19 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.798 0.808 . . . . 0.0 109.744 -176.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.409 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 48.3 tp -91.82 110.42 21.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.928 -177.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -109.49 108.89 19.54 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 171.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.445 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 8.3 tp10 -132.59 160.23 37.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.034 0.445 . . . . 0.0 111.204 -172.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.8 mt -82.62 137.02 34.64 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.828 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 72.3 mt -78.57 101.77 4.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.237 176.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.8 m -98.14 -9.95 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.591 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.53 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 6.1 tp10 -138.43 122.61 18.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.227 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -151.82 140.24 20.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -60.28 -54.24 48.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.32 -177.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.47 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 24.2 t-20 -85.34 137.87 36.65 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.751 -174.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -50.53 -37.79 53.01 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.454 2.769 . . . . 0.0 112.551 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -78.77 -62.7 1.61 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.224 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.605 ' HG ' HD23 ' A' ' 48' ' ' LEU . 23.2 tp 176.82 -76.37 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.57 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.463 ' HE3' ' O ' ' A' ' 49' ' ' PRO . 61.3 m95 -73.02 125.65 28.12 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.775 -174.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.528 ' HA2' ' HB2' ' A' ' 50' ' ' ALA . . . 179.54 -55.07 0.09 OUTLIER Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.107 -177.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.0 -137.4 2.34 Favored Glycine 0 C--O 1.226 -0.385 0 C-N-CA 121.232 -0.509 . . . . 0.0 112.045 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.76 155.53 39.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.301 0.572 . . . . 0.0 111.751 -176.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.02 151.8 13.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.106 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 62.6 m -142.55 132.63 24.52 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.964 0.411 . . . . 0.0 110.453 178.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.49 HD13 ' HB2' ' A' ' 14' ' ' ALA . 3.2 mm? -81.5 162.84 23.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.331 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.4 -22.73 65.25 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.199 0.523 . . . . 0.0 110.833 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.445 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 27.5 t-20 -73.93 -18.77 60.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.509 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.14 -15.88 30.38 Favored Glycine 0 C--N 1.331 0.258 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.396 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 12.7 t-105 -57.83 117.33 4.16 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.602 0.239 . . . . 0.0 110.418 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -92.37 134.16 35.19 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.603 HD23 HG11 ' A' ' 3' ' ' VAL . 37.4 tp -143.13 164.87 28.98 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -111.38 141.13 45.33 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.605 HD23 ' HG ' ' A' ' 33' ' ' LEU . 16.3 tp -123.12 95.94 45.26 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.235 -175.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.463 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 28.9 Cg_endo -60.89 131.37 36.97 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.147 2.564 . . . . 0.0 112.608 -175.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.528 ' HB2' ' HA2' ' A' ' 35' ' ' GLY . . . -70.29 82.21 0.54 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.853 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 37.4 mtm -98.75 -71.36 0.69 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.955 177.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.34 128.15 6.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.99 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -95.24 -12.13 26.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.586 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -78.83 -11.34 59.99 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.45 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.8 t -60.95 119.89 49.02 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 120.924 0.392 . . . . 0.0 110.667 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -90.98 9.71 2.99 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.326 2.684 . . . . 0.0 112.865 -175.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.3 pp -122.99 150.0 58.17 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.917 -174.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 58.2 Cg_endo -72.38 97.95 0.9 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.311 2.007 . . . . 0.0 111.54 175.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.9 tt -94.92 139.68 18.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.187 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 4' ' ' MET . 41.1 m -92.06 122.09 34.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.3 175.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.0 m -116.45 170.4 6.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.422 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.99 120.05 14.24 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.039 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.63 108.82 5.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.512 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -119.73 106.37 12.07 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 175.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.781 ' HB2' ' HZ3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -99.11 158.1 15.9 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.795 0.331 . . . . 0.0 111.278 -178.606 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.25 1.129 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 174.92 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.449 ' O ' ' HG2' ' A' ' 1' ' ' MET . 45.9 ttp . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 120.867 0.365 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.595 ' HD2' ' HB1' ' A' ' 17' ' ' ALA . 1.3 tmtp? -104.18 120.3 40.84 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -176.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.9 p -138.37 128.46 34.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.961 0.41 . . . . 0.0 110.101 175.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 51.0 ttm -103.1 110.12 21.94 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.4 mm -84.82 111.61 20.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.469 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 94.3 mtt180 -103.85 139.26 39.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.648 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -103.77 157.07 17.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.84 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.8 m -139.94 159.07 43.01 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -44.63 -50.19 9.9 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.091 0.472 . . . . 0.0 111.124 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.2 m -129.5 96.65 4.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.725 175.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.01 175.01 14.03 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 121.276 -0.487 . . . . 0.0 112.956 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.456 ' HB3' HD12 ' A' ' 25' ' ' ILE . 73.3 m80 -139.17 139.09 37.46 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.5 p -134.91 133.71 39.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.886 0.374 . . . . 0.0 110.624 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.496 ' HB2' HD13 ' A' ' 40' ' ' LEU . . . -105.23 123.08 47.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.533 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -93.94 103.84 15.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.638 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.4 HG11 ' HZ3' ' A' ' 44' ' ' TRP . 49.8 t -86.39 112.13 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.114 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.595 ' HB1' ' HD2' ' A' ' 2' ' ' LYS . . . -59.91 -46.53 89.07 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -173.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -59.3 -11.84 4.72 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -172.046 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -144.38 15.39 1.65 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 p30 42.03 29.98 0.16 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.516 0.727 . . . . 0.0 111.474 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.4 tt -88.72 117.55 27.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.372 -172.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -112.98 109.1 18.3 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 174.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 9.6 tp10 -117.29 163.24 16.63 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.034 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.0 mt -75.72 129.34 36.93 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.237 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.456 HD12 ' HB3' ' A' ' 12' ' ' HIS . 72.4 mt -78.06 98.11 2.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.119 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.471 HG23 ' HG2' ' A' ' 27' ' ' GLU . 16.7 m -91.38 -46.37 14.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.501 -177.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.548 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 20.9 mm-40 -113.11 107.35 15.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.413 -175.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.71 142.93 50.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.619 0.247 . . . . 0.0 110.346 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -62.57 -40.87 98.22 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.122 0.487 . . . . 0.0 110.643 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -91.79 139.82 24.85 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.868 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -48.17 -38.85 33.63 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.624 2.883 . . . . 0.0 112.828 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.691 ' HB1' ' HB1' ' A' ' 53' ' ' ALA . . . -89.05 -61.8 1.63 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.502 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.423 HD11 HD11 ' A' ' 25' ' ' ILE . 27.4 tp -175.25 -71.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -177.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.403 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 70.8 m95 -79.33 136.19 36.93 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -170.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 165.42 -45.97 0.28 Allowed Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.397 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.16 -134.59 1.71 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.38 -0.438 . . . . 0.0 112.245 -177.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.71 165.95 21.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.292 0.568 . . . . 0.0 111.931 -175.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.8 p -146.93 167.35 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.464 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 60.7 m -142.48 123.64 14.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.785 0.326 . . . . 0.0 110.202 175.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.496 HD13 ' HB2' ' A' ' 14' ' ' ALA . 3.4 mm? -73.09 159.81 32.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.824 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.84 -16.77 52.84 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.963 0.411 . . . . 0.0 110.999 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.403 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 25.0 t-20 -75.53 -31.43 60.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.966 178.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 126.38 -20.45 6.2 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.52 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.4 ' HZ3' HG11 ' A' ' 16' ' ' VAL . 29.6 m0 -61.15 132.81 54.91 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.753 0.311 . . . . 0.0 111.555 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -104.94 137.46 42.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.803 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.3 tp -134.41 141.41 46.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.909 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.507 ' HB3' ' HB2' ' A' ' 64' ' ' ARG . 27.2 tt0 -97.52 110.3 22.88 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 120.814 0.34 . . . . 0.0 111.042 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 3.9 mm? -93.32 144.48 28.37 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.365 176.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 48' ' ' LEU . 11.4 Cg_exo -70.83 158.63 55.02 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.42 2.08 . . . . 0.0 111.001 173.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.15 73.35 3.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.269 0.557 . . . . 0.0 110.293 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.4 mmt -95.74 -168.76 1.82 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.133 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.56 115.41 5.74 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 176.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.691 ' HB1' ' HB1' ' A' ' 32' ' ' ALA . . . -48.54 -35.8 14.06 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.583 0.552 . . . . 0.0 111.584 -174.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -119.96 86.47 2.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.18 0.514 . . . . 0.0 109.724 169.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 58.2 m -65.63 129.62 94.38 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.386 175.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.38 -34.21 40.28 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.171 2.581 . . . . 0.0 113.162 -175.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 pp -132.23 158.67 74.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.182 -176.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.469 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . 39.6 Cg_endo -66.54 105.3 0.88 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.393 2.062 . . . . 0.0 111.18 175.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.1 tt -104.56 145.39 13.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.184 -174.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 91.9 m -90.12 132.89 35.19 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.648 173.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.9 m -135.56 176.33 8.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 120.664 0.269 . . . . 0.0 111.096 -177.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.67 121.68 15.93 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.677 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.18 110.59 21.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.518 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.507 ' HB2' ' HB3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -113.38 100.71 8.75 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 172.265 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -82.79 119.17 24.01 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 75.8 mt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.629 -0.701 . . . . 0.0 110.14 -178.181 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.47 ' HE3' ' HD3' ' A' ' 18' ' ' LYS . 23.9 ptt? . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.42 ' HE3' HG23 ' A' ' 60' ' ' THR . 39.2 tptt -71.03 133.15 46.1 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -172.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.44 HG21 ' HA ' ' A' ' 16' ' ' VAL . 7.3 p -150.95 148.15 15.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.863 -178.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.9 ttt -102.96 124.82 49.19 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.732 0.301 . . . . 0.0 110.949 -176.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.456 HG13 HD11 ' A' ' 48' ' ' LEU . 42.4 mm -109.22 128.97 64.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.732 177.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.554 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 92.7 mtt180 -101.13 118.99 38.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.09 0.471 . . . . 0.0 111.34 -176.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.402 ' HD3' ' HG ' ' A' ' 33' ' ' LEU . 9.8 mmmm -107.68 116.53 32.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.233 171.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.1 m -139.96 72.84 1.41 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.349 0.595 . . . . 0.0 109.82 175.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 54.85 -93.79 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.945 -176.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.4 t -94.48 -25.94 16.67 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.225 0.536 . . . . 0.0 110.287 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.0 112.59 4.29 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -126.43 119.92 28.45 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.427 ' OG ' ' HD2' ' A' ' 6' ' ' ARG . 16.7 p -147.57 163.1 37.66 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.484 ' HB2' HD11 ' A' ' 40' ' ' LEU . . . -139.28 141.7 37.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.372 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -114.53 104.03 11.61 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.216 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.44 ' HA ' HG21 ' A' ' 3' ' ' VAL . 47.9 t -76.1 88.19 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.629 176.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.94 -29.18 41.38 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.239 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.47 ' HD3' ' HE3' ' A' ' 1' ' ' MET . 52.5 tptt -57.86 -38.05 75.03 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.419 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 19' ' ' LYS . 54.1 tttm -117.16 -1.81 11.79 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.472 -175.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.9 t70 64.71 23.73 12.8 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 122.033 0.921 . . . . 0.0 109.385 -174.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.3 tt -88.87 125.48 34.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.729 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -124.98 125.22 43.55 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.447 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 10.5 tp10 -154.44 162.26 41.25 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.893 0.378 . . . . 0.0 110.815 -176.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.1 mt -79.6 144.51 33.76 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.65 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.577 HG22 ' HE1' ' A' ' 28' ' ' MET . 67.3 mt -81.11 114.14 21.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.086 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.46 HG23 ' HG3' ' A' ' 27' ' ' GLU . 19.8 m -104.67 -26.15 3.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.488 -178.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.582 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 39.3 mt-10 -132.91 114.34 13.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.354 -176.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.577 ' HE1' HG22 ' A' ' 25' ' ' ILE . 0.6 OUTLIER -109.53 157.43 19.0 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 178.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.404 ' OE1' ' HG3' ' A' ' 37' ' ' LYS . 8.6 tp10 -72.32 -49.54 33.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.69 0.757 . . . . 0.0 109.428 171.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -95.57 138.48 21.82 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.717 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -50.29 -31.54 29.97 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.016 2.477 . . . . 0.0 111.562 173.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.92 -69.56 0.49 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.977 173.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.663 ' HB3' ' HD1' ' A' ' 34' ' ' TRP . 0.3 OUTLIER -178.43 -72.46 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.602 178.445 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.663 ' HD1' ' HB3' ' A' ' 33' ' ' LEU . 14.5 m95 -79.08 144.5 34.53 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.985 -174.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 176.83 -58.14 0.1 Allowed Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.08 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -146.47 -73.19 0.02 OUTLIER Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.242 -174.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.404 ' HG3' ' OE1' ' A' ' 29' ' ' GLU . 1.7 pptp? -132.97 167.7 19.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.169 0.509 . . . . 0.0 110.924 176.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.6 p -147.21 154.7 11.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.381 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 11.7 m -134.52 134.43 41.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.971 0.415 . . . . 0.0 110.624 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.484 HD11 ' HB2' ' A' ' 14' ' ' ALA . 2.9 mm? -87.08 169.76 12.12 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.582 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.52 -12.14 59.64 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.09 0.471 . . . . 0.0 110.884 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -80.83 -20.83 41.57 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.845 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.2 -8.92 59.26 Favored Glycine 0 C--N 1.332 0.335 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 -175.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -64.71 133.39 52.02 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -107.87 138.13 44.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.862 0.363 . . . . 0.0 110.465 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.437 HD12 HG12 ' A' ' 3' ' ' VAL . 3.4 tm? -138.27 132.41 31.64 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -84.07 113.33 20.96 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.456 HD11 HG13 ' A' ' 5' ' ' ILE . 18.2 tp -105.97 116.53 59.49 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.349 -173.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.415 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 3.0 Cg_exo -74.92 154.93 43.24 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.341 2.028 . . . . 0.0 111.419 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.57 74.09 5.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.294 0.568 . . . . 0.0 109.825 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.5 mmt -90.85 -54.89 3.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.997 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.439 ' O ' HG23 ' A' ' 55' ' ' THR . . . -163.21 95.08 0.84 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.237 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.481 ' HA ' ' CD1' ' A' ' 34' ' ' TRP . . . -71.48 -32.61 68.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.585 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.74 -52.93 54.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.861 -175.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 52' ' ' ALA . 9.8 t -28.51 120.82 0.27 Allowed Pre-proline 0 N--CA 1.477 0.897 0 O-C-N 124.224 0.952 . . . . 0.0 113.403 -169.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -85.66 10.43 3.7 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.205 2.604 . . . . 0.0 112.432 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.8 pp -131.76 153.18 81.39 Favored Pre-proline 0 C--O 1.236 0.395 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.568 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.554 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . 41.9 Cg_endo -66.63 149.9 83.89 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.826 2.35 . . . . 0.0 112.682 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.1 tt -152.03 146.93 15.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.252 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.42 HG23 ' HE3' ' A' ' 2' ' ' LYS . 17.0 m -102.02 128.27 48.54 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.315 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.401 HG12 ' HZ3' ' A' ' 34' ' ' TRP . 27.5 m -132.7 174.97 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 120.877 0.37 . . . . 0.0 111.393 -177.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -78.5 161.59 26.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.463 171.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -167.45 159.96 12.8 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.333 0.587 . . . . 0.0 112.543 -175.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -113.13 141.56 46.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.866 172.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.424 ' HZ2' ' C ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -96.51 126.16 41.5 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.489 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.424 ' C ' ' HZ2' ' A' ' 65' ' ' LYS . 2.8 mm? . . . . . 0 C--O 1.245 0.837 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.611 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -108.7 144.54 36.36 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 122.511 0.324 . . . . 0.0 110.57 -173.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.5 p -147.17 141.59 20.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.808 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.2 ttm -101.75 112.72 25.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.83 0.348 . . . . 0.0 110.268 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.458 HG13 HD12 ' A' ' 48' ' ' LEU . 41.0 mm -95.61 124.48 48.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.426 ' HB2' ' OG ' ' A' ' 13' ' ' SER . 97.4 mtt180 -97.39 118.32 33.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.148 0.499 . . . . 0.0 110.838 -175.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.54 ' HB3' ' HZ3' ' A' ' 7' ' ' LYS . 3.0 mmmp? -98.38 116.51 30.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.746 177.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.1 p -134.34 161.82 33.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.27 113.12 1.8 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.807 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.8 p 52.85 23.03 2.59 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.575 0.75 . . . . 0.0 111.688 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.85 134.84 7.84 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -133.81 117.9 17.4 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -178.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.426 ' OG ' ' HB2' ' A' ' 6' ' ' ARG . 15.3 p -135.88 161.8 34.61 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.516 ' HB1' HD12 ' A' ' 40' ' ' LEU . . . -146.24 146.24 30.69 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.66 -0.246 . . . . 0.0 110.523 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -129.7 110.25 11.63 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.94 0.4 . . . . 0.0 111.019 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.538 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 56.4 t -87.92 96.29 5.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 172.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.07 -37.88 84.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.251 -171.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.64 -22.76 66.68 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.621 0.248 . . . . 0.0 111.453 -174.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.469 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 6.4 tmtm? -119.36 -2.73 10.56 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.669 0.271 . . . . 0.0 110.586 -178.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 64.04 27.72 14.24 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.687 -177.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.538 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 54.2 tp -84.01 111.46 19.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.244 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -123.7 113.15 18.24 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -148.18 162.83 38.66 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.839 0.352 . . . . 0.0 110.825 -173.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.7 mt -84.14 151.63 24.78 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.332 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 78.6 mt -92.2 101.21 12.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.668 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.428 HG12 ' HB1' ' A' ' 41' ' ' ALA . 16.3 m -83.87 -37.34 13.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.934 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.537 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 47.2 mt-10 -125.26 139.96 53.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.021 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 16.1 ptt? -151.2 156.74 41.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.876 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.461 ' OE1' ' HG3' ' A' ' 37' ' ' LYS . 8.8 tp10 -67.1 -37.48 83.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.079 0.466 . . . . 0.0 111.273 -176.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -117.74 137.02 23.89 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.073 -172.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -47.61 -31.43 14.13 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.495 2.797 . . . . 0.0 112.099 175.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.16 -61.71 1.89 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.552 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 172.42 -67.25 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.973 0.796 . . . . 0.0 110.755 175.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.515 ' HZ3' HG21 ' A' ' 61' ' ' VAL . 44.4 m95 -74.06 133.38 42.89 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.461 -171.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.83 -56.63 0.05 OUTLIER Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.201 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.67 -67.3 0.01 OUTLIER Glycine 0 C--N 1.334 0.446 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.524 -174.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.461 ' HG3' ' OE1' ' A' ' 29' ' ' GLU . 1.9 pptp? -134.62 168.73 18.46 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.029 0.442 . . . . 0.0 111.152 175.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 46' ' ' LEU . 14.0 p -146.97 160.67 9.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.479 -177.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.537 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 33.0 m -138.89 126.3 21.68 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.83 0.348 . . . . 0.0 110.355 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.516 HD12 ' HB1' ' A' ' 14' ' ' ALA . 2.9 mm? -78.77 159.12 28.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.168 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.428 ' HB1' HG12 ' A' ' 26' ' ' VAL . . . -65.13 -12.06 46.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.087 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -85.3 2.78 42.6 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.48 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.26 -8.79 79.07 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.197 -0.525 . . . . 0.0 113.553 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 18.0 m0 -85.52 142.83 28.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.1 0.476 . . . . 0.0 111.274 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -101.69 159.8 15.01 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.756 -176.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.402 ' O ' HG13 ' A' ' 38' ' ' VAL . 3.2 tm? -159.37 136.33 9.53 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -176.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -82.84 122.8 28.69 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 122.247 -0.283 . . . . 0.0 110.28 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.458 HD12 HG13 ' A' ' 5' ' ' ILE . 22.7 tp -115.53 112.78 43.18 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.123 -174.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.415 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 60.0 Cg_endo -68.73 158.03 59.45 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.26 1.973 . . . . 0.0 111.961 -175.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.94 76.91 3.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.093 0.473 . . . . 0.0 110.514 178.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.443 ' HA ' ' HE2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -91.75 -164.8 1.23 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.627 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.3 109.66 17.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.743 0.306 . . . . 0.0 110.962 -178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.79 -7.49 54.57 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.714 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -60.86 -25.68 66.83 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.793 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.2 p -57.02 117.52 18.29 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.924 -176.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -92.14 10.88 2.41 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.145 2.563 . . . . 0.0 111.682 174.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 pp -139.5 160.85 59.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.212 -175.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -62.98 135.71 52.9 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.53 2.153 . . . . 0.0 112.726 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.9 tt -130.54 140.15 49.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.022 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.3 m -100.85 119.05 38.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.895 0.378 . . . . 0.0 110.786 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.515 HG21 ' HZ3' ' A' ' 34' ' ' TRP . 35.4 m -122.5 170.67 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.721 178.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 1' ' ' MET . 10.2 mt-10 -82.85 157.12 23.25 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 171.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -149.23 164.37 34.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.23 0.538 . . . . 0.0 111.923 -172.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.614 ' HG3' HH11 ' A' ' 64' ' ' ARG . 11.3 mmt85 -116.62 125.71 52.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.655 175.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -82.22 108.69 15.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.99 0.424 . . . . 0.0 110.354 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 78.0 mt . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.417 -0.802 . . . . 0.0 109.673 178.753 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.403 ' HZ3' HG23 ' A' ' 60' ' ' THR . 52.1 tptt -88.8 114.73 25.74 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.328 -172.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.506 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 9.5 p -147.38 141.98 19.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.092 174.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.448 ' SD ' ' HB2' ' A' ' 58' ' ' PRO . 51.0 ttm -117.18 120.28 37.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.676 0.274 . . . . 0.0 110.319 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.4 mm -88.62 115.1 28.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -111.03 118.97 37.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.784 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.458 ' O ' ' HD3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -127.74 138.44 52.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.023 0.44 . . . . 0.0 110.986 179.036 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.64 HG22 ' H ' ' A' ' 9' ' ' ALA . 3.0 m -147.19 -179.02 6.54 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.64 ' H ' HG22 ' A' ' 8' ' ' THR . . . -49.54 107.17 0.13 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 117.826 0.285 . . . . 0.0 110.729 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.2 p 67.79 -41.02 0.42 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.787 1.235 . . . . 0.0 112.746 -177.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.69 110.78 3.14 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.318 -0.467 . . . . 0.0 112.71 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -118.42 128.88 55.04 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.6 p -143.9 155.4 44.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.877 0.37 . . . . 0.0 110.648 -178.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.433 ' HB2' HD13 ' A' ' 40' ' ' LEU . . . -128.49 115.57 18.36 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -90.37 103.91 16.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.871 -176.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.1 t -80.25 99.59 4.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.39 175.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.28 -53.85 44.87 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -172.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -11.73 31.06 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -174.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -118.3 -8.98 10.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.723 0.297 . . . . 0.0 110.526 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.4 t70 57.65 26.65 13.19 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 122.032 0.92 . . . . 0.0 109.593 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.1 tt -86.98 123.54 32.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.127 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -133.16 104.48 6.52 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 171.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.32 165.16 19.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.904 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.7 mt -79.69 132.99 36.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.844 0.354 . . . . 0.0 110.63 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.431 HD12 HD11 ' A' ' 33' ' ' LEU . 69.5 mt -71.37 105.33 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.776 174.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.41 HG22 ' HG2' ' A' ' 27' ' ' GLU . 10.9 m -81.42 -49.25 18.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.173 -177.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.56 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 58.1 mm-40 -106.76 140.95 38.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.916 -177.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 59.5 mtt -132.96 156.73 46.75 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.408 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 10.6 tp10 -65.35 -49.13 70.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.551 0.691 . . . . 0.0 109.336 172.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -127.43 148.34 66.02 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.877 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.05 -23.08 11.68 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.337 2.691 . . . . 0.0 113.742 -174.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -71.25 -66.44 0.62 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.696 0.284 . . . . 0.0 110.547 176.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 18.7 tp 170.2 -70.48 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.008 -175.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 46.4 m95 -76.29 153.61 35.78 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.023 -176.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.485 ' HA2' ' HB1' ' A' ' 50' ' ' ALA . . . 159.62 -33.21 0.45 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.477 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.21 -78.24 0.05 OUTLIER Glycine 0 C--O 1.226 -0.393 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.421 ' HD3' ' C ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -129.73 161.3 30.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.919 0.39 . . . . 0.0 110.937 178.296 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.7 m -140.01 167.59 18.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 171.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.56 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 17.7 m -135.78 125.77 25.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.9 0.381 . . . . 0.0 110.671 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.433 HD13 ' HB2' ' A' ' 14' ' ' ALA . 3.7 mm? -77.88 161.45 27.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.558 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.8 -19.69 60.03 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.187 0.518 . . . . 0.0 110.395 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -63.08 -23.25 67.36 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.407 175.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.36 12.3 57.42 Favored Glycine 0 C--N 1.332 0.36 0 N-CA-C 111.621 -0.592 . . . . 0.0 111.621 -176.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.683 ' HZ2' ' HE2' ' A' ' 65' ' ' LYS . 45.8 t-105 -106.76 140.08 40.17 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 -178.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -94.41 149.04 21.63 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.954 -177.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.497 HD21 ' HB2' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -142.9 131.81 22.88 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.194 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 42.2 tt0 -89.9 120.88 31.5 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.79 0.329 . . . . 0.0 111.205 -175.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -121.03 113.32 32.85 Favored Pre-proline 0 C--O 1.235 0.332 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.371 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.51 152.89 79.83 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.384 2.056 . . . . 0.0 111.573 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.485 ' HB1' ' HA2' ' A' ' 35' ' ' GLY . . . -71.38 75.58 0.75 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.031 0.443 . . . . 0.0 110.434 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.6 mmt -87.99 -74.37 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.389 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.99 110.03 1.85 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.545 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.2 -30.87 70.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.238 0.542 . . . . 0.0 109.628 175.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -73.36 86.77 1.5 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.447 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.432 HG23 ' HB ' ' A' ' 59' ' ' ILE . 32.1 m -139.02 109.02 7.61 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.596 177.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -83.6 14.56 2.35 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.037 2.491 . . . . 0.0 113.22 -176.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.6 pp -145.66 159.98 45.87 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.648 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.448 ' HB2' ' SD ' ' A' ' 4' ' ' MET . 37.9 Cg_endo -66.62 106.27 1.05 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.258 1.972 . . . . 0.0 111.328 175.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.432 ' HB ' HG23 ' A' ' 55' ' ' THR . 8.7 tt -89.45 146.73 5.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.113 -174.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.403 HG23 ' HZ3' ' A' ' 2' ' ' LYS . 20.1 m -110.84 132.71 53.97 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.275 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.4 m -139.82 177.14 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 122.419 0.288 . . . . 0.0 110.505 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -86.01 118.17 25.31 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.224 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.506 ' HB1' ' HB ' ' A' ' 3' ' ' VAL . . . -70.28 109.83 4.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.945 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.544 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 1.4 tmm_? -93.59 101.73 13.9 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 174.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.683 ' HE2' ' HZ2' ' A' ' 44' ' ' TRP . 45.3 tttm -73.15 129.7 38.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.166 -176.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 66' ' ' LEU . 5.8 mp . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.553 -0.736 . . . . 0.0 109.485 176.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -101.61 121.56 42.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.008 -173.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.6 p -137.4 129.52 41.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 173.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.448 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 52.9 ttm -101.06 115.06 29.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.656 -175.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.1 mm -96.28 116.36 38.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.0 mtt85 -97.68 126.12 42.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.209 0.528 . . . . 0.0 110.853 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.585 ' HD3' ' HG ' ' A' ' 33' ' ' LEU . 16.1 mmmt -119.78 115.37 23.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.006 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.2 t -135.82 -167.46 2.04 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 175.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.21 -74.11 0.04 OUTLIER 'General case' 0 C--O 1.235 0.298 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -174.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.6 p -112.11 -28.51 7.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.985 0.421 . . . . 0.0 110.795 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.02 138.69 27.2 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.6 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -141.6 121.69 13.78 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 175.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.4 p -140.45 158.87 43.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.865 0.364 . . . . 0.0 111.277 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.477 ' HB3' HD13 ' A' ' 40' ' ' LEU . . . -131.05 137.88 49.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.792 176.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.448 ' HB3' ' HB3' ' A' ' 4' ' ' MET . 40.1 t80 -119.17 104.64 10.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.956 0.407 . . . . 0.0 111.207 -177.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 59.7 t -79.83 97.37 2.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.564 174.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.13 -40.64 77.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.778 -172.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.43 ' HE2' ' HB2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -69.32 -11.96 61.25 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -171.701 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -133.98 0.47 3.18 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.777 0.322 . . . . 0.0 111.008 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 59.32 24.06 12.56 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.782 -177.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.487 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 41.9 tp -83.07 108.26 16.23 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.17 -178.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -121.87 126.72 49.36 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.452 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 10.7 tp10 -147.61 162.63 38.74 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.556 -175.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.3 mt -78.29 139.59 38.86 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.576 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.67 HG23 ' HE2' ' A' ' 28' ' ' MET . 79.9 mt -82.16 104.84 11.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.852 176.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.6 m -94.84 -37.59 8.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 111.674 0.249 . . . . 0.0 111.674 -177.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.589 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 34.5 tt0 -127.95 134.39 49.3 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -176.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.67 ' HE2' HG23 ' A' ' 25' ' ' ILE . 0.9 OUTLIER -122.87 160.87 25.19 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.516 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -66.73 -49.06 67.21 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -106.88 142.92 26.01 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 173.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -54.91 -21.94 28.27 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.019 2.48 . . . . 0.0 113.135 -174.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.11 -71.83 0.2 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.623 0.249 . . . . 0.0 110.669 177.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.585 ' HG ' ' HD3' ' A' ' 7' ' ' LYS . 1.1 tm? -179.45 -63.23 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -178.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.407 ' HA ' HD21 ' A' ' 48' ' ' LEU . 58.1 m95 -83.57 165.28 19.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.464 -177.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 159.22 -70.39 0.24 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.718 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -147.57 -48.36 0.03 OUTLIER Glycine 0 C--N 1.33 0.198 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.138 -175.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.01 164.51 30.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.84 0.353 . . . . 0.0 110.315 178.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.8 p -143.41 137.24 25.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.725 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.589 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 30.5 m -112.31 116.12 29.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.81 0.338 . . . . 0.0 110.751 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.477 HD13 ' HB3' ' A' ' 14' ' ' ALA . 2.9 mm? -75.29 154.97 37.13 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.985 173.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.11 -16.5 52.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.079 0.466 . . . . 0.0 111.436 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -82.5 3.28 29.0 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.814 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.25 31.77 45.79 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.731 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 19.6 t-105 -113.7 113.91 25.65 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -98.93 121.08 40.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.276 0.56 . . . . 0.0 110.807 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.6 tp -110.62 147.85 33.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.026 178.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 35.6 tt0 -84.95 115.66 22.93 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.407 HD21 ' HA ' ' A' ' 34' ' ' TRP . 15.0 tp -112.54 116.68 48.04 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.631 -171.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.18 155.84 58.98 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.5 2.133 . . . . 0.0 112.27 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.09 79.6 5.49 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.955 0.407 . . . . 0.0 111.011 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.1 mmt -98.41 -169.16 1.76 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.122 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.37 116.79 2.62 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.971 178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.62 -46.69 28.88 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.75 0.657 . . . . 0.0 111.722 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.494 ' HA ' ' HE2' ' A' ' 7' ' ' LYS . 30.2 m-20 -116.37 79.47 1.32 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.085 0.469 . . . . 0.0 110.269 178.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.4 m -62.98 121.88 71.53 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.688 175.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.15 2.38 6.77 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.673 2.249 . . . . 0.0 113.184 -174.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 pp -151.86 156.88 34.47 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.631 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.21 110.24 1.95 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.462 2.108 . . . . 0.0 111.008 174.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.7 tt -105.36 137.18 36.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.101 0.476 . . . . 0.0 111.003 -175.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.9 m -95.81 118.84 33.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.303 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.9 178.11 2.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.832 -177.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -76.37 149.06 37.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.202 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.18 156.8 17.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.105 0.478 . . . . 0.0 111.47 -177.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.542 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -162.21 105.69 1.16 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.963 174.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -73.9 141.05 46.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.804 0.335 . . . . 0.0 111.118 -177.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.43 HD23 ' HB2' ' A' ' 47' ' ' GLU . 70.6 mt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.818 -0.61 . . . . 0.0 109.43 175.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptt? . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 121.286 0.565 . . . . 0.0 110.005 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.411 ' HG3' ' HB2' ' A' ' 17' ' ' ALA . 23.9 tptm -94.21 110.64 22.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.277 -169.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.471 HG22 ' HA ' ' A' ' 16' ' ' VAL . 11.7 p -146.98 141.67 20.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.051 174.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 47.5 ttp -125.05 129.02 49.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.49 -177.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.9 mm -96.94 123.81 49.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.635 ' HD3' ' HB3' ' A' ' 58' ' ' PRO . 22.2 mmt85 -99.1 131.53 45.07 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.205 0.526 . . . . 0.0 111.416 -177.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.417 ' NZ ' ' O ' ' A' ' 55' ' ' THR . 10.2 mmmm -93.55 120.25 33.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.968 176.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.5 p -123.32 146.43 47.93 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.75 -37.66 82.58 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.028 0.442 . . . . 0.0 110.514 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.6 m -110.27 76.27 0.98 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.076 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.54 -160.05 13.53 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.434 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -138.96 146.24 40.74 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.5 m -136.9 143.82 43.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.495 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -123.84 132.32 53.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.771 0.32 . . . . 0.0 110.151 177.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -104.93 102.39 11.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.158 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.471 ' HA ' HG22 ' A' ' 3' ' ' VAL . 47.8 t -76.36 90.75 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.295 174.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.411 ' HB2' ' HG3' ' A' ' 2' ' ' LYS . . . -62.48 -32.89 73.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.143 -172.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.784 ' HZ3' ' HB2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -69.05 -1.59 7.95 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.778 -0.192 . . . . 0.0 111.487 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -136.84 -1.74 2.19 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.342 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 56.49 29.9 16.19 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.053 0.454 . . . . 0.0 110.752 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.3 tp -98.12 117.21 31.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.874 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -109.33 125.08 51.96 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 169.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 8.0 tp10 -143.91 160.6 40.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.934 0.397 . . . . 0.0 110.767 -177.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.5 mt -76.45 134.79 39.45 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.231 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.438 HG22 HG12 ' A' ' 38' ' ' VAL . 64.5 mt -81.0 91.6 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.8 m -78.72 -32.78 16.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.79 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.561 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 8.5 tp10 -129.37 141.34 51.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.207 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.15 157.81 42.05 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.3 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -65.19 -67.03 0.47 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.776 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.473 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 56.5 t30 -90.39 130.98 39.72 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.839 -175.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.473 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 1.6 Cg_endo -40.55 -35.02 1.33 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.462 3.441 . . . . 0.0 113.567 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -67.91 -65.78 0.65 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.785 0.326 . . . . 0.0 110.535 176.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 29.6 tp 174.57 -69.21 0.01 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.161 -175.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.506 ' HE3' ' O ' ' A' ' 49' ' ' PRO . 49.1 m95 -75.26 130.9 39.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.407 -177.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.426 ' HA2' ' HB1' ' A' ' 50' ' ' ALA . . . -168.09 -57.44 0.03 OUTLIER Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.293 -178.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.37 -68.02 0.07 OUTLIER Glycine 0 C--O 1.225 -0.458 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 -177.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -101.3 146.57 27.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.648 0.261 . . . . 0.0 110.321 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.438 HG12 HG22 ' A' ' 25' ' ' ILE . 17.2 t -147.15 153.13 12.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 43.2 m -142.8 131.21 22.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.069 0.461 . . . . 0.0 111.025 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.495 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.2 mm? -86.21 165.33 16.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.622 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.32 -20.76 65.77 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.142 0.496 . . . . 0.0 110.908 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.408 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 8.0 t30 -77.34 -9.35 58.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.47 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.62 -10.61 68.77 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 121.252 -0.499 . . . . 0.0 111.992 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 27.1 t-105 -64.64 123.38 19.15 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.448 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 43.8 mt-30 -98.62 126.96 44.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.889 0.376 . . . . 0.0 110.378 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.7 tp -123.64 139.03 54.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.538 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 21.0 tt0 -95.67 101.97 13.72 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -178.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.7 tp -101.5 104.33 33.39 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.543 -173.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.506 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 59.2 Cg_endo -70.62 136.26 30.31 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.441 2.094 . . . . 0.0 111.639 -175.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.426 ' HB1' ' HA2' ' A' ' 35' ' ' GLY . . . -64.69 80.44 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.957 0.408 . . . . 0.0 111.578 -177.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.3 mmt -86.65 -59.87 2.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.282 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.45 116.96 5.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.775 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.74 -54.77 33.45 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.617 0.573 . . . . 0.0 111.516 -174.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -103.98 91.43 3.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.985 0.421 . . . . 0.0 110.295 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.417 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . 1.9 m -73.22 128.61 87.33 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.187 177.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.55 -44.09 11.96 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.403 2.069 . . . . 0.0 112.502 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.566 ' HB2' ' HD2' ' A' ' 58' ' ' PRO . 2.7 pp -132.56 165.99 32.26 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.405 -177.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.635 ' HB3' ' HD3' ' A' ' 6' ' ' ARG . 29.3 Cg_endo -60.73 110.23 0.79 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.382 2.054 . . . . 0.0 111.737 177.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.9 tt -101.63 147.81 8.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.019 -176.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 87.5 m -101.73 120.13 39.87 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.156 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.1 m -120.38 178.55 2.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.161 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.66 123.17 21.25 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.519 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.46 110.2 14.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.086 0.47 . . . . 0.0 110.782 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.409 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 3.5 tpm_? -122.14 105.16 10.01 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.203 176.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -83.58 151.28 25.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.893 0.378 . . . . 0.0 110.78 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 7.1 mp . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.331 -0.842 . . . . 0.0 109.34 174.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.738 ' SD ' ' HD3' ' A' ' 18' ' ' LYS . 24.2 ttt . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.453 ' HG3' HG23 ' A' ' 60' ' ' THR . 39.8 tttm -71.41 115.15 10.24 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.58 0.752 . . . . 0.0 110.678 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.528 HG21 ' HA ' ' A' ' 16' ' ' VAL . 8.2 p -134.24 136.31 53.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.954 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.7 ttm -104.28 116.53 32.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.967 0.413 . . . . 0.0 111.233 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.514 HG13 HD11 ' A' ' 48' ' ' LEU . 45.2 mm -91.18 115.55 30.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.489 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 74.3 mtp180 -97.46 118.78 34.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.127 0.489 . . . . 0.0 110.952 -171.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -100.03 116.59 32.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.857 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 t -149.16 -177.58 5.9 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.27 104.59 0.15 Allowed 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.386 0.429 . . . . 0.0 111.608 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.1 p 67.75 -52.96 0.51 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.005 1.322 . . . . 0.0 113.504 177.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.95 81.81 0.54 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.451 -0.404 . . . . 0.0 113.23 -174.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.413 ' HB3' HD12 ' A' ' 33' ' ' LEU . 61.2 m80 -70.84 110.42 5.59 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m -114.66 151.9 32.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.936 0.398 . . . . 0.0 111.546 -170.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.444 ' HB2' HD21 ' A' ' 40' ' ' LEU . . . -124.35 118.57 27.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.66 175.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -106.11 106.91 17.64 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.044 0.449 . . . . 0.0 110.912 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.528 ' HA ' HG21 ' A' ' 3' ' ' VAL . 29.9 t -93.71 96.51 6.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.666 176.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.82 -45.55 86.0 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.348 -173.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.738 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 49.2 pttt -63.79 -35.22 79.9 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.732 0.301 . . . . 0.0 111.054 -177.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.604 ' HZ2' HD11 ' A' ' 21' ' ' LEU . 48.0 tttm -90.42 -9.97 45.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.882 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 62.07 20.51 11.68 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.042 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.604 HD11 ' HZ2' ' A' ' 19' ' ' LYS . 4.2 tt -106.23 128.8 54.22 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -175.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.484 ' N ' HD22 ' A' ' 21' ' ' LEU . 45.3 tt0 -131.0 113.89 14.53 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 175.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.459 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 7.7 tp10 -136.4 160.36 38.99 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.941 0.401 . . . . 0.0 111.014 -175.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.2 mt -79.4 143.49 35.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.763 175.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 68.6 mt -90.0 123.13 42.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.2 m -110.59 -27.42 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -176.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.58 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 52.5 mm-40 -129.85 100.56 5.52 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.765 0.317 . . . . 0.0 110.988 -176.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.546 ' SD ' ' N ' ' A' ' 28' ' ' MET . 1.0 OUTLIER -99.97 155.37 17.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.399 -178.546 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -67.99 -53.54 25.22 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 170.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.519 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 59.3 t30 -97.42 131.16 27.77 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.042 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.519 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 2.8 Cg_endo -42.06 -39.98 6.07 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 124.185 3.257 . . . . 0.0 113.182 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.52 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -69.16 -66.39 0.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.462 177.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' A' ' 12' ' ' HIS . 4.5 mt 178.7 -72.63 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.255 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.592 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 41.1 m95 -72.66 140.41 47.91 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.053 -173.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.19 -23.83 0.88 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 121.278 -0.487 . . . . 0.0 112.287 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.86 -137.19 3.6 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.968 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.516 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -67.09 146.72 54.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.332 0.587 . . . . 0.0 111.941 -176.427 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.0 m -137.68 136.91 45.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 172.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 26.8 m -111.32 128.55 55.99 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.727 0.298 . . . . 0.0 110.765 -175.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.459 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . 80.6 mt -72.37 157.2 38.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.985 176.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.16 -17.74 58.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.306 0.574 . . . . 0.0 110.582 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -69.61 -28.55 66.03 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.49 176.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.78 -18.84 26.44 Favored Glycine 0 C--N 1.331 0.269 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -175.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.701 ' HZ2' ' HD2' ' A' ' 65' ' ' LYS . 41.2 t-105 -71.0 141.51 50.99 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -114.43 146.48 40.57 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.255 0.55 . . . . 0.0 111.735 -175.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.6 tp -135.3 141.9 45.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.659 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.579 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 38.5 tt0 -92.42 105.63 17.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.187 0.518 . . . . 0.0 110.049 -178.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.514 HD11 HG13 ' A' ' 5' ' ' ILE . 18.9 tp -83.22 126.44 72.05 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.537 -174.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.42 ' HB2' ' HE1' ' A' ' 51' ' ' MET . 75.2 Cg_exo -51.83 145.15 32.76 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.0 2.466 . . . . 0.0 113.203 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.7 88.2 7.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.967 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.42 ' HE1' ' HB2' ' A' ' 49' ' ' PRO . 23.5 ptp -135.37 -152.39 0.46 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.439 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.54 112.47 0.6 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.656 0.265 . . . . 0.0 110.562 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.592 ' HA ' ' HB2' ' A' ' 34' ' ' TRP . . . -63.91 -27.19 68.98 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.161 -173.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -135.66 93.51 2.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.148 0.499 . . . . 0.0 110.644 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.0 p -79.67 129.84 69.78 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.672 174.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.04 -8.43 23.58 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.398 2.065 . . . . 0.0 111.936 -178.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.2 pp -138.23 158.08 71.54 Favored Pre-proline 0 C--O 1.236 0.376 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.456 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.489 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . 38.2 Cg_endo -66.19 136.13 42.89 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.437 2.091 . . . . 0.0 111.058 174.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.5 tt -136.78 144.31 32.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.877 0.37 . . . . 0.0 110.944 -174.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.453 HG23 ' HG3' ' A' ' 2' ' ' LYS . 63.7 m -98.11 130.77 44.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.145 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 3' ' ' VAL . 26.3 m -140.14 179.41 2.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 120.968 0.413 . . . . 0.0 111.599 -174.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -64.03 138.67 58.57 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.212 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.434 ' HB3' ' HB ' ' A' ' 3' ' ' VAL . . . -108.37 123.41 48.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.022 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.579 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -122.89 102.04 7.79 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 175.047 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.701 ' HD2' ' HZ2' ' A' ' 44' ' ' TRP . 28.2 ttpt -65.16 145.3 56.45 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.691 -176.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.451 HD22 ' HB2' ' A' ' 47' ' ' GLU . 91.3 mt . . . . . 0 C--O 1.253 1.253 0 CA-C-O 118.821 -0.609 . . . . 0.0 109.847 175.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.671 ' SD ' ' NH1' ' A' ' 64' ' ' ARG . 59.1 mtt . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -114.32 115.33 27.21 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.99 -173.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.1 p -137.72 127.83 36.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.04 0.448 . . . . 0.0 110.002 174.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.459 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 23.2 ttt -101.71 111.87 24.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.349 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.1 mm -77.21 117.61 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -96.38 118.53 33.09 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.317 -172.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.448 ' NZ ' ' O ' ' A' ' 54' ' ' ASP . 14.3 mmmm -106.08 118.43 36.59 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.05 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 72.5 m -142.23 157.3 45.0 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.65 107.26 0.11 Allowed 'General case' 0 C--O 1.233 0.233 0 O-C-N 123.094 0.247 . . . . 0.0 110.675 178.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.5 p 66.92 -41.38 0.4 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.272 1.429 . . . . 0.0 112.916 -176.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.07 105.31 1.6 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.321 -0.466 . . . . 0.0 112.682 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -104.61 121.88 44.46 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 175.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.409 ' HB3' HD22 ' A' ' 24' ' ' LEU . 33.7 p -138.68 160.8 38.75 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.761 0.315 . . . . 0.0 110.177 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.495 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -128.0 115.81 19.07 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -87.22 103.19 15.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.59 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.1 t -74.34 89.04 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.207 175.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.3 -34.61 70.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.147 -172.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.43 -12.27 59.84 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -177.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.408 ' O ' ' HG2' ' A' ' 19' ' ' LYS . 39.1 tttm -127.2 -7.82 5.9 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.484 0.183 . . . . 0.0 110.973 178.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.3 t70 67.94 17.21 9.62 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.758 0.79 . . . . 0.0 110.332 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.45 HD22 ' HG2' ' A' ' 23' ' ' GLU . 7.6 tt -88.42 134.71 33.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.192 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -134.09 111.04 10.02 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 173.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.544 ' HB2' ' HB3' ' A' ' 40' ' ' LEU . 78.1 mm-40 -116.61 160.14 21.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.27 177.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.409 HD22 ' HB3' ' A' ' 13' ' ' SER . 83.1 mt -76.95 136.2 38.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.549 175.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.623 HG22 ' HE1' ' A' ' 28' ' ' MET . 85.9 mt -71.96 107.26 2.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.035 175.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.0 m -94.79 -22.77 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.179 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.565 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 32.7 tt0 -142.45 142.57 32.35 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.097 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.623 ' HE1' HG22 ' A' ' 25' ' ' ILE . 1.0 OUTLIER -123.72 177.24 5.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.096 -177.005 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.451 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 8.2 tp10 -84.2 -56.79 3.47 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 168.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.6 t-20 -95.59 137.63 21.93 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.819 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -44.64 -22.59 0.65 Allowed 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.642 2.895 . . . . 0.0 113.076 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.22 -69.25 0.62 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.169 173.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.4 tp -177.94 -75.55 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.922 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.475 ' HE3' ' O ' ' A' ' 49' ' ' PRO . 29.4 m95 -72.11 137.42 47.03 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.659 -176.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.506 ' HA2' ' HB3' ' A' ' 50' ' ' ALA . . . -179.67 -40.45 0.07 OUTLIER Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.419 -0.895 . . . . 0.0 113.356 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.49 -71.43 0.05 OUTLIER Glycine 0 C--O 1.225 -0.419 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.959 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.451 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -120.28 164.54 16.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.0 0.429 . . . . 0.0 111.143 176.348 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 46' ' ' LEU . 14.8 p -147.34 147.02 17.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 45.7 m -121.45 133.03 55.05 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.257 0.551 . . . . 0.0 111.126 -177.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.544 ' HB3' ' HB2' ' A' ' 23' ' ' GLU . 3.6 mm? -92.28 155.92 17.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.886 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.57 -34.68 51.64 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -90.03 -1.62 57.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.881 0.372 . . . . 0.0 111.442 -171.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.94 -27.61 8.15 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.518 174.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -59.4 140.23 56.34 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.872 0.336 . . . . 0.0 110.6 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.428 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 46.2 mt-30 -122.13 144.15 49.11 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.524 HD11 ' N ' ' A' ' 47' ' ' GLU . 1.6 tm? -133.67 140.49 47.09 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -176.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.524 ' N ' HD11 ' A' ' 46' ' ' LEU . 38.0 tt0 -81.69 112.13 18.59 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.9 tp -110.97 95.18 23.08 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.27 -175.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.475 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 21.7 Cg_exo -65.46 151.28 85.43 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.782 2.321 . . . . 0.0 112.298 -175.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.506 ' HB3' ' HA2' ' A' ' 35' ' ' GLY . . . -74.74 81.34 2.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.98 0.419 . . . . 0.0 110.491 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.2 mmt -95.08 -63.72 1.14 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.201 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.446 ' HB3' HG23 ' A' ' 55' ' ' THR . . . -144.73 112.67 6.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.003 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.12 99.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.5 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.448 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . 6.7 p-10 -70.74 -54.99 9.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.395 -176.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.446 HG23 ' HB3' ' A' ' 52' ' ' ALA . 1.2 p 41.63 88.38 0.1 Allowed Pre-proline 0 N--CA 1.471 0.6 0 C-N-CA 123.11 0.564 . . . . 0.0 112.0 -177.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.55 -20.94 30.47 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.783 2.322 . . . . 0.0 112.956 -173.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.4 pp -125.97 153.93 73.79 Favored Pre-proline 0 C--O 1.236 0.35 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.63 -177.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.67 94.7 0.39 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.511 2.141 . . . . 0.0 111.693 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.7 tt -89.19 143.36 11.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.968 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 4' ' ' MET . 28.0 m -97.76 130.6 44.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.917 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.7 m -126.57 177.05 5.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 121.028 0.442 . . . . 0.0 111.194 -177.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -78.11 125.18 28.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.249 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.17 122.95 28.01 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -173.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.671 ' NH1' ' SD ' ' A' ' 1' ' ' MET . 4.6 mpt_? -118.48 100.53 7.52 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 168.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -74.78 131.8 41.09 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 82.7 mt . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.554 -0.736 . . . . 0.0 109.698 178.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 49.0 ttm . . . . . 0 N--CA 1.484 1.229 0 CA-C-O 120.773 0.32 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -109.13 133.23 53.28 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 120.803 0.335 . . . . 0.0 111.416 -176.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.513 ' HB ' ' HB3' ' A' ' 63' ' ' ALA . 14.5 p -144.0 134.25 20.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.747 174.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.5 ttp -103.54 114.02 27.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.778 0.323 . . . . 0.0 110.224 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.4 mm -90.15 116.66 31.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.072 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -94.13 147.46 23.13 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.035 0.445 . . . . 0.0 110.198 -175.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 55' ' ' THR . 36.4 mmtm -121.3 151.58 39.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.446 -176.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.44 HG22 ' N ' ' A' ' 9' ' ' ALA . 59.9 m -159.59 164.01 34.57 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.44 ' N ' HG22 ' A' ' 8' ' ' THR . . . -39.37 -42.75 1.1 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.881 0.472 . . . . 0.0 112.002 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.6 t -146.75 -32.66 0.31 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.763 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.97 75.75 0.74 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.312 -0.471 . . . . 0.0 112.999 -177.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -68.33 138.0 55.08 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.8 p -145.08 162.8 36.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.697 0.284 . . . . 0.0 110.955 -178.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.483 ' HB1' HD11 ' A' ' 40' ' ' LEU . . . -139.61 143.88 37.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.655 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 59.7 t80 -126.37 112.44 15.66 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.0 t -85.6 123.01 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.281 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.49 -70.58 0.12 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.86 -15.88 60.0 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -172.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.764 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 57.9 tptt -101.41 -15.63 17.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.494 0.187 . . . . 0.0 110.712 -177.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 58.91 25.0 13.15 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.382 0.61 . . . . 0.0 110.188 -177.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.764 ' HB2' ' HG3' ' A' ' 19' ' ' LYS . 7.0 tt -90.96 124.33 35.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.181 -173.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -128.25 109.19 11.24 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -133.23 161.03 35.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.093 -176.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.4 mt -77.83 146.53 35.67 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.564 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.462 HG21 ' HE3' ' A' ' 28' ' ' MET . 72.2 mt -88.79 112.79 24.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.707 177.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.5 m -101.5 -37.46 5.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 116.805 -0.18 . . . . 0.0 111.482 -178.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.459 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 39.1 tt0 -127.43 119.5 26.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.896 0.379 . . . . 0.0 110.642 -178.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.517 ' SD ' ' N ' ' A' ' 28' ' ' MET . 1.2 mpt? -103.43 158.13 16.55 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 9.0 tp10 -60.12 -58.7 7.42 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.132 0.492 . . . . 0.0 109.924 174.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.461 HD21 ' N ' ' A' ' 30' ' ' ASN . 0.9 OUTLIER -96.98 153.4 38.55 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.248 175.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.8 -14.87 23.92 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.711 2.274 . . . . 0.0 112.741 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.82 -69.75 0.59 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.104 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.49 ' HA ' ' HG2' ' A' ' 28' ' ' MET . 1.3 tm? -176.05 -67.89 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -178.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 56.8 m95 -84.24 160.84 20.7 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.551 -177.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 168.89 -57.59 0.2 Allowed Glycine 0 C--N 1.337 0.596 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.338 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.42 -64.12 0.02 OUTLIER Glycine 0 C--N 1.33 0.226 0 C-N-CA 121.295 -0.479 . . . . 0.0 112.118 -175.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 1.7 pptp? -131.27 168.62 17.21 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.786 0.327 . . . . 0.0 110.901 175.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.0 p -147.08 152.35 13.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.589 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.459 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 44.9 m -123.26 127.82 49.11 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 120.982 0.42 . . . . 0.0 110.856 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.483 HD11 ' HB1' ' A' ' 14' ' ' ALA . 3.4 mm? -79.38 159.69 26.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.434 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.87 -29.0 66.66 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.021 -175.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -74.87 -31.68 61.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.891 0.377 . . . . 0.0 110.466 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 128.85 -10.32 6.32 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.494 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.524 ' CE3' HD11 ' A' ' 21' ' ' LEU . 3.2 m-90 -69.9 141.98 53.06 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.142 0.471 . . . . 0.0 110.985 178.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -103.48 137.35 41.68 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.602 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 58.3 tp -130.39 141.99 50.53 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 177.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 29.8 tt0 -80.88 122.45 27.24 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.0 tp -114.28 100.18 52.32 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.886 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.429 ' HB2' ' HE3' ' A' ' 51' ' ' MET . 20.9 Cg_endo -58.65 150.78 67.61 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.788 2.326 . . . . 0.0 112.687 -173.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.77 90.49 0.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.547 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.429 ' HE3' ' HB2' ' A' ' 49' ' ' PRO . 26.3 mmt -114.64 -173.09 2.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.427 176.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.62 114.21 2.16 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.672 0.273 . . . . 0.0 110.61 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.81 -50.48 73.82 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.213 -178.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -80.39 76.87 7.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.399 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.492 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 1.4 p -116.01 98.65 51.58 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.736 173.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -77.67 -7.12 16.57 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.65 2.233 . . . . 0.0 112.492 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.444 HD11 ' O ' ' A' ' 57' ' ' LEU . 2.5 pp -102.11 149.67 36.78 Favored Pre-proline 0 C--O 1.239 0.546 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.355 -177.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.57 92.56 0.68 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.54 2.16 . . . . 0.0 111.356 175.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.481 HG23 ' HZ3' ' A' ' 7' ' ' LYS . 8.7 tt -93.62 142.29 13.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.595 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.2 m -100.8 123.11 44.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.189 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.3 m -126.44 178.5 4.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 120.834 0.35 . . . . 0.0 110.736 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 1' ' ' MET . 6.7 mp0 -69.21 149.61 48.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.397 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.513 ' HB3' ' HB ' ' A' ' 3' ' ' VAL . . . -119.5 133.19 55.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.003 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.525 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 14.9 tpt180 -134.89 122.21 21.66 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 174.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -83.17 123.69 29.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.045 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.495 HD12 ' HB2' ' A' ' 47' ' ' GLU . 7.2 mp . . . . . 0 C--O 1.25 1.113 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.488 ' HE3' ' HG2' ' A' ' 18' ' ' LYS . 91.7 mmm . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.574 ' HZ1' ' HB2' ' A' ' 2' ' ' LYS . 4.3 ttmp? -113.25 137.8 50.95 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.618 0.247 . . . . 0.0 111.111 -174.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.457 HG23 ' HA ' ' A' ' 16' ' ' VAL . 14.5 p -145.91 138.78 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.306 175.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 47.0 ttm -111.2 114.79 28.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.301 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.2 mm -86.2 113.52 24.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -104.98 139.19 40.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.246 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -138.41 135.67 35.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.326 178.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.6 m -108.83 -53.8 2.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.366 0.603 . . . . 0.0 109.544 174.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -170.75 -91.03 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.576 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.5 t -76.84 -28.32 55.45 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 168.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.94 98.07 0.77 Allowed Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.798 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -107.5 121.86 45.47 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 175.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.3 p -135.17 161.04 36.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.918 0.389 . . . . 0.0 110.844 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.518 ' HB2' HD12 ' A' ' 40' ' ' LEU . . . -137.19 119.07 15.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.404 178.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -90.06 102.29 15.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.015 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.457 ' HA ' HG23 ' A' ' 3' ' ' VAL . 49.2 t -77.24 90.71 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.59 -31.54 57.11 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.184 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.488 ' HG2' ' HE3' ' A' ' 1' ' ' MET . 48.9 tptt -52.85 -54.64 31.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.136 176.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.552 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 9.3 tmtt? -94.92 -5.04 45.74 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.641 -176.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.7 t70 60.07 27.32 16.75 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 122.139 0.971 . . . . 0.0 109.06 -174.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.41 ' HB2' ' HD2' ' A' ' 19' ' ' LYS . 6.9 tt -106.31 118.5 36.8 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.686 -175.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -108.05 132.54 53.45 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 172.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -144.86 161.53 39.06 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -176.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.9 mt -78.23 140.16 38.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.427 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.671 HG23 ' HE2' ' A' ' 28' ' ' MET . 77.2 mt -84.6 122.86 38.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.036 178.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.9 m -112.3 -35.75 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -174.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.525 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 4.7 tm-20 -129.46 123.78 32.4 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -176.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.671 ' HE2' HG23 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -124.11 140.93 52.5 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.754 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.576 ' HB2' ' HD3' ' A' ' 37' ' ' LYS . 33.0 tt0 -58.22 -36.2 72.8 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.283 0.563 . . . . 0.0 110.362 176.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -109.05 140.36 21.85 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.898 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -49.54 -34.65 34.55 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.225 2.617 . . . . 0.0 112.637 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.78 -68.93 0.5 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.304 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.523 ' HB3' ' HD1' ' A' ' 34' ' ' TRP . 21.2 tp 178.89 -68.46 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.459 -178.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.523 ' HD1' ' HB3' ' A' ' 33' ' ' LEU . 13.6 m95 -78.14 135.23 37.62 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.516 -176.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 50' ' ' ALA . . . -172.17 -48.36 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.434 -177.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.34 -72.91 0.05 OUTLIER Glycine 0 C--O 1.226 -0.383 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -176.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.576 ' HD3' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -123.21 155.34 37.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.979 0.419 . . . . 0.0 111.004 176.456 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 46' ' ' LEU . 8.5 p -146.72 157.09 11.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.45 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 34.9 m -127.03 129.86 48.85 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.087 0.47 . . . . 0.0 111.111 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.518 HD12 ' HB2' ' A' ' 14' ' ' ALA . 3.7 mm? -81.23 163.75 22.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.086 175.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.1 -24.36 66.18 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.898 0.38 . . . . 0.0 111.432 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -83.99 5.59 25.11 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.67 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.34 8.39 87.21 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.589 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.447 ' HE1' HD21 ' A' ' 46' ' ' LEU . 33.3 t-105 -76.65 112.33 13.09 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -88.96 115.86 26.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.992 0.425 . . . . 0.0 110.48 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.49 HD23 ' HB1' ' A' ' 63' ' ' ALA . 2.3 tm? -118.9 136.27 54.14 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -176.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.468 ' N ' HD11 ' A' ' 46' ' ' LEU . 36.8 tt0 -79.8 111.85 16.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 0.0 110.366 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.5 tp -109.35 99.99 39.23 Favored Pre-proline 0 C--O 1.236 0.384 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.953 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.405 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 19.2 Cg_exo -65.36 153.33 78.74 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.612 2.208 . . . . 0.0 112.106 -174.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.433 ' HB3' ' HA2' ' A' ' 35' ' ' GLY . . . -79.53 83.76 5.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.785 0.326 . . . . 0.0 110.141 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 93.2 mmm -113.0 -79.6 0.58 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.309 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -127.84 101.12 6.21 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.481 ' HA ' ' CD1' ' A' ' 34' ' ' TRP . . . -79.14 -50.94 10.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.325 -175.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -95.25 27.07 3.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.929 -173.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.6 t -65.37 134.0 95.56 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -83.56 -1.62 10.2 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.613 2.209 . . . . 0.0 113.591 -175.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.421 HD13 ' O ' ' A' ' 57' ' ' LEU . 3.2 pp -120.9 149.36 50.71 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.441 0.163 . . . . 0.0 111.135 -175.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.35 95.71 0.46 Allowed 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.305 2.003 . . . . 0.0 111.244 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.6 tt -89.21 142.11 13.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.849 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.4 m -101.94 123.17 45.39 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.624 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.3 m -127.69 178.0 5.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.957 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -69.54 149.93 47.68 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.547 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.49 ' HB1' HD23 ' A' ' 46' ' ' LEU . . . -115.56 151.22 35.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.117 -177.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -153.3 121.47 6.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.616 175.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -87.19 121.31 29.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.816 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.419 HD22 ' N ' ' A' ' 66' ' ' LEU . 2.3 mm? . . . . . 0 C--O 1.248 1.026 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 172.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.623 ' SD ' ' HG2' ' A' ' 64' ' ' ARG . 59.9 mtt . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -130.52 111.76 12.57 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -169.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.555 HG12 HD12 ' A' ' 46' ' ' LEU . 7.4 p -142.09 130.45 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 171.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 46.8 ttm -101.06 112.05 24.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.0 mm -86.98 129.49 38.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -96.2 132.35 41.73 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 55' ' ' THR . 0.1 OUTLIER -107.98 116.58 32.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.368 0.604 . . . . 0.0 112.066 -166.038 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 t -177.41 131.35 0.16 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.783 171.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.55 -26.14 68.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.586 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.9 p -103.27 20.66 17.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.548 -176.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.87 49.43 0.12 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.82 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -57.4 123.74 16.51 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.469 ' HB3' HD22 ' A' ' 24' ' ' LEU . 10.7 p -151.03 162.48 40.77 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.367 -0.235 . . . . 0.0 110.367 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.415 ' HB3' HD21 ' A' ' 40' ' ' LEU . . . -145.57 136.11 24.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.233 -177.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -105.12 102.55 12.04 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 174.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.479 ' HA ' HG21 ' A' ' 3' ' ' VAL . 47.1 t -84.44 95.07 3.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.85 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.91 -26.4 64.29 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.562 -176.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -52.97 -39.44 63.0 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 175.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.515 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 2.6 tmtp? -116.05 -6.76 11.95 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 16' ' ' VAL . 19.1 m-20 59.69 26.01 15.05 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.614 -170.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.443 ' HB2' ' HB3' ' A' ' 19' ' ' LYS . 5.1 tt -84.33 125.95 32.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.67 -176.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.43 ' N ' HD22 ' A' ' 21' ' ' LEU . 43.0 tt0 -116.22 120.46 39.04 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.453 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 7.4 tp10 -147.81 161.97 40.18 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.986 0.422 . . . . 0.0 111.184 -176.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.469 HD22 ' HB3' ' A' ' 13' ' ' SER . 96.3 mt -82.05 137.86 34.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.689 174.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.2 mt -83.05 106.33 13.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.458 HG21 ' HG3' ' A' ' 27' ' ' GLU . 16.5 m -81.96 -34.4 12.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.398 -177.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.458 ' HG3' HG21 ' A' ' 26' ' ' VAL . 48.6 mt-10 -132.83 140.16 47.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.334 -177.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.462 ' HG2' ' HA ' ' A' ' 33' ' ' LEU . 2.5 mpp? -126.15 160.0 31.39 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.44 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 14.7 tp10 -64.53 -41.63 96.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.229 0.538 . . . . 0.0 109.702 174.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -118.8 152.2 51.18 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.543 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -49.62 -33.03 29.97 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.161 2.574 . . . . 0.0 113.21 -177.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.36 -68.67 0.48 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.744 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.462 ' HA ' ' HG2' ' A' ' 28' ' ' MET . 3.7 tt -178.39 -71.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.977 0.417 . . . . 0.0 110.227 -178.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.692 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 31.7 m95 -76.65 155.72 33.21 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.27 -173.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 162.34 -42.54 0.36 Allowed Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.836 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.0 -65.61 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.44 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -144.79 167.93 21.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.793 0.33 . . . . 0.0 111.205 178.153 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.4 m -139.41 172.43 12.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.339 174.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.2 m -132.79 122.39 24.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.319 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.545 HD11 ' HB3' ' A' ' 44' ' ' TRP . 85.9 mt -78.17 155.99 30.12 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.159 176.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.16 -9.31 22.04 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.022 0.439 . . . . 0.0 111.308 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.42 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 28.2 t-20 -86.54 -13.13 46.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.251 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.88 -1.32 59.55 Favored Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.785 -176.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.545 ' HB3' HD11 ' A' ' 40' ' ' LEU . 15.3 t-105 -80.16 121.02 25.06 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 178.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -94.84 131.11 41.07 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.555 HD12 HG12 ' A' ' 3' ' ' VAL . 1.0 OUTLIER -122.66 132.38 54.24 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.259 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.555 ' HB3' ' HB2' ' A' ' 64' ' ' ARG . 32.2 tt0 -90.6 122.69 33.62 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.774 0.321 . . . . 0.0 110.87 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.418 HD11 ' CZ3' ' A' ' 34' ' ' TRP . 3.2 mm? -109.6 100.76 43.58 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -65.34 71.22 0.29 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.344 2.696 . . . . 0.0 113.469 -173.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 36.9 89.05 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.375 1.07 . . . . 0.0 113.489 175.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.479 ' HB2' ' CE3' ' A' ' 34' ' ' TRP . 25.2 mmt -129.62 -169.02 2.03 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 174.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.64 108.72 0.37 Allowed 'General case' 0 CA--C 1.532 0.273 0 O-C-N 123.098 0.249 . . . . 0.0 110.794 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.692 ' HA ' ' HB2' ' A' ' 34' ' ' TRP . . . -50.57 -37.06 37.62 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.746 -175.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.428 ' CG ' ' HZ2' ' A' ' 7' ' ' LYS . 18.5 t70 -128.07 70.78 1.36 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 175.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.487 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 3.9 t -57.5 139.9 80.42 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.133 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.57 5.2 4.42 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.825 2.35 . . . . 0.0 113.352 -176.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.413 HD22 ' N ' ' A' ' 57' ' ' LEU . 2.5 pt? -152.07 147.69 20.2 Favored Pre-proline 0 C--O 1.234 0.267 0 O-C-N 122.512 -0.118 . . . . 0.0 110.966 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.99 94.33 0.28 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.622 2.215 . . . . 0.0 110.648 173.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.8 tt -96.35 150.56 4.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.08 0.467 . . . . 0.0 111.741 -172.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 90.3 m -98.93 127.75 44.93 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.14 175.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.408 ' O ' HG11 ' A' ' 3' ' ' VAL . 31.6 m -133.05 179.36 4.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 120.863 0.363 . . . . 0.0 111.02 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -55.97 108.87 0.5 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.042 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.482 ' HB3' ' HB ' ' A' ' 3' ' ' VAL . . . -72.56 109.59 6.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.531 173.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.623 ' HG2' ' SD ' ' A' ' 1' ' ' MET . 91.7 mtt180 -132.81 135.01 45.41 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -108.53 150.58 27.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.02 0.438 . . . . 0.0 110.947 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.7 mt . . . . . 0 C--O 1.252 1.22 0 CA-C-O 118.449 -0.786 . . . . 0.0 109.659 175.02 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.64 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 121.474 0.654 . . . . 0.0 110.748 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -100.84 118.97 37.96 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.469 -175.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.484 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 11.5 p -137.8 132.58 44.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 174.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 57.9 ttp -112.23 117.6 32.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.293 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 58' ' ' PRO . 43.0 mm -87.44 119.38 34.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 176.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 6' ' ' ARG . 41.7 mtm180 -96.28 125.65 40.94 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.948 0.404 . . . . 0.0 110.039 -179.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 55' ' ' THR . 32.3 mmtp -85.65 115.65 23.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.596 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.6 m -159.1 134.01 8.17 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.37 -74.73 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -173.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 42.1 m -74.58 -29.24 61.25 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.918 0.39 . . . . 0.0 110.584 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.06 40.57 2.38 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.144 -0.551 . . . . 0.0 113.674 -174.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -58.81 115.56 3.17 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 172.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.7 p -138.1 151.22 47.59 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.013 0.435 . . . . 0.0 111.364 -174.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -122.5 115.74 22.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.955 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -96.22 103.61 15.52 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.949 0.404 . . . . 0.0 111.166 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.9 t -79.93 101.74 5.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.846 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.13 -37.45 83.85 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -173.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.801 ' HZ1' ' HB2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -68.21 -3.96 12.4 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -175.677 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.681 ' HD2' ' HB2' ' A' ' 21' ' ' LEU . 7.4 tmtm? -131.75 -16.73 2.92 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.038 0.447 . . . . 0.0 109.836 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.6 t70 59.23 60.97 2.19 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.89 0.853 . . . . 0.0 109.265 -170.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.681 ' HB2' ' HD2' ' A' ' 19' ' ' LYS . 7.2 tt -132.18 119.86 21.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.995 -179.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -127.8 121.02 29.11 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.418 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 8.9 tp10 -130.31 162.28 29.38 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.4 mt -77.1 133.62 38.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.093 0.473 . . . . 0.0 110.857 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.455 HG23 ' HB ' ' A' ' 38' ' ' VAL . 73.9 mt -80.72 103.48 7.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.635 176.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.2 m -104.98 -1.0 9.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.976 0.417 . . . . 0.0 111.207 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.635 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 9.4 tp10 -147.61 137.85 23.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.935 -177.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 64.4 mtt -139.45 138.28 36.3 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -65.5 -45.56 83.1 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.07 143.65 27.02 Favored Pre-proline 0 N--CA 1.465 0.293 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 171.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.06 -21.88 67.23 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.892 2.395 . . . . 0.0 113.122 -174.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -75.24 -68.82 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.684 0.278 . . . . 0.0 110.55 178.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 3.8 tt 171.18 -60.29 0.01 OUTLIER 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.472 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 55.0 m95 -85.59 128.72 34.84 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.079 -178.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 148.1 50.55 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 -177.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 122.36 -95.22 0.54 Allowed Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 175.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.44 156.17 44.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.086 0.469 . . . . 0.0 111.039 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.455 ' HB ' HG23 ' A' ' 25' ' ' ILE . 20.4 m -125.78 149.35 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 172.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.635 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 22.6 m -109.91 121.07 44.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.084 0.468 . . . . 0.0 110.275 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.418 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . 3.1 mm? -67.01 157.03 34.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.831 177.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.71 -28.54 34.57 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -172.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -95.6 2.36 54.14 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -174.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.94 -14.49 28.94 Favored Glycine 0 N--CA 1.459 0.207 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.602 175.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -62.41 148.4 45.55 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.4 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 34.4 mt-30 -125.35 145.81 49.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.722 0.296 . . . . 0.0 110.369 177.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 52.9 tp -132.33 139.63 48.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -93.58 118.1 30.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.619 0.247 . . . . 0.0 110.891 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.415 ' N ' HD23 ' A' ' 48' ' ' LEU . 2.7 mm? -121.14 107.56 37.29 Favored Pre-proline 0 N--CA 1.465 0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.206 177.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.67 156.24 66.67 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.35 2.033 . . . . 0.0 111.017 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.56 74.25 0.78 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.006 0.431 . . . . 0.0 110.034 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 95.4 mmm -89.74 -65.2 1.04 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.878 -177.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.92 102.96 2.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.656 178.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.472 ' HA ' ' CD1' ' A' ' 34' ' ' TRP . . . -65.46 -37.65 87.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.873 -178.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.434 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . 5.3 p-10 -56.94 -69.28 0.16 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.176 -178.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.498 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 1.9 p 27.94 87.14 0.1 Allowed Pre-proline 0 N--CA 1.472 0.649 0 C-N-CA 123.837 0.855 . . . . 0.0 113.089 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -78.19 13.62 1.74 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.025 2.483 . . . . 0.0 112.829 -177.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -141.71 153.09 64.46 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.857 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 32.0 Cg_endo -63.91 97.36 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.453 2.102 . . . . 0.0 111.419 177.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.4 tt -89.43 148.35 4.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.811 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 63.2 m -111.54 120.54 42.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.688 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.8 m -125.04 177.66 4.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.089 0.471 . . . . 0.0 111.734 -176.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.43 ' HG3' ' HG3' ' A' ' 1' ' ' MET . 40.8 tt0 -61.43 108.96 1.03 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.731 177.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.484 ' HB1' ' HB ' ' A' ' 3' ' ' VAL . . . -74.47 123.57 24.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.484 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.7 ttm105 -138.44 102.77 4.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.876 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.42 ' C ' ' HD3' ' A' ' 65' ' ' LYS . 13.7 tmtt? -82.13 129.75 34.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.54 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 77.5 mt . . . . . 0 C--O 1.253 1.24 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.26 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.541 0.21 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.493 ' HE2' HG23 ' A' ' 60' ' ' THR . 15.4 tptm -125.3 142.65 51.38 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -178.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.58 HG12 HD21 ' A' ' 46' ' ' LEU . 12.3 p -147.62 147.07 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 116.662 -0.244 . . . . 0.0 110.78 -178.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.539 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 27.0 ttt -110.97 113.56 26.2 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 176.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.9 mm -92.41 128.43 44.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.085 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.418 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 81.1 mtp180 -97.02 118.89 34.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.067 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -121.1 124.98 46.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.534 -176.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 42.9 p -134.76 176.26 8.81 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 169.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.21 -33.43 73.46 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.893 0.378 . . . . 0.0 111.113 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.0 p -111.93 -56.58 2.37 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.315 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.58 137.48 20.28 Favored Glycine 0 C--O 1.237 0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 113.387 -174.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -128.2 118.72 23.85 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.418 ' HB3' ' HB2' ' A' ' 6' ' ' ARG . 23.1 t -142.22 162.37 35.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.739 0.304 . . . . 0.0 110.204 -176.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.465 ' HB2' HD11 ' A' ' 40' ' ' LEU . . . -140.74 134.97 31.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.277 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -118.91 107.68 13.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.222 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 37.1 t -75.85 104.51 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.35 -69.59 0.12 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -171.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -12.36 54.36 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -171.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.479 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 17.2 tppt? -100.17 -20.38 15.99 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.719 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 61.59 29.08 18.11 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.111 0.481 . . . . 0.0 110.732 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.479 ' HB2' ' HG3' ' A' ' 19' ' ' LYS . 7.4 tt -101.82 120.2 40.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.746 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -117.77 132.17 56.49 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 172.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 8.2 tp10 -147.03 165.6 29.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.419 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.409 HD13 ' N ' ' A' ' 25' ' ' ILE . 1.3 tp -86.71 140.66 29.56 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 122.988 0.515 . . . . 0.0 110.359 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.409 ' N ' HD13 ' A' ' 24' ' ' LEU . 79.4 mt -80.13 113.24 19.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.541 177.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.4 m -106.57 -27.52 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -177.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.483 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 4.0 tm-20 -138.17 133.32 33.14 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -177.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.447 ' SD ' ' O ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -142.59 147.0 35.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 0.0 111.082 -178.135 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -67.27 -65.0 0.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.956 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -75.36 138.37 71.44 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.17 -177.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -46.7 -26.11 4.21 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.63 2.887 . . . . 0.0 112.942 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -93.85 -68.44 0.8 Allowed 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 173.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 32.0 tp 174.44 -63.2 0.01 OUTLIER 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.553 -176.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.477 ' HZ3' HG21 ' A' ' 61' ' ' VAL . 63.9 m95 -75.47 134.82 40.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.241 -172.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.95 -13.45 5.0 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.17 -0.538 . . . . 0.0 112.041 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -168.85 -150.7 6.81 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.832 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.647 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -85.61 162.86 18.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.457 0.646 . . . . 0.0 112.696 -173.416 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 46' ' ' LEU . 8.7 p -146.7 158.82 10.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.2 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 31.4 m -133.29 128.27 35.4 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.083 0.468 . . . . 0.0 110.216 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' A' ' 14' ' ' ALA . 3.4 mm? -81.74 165.61 20.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.206 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.29 -19.61 63.45 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.104 0.478 . . . . 0.0 111.152 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.414 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 61.8 t30 -83.79 -4.39 58.61 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.522 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.33 0.36 82.62 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.971 -176.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 42.2 t-105 -66.06 121.7 15.73 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -100.5 120.2 39.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.902 0.382 . . . . 0.0 110.538 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.58 HD21 HG12 ' A' ' 3' ' ' VAL . 62.7 tp -130.25 135.26 47.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.588 -178.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.647 ' HA ' ' HA ' ' A' ' 37' ' ' LYS . 30.1 tt0 -104.63 126.36 51.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.792 0.329 . . . . 0.0 110.569 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.36 136.17 64.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.909 177.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -81.66 29.72 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.908 2.406 . . . . 0.0 112.834 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 62.52 104.97 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.559 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.5 mmt -139.36 -176.66 4.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.25 178.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.57 122.58 14.43 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.274 0.359 . . . . 0.0 110.47 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.16 -38.71 90.08 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.092 0.472 . . . . 0.0 109.794 176.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -69.95 94.82 0.88 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.957 177.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.6 p -131.67 90.17 37.54 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.272 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -86.33 12.9 2.88 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.142 2.561 . . . . 0.0 111.868 177.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.1 pp -145.84 154.87 51.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.332 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.8 125.24 10.87 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.387 2.058 . . . . 0.0 111.429 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.9 tt -126.08 137.08 58.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 120.883 0.373 . . . . 0.0 111.045 -177.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 4' ' ' MET . 26.1 m -90.66 120.02 31.38 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.169 177.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.477 HG21 ' HZ3' ' A' ' 34' ' ' TRP . 34.3 m -128.51 176.95 6.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.392 -175.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -70.28 149.31 47.55 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.935 176.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.443 ' HB2' HD11 ' A' ' 46' ' ' LEU . . . -120.14 121.07 37.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.61 0.243 . . . . 0.0 111.412 -174.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.538 ' HB2' ' HB3' ' A' ' 47' ' ' GLU . 31.3 mmt180 -113.83 100.75 8.68 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 174.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -79.95 148.34 31.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.898 0.38 . . . . 0.0 111.157 -175.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.477 HD11 ' HB2' ' A' ' 47' ' ' GLU . 5.5 mp . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.488 -0.768 . . . . 0.0 109.228 175.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.403 ' CG ' ' HB2' ' A' ' 63' ' ' ALA . 43.6 ttm . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.454 ' HZ1' HG23 ' A' ' 60' ' ' THR . 53.6 tttp -108.99 133.03 53.52 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 122.504 0.322 . . . . 0.0 110.626 -173.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' A' ' 63' ' ' ALA . 14.8 p -143.4 129.17 16.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.021 0.439 . . . . 0.0 110.499 174.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 47.7 ttm -105.55 120.9 42.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.216 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 46.9 mm -96.3 122.83 48.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -96.17 149.62 21.43 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.922 0.391 . . . . 0.0 109.964 -177.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -105.6 125.32 50.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.499 -178.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.0 m -158.84 144.05 16.2 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -177.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.405 ' C ' ' H ' ' A' ' 11' ' ' GLY . . . -54.45 100.52 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.233 0.333 . . . . 0.0 110.654 178.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.8 p 68.48 -32.9 0.22 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.935 1.294 . . . . 0.0 112.923 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 9' ' ' ALA . . . -82.12 54.05 4.82 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.699 -178.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -69.89 118.59 12.94 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.2 t -111.72 150.05 30.77 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.492 ' HB1' HD21 ' A' ' 40' ' ' LEU . . . -124.52 131.19 53.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.167 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -110.39 103.26 11.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.117 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.517 HG13 ' HG3' ' A' ' 18' ' ' LYS . 24.4 t -88.53 104.91 15.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.025 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.07 -26.76 68.38 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -171.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.517 ' HG3' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -65.07 -20.21 66.37 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.724 0.297 . . . . 0.0 111.22 -176.29 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.521 ' HD3' HD11 ' A' ' 21' ' ' LEU . 65.0 tttp -133.67 -3.01 2.96 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.779 -178.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 60.2 30.25 19.71 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.181 0.515 . . . . 0.0 109.69 -172.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.521 HD11 ' HD3' ' A' ' 19' ' ' LYS . 5.3 tt -82.99 121.18 26.67 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -176.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -123.15 111.48 16.56 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 7.5 tp10 -136.74 163.82 29.71 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.739 0.304 . . . . 0.0 110.474 -176.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.9 mt -85.55 142.45 29.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.209 176.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.484 HG22 ' HB ' ' A' ' 38' ' ' VAL . 74.7 mt -87.99 115.56 28.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.312 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.4 m -104.45 -45.4 9.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.314 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.591 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 36.9 tt0 -107.65 141.13 39.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 50.1 mtt -131.58 142.91 50.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.447 -178.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -66.75 -53.3 34.64 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 171.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.527 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 65.0 t30 -100.73 129.0 28.48 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.93 175.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.527 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 8.4 Cg_endo -45.91 -26.84 3.63 Favored 'Trans proline' 0 N--CA 1.476 0.491 0 C-N-CA 124.291 3.327 . . . . 0.0 113.646 -176.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -71.6 -70.88 0.3 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.865 0.364 . . . . 0.0 110.847 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 25.8 tp 173.35 -58.52 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.217 -175.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.431 ' CE3' ' HB2' ' A' ' 51' ' ' MET . 47.2 m95 -92.33 157.62 16.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.315 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.48 -38.24 1.91 Allowed Glycine 0 CA--C 1.507 -0.418 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.44 -149.51 5.33 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -77.76 149.37 34.52 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.14 0.495 . . . . 0.0 111.493 -177.788 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.484 ' HB ' HG22 ' A' ' 25' ' ' ILE . 35.8 m -124.62 139.39 51.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 170.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.591 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 22.1 m -100.61 117.06 33.98 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.994 0.426 . . . . 0.0 110.53 -178.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . 86.8 mt -65.56 152.16 44.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.989 174.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.67 -24.53 49.32 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.78 -177.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -79.27 -12.9 59.95 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.877 0.37 . . . . 0.0 111.263 -178.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.1 54.83 1.56 Allowed Glycine 0 CA--C 1.518 0.227 0 N-CA-C 111.541 -0.623 . . . . 0.0 111.541 -175.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.47 ' HB3' HD11 ' A' ' 40' ' ' LEU . 22.7 t-105 -136.62 115.83 12.55 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -93.75 120.19 33.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.892 0.377 . . . . 0.0 111.167 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.504 HD21 ' HB1' ' A' ' 63' ' ' ALA . 0.6 OUTLIER -116.82 126.41 53.02 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.788 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 37' ' ' LYS . 30.4 tt0 -86.84 128.42 35.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.987 0.422 . . . . 0.0 111.464 -176.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.426 HD11 ' CZ3' ' A' ' 34' ' ' TRP . 3.6 mm? -100.02 122.47 50.5 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.811 175.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.544 ' HB2' ' HE3' ' A' ' 51' ' ' MET . 7.6 Cg_exo -74.07 39.33 0.52 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.429 2.752 . . . . 0.0 113.234 -176.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 51.6 68.33 0.82 Allowed 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 176.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.544 ' HE3' ' HB2' ' A' ' 49' ' ' PRO . 25.5 mmt -104.06 176.61 5.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.761 176.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.412 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -62.75 117.3 6.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.856 0.36 . . . . 0.0 111.293 -178.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.6 -28.13 60.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.467 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -82.61 17.39 1.81 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.845 -177.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.412 HG21 ' HB3' ' A' ' 52' ' ' ALA . 1.2 p -59.79 115.74 14.04 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.491 174.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.79 10.37 1.67 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.934 2.423 . . . . 0.0 113.381 -172.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.9 pp -143.98 159.81 51.87 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 122.327 0.251 . . . . 0.0 110.359 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.43 97.83 0.45 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.242 1.961 . . . . 0.0 110.935 175.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.1 tt -89.19 141.03 14.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.92 -175.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.454 HG23 ' HZ1' ' A' ' 2' ' ' LYS . 67.3 m -107.58 127.02 53.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.398 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.15 177.18 5.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.462 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -72.1 130.65 41.41 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 176.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.54 ' HB3' ' HB ' ' A' ' 3' ' ' VAL . . . -87.64 146.73 25.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.83 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 64' ' ' ARG . 23.5 ttp180 -145.35 113.75 6.67 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 176.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -81.73 137.72 35.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.415 -175.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.519 HD13 ' HB2' ' A' ' 47' ' ' GLU . 5.0 mp . . . . . 0 C--O 1.245 0.827 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 171.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.543 ' HE2' ' HB3' ' A' ' 62' ' ' GLU . 26.8 ttt . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.425 ' HG3' HG23 ' A' ' 60' ' ' THR . 39.1 ttpt -129.62 132.0 46.62 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.95 0.405 . . . . 0.0 111.301 -174.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.0 p -138.4 120.11 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 169.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.4 ttt -107.56 110.46 22.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.222 -174.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 58' ' ' PRO . 45.7 mm -85.18 128.81 38.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.159 -178.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.551 ' HB2' ' HB2' ' A' ' 13' ' ' SER . 79.5 mtp180 -96.57 131.41 43.23 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.412 ' NZ ' ' O ' ' A' ' 54' ' ' ASP . 14.2 mmmm -121.82 118.81 29.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.025 -173.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.6 p -133.65 166.85 21.65 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.59 -24.21 39.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.1 0.476 . . . . 0.0 110.178 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.6 m -75.97 -31.82 59.19 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.259 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -176.34 -168.9 37.13 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.79 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.548 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 48.7 m80 -121.39 141.89 50.53 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.803 -0.444 . . . . 0.0 109.803 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.551 ' HB2' ' HB2' ' A' ' 6' ' ' ARG . 15.7 m -142.98 158.93 43.14 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.486 ' HB1' HD12 ' A' ' 40' ' ' LEU . . . -140.31 138.13 34.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.526 0.203 . . . . 0.0 110.831 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -111.12 103.57 12.02 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.403 HG11 ' HB3' ' A' ' 18' ' ' LYS . 41.3 t -88.24 96.32 5.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.004 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.05 -26.31 62.34 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.866 0.365 . . . . 0.0 111.533 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.403 ' HB3' HG11 ' A' ' 16' ' ' VAL . 18.2 tppt? -55.3 -26.84 42.85 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.139 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -133.5 0.24 3.3 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.372 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 57.75 28.39 15.82 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.467 0.651 . . . . 0.0 109.789 -172.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.3 tp -86.15 121.07 28.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.014 -175.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -112.72 115.82 29.14 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 173.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -139.37 161.59 37.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.955 0.407 . . . . 0.0 110.122 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.0 mt -80.46 141.63 35.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.317 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.548 ' HB ' ' HB2' ' A' ' 12' ' ' HIS . 74.6 mt -84.78 120.14 34.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.202 178.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.7 m -106.13 -27.15 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.042 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.615 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 8.0 tp10 -133.78 143.09 48.19 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.53 157.26 43.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.857 -178.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.461 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 10.8 tp10 -64.39 -37.88 89.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.842 0.353 . . . . 0.0 111.0 -177.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.477 ' OD1' ' HA3' ' A' ' 35' ' ' GLY . 12.9 m120 -125.91 148.81 64.0 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -45.63 -32.62 8.76 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.762 2.974 . . . . 0.0 113.614 -173.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -73.72 -69.71 0.42 Allowed 'General case' 0 C--O 1.234 0.284 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 176.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 3.4 tt 175.83 -66.82 0.01 OUTLIER 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.277 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -70.89 154.81 41.51 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.315 -175.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.477 ' HA3' ' OD1' ' A' ' 30' ' ' ASN . . . 128.89 0.62 6.01 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.858 -177.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 48' ' ' LEU . . . 155.43 -140.7 7.52 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.497 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.461 ' HE2' ' HA ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -71.28 166.23 22.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.285 0.564 . . . . 0.0 112.253 -174.654 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.7 p -144.33 163.54 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.13 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.615 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 37.2 m -142.11 126.18 17.34 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.008 0.432 . . . . 0.0 110.605 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.486 HD12 ' HB1' ' A' ' 14' ' ' ALA . 3.4 mm? -78.76 168.47 19.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.46 177.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.85 -22.52 65.57 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.565 -177.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -83.42 -13.97 53.65 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.094 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.79 -4.21 53.16 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.55 -178.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 49.3 t-105 -67.65 136.59 54.62 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -122.37 137.03 55.0 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -174.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -123.62 154.01 39.91 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.23 171.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.535 ' HB3' ' HB2' ' A' ' 64' ' ' ARG . 39.1 tt0 -105.91 113.02 26.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 3.3 mm? -96.07 135.15 22.9 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.403 -178.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.79 156.73 64.8 Favored 'Trans proline' 0 C--O 1.238 0.485 0 C-N-CA 122.181 1.92 . . . . 0.0 110.808 173.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.21 87.95 0.17 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.091 0.472 . . . . 0.0 110.8 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.5 mmt -104.87 179.65 4.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.628 176.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.29 125.48 23.77 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.794 177.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.0 -23.2 64.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.819 -174.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.412 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . 15.3 p-10 -74.31 -57.01 4.22 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.792 -0.185 . . . . 0.0 110.617 -177.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.4 p 33.48 81.63 0.23 Allowed Pre-proline 0 CA--C 1.537 0.458 0 O-C-N 123.809 0.693 . . . . 0.0 112.263 -178.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -76.33 -2.52 12.72 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.626 2.217 . . . . 0.0 112.21 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.408 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.5 pp -128.28 157.39 74.6 Favored Pre-proline 0 C--O 1.235 0.327 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.742 -177.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 59.1 Cg_endo -72.04 98.38 0.9 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.204 1.936 . . . . 0.0 111.504 176.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.6 tt -97.38 143.77 11.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.034 -177.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.425 HG23 ' HG3' ' A' ' 2' ' ' LYS . 38.4 m -100.86 136.05 41.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.26 176.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.9 m -137.42 177.4 5.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 120.703 0.287 . . . . 0.0 110.521 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.543 ' HB3' ' HE2' ' A' ' 1' ' ' MET . 4.8 mp0 -64.34 134.82 55.39 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.586 177.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.94 114.02 25.69 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.48 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.535 ' HB2' ' HB3' ' A' ' 47' ' ' GLU . 2.7 mmp_? -117.58 125.85 51.52 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 172.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -97.24 146.82 24.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.57 0.224 . . . . 0.0 110.625 -178.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.3 mp . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.56 175.304 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.618 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.17 0 CA-C-O 121.304 0.573 . . . . 0.0 110.212 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -119.2 137.65 53.49 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.948 -173.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 p -149.65 128.59 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.513 174.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 53.0 ttm -102.16 111.05 23.18 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.4 mm -79.24 111.83 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -102.67 118.96 37.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.995 -176.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -86.9 128.31 35.05 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 170.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.3 p -140.41 163.32 33.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.714 -173.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.21 -22.9 66.36 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.331 0.586 . . . . 0.0 109.992 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 m -67.17 -14.73 63.18 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.386 174.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.47 -99.78 0.61 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.969 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -130.84 128.57 40.91 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.4 p -139.33 150.95 45.97 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.289 -0.264 . . . . 0.0 110.289 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.49 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -141.5 131.34 24.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.755 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -99.37 103.36 15.15 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.1 t -91.54 105.0 16.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.216 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.24 -30.04 71.26 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.822 0.344 . . . . 0.0 111.233 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -55.2 -46.71 75.89 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.964 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.674 ' HD2' ' HB2' ' A' ' 21' ' ' LEU . 4.7 tmtm? -99.6 -11.63 20.8 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -178.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 60.52 31.55 20.29 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.218 -171.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.674 ' HB2' ' HD2' ' A' ' 19' ' ' LYS . 49.1 tp -106.31 121.89 45.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.055 -174.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -107.25 108.16 19.44 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.412 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 9.0 tp10 -137.09 163.68 30.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.76 0.314 . . . . 0.0 110.675 -175.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.3 mt -80.65 137.02 36.31 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.811 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.6 mt -82.07 85.2 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.37 0.605 . . . . 0.0 109.405 175.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.435 HG23 ' HG3' ' A' ' 27' ' ' GLU . 15.8 m -73.45 -27.98 24.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.086 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.464 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 44.3 mt-10 -127.21 126.42 42.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.901 -178.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -145.08 143.47 30.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 -174.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.417 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 10.2 tp10 -58.18 -54.36 47.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.484 -177.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -90.08 144.74 31.74 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.366 -173.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.7 -31.06 39.59 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.962 2.441 . . . . 0.0 112.35 176.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -84.4 -63.88 1.26 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.272 175.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 25.0 tp 176.94 -71.87 0.01 OUTLIER 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.603 -177.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -71.41 121.1 17.98 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.741 -176.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.03 -52.76 0.02 OUTLIER Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.011 -176.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.64 -66.64 0.02 OUTLIER Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.216 -176.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.417 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -134.05 162.02 33.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.673 0.273 . . . . 0.0 110.948 178.368 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.4 m -146.28 169.79 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 176.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.464 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 27.9 m -143.36 127.24 17.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.272 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.49 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.2 mm? -74.83 155.95 37.01 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.137 176.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.04 -18.3 33.48 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -176.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.629 HD21 HD13 ' A' ' 21' ' ' LEU . 91.4 m-20 -90.98 8.87 33.11 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.654 0.264 . . . . 0.0 111.34 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.83 32.58 44.81 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.817 176.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 24.9 t90 -107.82 116.67 32.37 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 175.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -86.83 139.99 30.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.084 0.469 . . . . 0.0 111.149 -177.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 59.7 tp -136.29 139.68 42.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.467 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 64' ' ' ARG . 34.5 tt0 -81.37 132.96 35.35 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.0 tp -133.09 98.38 15.76 Favored Pre-proline 0 C--O 1.236 0.391 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 -177.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.27 156.34 41.02 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.877 2.385 . . . . 0.0 112.598 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.34 82.01 3.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.104 0.478 . . . . 0.0 110.264 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.5 mmt -113.58 -174.31 2.44 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.58 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.16 101.78 0.32 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.644 -177.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.05 -18.25 40.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.178 176.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -73.77 -4.75 36.53 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.388 -178.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.0 t -56.74 135.14 78.53 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.544 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -87.22 12.47 2.94 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.973 2.448 . . . . 0.0 112.872 -176.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 pp -140.19 154.06 69.66 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.186 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.26 104.59 1.58 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.402 2.068 . . . . 0.0 111.214 176.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.5 tt -88.95 140.28 16.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.148 -176.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 65.3 m -95.89 130.28 42.9 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.346 177.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.5 m -127.95 175.01 10.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.699 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -73.03 123.33 23.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.202 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 1' ' ' MET . . . -83.02 109.83 17.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.381 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.545 ' HB2' ' HB3' ' A' ' 47' ' ' GLU . 4.1 mpt_? -102.79 114.78 29.33 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 172.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -78.47 125.86 29.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.051 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.063 179.444 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.518 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -121.1 129.95 53.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.787 0.327 . . . . 0.0 111.77 -172.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.6 p -145.27 143.04 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.055 174.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 49.6 ttm -112.52 119.87 39.68 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.9 mm -89.58 116.04 30.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -97.58 149.1 22.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.456 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -133.93 149.29 51.28 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.928 0.394 . . . . 0.0 110.849 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.4 p -142.54 -167.86 2.6 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 171.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.35 90.45 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.5 m 74.85 -41.39 0.47 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.79 0.836 . . . . 0.0 111.683 -177.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.24 118.76 15.39 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.421 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.512 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 26.2 m80 -110.34 147.94 32.94 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.7 p -150.67 160.95 43.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.797 0.332 . . . . 0.0 110.68 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.426 ' HB2' HD21 ' A' ' 40' ' ' LEU . . . -129.62 130.92 46.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.061 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -120.23 104.85 10.41 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.985 -177.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.3 t -79.83 90.41 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 173.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.19 -48.37 54.18 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.697 -172.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.07 -23.06 66.26 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.698 0.285 . . . . 0.0 111.636 -174.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -107.86 -16.02 14.41 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.69 -178.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.2 t70 70.01 22.17 5.87 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.726 0.774 . . . . 0.0 110.015 -175.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 22' ' ' GLU . 5.5 tt -83.98 123.06 29.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.222 178.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.414 ' N ' HD22 ' A' ' 21' ' ' LEU . 32.8 tt0 -134.31 116.91 15.81 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 174.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.502 ' HB3' HD11 ' A' ' 40' ' ' LEU . 7.2 tp10 -133.71 157.88 44.7 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.874 0.368 . . . . 0.0 110.219 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.9 mt -76.8 140.78 40.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.433 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.512 ' HB ' ' HB2' ' A' ' 12' ' ' HIS . 64.6 mt -83.45 114.96 24.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.806 176.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.4 m -102.23 -44.71 10.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -128.97 125.94 38.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.718 0.294 . . . . 0.0 111.034 -177.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.527 ' HG2' ' HA ' ' A' ' 33' ' ' LEU . 2.1 mpp? -111.51 167.85 10.0 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 174.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -84.86 -10.1 57.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.454 0.645 . . . . 0.0 109.38 173.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 28' ' ' MET . 15.5 m120 -127.61 142.4 44.0 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.292 177.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -56.83 -36.93 99.05 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.79 2.327 . . . . 0.0 112.733 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.16 -70.81 0.34 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.893 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.527 ' HA ' ' HG2' ' A' ' 28' ' ' MET . 2.5 tt 178.35 -65.55 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 71.0 m95 -83.6 158.51 21.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.238 -174.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.88 -63.98 0.52 Allowed Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -131.84 -127.68 2.86 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.444 -0.407 . . . . 0.0 112.228 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 8.3 ptpp? -90.25 166.26 13.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.139 0.495 . . . . 0.0 111.834 -173.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 46' ' ' LEU . 9.2 p -146.69 162.18 9.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.81 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 34.8 m -131.67 126.01 33.54 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.742 0.306 . . . . 0.0 110.414 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.502 HD11 ' HB3' ' A' ' 23' ' ' GLU . 59.8 mt -70.83 159.32 34.82 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.288 177.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.72 -24.46 57.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.13 -177.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -106.7 21.52 17.35 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.078 0.466 . . . . 0.0 111.382 -177.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.89 -33.71 6.2 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 114.774 0.67 . . . . 0.0 114.774 168.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.5 ' HB2' HD12 ' A' ' 40' ' ' LEU . 5.3 m-90 -53.9 128.51 30.43 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 117.418 0.609 . . . . 0.0 110.946 -177.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -103.71 138.52 40.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 110.982 -178.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 47' ' ' GLU . 2.8 tm? -137.72 144.56 41.77 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.594 ' HA ' ' HA ' ' A' ' 37' ' ' LYS . 29.7 tt0 -111.5 129.58 56.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.889 0.376 . . . . 0.0 110.955 -177.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -81.33 144.5 53.85 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.604 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -84.05 28.15 0.58 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.947 2.431 . . . . 0.0 112.65 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 57.73 96.0 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.094 0.557 . . . . 0.0 112.219 178.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.6 mmt -133.49 -173.74 3.31 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.96 145.4 25.14 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 173.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.14 -28.09 64.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.974 0.416 . . . . 0.0 110.78 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -79.26 50.69 1.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.395 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.9 p -74.59 123.1 88.84 Favored Pre-proline 0 N--CA 1.453 -0.308 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 172.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.16 -7.77 19.87 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.579 2.186 . . . . 0.0 112.632 -175.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.1 pp -152.16 163.75 22.54 Favored Pre-proline 0 C--O 1.235 0.336 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.471 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.64 99.15 0.43 Allowed 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.073 1.849 . . . . 0.0 110.283 172.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.3 tt -88.05 143.49 11.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.223 0.535 . . . . 0.0 111.406 -170.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.2 m -96.06 122.51 38.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.659 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.9 m -129.78 174.3 12.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 120.956 0.408 . . . . 0.0 111.508 -175.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -63.53 126.34 27.19 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.381 177.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.51 109.57 20.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.697 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.574 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 30.1 tpt180 -101.47 100.41 10.86 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -79.62 133.68 36.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.805 -176.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.511 HD12 ' HB2' ' A' ' 47' ' ' GLU . 6.4 mp . . . . . 0 C--O 1.252 1.192 0 CA-C-O 118.256 -0.878 . . . . 0.0 109.42 175.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.678 ' HG3' ' HB1' ' A' ' 63' ' ' ALA . 24.6 ptp . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -103.68 127.51 51.12 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.125 0.488 . . . . 0.0 112.024 -163.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.557 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 14.4 p -140.21 128.0 24.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.376 170.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 51.8 ttp -109.32 110.88 22.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.905 0.383 . . . . 0.0 110.465 -177.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.8 mm -84.01 131.49 33.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.423 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -96.46 121.74 38.6 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 176.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.852 ' HE2' ' HA ' ' A' ' 54' ' ' ASP . 27.1 mmmt -92.96 116.01 28.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.371 177.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 11' ' ' GLY . 84.8 m -152.33 127.18 9.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.303 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.57 3.9 4.46 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -172.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.465 ' H ' HG22 ' A' ' 8' ' ' THR . 5.6 p -127.75 -0.5 6.06 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.736 0.272 . . . . 0.0 111.736 177.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.474 ' O ' ' HB ' ' A' ' 8' ' ' THR . . . -179.3 102.0 0.16 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.543 -177.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.548 ' CD2' HD21 ' A' ' 33' ' ' LEU . 64.7 m80 -81.07 143.82 32.18 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.9 t -143.13 162.31 35.89 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.492 ' HB2' HD12 ' A' ' 40' ' ' LEU . . . -145.73 122.95 11.52 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.639 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.414 ' HD1' ' HB2' ' A' ' 22' ' ' GLU . 41.9 t80 -102.35 102.73 13.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.575 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.9 t -83.78 98.27 5.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.716 175.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.35 -39.82 91.98 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.004 -173.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.469 ' NZ ' ' SD ' ' A' ' 1' ' ' MET . 0.1 OUTLIER -70.06 -5.91 30.01 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -177.167 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -130.49 10.61 5.24 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 41.58 29.59 0.11 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.677 0.791 . . . . 0.0 111.407 -175.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.591 HD21 HD22 ' A' ' 42' ' ' ASN . 52.1 tp -100.64 132.29 46.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.73 -174.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.414 ' HB2' ' HD1' ' A' ' 15' ' ' TYR . 41.0 tt0 -134.24 112.46 11.08 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 170.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -129.77 163.41 26.27 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.023 -176.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.7 mt -79.23 132.2 36.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.574 178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.548 ' HB ' ' HB2' ' A' ' 12' ' ' HIS . 70.3 mt -77.03 98.03 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.582 175.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.2 m -88.38 -29.99 5.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.87 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.585 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 9.9 tp10 -123.25 139.56 53.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.792 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.43 ' HA ' HG22 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -150.48 147.92 28.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.225 -178.463 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -55.46 -42.82 74.81 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.703 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -131.92 144.92 55.24 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.356 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.89 -27.47 20.81 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.154 2.569 . . . . 0.0 112.784 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.568 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -64.59 -61.88 1.93 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.353 175.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.568 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 1.5 tm? 167.04 -62.82 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.469 -177.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.564 ' CD1' ' HB3' ' A' ' 33' ' ' LEU . 39.1 m95 -88.0 157.81 18.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.297 -171.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.81 -32.73 0.48 Allowed Glycine 0 C--N 1.331 0.294 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.153 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.17 -78.29 0.06 OUTLIER Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.384 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -130.21 162.29 29.24 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.269 0.557 . . . . 0.0 111.703 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.53 HG11 HG22 ' A' ' 25' ' ' ILE . 9.8 t -143.71 155.61 16.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.16 -177.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.585 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 20.1 m -134.03 127.27 31.92 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.782 0.325 . . . . 0.0 110.61 176.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.492 HD12 ' HB2' ' A' ' 14' ' ' ALA . 3.5 mm? -75.66 167.14 22.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.149 176.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.5 -21.98 64.7 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.791 0.329 . . . . 0.0 111.559 -178.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.591 HD22 HD21 ' A' ' 21' ' ' LEU . 27.4 p30 -90.81 1.26 57.08 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.627 -178.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.07 8.29 64.93 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.319 176.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.531 ' HE1' HD22 ' A' ' 46' ' ' LEU . 62.0 t-105 -76.35 117.86 18.45 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 176.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -92.53 116.49 29.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.74 0.305 . . . . 0.0 110.806 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.531 HD22 ' HE1' ' A' ' 44' ' ' TRP . 0.6 OUTLIER -115.23 134.72 54.88 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -178.221 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.579 ' HB3' ' HB2' ' A' ' 64' ' ' ARG . 31.6 tt0 -91.01 120.39 31.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.775 0.322 . . . . 0.0 110.636 -178.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.407 HD13 ' CZ3' ' A' ' 34' ' ' TRP . 3.6 mm? -110.07 106.34 58.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 175.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.8 44.33 1.53 Allowed 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.225 2.617 . . . . 0.0 113.878 -167.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 51.16 82.68 0.06 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.373 0.606 . . . . 0.0 111.848 176.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 97.0 mmm -119.16 -155.45 0.61 Allowed 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -50.12 107.77 0.18 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.828 0.347 . . . . 0.0 110.589 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.01 -34.9 77.05 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.593 -174.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.852 ' HA ' ' HE2' ' A' ' 7' ' ' LYS . 12.6 t70 -134.33 102.11 5.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.877 0.37 . . . . 0.0 110.479 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.4 p -97.14 139.98 21.8 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.08 175.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.52 7.63 3.36 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.693 2.262 . . . . 0.0 112.242 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 pp -147.4 161.01 37.63 Favored Pre-proline 0 C--O 1.236 0.374 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.89 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.28 108.26 1.33 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.017 1.811 . . . . 0.0 110.495 173.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.2 tt -88.02 137.81 20.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.15 -171.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.4 m -106.13 127.4 53.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.678 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.6 m -138.78 178.15 4.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 120.951 0.405 . . . . 0.0 111.056 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 1' ' ' MET . 41.1 tt0 -73.89 124.59 26.43 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.725 178.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.678 ' HB1' ' HG3' ' A' ' 1' ' ' MET . . . -80.74 109.96 15.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.132 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.579 ' HB2' ' HB3' ' A' ' 47' ' ' GLU . 89.5 mtt180 -110.2 137.72 47.55 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 176.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -111.65 124.39 52.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.088 -172.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 C--O 1.25 1.082 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 174.45 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.544 ' HB3' ' HB3' ' A' ' 63' ' ' ALA . 64.8 mtt . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -130.33 130.25 44.22 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.871 0.367 . . . . 0.0 111.722 -174.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.519 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 14.5 p -144.58 138.7 23.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 172.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 52.3 ttm -113.45 110.64 20.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.703 0.287 . . . . 0.0 110.378 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.1 mm -84.51 110.98 19.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -99.17 134.18 42.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.129 0.49 . . . . 0.0 109.725 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.559 ' HG3' ' HB ' ' A' ' 55' ' ' THR . 4.4 mmmp? -128.46 149.02 50.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.973 0.892 . . . . 0.0 113.292 -165.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.486 HG22 ' H ' ' A' ' 9' ' ' ALA . 8.7 m -136.81 174.41 10.65 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 165.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.486 ' H ' HG22 ' A' ' 8' ' ' THR . . . -57.12 -50.65 72.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.472 0.578 . . . . 0.0 110.64 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 51.7 p -101.33 -31.27 11.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.7 136.36 19.79 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.865 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.543 ' HB3' HD12 ' A' ' 25' ' ' ILE . 72.8 m80 -134.99 112.76 10.86 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 176.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.4 m -130.66 145.27 51.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.417 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.664 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -126.68 126.25 43.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.463 177.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -107.46 103.56 12.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.766 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.45 98.17 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.716 174.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.64 -46.64 77.4 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.306 -173.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.537 ' HB2' ' NZ ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -62.66 -17.09 59.82 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -174.659 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -117.48 -10.07 10.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.919 0.39 . . . . 0.0 110.205 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.2 t70 60.86 30.2 19.5 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.663 0.744 . . . . 0.0 109.511 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.5 tp -99.06 114.38 27.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.601 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -110.44 118.49 36.4 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 172.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.448 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 9.8 tp10 -134.48 158.75 43.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.993 0.425 . . . . 0.0 110.798 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.3 mt -77.19 141.19 40.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.594 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.543 HD12 ' HB3' ' A' ' 12' ' ' HIS . 71.9 mt -83.08 110.19 17.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.4 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.7 m -102.89 -23.61 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.507 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.65 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 8.0 tp10 -133.9 133.66 41.73 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.501 ' SD ' ' N ' ' A' ' 28' ' ' MET . 0.8 OUTLIER -128.74 153.01 47.79 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.391 -174.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 7.4 tp10 -66.75 -51.77 52.08 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 169.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.469 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 40.3 t30 -114.57 135.52 22.31 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.625 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.469 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 2.0 Cg_endo -38.39 -31.49 0.21 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 124.184 3.256 . . . . 0.0 113.436 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 54' ' ' ASP . . . -72.28 -69.52 0.39 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.155 174.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 3.4 tt 176.65 -71.74 0.01 OUTLIER 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.831 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.725 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 41.2 m95 -68.14 160.32 29.27 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.621 -173.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.21 -46.22 0.73 Allowed Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.598 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.63 -85.83 0.05 OUTLIER Glycine 0 C--O 1.225 -0.456 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.055 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -120.63 157.38 29.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.291 0.567 . . . . 0.0 111.743 -179.769 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 46' ' ' LEU . 9.8 p -135.23 149.04 28.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 174.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.65 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 18.7 m -125.79 126.34 44.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.013 0.435 . . . . 0.0 110.316 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.664 HD11 ' HB3' ' A' ' 14' ' ' ALA . 2.6 mm? -82.44 166.68 19.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.602 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.7 -10.09 33.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.298 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -89.19 -13.33 38.55 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.981 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.53 -13.08 56.79 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.681 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -69.56 141.8 53.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.882 0.373 . . . . 0.0 110.952 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 39.6 mt-30 -113.23 135.19 54.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.799 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.494 HD13 ' N ' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -127.39 137.08 52.67 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.613 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.494 ' N ' HD13 ' A' ' 46' ' ' LEU . 32.3 tt0 -89.97 137.59 32.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.012 0.434 . . . . 0.0 111.268 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.469 ' HB3' ' CE3' ' A' ' 34' ' ' TRP . 3.0 mm? -107.01 122.93 39.99 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.096 177.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.451 ' HD2' ' HZ3' ' A' ' 34' ' ' TRP . 37.8 Cg_exo -59.38 -4.65 2.52 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.864 2.376 . . . . 0.0 113.43 176.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.415 ' HA ' ' HB3' ' A' ' 34' ' ' TRP . . . 71.07 89.77 0.1 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.224 0.61 . . . . 0.0 112.075 177.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 22.2 ptm -162.09 127.14 3.38 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 56.53 79.0 0.19 Allowed 'General case' 0 C--O 1.234 0.268 0 O-C-N 123.328 0.392 . . . . 0.0 109.986 -173.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.725 ' HA ' ' HB2' ' A' ' 34' ' ' TRP . . . -46.5 -40.76 13.02 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.323 -171.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.49 ' HB2' ' HB1' ' A' ' 32' ' ' ALA . 16.3 t70 -125.2 94.49 4.18 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 170.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.559 ' HB ' ' HG3' ' A' ' 7' ' ' LYS . 1.3 m -63.61 131.59 94.91 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.638 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -83.13 0.34 9.62 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.689 2.259 . . . . 0.0 112.838 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.405 ' HB2' ' HD2' ' A' ' 58' ' ' PRO . 2.9 pp -146.54 161.87 36.47 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.387 -178.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 57' ' ' LEU . 39.3 Cg_endo -66.25 112.39 2.31 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.259 1.972 . . . . 0.0 111.362 175.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.3 tt -108.7 142.16 22.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.503 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.7 m -109.97 115.08 29.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.279 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.506 HG11 ' HH2' ' A' ' 34' ' ' TRP . 21.3 m -125.49 178.52 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.883 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -74.33 146.59 42.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.892 0.377 . . . . 0.0 110.905 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' A' ' 1' ' ' MET . . . -90.73 129.39 36.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.595 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -145.42 99.6 3.32 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 174.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.473 ' HB2' ' HE2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -88.79 155.02 19.81 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.924 -173.149 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 66' ' ' LEU . 4.7 mp . . . . . 0 C--O 1.248 0.979 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.4 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 22.8 ptt? . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 120.494 0.188 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -129.55 142.97 50.64 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 122.545 0.338 . . . . 0.0 110.367 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.647 HG11 HD21 ' A' ' 46' ' ' LEU . 10.7 p -151.3 138.83 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 175.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.476 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 47.3 ttm -103.7 122.45 45.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.734 0.302 . . . . 0.0 110.609 -176.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 58' ' ' PRO . 45.0 mm -96.09 128.79 46.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.5 mtp180 -97.4 123.63 41.31 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.997 0.427 . . . . 0.0 110.747 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -95.17 116.68 29.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.806 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.8 t -159.68 143.67 14.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.474 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.35 -26.63 46.8 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.79 0.329 . . . . 0.0 111.513 -175.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.5 p -64.89 -27.43 68.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.294 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 167.89 113.66 0.28 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.082 -0.58 . . . . 0.0 111.803 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -53.84 137.38 38.65 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.4 t -138.86 162.65 34.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.904 0.383 . . . . 0.0 110.705 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.592 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -145.18 139.43 27.23 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.925 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -115.05 109.35 17.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.099 0.476 . . . . 0.0 110.994 -177.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 46.6 t -84.41 97.09 4.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.075 174.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.22 -55.34 28.96 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -170.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.607 ' H ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -55.17 -32.39 62.11 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.844 0.354 . . . . 0.0 111.587 -176.353 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -96.57 -9.98 28.23 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.565 -176.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.8 t70 58.49 27.89 16.19 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.798 0.808 . . . . 0.0 109.744 -176.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.425 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 48.3 tp -91.82 110.42 21.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.928 -177.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -109.49 108.89 19.54 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 171.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.506 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 8.3 tp10 -132.59 160.23 37.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.034 0.445 . . . . 0.0 111.204 -172.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.8 mt -82.62 137.02 34.64 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.828 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 72.3 mt -78.57 101.77 4.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.237 176.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.8 m -98.14 -9.95 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.591 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.546 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 6.1 tp10 -138.43 122.61 18.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.227 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -151.82 140.24 20.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -60.28 -54.24 48.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.32 -177.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.482 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 24.2 t-20 -85.34 137.87 36.65 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.751 -174.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -50.53 -37.79 53.01 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.454 2.769 . . . . 0.0 112.551 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -78.77 -62.7 1.61 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.224 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.612 ' HG ' HD21 ' A' ' 48' ' ' LEU . 23.2 tp 176.82 -76.37 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.57 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.466 ' HE3' ' O ' ' A' ' 49' ' ' PRO . 61.3 m95 -73.02 125.65 28.12 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.775 -174.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.607 ' HA2' ' HB2' ' A' ' 50' ' ' ALA . . . 179.54 -55.07 0.09 OUTLIER Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.107 -177.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.0 -137.4 2.34 Favored Glycine 0 C--O 1.226 -0.385 0 C-N-CA 121.232 -0.509 . . . . 0.0 112.045 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.76 155.53 39.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.301 0.572 . . . . 0.0 111.751 -176.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.02 151.8 13.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.106 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.546 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 62.6 m -142.55 132.63 24.52 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.964 0.411 . . . . 0.0 110.453 178.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.592 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.2 mm? -81.5 162.84 23.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.331 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.4 -22.73 65.25 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.199 0.523 . . . . 0.0 110.833 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.506 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 27.5 t-20 -73.93 -18.77 60.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.509 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.14 -15.88 30.38 Favored Glycine 0 C--N 1.331 0.258 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.396 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 12.7 t-105 -57.83 117.33 4.16 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.602 0.239 . . . . 0.0 110.418 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -92.37 134.16 35.19 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.647 HD21 HG11 ' A' ' 3' ' ' VAL . 37.4 tp -143.13 164.87 28.98 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -111.38 141.13 45.33 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.612 HD21 ' HG ' ' A' ' 33' ' ' LEU . 16.3 tp -123.12 95.94 45.26 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.235 -175.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.466 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 28.9 Cg_endo -60.89 131.37 36.97 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.147 2.564 . . . . 0.0 112.608 -175.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.607 ' HB2' ' HA2' ' A' ' 35' ' ' GLY . . . -70.29 82.21 0.54 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.853 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 37.4 mtm -98.75 -71.36 0.69 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.955 177.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.34 128.15 6.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.99 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -95.24 -12.13 26.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.586 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -78.83 -11.34 59.99 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.45 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.8 t -60.95 119.89 49.02 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 120.924 0.392 . . . . 0.0 110.667 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -90.98 9.71 2.99 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.326 2.684 . . . . 0.0 112.865 -175.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.3 pp -122.99 150.0 58.17 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.917 -174.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 58.2 Cg_endo -72.38 97.95 0.9 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.311 2.007 . . . . 0.0 111.54 175.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.9 tt -94.92 139.68 18.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.187 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 4' ' ' MET . 41.1 m -92.06 122.09 34.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.3 175.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.0 m -116.45 170.4 6.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.422 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 1' ' ' MET . 33.7 tt0 -68.99 120.05 14.24 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.039 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.63 108.82 5.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.512 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -119.73 106.37 12.07 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 175.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -99.11 158.1 15.9 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.795 0.331 . . . . 0.0 111.278 -178.606 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.25 1.129 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 174.92 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.453 ' O ' ' HG2' ' A' ' 1' ' ' MET . 45.9 ttp . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 120.867 0.365 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.644 ' HD2' ' HB2' ' A' ' 17' ' ' ALA . 1.3 tmtp? -104.18 120.3 40.84 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -176.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.43 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 13.9 p -138.37 128.46 34.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.961 0.41 . . . . 0.0 110.101 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 51.0 ttm -103.1 110.12 21.94 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.432 HG21 HD21 ' A' ' 33' ' ' LEU . 43.4 mm -84.82 111.61 20.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.496 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 94.3 mtt180 -103.85 139.26 39.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.648 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -103.77 157.07 17.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.84 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.8 m -139.94 159.07 43.01 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -44.63 -50.19 9.9 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.091 0.472 . . . . 0.0 111.124 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.2 m -129.5 96.65 4.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.725 175.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.01 175.01 14.03 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 121.276 -0.487 . . . . 0.0 112.956 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.486 ' HB3' HD12 ' A' ' 25' ' ' ILE . 89.5 m-70 -139.17 139.09 37.46 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.5 p -134.91 133.71 39.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.886 0.374 . . . . 0.0 110.624 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.578 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -105.23 123.08 47.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.533 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -93.94 103.84 15.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.638 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.408 HG11 ' HZ3' ' A' ' 44' ' ' TRP . 49.8 t -86.39 112.13 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.114 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.644 ' HB2' ' HD2' ' A' ' 2' ' ' LYS . . . -59.91 -46.53 89.07 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -173.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -11.84 4.72 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -172.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -144.38 15.39 1.65 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 p30 42.03 29.98 0.16 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.516 0.727 . . . . 0.0 111.474 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.4 tt -88.72 117.55 27.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.372 -172.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -112.98 109.1 18.3 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 174.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.438 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 9.6 tp10 -117.29 163.24 16.63 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.034 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.0 mt -75.72 129.34 36.93 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.237 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 12' ' ' HIS . 72.4 mt -78.06 98.11 2.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.119 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.491 HG23 ' HG2' ' A' ' 27' ' ' GLU . 16.7 m -91.38 -46.37 14.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.501 -177.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.58 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 20.9 mm-40 -113.11 107.35 15.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.413 -175.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.71 142.93 50.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.619 0.247 . . . . 0.0 110.346 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -62.57 -40.87 98.22 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.122 0.487 . . . . 0.0 110.643 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -91.79 139.82 24.85 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.868 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -48.17 -38.85 33.63 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.624 2.883 . . . . 0.0 112.828 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.737 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -89.05 -61.8 1.63 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.502 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.432 HD21 HG21 ' A' ' 5' ' ' ILE . 27.4 tp -175.25 -71.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -177.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -79.33 136.19 36.93 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -170.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 165.42 -45.97 0.28 Allowed Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.397 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.16 -134.59 1.71 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.38 -0.438 . . . . 0.0 112.245 -177.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.71 165.95 21.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.292 0.568 . . . . 0.0 111.931 -175.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.8 p -146.93 167.35 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.464 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 60.7 m -142.48 123.64 14.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.785 0.326 . . . . 0.0 110.202 175.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.578 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.4 mm? -73.09 159.81 32.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.824 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.84 -16.77 52.84 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.963 0.411 . . . . 0.0 110.999 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.438 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 25.0 t-20 -75.53 -31.43 60.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.966 178.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 126.38 -20.45 6.2 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.52 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.408 ' HZ3' HG11 ' A' ' 16' ' ' VAL . 29.6 m0 -61.15 132.81 54.91 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.753 0.311 . . . . 0.0 111.555 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -104.94 137.46 42.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.803 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.407 HD21 HG11 ' A' ' 3' ' ' VAL . 48.3 tp -134.41 141.41 46.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.909 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 64' ' ' ARG . 27.2 tt0 -97.52 110.3 22.88 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 120.814 0.34 . . . . 0.0 111.042 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 3.9 mm? -93.32 144.48 28.37 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.365 176.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 48' ' ' LEU . 11.4 Cg_exo -70.83 158.63 55.02 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.42 2.08 . . . . 0.0 111.001 173.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.15 73.35 3.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.269 0.557 . . . . 0.0 110.293 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.4 mmt -95.74 -168.76 1.82 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.133 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.56 115.41 5.74 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 176.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.737 ' HB1' ' HB3' ' A' ' 32' ' ' ALA . . . -48.54 -35.8 14.06 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.583 0.552 . . . . 0.0 111.584 -174.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -119.96 86.47 2.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.18 0.514 . . . . 0.0 109.724 169.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 58.2 m -65.63 129.62 94.38 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.386 175.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.38 -34.21 40.28 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.171 2.581 . . . . 0.0 113.162 -175.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 pp -132.23 158.67 74.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.182 -176.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.496 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . 39.6 Cg_endo -66.54 105.3 0.88 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.393 2.062 . . . . 0.0 111.18 175.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.1 tt -104.56 145.39 13.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.184 -174.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 91.9 m -90.12 132.89 35.19 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.648 173.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.9 m -135.56 176.33 8.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 120.664 0.269 . . . . 0.0 111.096 -177.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.67 121.68 15.93 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.677 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.43 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . . . -90.18 110.59 21.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.518 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.533 ' HB2' ' HB3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -113.38 100.71 8.75 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 172.265 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -82.79 119.17 24.01 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 75.8 mt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.629 -0.701 . . . . 0.0 110.14 -178.181 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.446 ' HE3' HG22 ' A' ' 60' ' ' THR . 39.2 tptt -71.03 133.15 46.1 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -172.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.456 HG23 ' HA ' ' A' ' 16' ' ' VAL . 7.3 p -150.95 148.15 15.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.863 -178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.9 ttt -102.96 124.82 49.19 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.732 0.301 . . . . 0.0 110.949 -176.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.464 HG13 HD11 ' A' ' 48' ' ' LEU . 42.4 mm -109.22 128.97 64.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.732 177.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.546 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 92.7 mtt180 -101.13 118.99 38.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.09 0.471 . . . . 0.0 111.34 -176.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.437 ' HD3' ' HG ' ' A' ' 33' ' ' LEU . 9.8 mmmm -107.68 116.53 32.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.233 171.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.1 m -139.96 72.84 1.41 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.349 0.595 . . . . 0.0 109.82 175.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 54.85 -93.79 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.945 -176.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.4 t -94.48 -25.94 16.67 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.225 0.536 . . . . 0.0 110.287 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.0 112.59 4.29 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -126.43 119.92 28.45 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.438 ' OG ' ' HD2' ' A' ' 6' ' ' ARG . 16.7 p -147.57 163.1 37.66 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.584 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -139.28 141.7 37.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.372 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -114.53 104.03 11.61 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.216 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.456 ' HA ' HG23 ' A' ' 3' ' ' VAL . 47.9 t -76.1 88.19 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.629 176.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.94 -29.18 41.38 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.239 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -57.86 -38.05 75.03 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.419 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 19' ' ' LYS . 54.1 tttm -117.16 -1.81 11.79 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.472 -175.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' A' ' 19' ' ' LYS . 30.9 t70 64.71 23.73 12.8 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 122.033 0.921 . . . . 0.0 109.385 -174.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.3 tt -88.87 125.48 34.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.729 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -124.98 125.22 43.55 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 10.5 tp10 -154.44 162.26 41.25 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.893 0.378 . . . . 0.0 110.815 -176.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.406 HD23 ' HB3' ' A' ' 13' ' ' SER . 91.1 mt -79.6 144.51 33.76 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.65 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.3 mt -81.11 114.14 21.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.086 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.464 HG23 ' HG3' ' A' ' 27' ' ' GLU . 19.8 m -104.67 -26.15 3.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.488 -178.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.603 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 39.3 mt-10 -132.91 114.34 13.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.354 -176.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.561 ' SD ' ' N ' ' A' ' 28' ' ' MET . 0.6 OUTLIER -109.53 157.43 19.0 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 178.861 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.457 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 8.6 tp10 -72.32 -49.54 33.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.69 0.757 . . . . 0.0 109.428 171.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.419 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 50.8 t-20 -95.57 138.48 21.82 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.717 -175.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 30' ' ' ASN . 9.5 Cg_endo -50.29 -31.54 29.97 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.016 2.477 . . . . 0.0 111.562 173.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.92 -69.56 0.49 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.977 173.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.669 ' HB3' ' HD1' ' A' ' 34' ' ' TRP . 0.3 OUTLIER -178.43 -72.46 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.602 178.445 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.669 ' HD1' ' HB3' ' A' ' 33' ' ' LEU . 14.5 m95 -79.08 144.5 34.53 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.985 -174.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 176.83 -58.14 0.1 Allowed Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.08 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -146.47 -73.19 0.02 OUTLIER Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.242 -174.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.457 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 1.7 pptp? -132.97 167.7 19.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.169 0.509 . . . . 0.0 110.924 176.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.6 p -147.21 154.7 11.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.381 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.603 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 11.7 m -134.52 134.43 41.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.971 0.415 . . . . 0.0 110.624 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.584 HD11 ' HB3' ' A' ' 14' ' ' ALA . 2.9 mm? -87.08 169.76 12.12 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.582 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.52 -12.14 59.64 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.09 0.471 . . . . 0.0 110.884 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -80.83 -20.83 41.57 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.845 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.2 -8.92 59.26 Favored Glycine 0 C--N 1.332 0.335 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 -175.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -64.71 133.39 52.02 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 45.2 mt-30 -107.87 138.13 44.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.862 0.363 . . . . 0.0 110.465 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.434 HD11 HG11 ' A' ' 3' ' ' VAL . 3.4 tm? -138.27 132.41 31.64 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -84.07 113.33 20.96 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.464 HD11 HG13 ' A' ' 5' ' ' ILE . 18.2 tp -105.97 116.53 59.49 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.349 -173.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.419 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 3.0 Cg_exo -74.92 154.93 43.24 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.341 2.028 . . . . 0.0 111.419 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.57 74.09 5.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.294 0.568 . . . . 0.0 109.825 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.5 mmt -90.85 -54.89 3.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.997 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.463 ' O ' HG22 ' A' ' 55' ' ' THR . . . -163.21 95.08 0.84 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.237 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.489 ' HA ' ' CD1' ' A' ' 34' ' ' TRP . . . -71.48 -32.61 68.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.585 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.74 -52.93 54.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.861 -175.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.463 HG22 ' O ' ' A' ' 52' ' ' ALA . 9.8 t -28.51 120.82 0.27 Allowed Pre-proline 0 N--CA 1.477 0.897 0 O-C-N 124.224 0.952 . . . . 0.0 113.403 -169.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -85.66 10.43 3.7 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.205 2.604 . . . . 0.0 112.432 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.8 pp -131.76 153.18 81.39 Favored Pre-proline 0 C--O 1.236 0.395 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.568 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.546 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . 41.9 Cg_endo -66.63 149.9 83.89 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.826 2.35 . . . . 0.0 112.682 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.1 tt -152.03 146.93 15.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.252 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.446 HG22 ' HE3' ' A' ' 2' ' ' LYS . 17.0 m -102.02 128.27 48.54 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.315 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.415 HG11 ' HZ3' ' A' ' 34' ' ' TRP . 27.5 m -132.7 174.97 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 120.877 0.37 . . . . 0.0 111.393 -177.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -78.5 161.59 26.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.463 171.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -167.45 159.96 12.8 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.333 0.587 . . . . 0.0 112.543 -175.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -113.13 141.56 46.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.866 172.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.51 126.16 41.5 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.433 HD22 ' N ' ' A' ' 66' ' ' LEU . 2.8 mm? . . . . . 0 C--O 1.245 0.837 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.611 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -108.7 144.54 36.36 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 122.511 0.324 . . . . 0.0 110.57 -173.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.5 p -147.17 141.59 20.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.808 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.2 ttm -101.75 112.72 25.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.83 0.348 . . . . 0.0 110.268 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.465 HG13 HD11 ' A' ' 48' ' ' LEU . 41.0 mm -95.61 124.48 48.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.439 ' HB2' ' OG ' ' A' ' 13' ' ' SER . 97.4 mtt180 -97.39 118.32 33.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.148 0.499 . . . . 0.0 110.838 -175.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.464 ' NZ ' ' HB3' ' A' ' 7' ' ' LYS . 3.0 mmmp? -98.38 116.51 30.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.746 177.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.1 p -134.34 161.82 33.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.27 113.12 1.8 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.807 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.8 p 52.85 23.03 2.59 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.575 0.75 . . . . 0.0 111.688 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.85 134.84 7.84 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -133.81 117.9 17.4 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -178.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.439 ' OG ' ' HB2' ' A' ' 6' ' ' ARG . 15.3 p -135.88 161.8 34.61 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.551 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -146.24 146.24 30.69 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.66 -0.246 . . . . 0.0 110.523 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -129.7 110.25 11.63 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.94 0.4 . . . . 0.0 111.019 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.556 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 56.4 t -87.92 96.29 5.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 172.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.07 -37.88 84.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.251 -171.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.64 -22.76 66.68 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.621 0.248 . . . . 0.0 111.453 -174.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 6.4 tmtm? -119.36 -2.73 10.56 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.669 0.271 . . . . 0.0 110.586 -178.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 64.04 27.72 14.24 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.687 -177.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.556 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 54.2 tp -84.01 111.46 19.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.244 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -123.7 113.15 18.24 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.419 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 10.2 tp10 -148.18 162.83 38.66 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.839 0.352 . . . . 0.0 110.825 -173.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.7 mt -84.14 151.63 24.78 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.332 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.545 HD13 HD21 ' A' ' 33' ' ' LEU . 78.6 mt -92.2 101.21 12.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.668 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.458 HG13 ' HB2' ' A' ' 41' ' ' ALA . 16.3 m -83.87 -37.34 13.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.934 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.553 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 47.2 mt-10 -125.26 139.96 53.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.021 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.411 ' SD ' ' HA ' ' A' ' 33' ' ' LEU . 16.1 ptt? -151.2 156.74 41.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.876 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.47 ' OE1' ' HG3' ' A' ' 37' ' ' LYS . 8.8 tp10 -67.1 -37.48 83.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.079 0.466 . . . . 0.0 111.273 -176.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.416 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 45.0 t-20 -117.74 137.02 23.89 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.073 -172.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 30' ' ' ASN . 8.4 Cg_endo -47.61 -31.43 14.13 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.495 2.797 . . . . 0.0 112.099 175.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.16 -61.71 1.89 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.552 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.545 HD21 HD13 ' A' ' 25' ' ' ILE . 0.4 OUTLIER 172.42 -67.25 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.973 0.796 . . . . 0.0 110.755 175.489 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.521 ' HZ3' HG21 ' A' ' 61' ' ' VAL . 44.4 m95 -74.06 133.38 42.89 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.461 -171.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.83 -56.63 0.05 OUTLIER Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.201 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.67 -67.3 0.01 OUTLIER Glycine 0 C--N 1.334 0.446 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.524 -174.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.47 ' HG3' ' OE1' ' A' ' 29' ' ' GLU . 1.9 pptp? -134.62 168.73 18.46 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.029 0.442 . . . . 0.0 111.152 175.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 46' ' ' LEU . 14.0 p -146.97 160.67 9.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.479 -177.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.553 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 33.0 m -138.89 126.3 21.68 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.83 0.348 . . . . 0.0 110.355 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.551 HD11 ' HB3' ' A' ' 14' ' ' ALA . 2.9 mm? -78.77 159.12 28.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.168 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.458 ' HB2' HG13 ' A' ' 26' ' ' VAL . . . -65.13 -12.06 46.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.087 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.419 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 65.1 t30 -85.3 2.78 42.6 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.48 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.26 -8.79 79.07 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.197 -0.525 . . . . 0.0 113.553 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 18.0 m0 -85.52 142.83 28.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.1 0.476 . . . . 0.0 111.274 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -101.69 159.8 15.01 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.756 -176.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.404 ' O ' HG12 ' A' ' 38' ' ' VAL . 3.2 tm? -159.37 136.33 9.53 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -176.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -82.84 122.8 28.69 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 122.247 -0.283 . . . . 0.0 110.28 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.465 HD11 HG13 ' A' ' 5' ' ' ILE . 22.7 tp -115.53 112.78 43.18 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.123 -174.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.419 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 60.0 Cg_endo -68.73 158.03 59.45 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.26 1.973 . . . . 0.0 111.961 -175.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.94 76.91 3.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.093 0.473 . . . . 0.0 110.514 178.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.416 ' SD ' ' N ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -91.75 -164.8 1.23 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.627 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.416 ' N ' ' SD ' ' A' ' 51' ' ' MET . . . -83.3 109.66 17.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.743 0.306 . . . . 0.0 110.962 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.79 -7.49 54.57 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.714 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -60.86 -25.68 66.83 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.793 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.2 p -57.02 117.52 18.29 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.924 -176.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -92.14 10.88 2.41 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.145 2.563 . . . . 0.0 111.682 174.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 pp -139.5 160.85 59.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.212 -175.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -62.98 135.71 52.9 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.53 2.153 . . . . 0.0 112.726 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.9 tt -130.54 140.15 49.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.022 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.3 m -100.85 119.05 38.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.895 0.378 . . . . 0.0 110.786 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.521 HG21 ' HZ3' ' A' ' 34' ' ' TRP . 35.4 m -122.5 170.67 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.721 178.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 1' ' ' MET . 10.2 mt-10 -82.85 157.12 23.25 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 171.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -149.23 164.37 34.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.23 0.538 . . . . 0.0 111.923 -172.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.622 HH11 ' HG3' ' A' ' 64' ' ' ARG . 11.3 mmt85 -116.62 125.71 52.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.655 175.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -82.22 108.69 15.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.99 0.424 . . . . 0.0 110.354 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 78.0 mt . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.417 -0.802 . . . . 0.0 109.673 178.753 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.4 ' HB3' ' HB3' ' A' ' 63' ' ' ALA . 24.8 mmt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -88.8 114.73 25.74 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.328 -172.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 9.5 p -147.38 141.98 19.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.092 174.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.461 ' SD ' ' HB2' ' A' ' 58' ' ' PRO . 51.0 ttm -117.18 120.28 37.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.676 0.274 . . . . 0.0 110.319 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.4 mm -88.62 115.1 28.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.419 ' HG2' ' HB3' ' A' ' 58' ' ' PRO . 94.5 mtt180 -111.03 118.97 37.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.784 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.455 ' HD3' ' O ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -127.74 138.44 52.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.023 0.44 . . . . 0.0 110.986 179.036 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.63 HG22 ' H ' ' A' ' 9' ' ' ALA . 3.0 m -147.19 -179.02 6.54 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.63 ' H ' HG22 ' A' ' 8' ' ' THR . . . -49.54 107.17 0.13 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 117.826 0.285 . . . . 0.0 110.729 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.2 p 67.79 -41.02 0.42 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.787 1.235 . . . . 0.0 112.746 -177.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.69 110.78 3.14 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.318 -0.467 . . . . 0.0 112.71 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -118.42 128.88 55.04 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.6 p -143.9 155.4 44.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.877 0.37 . . . . 0.0 110.648 -178.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.515 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -128.49 115.57 18.36 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -90.37 103.91 16.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.871 -176.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.1 t -80.25 99.59 4.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.39 175.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.28 -53.85 44.87 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -172.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -11.73 31.06 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -174.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -118.3 -8.98 10.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.723 0.297 . . . . 0.0 110.526 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.4 t70 57.65 26.65 13.19 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 122.032 0.92 . . . . 0.0 109.593 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.406 ' C ' HD23 ' A' ' 21' ' ' LEU . 8.1 tt -86.98 123.54 32.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.127 -176.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -133.16 104.48 6.52 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 171.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.32 165.16 19.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.904 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.7 mt -79.69 132.99 36.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.844 0.354 . . . . 0.0 110.63 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.464 HD12 HD11 ' A' ' 33' ' ' LEU . 69.5 mt -71.37 105.33 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.776 174.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.424 HG23 ' HG2' ' A' ' 27' ' ' GLU . 10.9 m -81.42 -49.25 18.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.173 -177.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.545 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 58.1 mm-40 -106.76 140.95 38.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.916 -177.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 59.5 mtt -132.96 156.73 46.75 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.466 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 10.6 tp10 -65.35 -49.13 70.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.551 0.691 . . . . 0.0 109.336 172.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -127.43 148.34 66.02 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.877 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.05 -23.08 11.68 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.337 2.691 . . . . 0.0 113.742 -174.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -71.25 -66.44 0.62 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.696 0.284 . . . . 0.0 110.547 176.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 18.7 tp 170.2 -70.48 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.008 -175.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 46.4 m95 -76.29 153.61 35.78 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.023 -176.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' A' ' 50' ' ' ALA . . . 159.62 -33.21 0.45 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.477 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.21 -78.24 0.05 OUTLIER Glycine 0 C--O 1.226 -0.393 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.466 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -129.73 161.3 30.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.919 0.39 . . . . 0.0 110.937 178.296 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.7 m -140.01 167.59 18.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 171.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.545 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 17.7 m -135.78 125.77 25.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.9 0.381 . . . . 0.0 110.671 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.515 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.7 mm? -77.88 161.45 27.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.558 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.8 -19.69 60.03 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.187 0.518 . . . . 0.0 110.395 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -63.08 -23.25 67.36 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.407 175.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.36 12.3 57.42 Favored Glycine 0 C--N 1.332 0.36 0 N-CA-C 111.621 -0.592 . . . . 0.0 111.621 -176.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.69 ' HZ2' ' HE2' ' A' ' 65' ' ' LYS . 45.8 t-105 -106.76 140.08 40.17 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 -178.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -94.41 149.04 21.63 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.954 -177.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.523 HD21 ' HB1' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -142.9 131.81 22.88 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.194 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.578 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 42.2 tt0 -89.9 120.88 31.5 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.79 0.329 . . . . 0.0 111.205 -175.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -121.03 113.32 32.85 Favored Pre-proline 0 C--O 1.235 0.332 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.371 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.51 152.89 79.83 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.384 2.056 . . . . 0.0 111.573 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.524 ' HB2' ' HA2' ' A' ' 35' ' ' GLY . . . -71.38 75.58 0.75 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.031 0.443 . . . . 0.0 110.434 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.6 mmt -87.99 -74.37 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.389 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.99 110.03 1.85 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.545 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.2 -30.87 70.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.238 0.542 . . . . 0.0 109.628 175.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -73.36 86.77 1.5 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.447 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.438 HG21 ' HB ' ' A' ' 59' ' ' ILE . 32.1 m -139.02 109.02 7.61 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.596 177.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -83.6 14.56 2.35 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.037 2.491 . . . . 0.0 113.22 -176.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.6 pp -145.66 159.98 45.87 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.648 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.461 ' HB2' ' SD ' ' A' ' 4' ' ' MET . 37.9 Cg_endo -66.62 106.27 1.05 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.258 1.972 . . . . 0.0 111.328 175.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.438 ' HB ' HG21 ' A' ' 55' ' ' THR . 8.7 tt -89.45 146.73 5.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.113 -174.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.1 m -110.84 132.71 53.97 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.275 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.4 m -139.82 177.14 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 122.419 0.288 . . . . 0.0 110.505 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -86.01 118.17 25.31 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.224 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.523 ' HB1' HD21 ' A' ' 46' ' ' LEU . . . -70.28 109.83 4.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.945 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.578 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 1.4 tmm_? -93.59 101.73 13.9 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 174.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.69 ' HE2' ' HZ2' ' A' ' 44' ' ' TRP . 45.3 tttm -73.15 129.7 38.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.166 -176.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.457 ' N ' HD12 ' A' ' 66' ' ' LEU . 5.8 mp . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.553 -0.736 . . . . 0.0 109.485 176.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.401 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 64.6 mtt . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.409 ' HG3' ' CG2' ' A' ' 60' ' ' THR . 86.3 tttt -101.61 121.56 42.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.008 -173.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.6 p -137.4 129.52 41.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 173.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.463 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 52.9 ttm -101.06 115.06 29.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.656 -175.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.1 mm -96.28 116.36 38.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 6' ' ' ARG . 64.0 mtt85 -97.68 126.12 42.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.209 0.528 . . . . 0.0 110.853 -178.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.623 ' HD3' ' HG ' ' A' ' 33' ' ' LEU . 16.1 mmmt -119.78 115.37 23.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.006 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.2 t -135.82 -167.46 2.04 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 175.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.21 -74.11 0.04 OUTLIER 'General case' 0 C--O 1.235 0.298 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -174.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.6 p -112.11 -28.51 7.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.985 0.421 . . . . 0.0 110.795 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.02 138.69 27.2 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.6 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -141.6 121.69 13.78 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 175.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.4 p -140.45 158.87 43.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.865 0.364 . . . . 0.0 111.277 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.577 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -131.05 137.88 49.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.792 176.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.463 ' HB3' ' HB3' ' A' ' 4' ' ' MET . 40.1 t80 -119.17 104.64 10.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.956 0.407 . . . . 0.0 111.207 -177.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 59.7 t -79.83 97.37 2.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.564 174.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.13 -40.64 77.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.778 -172.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.432 ' HB2' ' HE2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -69.32 -11.96 61.25 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -171.701 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -133.98 0.47 3.18 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.777 0.322 . . . . 0.0 111.008 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 59.32 24.06 12.56 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.782 -177.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.502 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 41.9 tp -83.07 108.26 16.23 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.17 -178.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 14' ' ' ALA . 32.9 tt0 -121.87 126.72 49.36 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.443 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 10.7 tp10 -147.61 162.63 38.74 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.556 -175.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.3 mt -78.29 139.59 38.86 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.576 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.405 HG23 HG23 ' A' ' 38' ' ' VAL . 79.9 mt -82.16 104.84 11.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.852 176.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.6 m -94.84 -37.59 8.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 111.674 0.249 . . . . 0.0 111.674 -177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.601 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 34.5 tt0 -127.95 134.39 49.3 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -176.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.547 ' HG2' ' HA ' ' A' ' 33' ' ' LEU . 0.9 OUTLIER -122.87 160.87 25.19 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.516 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.465 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 11.6 tp10 -66.73 -49.06 67.21 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -106.88 142.92 26.01 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 173.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -54.91 -21.94 28.27 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.019 2.48 . . . . 0.0 113.135 -174.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.11 -71.83 0.2 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.623 0.249 . . . . 0.0 110.669 177.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.623 ' HG ' ' HD3' ' A' ' 7' ' ' LYS . 1.1 tm? -179.45 -63.23 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -178.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.422 ' HA ' HD23 ' A' ' 48' ' ' LEU . 58.1 m95 -83.57 165.28 19.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.464 -177.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 159.22 -70.39 0.24 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.718 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -147.57 -48.36 0.03 OUTLIER Glycine 0 C--N 1.33 0.198 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.138 -175.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.465 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -145.01 164.51 30.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.84 0.353 . . . . 0.0 110.315 178.607 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.405 HG23 HG23 ' A' ' 25' ' ' ILE . 6.8 p -143.41 137.24 25.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.725 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.601 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 30.5 m -112.31 116.12 29.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.81 0.338 . . . . 0.0 110.751 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.577 HD11 ' HB3' ' A' ' 14' ' ' ALA . 2.9 mm? -75.29 154.97 37.13 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.985 173.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.11 -16.5 52.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.079 0.466 . . . . 0.0 111.436 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.44 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 7.1 t30 -82.5 3.28 29.0 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.814 -178.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.25 31.77 45.79 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.731 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 19.6 t-105 -113.7 113.91 25.65 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.404 ' HB3' HD12 ' A' ' 66' ' ' LEU . 42.3 mt-30 -98.93 121.08 40.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.276 0.56 . . . . 0.0 110.807 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.6 tp -110.62 147.85 33.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.026 178.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.566 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 35.6 tt0 -84.95 115.66 22.93 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 34' ' ' TRP . 15.0 tp -112.54 116.68 48.04 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.631 -171.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.18 155.84 58.98 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.5 2.133 . . . . 0.0 112.27 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.09 79.6 5.49 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.955 0.407 . . . . 0.0 111.011 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.1 mmt -98.41 -169.16 1.76 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.122 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.37 116.79 2.62 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.971 178.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.62 -46.69 28.88 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.75 0.657 . . . . 0.0 111.722 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.488 ' HA ' ' HE2' ' A' ' 7' ' ' LYS . 30.2 m-20 -116.37 79.47 1.32 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.085 0.469 . . . . 0.0 110.269 178.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.4 m -62.98 121.88 71.53 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.688 175.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.15 2.38 6.77 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.673 2.249 . . . . 0.0 113.184 -174.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 pp -151.86 156.88 34.47 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.631 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.21 110.24 1.95 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.462 2.108 . . . . 0.0 111.008 174.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.7 tt -105.36 137.18 36.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.101 0.476 . . . . 0.0 111.003 -175.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.409 ' CG2' ' HG3' ' A' ' 2' ' ' LYS . 86.9 m -95.81 118.84 33.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.303 177.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.9 178.11 2.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.832 -177.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 1' ' ' MET . 4.0 mp0 -76.37 149.06 37.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.202 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.18 156.8 17.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.105 0.478 . . . . 0.0 111.47 -177.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.566 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -162.21 105.69 1.16 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.963 174.898 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -73.9 141.05 46.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.804 0.335 . . . . 0.0 111.118 -177.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 47' ' ' GLU . 70.6 mt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.818 -0.61 . . . . 0.0 109.43 175.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptt? . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 121.286 0.565 . . . . 0.0 110.005 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.425 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 23.9 tptm -94.21 110.64 22.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.277 -169.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.486 HG23 ' HA ' ' A' ' 16' ' ' VAL . 11.7 p -146.98 141.67 20.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.051 174.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 47.5 ttp -125.05 129.02 49.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.49 -177.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.9 mm -96.94 123.81 49.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.669 ' HD3' ' HB3' ' A' ' 58' ' ' PRO . 22.2 mmt85 -99.1 131.53 45.07 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.205 0.526 . . . . 0.0 111.416 -177.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -93.55 120.25 33.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.968 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.5 p -123.32 146.43 47.93 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.75 -37.66 82.58 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.028 0.442 . . . . 0.0 110.514 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.6 m -110.27 76.27 0.98 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.076 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.54 -160.05 13.53 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.434 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -138.96 146.24 40.74 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.5 m -136.9 143.82 43.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.64 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -123.84 132.32 53.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.771 0.32 . . . . 0.0 110.151 177.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -104.93 102.39 11.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.158 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.486 ' HA ' HG23 ' A' ' 3' ' ' VAL . 47.8 t -76.36 90.75 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.295 174.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.425 ' HB3' ' HG3' ' A' ' 2' ' ' LYS . . . -62.48 -32.89 73.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.143 -172.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.474 ' HB2' ' NZ ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -69.05 -1.59 7.95 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.778 -0.192 . . . . 0.0 111.487 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 19' ' ' LYS . 56.8 tttm -136.84 -1.74 2.19 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.342 176.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 56.49 29.9 16.19 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.053 0.454 . . . . 0.0 110.752 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.3 tp -98.12 117.21 31.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.874 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -109.33 125.08 51.96 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 169.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.449 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 8.0 tp10 -143.91 160.6 40.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.934 0.397 . . . . 0.0 110.767 -177.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.5 mt -76.45 134.79 39.45 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.231 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.453 HG23 HG13 ' A' ' 38' ' ' VAL . 64.5 mt -81.0 91.6 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.8 m -78.72 -32.78 16.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.79 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.577 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 8.5 tp10 -129.37 141.34 51.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.207 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.417 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -152.15 157.81 42.05 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.3 -179.587 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.485 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 6.6 tp10 -65.19 -67.03 0.47 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.776 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.45 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 56.5 t30 -90.39 130.98 39.72 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.839 -175.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.45 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 1.6 Cg_endo -40.55 -35.02 1.33 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.462 3.441 . . . . 0.0 113.567 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -67.91 -65.78 0.65 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.785 0.326 . . . . 0.0 110.535 176.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 29.6 tp 174.57 -69.21 0.01 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.161 -175.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.508 ' HE3' ' O ' ' A' ' 49' ' ' PRO . 49.1 m95 -75.26 130.9 39.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.407 -177.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 50' ' ' ALA . . . -168.09 -57.44 0.03 OUTLIER Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.293 -178.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.37 -68.02 0.07 OUTLIER Glycine 0 C--O 1.225 -0.458 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 -177.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.485 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 9.6 ptpp? -101.3 146.57 27.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.648 0.261 . . . . 0.0 110.321 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.453 HG13 HG23 ' A' ' 25' ' ' ILE . 17.2 t -147.15 153.13 12.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.577 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 43.2 m -142.8 131.21 22.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.069 0.461 . . . . 0.0 111.025 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.64 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.2 mm? -86.21 165.33 16.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.622 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.32 -20.76 65.77 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.142 0.496 . . . . 0.0 110.908 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.449 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 8.0 t30 -77.34 -9.35 58.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.47 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.62 -10.61 68.77 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 121.252 -0.499 . . . . 0.0 111.992 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 27.1 t-105 -64.64 123.38 19.15 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.478 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 43.8 mt-30 -98.62 126.96 44.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.889 0.376 . . . . 0.0 110.378 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.7 tp -123.64 139.03 54.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.538 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 21.0 tt0 -95.67 101.97 13.72 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -178.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.7 tp -101.5 104.33 33.39 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.543 -173.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.508 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 59.2 Cg_endo -70.62 136.26 30.31 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.441 2.094 . . . . 0.0 111.639 -175.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.455 ' HB2' ' HA2' ' A' ' 35' ' ' GLY . . . -64.69 80.44 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.957 0.408 . . . . 0.0 111.578 -177.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.3 mmt -86.65 -59.87 2.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.282 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.45 116.96 5.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.775 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.74 -54.77 33.45 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.617 0.573 . . . . 0.0 111.516 -174.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -103.98 91.43 3.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.985 0.421 . . . . 0.0 110.295 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.9 m -73.22 128.61 87.33 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.187 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.55 -44.09 11.96 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.403 2.069 . . . . 0.0 112.502 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.569 ' HB2' ' HD2' ' A' ' 58' ' ' PRO . 2.7 pp -132.56 165.99 32.26 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.405 -177.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.669 ' HB3' ' HD3' ' A' ' 6' ' ' ARG . 29.3 Cg_endo -60.73 110.23 0.79 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.382 2.054 . . . . 0.0 111.737 177.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.9 tt -101.63 147.81 8.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.019 -176.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 87.5 m -101.73 120.13 39.87 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.156 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.1 m -120.38 178.55 2.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.161 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.66 123.17 21.25 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.519 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.46 110.2 14.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.086 0.47 . . . . 0.0 110.782 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.415 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 3.5 tpm_? -122.14 105.16 10.01 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.203 176.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -83.58 151.28 25.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.893 0.378 . . . . 0.0 110.78 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 7.1 mp . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.331 -0.842 . . . . 0.0 109.34 174.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.748 ' SD ' ' HD3' ' A' ' 18' ' ' LYS . 24.2 ttt . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.478 ' HG3' HG21 ' A' ' 60' ' ' THR . 39.8 tttm -71.41 115.15 10.24 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.58 0.752 . . . . 0.0 110.678 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.555 HG23 ' HA ' ' A' ' 16' ' ' VAL . 8.2 p -134.24 136.31 53.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.954 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.7 ttm -104.28 116.53 32.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.967 0.413 . . . . 0.0 111.233 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.525 HG13 HD11 ' A' ' 48' ' ' LEU . 45.2 mm -91.18 115.55 30.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.507 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 74.3 mtp180 -97.46 118.78 34.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.127 0.489 . . . . 0.0 110.952 -171.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -100.03 116.59 32.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.857 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 t -149.16 -177.58 5.9 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.27 104.59 0.15 Allowed 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.386 0.429 . . . . 0.0 111.608 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.1 p 67.75 -52.96 0.51 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.005 1.322 . . . . 0.0 113.504 177.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.95 81.81 0.54 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.451 -0.404 . . . . 0.0 113.23 -174.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.411 ' HB3' HD11 ' A' ' 33' ' ' LEU . 61.2 m80 -70.84 110.42 5.59 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m -114.66 151.9 32.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.936 0.398 . . . . 0.0 111.546 -170.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.453 ' HB3' HD21 ' A' ' 40' ' ' LEU . . . -124.35 118.57 27.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.66 175.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -106.11 106.91 17.64 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.044 0.449 . . . . 0.0 110.912 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.555 ' HA ' HG23 ' A' ' 3' ' ' VAL . 29.9 t -93.71 96.51 6.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.666 176.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.82 -45.55 86.0 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.348 -173.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.748 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 49.2 pttt -63.79 -35.22 79.9 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.732 0.301 . . . . 0.0 111.054 -177.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.403 ' N ' ' HG3' ' A' ' 18' ' ' LYS . 48.0 tttm -90.42 -9.97 45.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.882 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 62.07 20.51 11.68 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.042 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 22' ' ' GLU . 4.2 tt -106.23 128.8 54.22 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -175.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.507 ' N ' HD23 ' A' ' 21' ' ' LEU . 45.3 tt0 -131.0 113.89 14.53 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 175.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 7.7 tp10 -136.4 160.36 38.99 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.941 0.401 . . . . 0.0 111.014 -175.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.2 mt -79.4 143.49 35.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.763 175.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 68.6 mt -90.0 123.13 42.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.2 m -110.59 -27.42 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -176.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.604 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 52.5 mm-40 -129.85 100.56 5.52 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.765 0.317 . . . . 0.0 110.988 -176.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.546 ' SD ' ' N ' ' A' ' 28' ' ' MET . 1.0 OUTLIER -99.97 155.37 17.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.399 -178.546 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -67.99 -53.54 25.22 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 170.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.497 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 59.3 t30 -97.42 131.16 27.77 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.042 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.497 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 2.8 Cg_endo -42.06 -39.98 6.07 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 124.185 3.257 . . . . 0.0 113.182 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.553 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -69.16 -66.39 0.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.462 177.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.411 HD11 ' HB3' ' A' ' 12' ' ' HIS . 4.5 mt 178.7 -72.63 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.255 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.594 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 41.1 m95 -72.66 140.41 47.91 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.053 -173.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.19 -23.83 0.88 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 121.278 -0.487 . . . . 0.0 112.287 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.86 -137.19 3.6 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.968 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.517 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -67.09 146.72 54.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.332 0.587 . . . . 0.0 111.941 -176.427 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.0 m -137.68 136.91 45.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 172.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.604 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 26.8 m -111.32 128.55 55.99 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.727 0.298 . . . . 0.0 110.765 -175.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . 80.6 mt -72.37 157.2 38.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.985 176.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.16 -17.74 58.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.306 0.574 . . . . 0.0 110.582 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.424 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 25.3 t-20 -69.61 -28.55 66.03 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.49 176.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.78 -18.84 26.44 Favored Glycine 0 C--N 1.331 0.269 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -175.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.721 ' HZ2' ' HD2' ' A' ' 65' ' ' LYS . 41.2 t-105 -71.0 141.51 50.99 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -114.43 146.48 40.57 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.255 0.55 . . . . 0.0 111.735 -175.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.6 tp -135.3 141.9 45.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.659 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.601 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 38.5 tt0 -92.42 105.63 17.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.187 0.518 . . . . 0.0 110.049 -178.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.525 HD11 HG13 ' A' ' 5' ' ' ILE . 18.9 tp -83.22 126.44 72.05 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.537 -174.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -51.83 145.15 32.76 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.0 2.466 . . . . 0.0 113.203 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.7 88.2 7.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.967 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 23.5 ptp -135.37 -152.39 0.46 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.439 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.54 112.47 0.6 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.656 0.265 . . . . 0.0 110.562 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.594 ' HA ' ' HB2' ' A' ' 34' ' ' TRP . . . -63.91 -27.19 68.98 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.161 -173.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -135.66 93.51 2.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.148 0.499 . . . . 0.0 110.644 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.0 p -79.67 129.84 69.78 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.672 174.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.04 -8.43 23.58 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.398 2.065 . . . . 0.0 111.936 -178.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.2 pp -138.23 158.08 71.54 Favored Pre-proline 0 C--O 1.236 0.376 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.456 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.507 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . 38.2 Cg_endo -66.19 136.13 42.89 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.437 2.091 . . . . 0.0 111.058 174.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.5 tt -136.78 144.31 32.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.877 0.37 . . . . 0.0 110.944 -174.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.478 HG21 ' HG3' ' A' ' 2' ' ' LYS . 63.7 m -98.11 130.77 44.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.145 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.41 ' O ' HG12 ' A' ' 3' ' ' VAL . 26.3 m -140.14 179.41 2.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 120.968 0.413 . . . . 0.0 111.599 -174.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -64.03 138.67 58.57 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.212 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.454 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . . . -108.37 123.41 48.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.022 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.601 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -122.89 102.04 7.79 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 175.047 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.721 ' HD2' ' HZ2' ' A' ' 44' ' ' TRP . 28.2 ttpt -65.16 145.3 56.45 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.691 -176.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.474 HD21 ' HB2' ' A' ' 47' ' ' GLU . 91.3 mt . . . . . 0 C--O 1.253 1.253 0 CA-C-O 118.821 -0.609 . . . . 0.0 109.847 175.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.671 ' SD ' ' NH1' ' A' ' 64' ' ' ARG . 59.1 mtt . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -114.32 115.33 27.21 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.99 -173.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.1 p -137.72 127.83 36.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.04 0.448 . . . . 0.0 110.002 174.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.473 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 23.2 ttt -101.71 111.87 24.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.349 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.1 mm -77.21 117.61 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -96.38 118.53 33.09 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.317 -172.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.448 ' NZ ' ' O ' ' A' ' 54' ' ' ASP . 14.3 mmmm -106.08 118.43 36.59 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.05 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 72.5 m -142.23 157.3 45.0 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.65 107.26 0.11 Allowed 'General case' 0 C--O 1.233 0.233 0 O-C-N 123.094 0.247 . . . . 0.0 110.675 178.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.5 p 66.92 -41.38 0.4 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.272 1.429 . . . . 0.0 112.916 -176.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.07 105.31 1.6 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.321 -0.466 . . . . 0.0 112.682 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -104.61 121.88 44.46 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 175.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.435 ' HB3' HD23 ' A' ' 24' ' ' LEU . 33.7 p -138.68 160.8 38.75 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.761 0.315 . . . . 0.0 110.177 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.587 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -128.0 115.81 19.07 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.408 ' HB3' ' HB3' ' A' ' 4' ' ' MET . 59.5 t80 -87.22 103.19 15.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.59 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.1 t -74.34 89.04 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.207 175.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.3 -34.61 70.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.147 -172.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.43 -12.27 59.84 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -177.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 19' ' ' LYS . 39.1 tttm -127.2 -7.82 5.9 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.484 0.183 . . . . 0.0 110.973 178.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.3 t70 67.94 17.21 9.62 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.758 0.79 . . . . 0.0 110.332 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.487 HD21 ' HG2' ' A' ' 23' ' ' GLU . 7.6 tt -88.42 134.71 33.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.192 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -134.09 111.04 10.02 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 173.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 40' ' ' LEU . 78.1 mm-40 -116.61 160.14 21.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.27 177.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.435 HD23 ' HB3' ' A' ' 13' ' ' SER . 83.1 mt -76.95 136.2 38.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.549 175.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 85.9 mt -71.96 107.26 2.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.035 175.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.0 m -94.79 -22.77 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.179 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.578 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 32.7 tt0 -142.45 142.57 32.35 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.097 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.54 ' SD ' ' N ' ' A' ' 28' ' ' MET . 1.0 OUTLIER -123.72 177.24 5.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.096 -177.005 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.511 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 8.2 tp10 -84.2 -56.79 3.47 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 168.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.421 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 35.6 t-20 -95.59 137.63 21.93 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.819 177.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 30' ' ' ASN . 5.2 Cg_endo -44.64 -22.59 0.65 Allowed 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.642 2.895 . . . . 0.0 113.076 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.22 -69.25 0.62 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.169 173.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.4 tp -177.94 -75.55 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.922 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.478 ' HE3' ' O ' ' A' ' 49' ' ' PRO . 29.4 m95 -72.11 137.42 47.03 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.659 -176.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.538 ' HA2' ' HB2' ' A' ' 50' ' ' ALA . . . -179.67 -40.45 0.07 OUTLIER Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.419 -0.895 . . . . 0.0 113.356 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.49 -71.43 0.05 OUTLIER Glycine 0 C--O 1.225 -0.419 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.959 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.511 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -120.28 164.54 16.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.0 0.429 . . . . 0.0 111.143 176.348 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 46' ' ' LEU . 14.8 p -147.34 147.02 17.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.578 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 45.7 m -121.45 133.03 55.05 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.257 0.551 . . . . 0.0 111.126 -177.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.6 mm? -92.28 155.92 17.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.886 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.57 -34.68 51.64 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.03 -1.62 57.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.881 0.372 . . . . 0.0 111.442 -171.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.94 -27.61 8.15 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.518 174.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -59.4 140.23 56.34 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.872 0.336 . . . . 0.0 110.6 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.453 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 46.2 mt-30 -122.13 144.15 49.11 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.555 HD13 ' N ' ' A' ' 47' ' ' GLU . 1.6 tm? -133.67 140.49 47.09 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -176.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.555 ' N ' HD13 ' A' ' 46' ' ' LEU . 38.0 tt0 -81.69 112.13 18.59 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.9 tp -110.97 95.18 23.08 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.27 -175.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.478 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 21.7 Cg_exo -65.46 151.28 85.43 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.782 2.321 . . . . 0.0 112.298 -175.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.538 ' HB2' ' HA2' ' A' ' 35' ' ' GLY . . . -74.74 81.34 2.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.98 0.419 . . . . 0.0 110.491 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.2 mmt -95.08 -63.72 1.14 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.201 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.448 ' HB3' HG23 ' A' ' 55' ' ' THR . . . -144.73 112.67 6.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.003 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.12 99.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.5 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.448 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . 6.7 p-10 -70.74 -54.99 9.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.395 -176.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.448 HG23 ' HB3' ' A' ' 52' ' ' ALA . 1.2 p 41.63 88.38 0.1 Allowed Pre-proline 0 N--CA 1.471 0.6 0 C-N-CA 123.11 0.564 . . . . 0.0 112.0 -177.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.55 -20.94 30.47 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.783 2.322 . . . . 0.0 112.956 -173.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.4 pp -125.97 153.93 73.79 Favored Pre-proline 0 C--O 1.236 0.35 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.63 -177.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.67 94.7 0.39 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.511 2.141 . . . . 0.0 111.693 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.7 tt -89.19 143.36 11.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.968 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 4' ' ' MET . 28.0 m -97.76 130.6 44.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.917 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.7 m -126.57 177.05 5.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 121.028 0.442 . . . . 0.0 111.194 -177.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -78.11 125.18 28.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.249 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.17 122.95 28.01 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -173.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.671 ' NH1' ' SD ' ' A' ' 1' ' ' MET . 4.6 mpt_? -118.48 100.53 7.52 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 168.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -74.78 131.8 41.09 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 82.7 mt . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.554 -0.736 . . . . 0.0 109.698 178.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.519 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 49.0 ttm . . . . . 0 N--CA 1.484 1.229 0 CA-C-O 120.773 0.32 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -109.13 133.23 53.28 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 120.803 0.335 . . . . 0.0 111.416 -176.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.561 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 14.5 p -144.0 134.25 20.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.747 174.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.5 ttp -103.54 114.02 27.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.778 0.323 . . . . 0.0 110.224 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 58' ' ' PRO . 41.4 mm -90.15 116.66 31.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.072 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -94.13 147.46 23.13 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.035 0.445 . . . . 0.0 110.198 -175.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 55' ' ' THR . 36.4 mmtm -121.3 151.58 39.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.446 -176.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.448 HG22 ' N ' ' A' ' 9' ' ' ALA . 59.9 m -159.59 164.01 34.57 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.448 ' N ' HG22 ' A' ' 8' ' ' THR . . . -39.37 -42.75 1.1 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.881 0.472 . . . . 0.0 112.002 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.6 t -146.75 -32.66 0.31 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.763 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.97 75.75 0.74 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.312 -0.471 . . . . 0.0 112.999 -177.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -68.33 138.0 55.08 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.8 p -145.08 162.8 36.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.697 0.284 . . . . 0.0 110.955 -178.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.517 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -139.61 143.88 37.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.655 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.476 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 59.7 t80 -126.37 112.44 15.66 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.0 t -85.6 123.01 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.281 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.49 -70.58 0.12 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.86 -15.88 60.0 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -172.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.802 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 57.9 tptt -101.41 -15.63 17.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.494 0.187 . . . . 0.0 110.712 -177.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 58.91 25.0 13.15 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.382 0.61 . . . . 0.0 110.188 -177.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.802 ' HB2' ' HG3' ' A' ' 19' ' ' LYS . 7.0 tt -90.96 124.33 35.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.181 -173.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -128.25 109.19 11.24 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -133.23 161.03 35.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.093 -176.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.4 mt -77.83 146.53 35.67 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.564 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 72.2 mt -88.79 112.79 24.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.707 177.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.5 m -101.5 -37.46 5.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 116.805 -0.18 . . . . 0.0 111.482 -178.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.467 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 39.1 tt0 -127.43 119.5 26.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.896 0.379 . . . . 0.0 110.642 -178.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.517 ' SD ' ' N ' ' A' ' 28' ' ' MET . 1.2 mpt? -103.43 158.13 16.55 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.038 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 9.0 tp10 -60.12 -58.7 7.42 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.132 0.492 . . . . 0.0 109.924 174.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -96.98 153.4 38.55 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.248 175.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.8 -14.87 23.92 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.711 2.274 . . . . 0.0 112.741 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.82 -69.75 0.59 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.104 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.505 ' HA ' ' HG2' ' A' ' 28' ' ' MET . 1.3 tm? -176.05 -67.89 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -178.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 56.8 m95 -84.24 160.84 20.7 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.551 -177.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 168.89 -57.59 0.2 Allowed Glycine 0 C--N 1.337 0.596 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.338 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.42 -64.12 0.02 OUTLIER Glycine 0 C--N 1.33 0.226 0 C-N-CA 121.295 -0.479 . . . . 0.0 112.118 -175.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 1.7 pptp? -131.27 168.62 17.21 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.786 0.327 . . . . 0.0 110.901 175.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.0 p -147.08 152.35 13.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.589 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 44.9 m -123.26 127.82 49.11 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 120.982 0.42 . . . . 0.0 110.856 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.517 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.4 mm? -79.38 159.69 26.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.434 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.87 -29.0 66.66 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.021 -175.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -74.87 -31.68 61.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.891 0.377 . . . . 0.0 110.466 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 128.85 -10.32 6.32 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.494 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.534 ' CE3' HD11 ' A' ' 21' ' ' LEU . 3.2 m-90 -69.9 141.98 53.06 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.142 0.471 . . . . 0.0 110.985 178.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -103.48 137.35 41.68 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.602 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 58.3 tp -130.39 141.99 50.53 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 177.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.55 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 29.8 tt0 -80.88 122.45 27.24 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.0 tp -114.28 100.18 52.32 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.886 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -58.65 150.78 67.61 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.788 2.326 . . . . 0.0 112.687 -173.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.77 90.49 0.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.547 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.3 mmt -114.64 -173.09 2.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.427 176.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.62 114.21 2.16 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.672 0.273 . . . . 0.0 110.61 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.81 -50.48 73.82 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.213 -178.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -80.39 76.87 7.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.399 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.491 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 1.4 p -116.01 98.65 51.58 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.736 173.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -77.67 -7.12 16.57 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.65 2.233 . . . . 0.0 112.492 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.458 ' O ' HD12 ' A' ' 57' ' ' LEU . 2.5 pp -102.11 149.67 36.78 Favored Pre-proline 0 C--O 1.239 0.546 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.355 -177.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 57.5 Cg_endo -71.57 92.56 0.68 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.54 2.16 . . . . 0.0 111.356 175.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.7 tt -93.62 142.29 13.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.595 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.2 m -100.8 123.11 44.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.189 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.3 m -126.44 178.5 4.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 120.834 0.35 . . . . 0.0 110.736 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.519 ' HA ' ' O ' ' A' ' 1' ' ' MET . 6.7 mp0 -69.21 149.61 48.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.397 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.561 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . . . -119.5 133.19 55.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.003 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.55 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 14.9 tpt180 -134.89 122.21 21.66 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 174.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -83.17 123.69 29.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.045 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.498 HD11 ' HB2' ' A' ' 47' ' ' GLU . 7.2 mp . . . . . 0 C--O 1.25 1.113 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.7 mmm . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -113.25 137.8 50.95 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.618 0.247 . . . . 0.0 111.111 -174.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 14.5 p -145.91 138.78 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.306 175.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 47.0 ttm -111.2 114.79 28.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.301 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 58' ' ' PRO . 47.2 mm -86.2 113.52 24.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -104.98 139.19 40.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.246 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -138.41 135.67 35.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.326 178.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.6 m -108.83 -53.8 2.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.366 0.603 . . . . 0.0 109.544 174.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -170.75 -91.03 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.576 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.5 t -76.84 -28.32 55.45 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 168.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.94 98.07 0.77 Allowed Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.798 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -107.5 121.86 45.47 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 175.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.3 p -135.17 161.04 36.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.918 0.389 . . . . 0.0 110.844 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.598 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -137.19 119.07 15.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.404 178.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -90.06 102.29 15.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.015 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.475 ' HA ' HG23 ' A' ' 3' ' ' VAL . 49.2 t -77.24 90.71 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.59 -31.54 57.11 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.184 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -52.85 -54.64 31.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.136 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.567 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 9.3 tmtt? -94.92 -5.04 45.74 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.641 -176.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.7 t70 60.07 27.32 16.75 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 122.139 0.971 . . . . 0.0 109.06 -174.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.439 ' HB2' ' HD2' ' A' ' 19' ' ' LYS . 6.9 tt -106.31 118.5 36.8 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.686 -175.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -108.05 132.54 53.45 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 172.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 10.9 tp10 -144.86 161.53 39.06 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -176.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.9 mt -78.23 140.16 38.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.427 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 77.2 mt -84.6 122.86 38.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.036 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.9 m -112.3 -35.75 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -174.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.53 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 4.7 tm-20 -129.46 123.78 32.4 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -176.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.463 ' HG2' HD12 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -124.11 140.93 52.5 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.754 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.598 ' HB2' ' HD3' ' A' ' 37' ' ' LYS . 33.0 tt0 -58.22 -36.2 72.8 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.283 0.563 . . . . 0.0 110.362 176.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -109.05 140.36 21.85 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.898 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -49.54 -34.65 34.55 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.225 2.617 . . . . 0.0 112.637 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.78 -68.93 0.5 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.304 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.521 ' HB3' ' HD1' ' A' ' 34' ' ' TRP . 21.2 tp 178.89 -68.46 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.459 -178.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.521 ' HD1' ' HB3' ' A' ' 33' ' ' LEU . 13.6 m95 -78.14 135.23 37.62 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.516 -176.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.464 ' HA2' ' HB2' ' A' ' 50' ' ' ALA . . . -172.17 -48.36 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.434 -177.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.34 -72.91 0.05 OUTLIER Glycine 0 C--O 1.226 -0.383 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -176.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.598 ' HD3' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -123.21 155.34 37.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.979 0.419 . . . . 0.0 111.004 176.456 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 46' ' ' LEU . 8.5 p -146.72 157.09 11.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.45 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 34.9 m -127.03 129.86 48.85 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.087 0.47 . . . . 0.0 111.111 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.598 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.7 mm? -81.23 163.75 22.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.086 175.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.1 -24.36 66.18 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.898 0.38 . . . . 0.0 111.432 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.407 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 2.7 t-20 -83.99 5.59 25.11 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.67 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.34 8.39 87.21 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.589 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.489 ' HE1' HD23 ' A' ' 46' ' ' LEU . 33.3 t-105 -76.65 112.33 13.09 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -88.96 115.86 26.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.992 0.425 . . . . 0.0 110.48 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.499 HD13 ' N ' ' A' ' 47' ' ' GLU . 2.3 tm? -118.9 136.27 54.14 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -176.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.499 ' N ' HD13 ' A' ' 46' ' ' LEU . 36.8 tt0 -79.8 111.85 16.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 0.0 110.366 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.5 tp -109.35 99.99 39.23 Favored Pre-proline 0 C--O 1.236 0.384 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.953 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.407 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 19.2 Cg_exo -65.36 153.33 78.74 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.612 2.208 . . . . 0.0 112.106 -174.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.464 ' HB2' ' HA2' ' A' ' 35' ' ' GLY . . . -79.53 83.76 5.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.785 0.326 . . . . 0.0 110.141 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 93.2 mmm -113.0 -79.6 0.58 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.309 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -127.84 101.12 6.21 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.493 ' HA ' ' CD1' ' A' ' 34' ' ' TRP . . . -79.14 -50.94 10.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.325 -175.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -95.25 27.07 3.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.929 -173.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.6 t -65.37 134.0 95.56 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -83.56 -1.62 10.2 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.613 2.209 . . . . 0.0 113.591 -175.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 57' ' ' LEU . 3.2 pp -120.9 149.36 50.71 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.441 0.163 . . . . 0.0 111.135 -175.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 44.1 Cg_endo -68.35 95.71 0.46 Allowed 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.305 2.003 . . . . 0.0 111.244 176.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.6 tt -89.21 142.11 13.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.849 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.4 m -101.94 123.17 45.39 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.624 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.3 m -127.69 178.0 5.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.957 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -69.54 149.93 47.68 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.547 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.487 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . . . -115.56 151.22 35.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.117 -177.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.424 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 37.5 ttt180 -153.3 121.47 6.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.616 175.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -87.19 121.31 29.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.816 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.427 HD22 ' N ' ' A' ' 66' ' ' LEU . 2.3 mm? . . . . . 0 C--O 1.248 1.026 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 172.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.644 ' SD ' ' HG2' ' A' ' 64' ' ' ARG . 59.9 mtt . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -130.52 111.76 12.57 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -169.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.556 HG11 HD11 ' A' ' 46' ' ' LEU . 7.4 p -142.09 130.45 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 171.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 46.8 ttm -101.06 112.05 24.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.0 mm -86.98 129.49 38.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -96.2 132.35 41.73 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 55' ' ' THR . 0.1 OUTLIER -107.98 116.58 32.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.368 0.604 . . . . 0.0 112.066 -166.038 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 t -177.41 131.35 0.16 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.783 171.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.55 -26.14 68.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.586 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.9 p -103.27 20.66 17.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.548 -176.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.87 49.43 0.12 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.82 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -57.4 123.74 16.51 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.492 ' HB3' HD23 ' A' ' 24' ' ' LEU . 10.7 p -151.03 162.48 40.77 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.367 -0.235 . . . . 0.0 110.367 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.439 ' HB3' HD21 ' A' ' 40' ' ' LEU . . . -145.57 136.11 24.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.233 -177.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.4 ' HD1' ' HB2' ' A' ' 22' ' ' GLU . 74.8 t80 -105.12 102.55 12.04 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 174.101 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.513 ' HA ' HG23 ' A' ' 3' ' ' VAL . 47.1 t -84.44 95.07 3.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.85 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.91 -26.4 64.29 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.562 -176.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.409 ' HB3' HG12 ' A' ' 16' ' ' VAL . 55.5 tptt -52.97 -39.44 63.0 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 175.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.532 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 2.6 tmtp? -116.05 -6.76 11.95 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 16' ' ' VAL . 19.1 m-20 59.69 26.01 15.05 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.614 -170.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 19' ' ' LYS . 5.1 tt -84.33 125.95 32.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.67 -176.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.458 ' N ' HD23 ' A' ' 21' ' ' LEU . 43.0 tt0 -116.22 120.46 39.04 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.463 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 7.4 tp10 -147.81 161.97 40.18 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.986 0.422 . . . . 0.0 111.184 -176.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.492 HD23 ' HB3' ' A' ' 13' ' ' SER . 96.3 mt -82.05 137.86 34.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.689 174.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.2 mt -83.05 106.33 13.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.462 HG23 ' HG3' ' A' ' 27' ' ' GLU . 16.5 m -81.96 -34.4 12.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.398 -177.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.462 ' HG3' HG23 ' A' ' 26' ' ' VAL . 48.6 mt-10 -132.83 140.16 47.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.334 -177.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.481 ' HG2' ' HA ' ' A' ' 33' ' ' LEU . 2.5 mpp? -126.15 160.0 31.39 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.51 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 14.7 tp10 -64.53 -41.63 96.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.229 0.538 . . . . 0.0 109.702 174.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -118.8 152.2 51.18 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.543 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -49.62 -33.03 29.97 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.161 2.574 . . . . 0.0 113.21 -177.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.36 -68.67 0.48 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.744 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.481 ' HA ' ' HG2' ' A' ' 28' ' ' MET . 3.7 tt -178.39 -71.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.977 0.417 . . . . 0.0 110.227 -178.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.698 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 31.7 m95 -76.65 155.72 33.21 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.27 -173.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 162.34 -42.54 0.36 Allowed Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.836 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.0 -65.61 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.51 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -144.79 167.93 21.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.793 0.33 . . . . 0.0 111.205 178.153 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.429 HG13 HD23 ' A' ' 48' ' ' LEU . 33.4 m -139.41 172.43 12.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.339 174.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.2 m -132.79 122.39 24.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.319 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.555 HD12 ' HB3' ' A' ' 44' ' ' TRP . 85.9 mt -78.17 155.99 30.12 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.159 176.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.16 -9.31 22.04 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.022 0.439 . . . . 0.0 111.308 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.463 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 28.2 t-20 -86.54 -13.13 46.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.251 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.88 -1.32 59.55 Favored Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.785 -176.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.555 ' HB3' HD12 ' A' ' 40' ' ' LEU . 15.3 t-105 -80.16 121.02 25.06 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 178.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -94.84 131.11 41.07 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.556 HD11 HG11 ' A' ' 3' ' ' VAL . 1.0 OUTLIER -122.66 132.38 54.24 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.259 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.589 ' HB3' ' HB2' ' A' ' 64' ' ' ARG . 32.2 tt0 -90.6 122.69 33.62 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.774 0.321 . . . . 0.0 110.87 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.43 HD22 ' N ' ' A' ' 48' ' ' LEU . 3.2 mm? -109.6 100.76 43.58 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -65.34 71.22 0.29 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.344 2.696 . . . . 0.0 113.469 -173.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 36.9 89.05 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.375 1.07 . . . . 0.0 113.489 175.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.485 ' HB2' ' CE3' ' A' ' 34' ' ' TRP . 25.2 mmt -129.62 -169.02 2.03 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 174.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.64 108.72 0.37 Allowed 'General case' 0 CA--C 1.532 0.273 0 O-C-N 123.098 0.249 . . . . 0.0 110.794 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.698 ' HA ' ' HB2' ' A' ' 34' ' ' TRP . . . -50.57 -37.06 37.62 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.746 -175.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -128.07 70.78 1.36 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.489 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 3.9 t -57.5 139.9 80.42 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.133 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.57 5.2 4.42 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.825 2.35 . . . . 0.0 113.352 -176.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.413 HD23 ' N ' ' A' ' 57' ' ' LEU . 2.5 pt? -152.07 147.69 20.2 Favored Pre-proline 0 C--O 1.234 0.267 0 O-C-N 122.512 -0.118 . . . . 0.0 110.966 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.99 94.33 0.28 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.622 2.215 . . . . 0.0 110.648 173.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.8 tt -96.35 150.56 4.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.08 0.467 . . . . 0.0 111.741 -172.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 90.3 m -98.93 127.75 44.93 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.14 175.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.414 ' O ' HG12 ' A' ' 3' ' ' VAL . 31.6 m -133.05 179.36 4.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 120.863 0.363 . . . . 0.0 111.02 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -55.97 108.87 0.5 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.042 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.521 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . . . -72.56 109.59 6.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.531 173.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.644 ' HG2' ' SD ' ' A' ' 1' ' ' MET . 91.7 mtt180 -132.81 135.01 45.41 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -108.53 150.58 27.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.02 0.438 . . . . 0.0 110.947 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.7 mt . . . . . 0 C--O 1.252 1.22 0 CA-C-O 118.449 -0.786 . . . . 0.0 109.659 175.02 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.64 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 121.474 0.654 . . . . 0.0 110.748 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -100.84 118.97 37.96 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.469 -175.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 11.5 p -137.8 132.58 44.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 174.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 57.9 ttp -112.23 117.6 32.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.293 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 58' ' ' PRO . 43.0 mm -87.44 119.38 34.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 176.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -96.28 125.65 40.94 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.948 0.404 . . . . 0.0 110.039 -179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 55' ' ' THR . 32.3 mmtp -85.65 115.65 23.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.596 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.6 m -159.1 134.01 8.17 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.37 -74.73 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -173.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 42.1 m -74.58 -29.24 61.25 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.918 0.39 . . . . 0.0 110.584 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.06 40.57 2.38 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.144 -0.551 . . . . 0.0 113.674 -174.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -58.81 115.56 3.17 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 172.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.7 p -138.1 151.22 47.59 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.013 0.435 . . . . 0.0 111.364 -174.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -122.5 115.74 22.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.955 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -96.22 103.61 15.52 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.949 0.404 . . . . 0.0 111.166 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.9 t -79.93 101.74 5.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.846 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.13 -37.45 83.85 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -173.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.516 ' HB2' ' NZ ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -68.21 -3.96 12.4 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -175.677 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.717 ' HD2' ' HB2' ' A' ' 21' ' ' LEU . 7.4 tmtm? -131.75 -16.73 2.92 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.038 0.447 . . . . 0.0 109.836 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.6 t70 59.23 60.97 2.19 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.89 0.853 . . . . 0.0 109.265 -170.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.717 ' HB2' ' HD2' ' A' ' 19' ' ' LYS . 7.2 tt -132.18 119.86 21.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.995 -179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -127.8 121.02 29.11 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 8.9 tp10 -130.31 162.28 29.38 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.4 mt -77.1 133.62 38.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.093 0.473 . . . . 0.0 110.857 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.474 HG23 ' HB ' ' A' ' 38' ' ' VAL . 73.9 mt -80.72 103.48 7.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.635 176.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.2 m -104.98 -1.0 9.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.976 0.417 . . . . 0.0 111.207 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.661 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 9.4 tp10 -147.61 137.85 23.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.935 -177.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 64.4 mtt -139.45 138.28 36.3 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -65.5 -45.56 83.1 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -102.07 143.65 27.02 Favored Pre-proline 0 N--CA 1.465 0.293 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 171.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.06 -21.88 67.23 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.892 2.395 . . . . 0.0 113.122 -174.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -75.24 -68.82 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.684 0.278 . . . . 0.0 110.55 178.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 3.8 tt 171.18 -60.29 0.01 OUTLIER 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.484 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 55.0 m95 -85.59 128.72 34.84 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.079 -178.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 148.1 50.55 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 -177.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 122.36 -95.22 0.54 Allowed Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 175.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.44 156.17 44.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.086 0.469 . . . . 0.0 111.039 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.474 ' HB ' HG23 ' A' ' 25' ' ' ILE . 20.4 m -125.78 149.35 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 172.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.661 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 22.6 m -109.91 121.07 44.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.084 0.468 . . . . 0.0 110.275 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . 3.1 mm? -67.01 157.03 34.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.831 177.103 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.71 -28.54 34.57 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -172.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -95.6 2.36 54.14 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -174.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.94 -14.49 28.94 Favored Glycine 0 N--CA 1.459 0.207 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.602 175.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -62.41 148.4 45.55 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.427 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 34.4 mt-30 -125.35 145.81 49.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.722 0.296 . . . . 0.0 110.369 177.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 52.9 tp -132.33 139.63 48.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -93.58 118.1 30.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.619 0.247 . . . . 0.0 110.891 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.449 HD22 ' N ' ' A' ' 48' ' ' LEU . 2.7 mm? -121.14 107.56 37.29 Favored Pre-proline 0 N--CA 1.465 0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.206 177.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.67 156.24 66.67 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.35 2.033 . . . . 0.0 111.017 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.56 74.25 0.78 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.006 0.431 . . . . 0.0 110.034 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 95.4 mmm -89.74 -65.2 1.04 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.878 -177.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.92 102.96 2.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.656 178.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.484 ' HA ' ' CD1' ' A' ' 34' ' ' TRP . . . -65.46 -37.65 87.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.873 -178.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.434 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . 5.3 p-10 -56.94 -69.28 0.16 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.176 -178.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.514 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 1.9 p 27.94 87.14 0.1 Allowed Pre-proline 0 N--CA 1.472 0.649 0 C-N-CA 123.837 0.855 . . . . 0.0 113.089 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -78.19 13.62 1.74 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.025 2.483 . . . . 0.0 112.829 -177.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.446 ' H ' HD23 ' A' ' 57' ' ' LEU . 2.5 pt? -141.71 153.09 64.46 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.857 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 32.0 Cg_endo -63.91 97.36 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.453 2.102 . . . . 0.0 111.419 177.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.4 tt -89.43 148.35 4.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.811 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 63.2 m -111.54 120.54 42.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.688 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.8 m -125.04 177.66 4.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.089 0.471 . . . . 0.0 111.734 -176.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.469 ' HG3' ' HG3' ' A' ' 1' ' ' MET . 40.8 tt0 -61.43 108.96 1.03 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.731 177.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . . . -74.47 123.57 24.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.484 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.7 ttm105 -138.44 102.77 4.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.876 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.427 ' C ' ' HD3' ' A' ' 65' ' ' LYS . 13.7 tmtt? -82.13 129.75 34.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.54 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 77.5 mt . . . . . 0 C--O 1.253 1.24 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.26 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.541 0.21 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.502 ' HE2' HG22 ' A' ' 60' ' ' THR . 15.4 tptm -125.3 142.65 51.38 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.596 HG11 HD21 ' A' ' 46' ' ' LEU . 12.3 p -147.62 147.07 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 116.662 -0.244 . . . . 0.0 110.78 -178.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.554 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 27.0 ttt -110.97 113.56 26.2 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 176.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.9 mm -92.41 128.43 44.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.085 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.433 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 81.1 mtp180 -97.02 118.89 34.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.067 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -121.1 124.98 46.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.534 -176.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 42.9 p -134.76 176.26 8.81 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 169.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.21 -33.43 73.46 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.893 0.378 . . . . 0.0 111.113 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.0 p -111.93 -56.58 2.37 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.315 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.58 137.48 20.28 Favored Glycine 0 C--O 1.237 0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 113.387 -174.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -128.2 118.72 23.85 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.433 ' HB3' ' HB2' ' A' ' 6' ' ' ARG . 23.1 t -142.22 162.37 35.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.739 0.304 . . . . 0.0 110.204 -176.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.568 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -140.74 134.97 31.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.277 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -118.91 107.68 13.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.222 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 37.1 t -75.85 104.51 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.35 -69.59 0.12 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -171.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -12.36 54.36 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -171.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.515 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 17.2 tppt? -100.17 -20.38 15.99 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.719 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 61.59 29.08 18.11 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.111 0.481 . . . . 0.0 110.732 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.515 ' HB2' ' HG3' ' A' ' 19' ' ' LYS . 7.4 tt -101.82 120.2 40.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.746 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -117.77 132.17 56.49 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 172.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.461 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 8.2 tp10 -147.03 165.6 29.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.419 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.422 HD12 ' N ' ' A' ' 25' ' ' ILE . 1.3 tp -86.71 140.66 29.56 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 122.988 0.515 . . . . 0.0 110.359 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 24' ' ' LEU . 79.4 mt -80.13 113.24 19.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.541 177.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.4 m -106.57 -27.52 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -177.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.49 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 4.0 tm-20 -138.17 133.32 33.14 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -177.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.447 ' SD ' ' O ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -142.59 147.0 35.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 0.0 111.082 -178.135 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -67.27 -65.0 0.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.956 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -75.36 138.37 71.44 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.17 -177.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -46.7 -26.11 4.21 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.63 2.887 . . . . 0.0 112.942 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -93.85 -68.44 0.8 Allowed 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 173.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 32.0 tp 174.44 -63.2 0.01 OUTLIER 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.553 -176.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.484 ' HZ3' HG21 ' A' ' 61' ' ' VAL . 63.9 m95 -75.47 134.82 40.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.241 -172.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.95 -13.45 5.0 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.17 -0.538 . . . . 0.0 112.041 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -168.85 -150.7 6.81 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.832 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.666 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -85.61 162.86 18.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.457 0.646 . . . . 0.0 112.696 -173.416 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 46' ' ' LEU . 8.7 p -146.7 158.82 10.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.2 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 31.4 m -133.29 128.27 35.4 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.083 0.468 . . . . 0.0 110.216 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.568 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.4 mm? -81.74 165.61 20.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.206 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.29 -19.61 63.45 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.104 0.478 . . . . 0.0 111.152 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.461 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 3.6 t-20 -83.79 -4.39 58.61 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.522 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.33 0.36 82.62 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.971 -176.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 42.2 t-105 -66.06 121.7 15.73 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -100.5 120.2 39.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.902 0.382 . . . . 0.0 110.538 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.596 HD21 HG11 ' A' ' 3' ' ' VAL . 62.7 tp -130.25 135.26 47.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.588 -178.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.666 ' HA ' ' HA ' ' A' ' 37' ' ' LYS . 30.1 tt0 -104.63 126.36 51.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.792 0.329 . . . . 0.0 110.569 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.36 136.17 64.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.909 177.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -81.66 29.72 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.908 2.406 . . . . 0.0 112.834 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 62.52 104.97 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.559 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.5 mmt -139.36 -176.66 4.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.25 178.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.57 122.58 14.43 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.274 0.359 . . . . 0.0 110.47 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.16 -38.71 90.08 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.092 0.472 . . . . 0.0 109.794 176.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -69.95 94.82 0.88 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.957 177.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.413 ' HG1' ' HE1' ' A' ' 34' ' ' TRP . 2.6 p -131.67 90.17 37.54 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.272 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -86.33 12.9 2.88 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.142 2.561 . . . . 0.0 111.868 177.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.4 ' O ' HD12 ' A' ' 57' ' ' LEU . 3.1 pp -145.84 154.87 51.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.332 -178.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.405 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . 59.7 Cg_endo -71.8 125.24 10.87 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.387 2.058 . . . . 0.0 111.429 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.9 tt -126.08 137.08 58.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 120.883 0.373 . . . . 0.0 111.045 -177.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 4' ' ' MET . 26.1 m -90.66 120.02 31.38 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.169 177.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.484 HG21 ' HZ3' ' A' ' 34' ' ' TRP . 34.3 m -128.51 176.95 6.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.392 -175.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -70.28 149.31 47.55 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.935 176.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.41 ' HB1' HD11 ' A' ' 46' ' ' LEU . . . -120.14 121.07 37.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.61 0.243 . . . . 0.0 111.412 -174.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.56 ' HB2' ' HB3' ' A' ' 47' ' ' GLU . 31.3 mmt180 -113.83 100.75 8.68 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 174.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -79.95 148.34 31.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.898 0.38 . . . . 0.0 111.157 -175.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.495 HD11 ' HB2' ' A' ' 47' ' ' GLU . 5.5 mp . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.488 -0.768 . . . . 0.0 109.228 175.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.411 ' CG ' ' HB3' ' A' ' 63' ' ' ALA . 43.6 ttm . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -108.99 133.03 53.52 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 122.504 0.322 . . . . 0.0 110.626 -173.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 14.8 p -143.4 129.17 16.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.021 0.439 . . . . 0.0 110.499 174.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 47.7 ttm -105.55 120.9 42.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.216 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 46.9 mm -96.3 122.83 48.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -96.17 149.62 21.43 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.922 0.391 . . . . 0.0 109.964 -177.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -105.6 125.32 50.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.499 -178.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.0 m -158.84 144.05 16.2 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -177.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.45 100.52 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.233 0.333 . . . . 0.0 110.654 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.8 p 68.48 -32.9 0.22 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.935 1.294 . . . . 0.0 112.923 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.12 54.05 4.82 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.699 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -69.89 118.59 12.94 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.2 t -111.72 150.05 30.77 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.54 ' HB3' HD21 ' A' ' 40' ' ' LEU . . . -124.52 131.19 53.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.167 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -110.39 103.26 11.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.117 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.571 HG12 ' HG3' ' A' ' 18' ' ' LYS . 24.4 t -88.53 104.91 15.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.025 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.07 -26.76 68.38 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -171.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.571 ' HG3' HG12 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -65.07 -20.21 66.37 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.724 0.297 . . . . 0.0 111.22 -176.29 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.532 ' HD3' HD12 ' A' ' 21' ' ' LEU . 65.0 tttp -133.67 -3.01 2.96 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.779 -178.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 60.2 30.25 19.71 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.181 0.515 . . . . 0.0 109.69 -172.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.532 HD12 ' HD3' ' A' ' 19' ' ' LYS . 5.3 tt -82.99 121.18 26.67 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -176.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.407 ' N ' HD23 ' A' ' 21' ' ' LEU . 33.7 tt0 -123.15 111.48 16.56 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.12 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 7.5 tp10 -136.74 163.82 29.71 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.739 0.304 . . . . 0.0 110.474 -176.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.9 mt -85.55 142.45 29.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.209 176.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.502 HG23 ' HB ' ' A' ' 38' ' ' VAL . 74.7 mt -87.99 115.56 28.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.312 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.4 m -104.45 -45.4 9.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.314 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.606 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 36.9 tt0 -107.65 141.13 39.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.002 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 50.1 mtt -131.58 142.91 50.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.447 -178.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -66.75 -53.3 34.64 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 171.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.511 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 65.0 t30 -100.73 129.0 28.48 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.93 175.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.511 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 8.4 Cg_endo -45.91 -26.84 3.63 Favored 'Trans proline' 0 N--CA 1.476 0.491 0 C-N-CA 124.291 3.327 . . . . 0.0 113.646 -176.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -71.6 -70.88 0.3 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.865 0.364 . . . . 0.0 110.847 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.431 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 25.8 tp 173.35 -58.52 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.217 -175.041 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.44 ' CZ3' HD12 ' A' ' 48' ' ' LEU . 47.2 m95 -92.33 157.62 16.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.315 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.48 -38.24 1.91 Allowed Glycine 0 CA--C 1.507 -0.418 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.44 -149.51 5.33 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -77.76 149.37 34.52 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.14 0.495 . . . . 0.0 111.493 -177.788 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.502 ' HB ' HG23 ' A' ' 25' ' ' ILE . 35.8 m -124.62 139.39 51.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 170.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 22.1 m -100.61 117.06 33.98 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.994 0.426 . . . . 0.0 110.53 -178.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.54 HD21 ' HB3' ' A' ' 14' ' ' ALA . 86.8 mt -65.56 152.16 44.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.989 174.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.67 -24.53 49.32 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.78 -177.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.426 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 6.2 t30 -79.27 -12.9 59.95 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.877 0.37 . . . . 0.0 111.263 -178.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.1 54.83 1.56 Allowed Glycine 0 CA--C 1.518 0.227 0 N-CA-C 111.541 -0.623 . . . . 0.0 111.541 -175.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.474 ' HB3' HD12 ' A' ' 40' ' ' LEU . 22.7 t-105 -136.62 115.83 12.55 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -93.75 120.19 33.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.892 0.377 . . . . 0.0 111.167 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.516 HD21 ' HB1' ' A' ' 63' ' ' ALA . 0.6 OUTLIER -116.82 126.41 53.02 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.788 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.582 ' HB2' HD11 ' A' ' 66' ' ' LEU . 30.4 tt0 -86.84 128.42 35.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.987 0.422 . . . . 0.0 111.464 -176.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.44 HD12 ' CZ3' ' A' ' 34' ' ' TRP . 3.6 mm? -100.02 122.47 50.5 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.811 175.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 48' ' ' LEU . 7.6 Cg_exo -74.07 39.33 0.52 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.429 2.752 . . . . 0.0 113.234 -176.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 51.6 68.33 0.82 Allowed 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 176.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.432 ' HB2' ' CE3' ' A' ' 34' ' ' TRP . 25.5 mmt -104.06 176.61 5.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.761 176.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.404 ' HB3' HG23 ' A' ' 55' ' ' THR . . . -62.75 117.3 6.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.856 0.36 . . . . 0.0 111.293 -178.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.6 -28.13 60.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.467 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -82.61 17.39 1.81 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.845 -177.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 52' ' ' ALA . 1.2 p -59.79 115.74 14.04 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.491 174.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.79 10.37 1.67 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.934 2.423 . . . . 0.0 113.381 -172.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.9 pp -143.98 159.81 51.87 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 122.327 0.251 . . . . 0.0 110.359 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.43 97.83 0.45 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.242 1.961 . . . . 0.0 110.935 175.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.1 tt -89.19 141.03 14.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.92 -175.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.3 m -107.58 127.02 53.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.398 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.15 177.18 5.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.462 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -72.1 130.65 41.41 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 176.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.587 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . . . -87.64 146.73 25.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.83 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 64' ' ' ARG . 23.5 ttp180 -145.35 113.75 6.67 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 176.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -81.73 137.72 35.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.415 -175.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.582 HD11 ' HB2' ' A' ' 47' ' ' GLU . 5.0 mp . . . . . 0 C--O 1.245 0.827 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 171.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.448 ' HG3' HG21 ' A' ' 60' ' ' THR . 39.1 ttpt -129.62 132.0 46.62 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.95 0.405 . . . . 0.0 111.301 -174.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.0 p -138.4 120.11 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 169.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.4 ttt -107.56 110.46 22.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.222 -174.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 58' ' ' PRO . 45.7 mm -85.18 128.81 38.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.159 -178.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.571 ' HB2' ' HB2' ' A' ' 13' ' ' SER . 79.5 mtp180 -96.57 131.41 43.23 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.412 ' NZ ' ' O ' ' A' ' 54' ' ' ASP . 14.2 mmmm -121.82 118.81 29.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.025 -173.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.6 p -133.65 166.85 21.65 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.59 -24.21 39.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.1 0.476 . . . . 0.0 110.178 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.6 m -75.97 -31.82 59.19 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.259 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -176.34 -168.9 37.13 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.79 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.582 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 92.6 m-70 -121.39 141.89 50.53 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.803 -0.444 . . . . 0.0 109.803 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.571 ' HB2' ' HB2' ' A' ' 6' ' ' ARG . 15.7 m -142.98 158.93 43.14 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.604 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -140.31 138.13 34.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.526 0.203 . . . . 0.0 110.831 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -111.12 103.57 12.02 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.418 HG12 ' HB3' ' A' ' 18' ' ' LYS . 41.3 t -88.24 96.32 5.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.004 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.05 -26.31 62.34 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.866 0.365 . . . . 0.0 111.533 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.418 ' HB3' HG12 ' A' ' 16' ' ' VAL . 18.2 tppt? -55.3 -26.84 42.85 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.139 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -133.5 0.24 3.3 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.372 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 57.75 28.39 15.82 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.467 0.651 . . . . 0.0 109.789 -172.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.3 tp -86.15 121.07 28.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.014 -175.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -112.72 115.82 29.14 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 173.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -139.37 161.59 37.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.955 0.407 . . . . 0.0 110.122 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.0 mt -80.46 141.63 35.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.317 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.582 ' HB ' ' HB2' ' A' ' 12' ' ' HIS . 74.6 mt -84.78 120.14 34.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.202 178.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.7 m -106.13 -27.15 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.042 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.638 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 8.0 tp10 -133.78 143.09 48.19 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.53 157.26 43.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.857 -178.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.473 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 10.8 tp10 -64.39 -37.88 89.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.842 0.353 . . . . 0.0 111.0 -177.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.485 ' OD1' ' HA3' ' A' ' 35' ' ' GLY . 12.9 m120 -125.91 148.81 64.0 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -45.63 -32.62 8.76 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.762 2.974 . . . . 0.0 113.614 -173.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -73.72 -69.71 0.42 Allowed 'General case' 0 C--O 1.234 0.284 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 176.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.41 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 3.4 tt 175.83 -66.82 0.01 OUTLIER 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.277 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -70.89 154.81 41.51 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.315 -175.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.485 ' HA3' ' OD1' ' A' ' 30' ' ' ASN . . . 128.89 0.62 6.01 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.858 -177.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 48' ' ' LEU . . . 155.43 -140.7 7.52 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.497 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -71.28 166.23 22.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.285 0.564 . . . . 0.0 112.253 -174.654 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.7 p -144.33 163.54 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.13 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.638 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 37.2 m -142.11 126.18 17.34 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.008 0.432 . . . . 0.0 110.605 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.604 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.4 mm? -78.76 168.47 19.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.46 177.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.85 -22.52 65.57 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.565 -177.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -83.42 -13.97 53.65 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.094 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.79 -4.21 53.16 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.55 -178.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 49.3 t-105 -67.65 136.59 54.62 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -122.37 137.03 55.0 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -174.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -123.62 154.01 39.91 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.23 171.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.572 ' HB3' ' HB2' ' A' ' 64' ' ' ARG . 39.1 tt0 -105.91 113.02 26.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 48' ' ' LEU . 3.3 mm? -96.07 135.15 22.9 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.403 -178.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.79 156.73 64.8 Favored 'Trans proline' 0 C--O 1.238 0.485 0 C-N-CA 122.181 1.92 . . . . 0.0 110.808 173.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.21 87.95 0.17 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.091 0.472 . . . . 0.0 110.8 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.5 mmt -104.87 179.65 4.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.628 176.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.29 125.48 23.77 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.794 177.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.0 -23.2 64.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.819 -174.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.412 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . 15.3 p-10 -74.31 -57.01 4.22 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.792 -0.185 . . . . 0.0 110.617 -177.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.4 p 33.48 81.63 0.23 Allowed Pre-proline 0 CA--C 1.537 0.458 0 O-C-N 123.809 0.693 . . . . 0.0 112.263 -178.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -76.33 -2.52 12.72 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.626 2.217 . . . . 0.0 112.21 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.431 ' O ' HD12 ' A' ' 57' ' ' LEU . 1.5 pp -128.28 157.39 74.6 Favored Pre-proline 0 C--O 1.235 0.327 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.742 -177.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 59.1 Cg_endo -72.04 98.38 0.9 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.204 1.936 . . . . 0.0 111.504 176.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.6 tt -97.38 143.77 11.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.034 -177.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.448 HG21 ' HG3' ' A' ' 2' ' ' LYS . 38.4 m -100.86 136.05 41.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.26 176.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.9 m -137.42 177.4 5.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 120.703 0.287 . . . . 0.0 110.521 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -64.34 134.82 55.39 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.586 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.94 114.02 25.69 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.48 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.572 ' HB2' ' HB3' ' A' ' 47' ' ' GLU . 2.7 mmp_? -117.58 125.85 51.52 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 172.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -97.24 146.82 24.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.57 0.224 . . . . 0.0 110.625 -178.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.3 mp . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.56 175.304 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.488 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.17 0 CA-C-O 121.304 0.573 . . . . 0.0 110.212 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -119.2 137.65 53.49 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.948 -173.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 p -149.65 128.59 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.513 174.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.405 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 53.0 ttm -102.16 111.05 23.18 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.4 mm -79.24 111.83 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -102.67 118.96 37.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.995 -176.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -86.9 128.31 35.05 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 170.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.3 p -140.41 163.32 33.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.714 -173.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.21 -22.9 66.36 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.331 0.586 . . . . 0.0 109.992 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 m -67.17 -14.73 63.18 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.386 174.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.47 -99.78 0.61 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.969 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -130.84 128.57 40.91 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.4 p -139.33 150.95 45.97 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.289 -0.264 . . . . 0.0 110.289 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.532 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -141.5 131.34 24.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.755 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -99.37 103.36 15.15 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.1 t -91.54 105.0 16.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.216 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.24 -30.04 71.26 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.822 0.344 . . . . 0.0 111.233 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -55.2 -46.71 75.89 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.964 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.691 ' HD2' ' HB2' ' A' ' 21' ' ' LEU . 4.7 tmtm? -99.6 -11.63 20.8 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -178.181 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 60.52 31.55 20.29 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.218 -171.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.691 ' HB2' ' HD2' ' A' ' 19' ' ' LYS . 49.1 tp -106.31 121.89 45.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.055 -174.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -107.25 108.16 19.44 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 9.0 tp10 -137.09 163.68 30.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.76 0.314 . . . . 0.0 110.675 -175.027 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.3 mt -80.65 137.02 36.31 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.811 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.6 mt -82.07 85.2 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.37 0.605 . . . . 0.0 109.405 175.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.448 HG23 ' HG3' ' A' ' 27' ' ' GLU . 15.8 m -73.45 -27.98 24.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.086 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.484 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 44.3 mt-10 -127.21 126.42 42.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.901 -178.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -145.08 143.47 30.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 -174.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.49 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 10.2 tp10 -58.18 -54.36 47.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.484 -177.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.416 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 21.3 t-20 -90.08 144.74 31.74 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.366 -173.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.7 -31.06 39.59 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.962 2.441 . . . . 0.0 112.35 176.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -84.4 -63.88 1.26 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.272 175.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 25.0 tp 176.94 -71.87 0.01 OUTLIER 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.603 -177.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -71.41 121.1 17.98 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.741 -176.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.416 ' HA3' ' HB2' ' A' ' 30' ' ' ASN . . . -163.03 -52.76 0.02 OUTLIER Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.011 -176.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.64 -66.64 0.02 OUTLIER Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.216 -176.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.49 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -134.05 162.02 33.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.673 0.273 . . . . 0.0 110.948 178.368 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.4 m -146.28 169.79 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 176.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.484 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 27.9 m -143.36 127.24 17.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.272 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.532 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.2 mm? -74.83 155.95 37.01 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.137 176.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.04 -18.3 33.48 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -176.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -90.98 8.87 33.11 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.654 0.264 . . . . 0.0 111.34 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.83 32.58 44.81 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.817 176.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.403 ' HZ3' ' HB2' ' A' ' 46' ' ' LEU . 24.9 t90 -107.82 116.67 32.37 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 175.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -86.83 139.99 30.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.084 0.469 . . . . 0.0 111.149 -177.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.403 ' HB2' ' HZ3' ' A' ' 44' ' ' TRP . 59.7 tp -136.29 139.68 42.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.467 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 64' ' ' ARG . 34.5 tt0 -81.37 132.96 35.35 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.0 tp -133.09 98.38 15.76 Favored Pre-proline 0 C--O 1.236 0.391 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 -177.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.27 156.34 41.02 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.877 2.385 . . . . 0.0 112.598 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.34 82.01 3.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.104 0.478 . . . . 0.0 110.264 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.5 mmt -113.58 -174.31 2.44 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.58 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.16 101.78 0.32 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.644 -177.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.05 -18.25 40.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.178 176.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -73.77 -4.75 36.53 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.388 -178.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.0 t -56.74 135.14 78.53 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.544 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -87.22 12.47 2.94 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.973 2.448 . . . . 0.0 112.872 -176.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 pp -140.19 154.06 69.66 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.186 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.26 104.59 1.58 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.402 2.068 . . . . 0.0 111.214 176.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.5 tt -88.95 140.28 16.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.148 -176.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 4' ' ' MET . 65.3 m -95.89 130.28 42.9 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.346 177.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.5 m -127.95 175.01 10.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.699 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -73.03 123.33 23.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.202 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 1' ' ' MET . . . -83.02 109.83 17.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.381 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.573 ' HB2' ' HB3' ' A' ' 47' ' ' GLU . 4.1 mpt_? -102.79 114.78 29.33 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 172.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -78.47 125.86 29.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.051 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.063 179.444 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.473 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -121.1 129.95 53.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.787 0.327 . . . . 0.0 111.77 -172.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.6 p -145.27 143.04 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.055 174.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 49.6 ttm -112.52 119.87 39.68 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.9 mm -89.58 116.04 30.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -97.58 149.1 22.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.456 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -133.93 149.29 51.28 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.928 0.394 . . . . 0.0 110.849 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.4 p -142.54 -167.86 2.6 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 171.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.35 90.45 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.5 m 74.85 -41.39 0.47 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.79 0.836 . . . . 0.0 111.683 -177.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.24 118.76 15.39 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.421 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.546 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 26.2 m80 -110.34 147.94 32.94 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.7 p -150.67 160.95 43.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.797 0.332 . . . . 0.0 110.68 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.452 ' HB3' HD21 ' A' ' 40' ' ' LEU . . . -129.62 130.92 46.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.061 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -120.23 104.85 10.41 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.985 -177.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.3 t -79.83 90.41 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 173.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.19 -48.37 54.18 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.697 -172.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.07 -23.06 66.26 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.698 0.285 . . . . 0.0 111.636 -174.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 60.6 tttm -107.86 -16.02 14.41 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.69 -178.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 19' ' ' LYS . 39.2 t70 70.01 22.17 5.87 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.726 0.774 . . . . 0.0 110.015 -175.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.444 HD23 ' N ' ' A' ' 22' ' ' GLU . 5.5 tt -83.98 123.06 29.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.222 178.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.444 ' N ' HD23 ' A' ' 21' ' ' LEU . 32.8 tt0 -134.31 116.91 15.81 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 174.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.555 ' HB3' HD13 ' A' ' 40' ' ' LEU . 7.2 tp10 -133.71 157.88 44.7 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.874 0.368 . . . . 0.0 110.219 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.9 mt -76.8 140.78 40.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.433 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' A' ' 12' ' ' HIS . 64.6 mt -83.45 114.96 24.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.806 176.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.4 m -102.23 -44.71 10.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -128.97 125.94 38.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.718 0.294 . . . . 0.0 111.034 -177.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.541 ' HG2' ' HA ' ' A' ' 33' ' ' LEU . 2.1 mpp? -111.51 167.85 10.0 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 174.272 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -84.86 -10.1 57.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.454 0.645 . . . . 0.0 109.38 173.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' A' ' 28' ' ' MET . 15.5 m120 -127.61 142.4 44.0 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.292 177.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -56.83 -36.93 99.05 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.79 2.327 . . . . 0.0 112.733 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.16 -70.81 0.34 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.893 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.541 ' HA ' ' HG2' ' A' ' 28' ' ' MET . 2.5 tt 178.35 -65.55 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.449 ' HB3' ' H ' ' A' ' 51' ' ' MET . 71.0 m95 -83.6 158.51 21.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.238 -174.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.88 -63.98 0.52 Allowed Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -131.84 -127.68 2.86 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.444 -0.407 . . . . 0.0 112.228 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 8.3 ptpp? -90.25 166.26 13.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.139 0.495 . . . . 0.0 111.834 -173.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 46' ' ' LEU . 9.2 p -146.69 162.18 9.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.81 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.419 ' N ' HG22 ' A' ' 38' ' ' VAL . 34.8 m -131.67 126.01 33.54 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.742 0.306 . . . . 0.0 110.414 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.555 HD13 ' HB3' ' A' ' 23' ' ' GLU . 59.8 mt -70.83 159.32 34.82 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.288 177.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.72 -24.46 57.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.13 -177.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -106.7 21.52 17.35 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.078 0.466 . . . . 0.0 111.382 -177.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.89 -33.71 6.2 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 114.774 0.67 . . . . 0.0 114.774 168.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.527 ' HB2' HD12 ' A' ' 40' ' ' LEU . 5.3 m-90 -53.9 128.51 30.43 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 117.418 0.609 . . . . 0.0 110.946 -177.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 44.1 mt-30 -103.71 138.52 40.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 110.982 -178.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.592 HD13 ' N ' ' A' ' 47' ' ' GLU . 2.8 tm? -137.72 144.56 41.77 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 37' ' ' LYS . 29.7 tt0 -111.5 129.58 56.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.889 0.376 . . . . 0.0 110.955 -177.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.405 HD22 ' N ' ' A' ' 48' ' ' LEU . 3.1 mm? -81.33 144.5 53.85 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.604 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -84.05 28.15 0.58 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.947 2.431 . . . . 0.0 112.65 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 57.73 96.0 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.094 0.557 . . . . 0.0 112.219 178.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.449 ' H ' ' HB3' ' A' ' 34' ' ' TRP . 25.6 mmt -133.49 -173.74 3.31 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.96 145.4 25.14 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 173.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.14 -28.09 64.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.974 0.416 . . . . 0.0 110.78 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -79.26 50.69 1.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.395 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.9 p -74.59 123.1 88.84 Favored Pre-proline 0 N--CA 1.453 -0.308 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 172.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.16 -7.77 19.87 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.579 2.186 . . . . 0.0 112.632 -175.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.1 pp -152.16 163.75 22.54 Favored Pre-proline 0 C--O 1.235 0.336 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.471 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.64 99.15 0.43 Allowed 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.073 1.849 . . . . 0.0 110.283 172.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.3 tt -88.05 143.49 11.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.223 0.535 . . . . 0.0 111.406 -170.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.2 m -96.06 122.51 38.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.659 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.9 m -129.78 174.3 12.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 120.956 0.408 . . . . 0.0 111.508 -175.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -63.53 126.34 27.19 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.381 177.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 1' ' ' MET . . . -90.51 109.57 20.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.697 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 30.1 tpt180 -101.47 100.41 10.86 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -79.62 133.68 36.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.805 -176.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 47' ' ' GLU . 6.4 mp . . . . . 0 C--O 1.252 1.192 0 CA-C-O 118.256 -0.878 . . . . 0.0 109.42 175.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.741 ' HG3' ' HB3' ' A' ' 63' ' ' ALA . 24.6 ptp . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -103.68 127.51 51.12 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.125 0.488 . . . . 0.0 112.024 -163.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.651 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 14.4 p -140.21 128.0 24.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.376 170.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 51.8 ttp -109.32 110.88 22.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.905 0.383 . . . . 0.0 110.465 -177.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.8 mm -84.01 131.49 33.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.423 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -96.46 121.74 38.6 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 176.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.867 ' HE2' ' HA ' ' A' ' 54' ' ' ASP . 27.1 mmmt -92.96 116.01 28.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.371 177.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.542 HG22 ' H ' ' A' ' 10' ' ' THR . 84.8 m -152.33 127.18 9.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.303 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.57 3.9 4.46 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -172.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.542 ' H ' HG22 ' A' ' 8' ' ' THR . 5.6 p -127.75 -0.5 6.06 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.736 0.272 . . . . 0.0 111.736 177.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.478 ' O ' ' HB ' ' A' ' 8' ' ' THR . . . -179.3 102.0 0.16 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.543 -177.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.587 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 64.7 m80 -81.07 143.82 32.18 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.9 t -143.13 162.31 35.89 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.554 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -145.73 122.95 11.52 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.639 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.423 ' HD1' ' HB2' ' A' ' 22' ' ' GLU . 41.9 t80 -102.35 102.73 13.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.575 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.9 t -83.78 98.27 5.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.716 175.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.35 -39.82 91.98 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.004 -173.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.469 ' NZ ' ' SD ' ' A' ' 1' ' ' MET . 0.1 OUTLIER -70.06 -5.91 30.01 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -177.167 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -130.49 10.61 5.24 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 41.58 29.59 0.11 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.677 0.791 . . . . 0.0 111.407 -175.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.64 HD21 HD21 ' A' ' 42' ' ' ASN . 52.1 tp -100.64 132.29 46.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.73 -174.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.423 ' HB2' ' HD1' ' A' ' 15' ' ' TYR . 41.0 tt0 -134.24 112.46 11.08 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 170.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -129.77 163.41 26.27 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.023 -176.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.7 mt -79.23 132.2 36.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.574 178.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.587 ' HB ' ' HB2' ' A' ' 12' ' ' HIS . 70.3 mt -77.03 98.03 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.582 175.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.2 m -88.38 -29.99 5.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.87 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.609 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 9.9 tp10 -123.25 139.56 53.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.792 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.481 ' HA ' HG22 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -150.48 147.92 28.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.225 -178.463 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -55.46 -42.82 74.81 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.703 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -131.92 144.92 55.24 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.356 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.89 -27.47 20.81 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.154 2.569 . . . . 0.0 112.784 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.57 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -64.59 -61.88 1.93 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.353 175.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.572 ' HB3' ' CD1' ' A' ' 34' ' ' TRP . 1.5 tm? 167.04 -62.82 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.469 -177.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.572 ' CD1' ' HB3' ' A' ' 33' ' ' LEU . 39.1 m95 -88.0 157.81 18.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.297 -171.127 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.81 -32.73 0.48 Allowed Glycine 0 C--N 1.331 0.294 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.153 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.17 -78.29 0.06 OUTLIER Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.384 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -130.21 162.29 29.24 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.269 0.557 . . . . 0.0 111.703 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.556 HG13 HG23 ' A' ' 25' ' ' ILE . 9.8 t -143.71 155.61 16.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.16 -177.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.609 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 20.1 m -134.03 127.27 31.92 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.782 0.325 . . . . 0.0 110.61 176.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.554 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.5 mm? -75.66 167.14 22.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.149 176.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.5 -21.98 64.7 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.791 0.329 . . . . 0.0 111.559 -178.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.64 HD21 HD21 ' A' ' 21' ' ' LEU . 27.4 p30 -90.81 1.26 57.08 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.627 -178.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.07 8.29 64.93 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.319 176.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.564 ' HE1' HD23 ' A' ' 46' ' ' LEU . 62.0 t-105 -76.35 117.86 18.45 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 176.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -92.53 116.49 29.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.74 0.305 . . . . 0.0 110.806 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.564 HD23 ' HE1' ' A' ' 44' ' ' TRP . 0.6 OUTLIER -115.23 134.72 54.88 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -178.221 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.622 ' HB3' ' HB2' ' A' ' 64' ' ' ARG . 31.6 tt0 -91.01 120.39 31.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.775 0.322 . . . . 0.0 110.636 -178.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.411 HD12 ' CZ3' ' A' ' 34' ' ' TRP . 3.6 mm? -110.07 106.34 58.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 175.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.8 44.33 1.53 Allowed 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.225 2.617 . . . . 0.0 113.878 -167.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 51.16 82.68 0.06 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.373 0.606 . . . . 0.0 111.848 176.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 97.0 mmm -119.16 -155.45 0.61 Allowed 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -50.12 107.77 0.18 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.828 0.347 . . . . 0.0 110.589 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.01 -34.9 77.05 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.593 -174.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.867 ' HA ' ' HE2' ' A' ' 7' ' ' LYS . 12.6 t70 -134.33 102.11 5.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.877 0.37 . . . . 0.0 110.479 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.4 p -97.14 139.98 21.8 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.08 175.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.52 7.63 3.36 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.693 2.262 . . . . 0.0 112.242 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 pp -147.4 161.01 37.63 Favored Pre-proline 0 C--O 1.236 0.374 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.89 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.28 108.26 1.33 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.017 1.811 . . . . 0.0 110.495 173.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.2 tt -88.02 137.81 20.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.15 -171.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.4 m -106.13 127.4 53.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.678 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.421 HG11 ' HH2' ' A' ' 34' ' ' TRP . 18.6 m -138.78 178.15 4.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 120.951 0.405 . . . . 0.0 111.056 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 1' ' ' MET . 41.1 tt0 -73.89 124.59 26.43 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.725 178.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.741 ' HB3' ' HG3' ' A' ' 1' ' ' MET . . . -80.74 109.96 15.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.132 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.622 ' HB2' ' HB3' ' A' ' 47' ' ' GLU . 89.5 mtt180 -110.2 137.72 47.55 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 176.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -111.65 124.39 52.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.088 -172.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.411 HD22 ' N ' ' A' ' 66' ' ' LEU . 2.9 mm? . . . . . 0 C--O 1.25 1.082 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 174.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.544 ' HB3' ' HB3' ' A' ' 63' ' ' ALA . 64.8 mtt . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -130.33 130.25 44.22 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.871 0.367 . . . . 0.0 111.722 -174.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.519 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 14.5 p -144.58 138.7 23.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 172.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 52.3 ttm -113.45 110.64 20.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.703 0.287 . . . . 0.0 110.378 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.1 mm -84.51 110.98 19.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -99.17 134.18 42.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.129 0.49 . . . . 0.0 109.725 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.559 ' HG3' ' HB ' ' A' ' 55' ' ' THR . 4.4 mmmp? -128.46 149.02 50.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.973 0.892 . . . . 0.0 113.292 -165.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.486 HG22 ' H ' ' A' ' 9' ' ' ALA . 8.7 m -136.81 174.41 10.65 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 165.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.486 ' H ' HG22 ' A' ' 8' ' ' THR . . . -57.12 -50.65 72.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.472 0.578 . . . . 0.0 110.64 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 51.7 p -101.33 -31.27 11.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.7 136.36 19.79 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.865 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.543 ' HB3' HD12 ' A' ' 25' ' ' ILE . 72.8 m80 -134.99 112.76 10.86 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 176.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.4 m -130.66 145.27 51.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.417 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.664 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -126.68 126.25 43.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.463 177.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -107.46 103.56 12.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.766 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.45 98.17 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.716 174.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.64 -46.64 77.4 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.306 -173.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.537 ' HB2' ' NZ ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -62.66 -17.09 59.82 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -174.659 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -117.48 -10.07 10.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.919 0.39 . . . . 0.0 110.205 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.2 t70 60.86 30.2 19.5 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.663 0.744 . . . . 0.0 109.511 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.5 tp -99.06 114.38 27.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.601 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -110.44 118.49 36.4 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 172.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.448 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 9.8 tp10 -134.48 158.75 43.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.993 0.425 . . . . 0.0 110.798 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.3 mt -77.19 141.19 40.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.594 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.543 HD12 ' HB3' ' A' ' 12' ' ' HIS . 71.9 mt -83.08 110.19 17.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.4 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.7 m -102.89 -23.61 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.507 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.65 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 8.0 tp10 -133.9 133.66 41.73 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.501 ' SD ' ' N ' ' A' ' 28' ' ' MET . 0.8 OUTLIER -128.74 153.01 47.79 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.391 -174.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 7.4 tp10 -66.75 -51.77 52.08 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 169.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.469 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 40.3 t30 -114.57 135.52 22.31 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.625 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.469 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 2.0 Cg_endo -38.39 -31.49 0.21 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 124.184 3.256 . . . . 0.0 113.436 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 54' ' ' ASP . . . -72.28 -69.52 0.39 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.155 174.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 3.4 tt 176.65 -71.74 0.01 OUTLIER 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.831 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.725 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 41.2 m95 -68.14 160.32 29.27 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.621 -173.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.21 -46.22 0.73 Allowed Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.598 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.63 -85.83 0.05 OUTLIER Glycine 0 C--O 1.225 -0.456 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.055 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -120.63 157.38 29.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.291 0.567 . . . . 0.0 111.743 -179.769 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 46' ' ' LEU . 9.8 p -135.23 149.04 28.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 174.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.65 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 18.7 m -125.79 126.34 44.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.013 0.435 . . . . 0.0 110.316 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.664 HD11 ' HB3' ' A' ' 14' ' ' ALA . 2.6 mm? -82.44 166.68 19.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.602 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.7 -10.09 33.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.298 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -89.19 -13.33 38.55 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.981 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.53 -13.08 56.79 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.681 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -69.56 141.8 53.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.882 0.373 . . . . 0.0 110.952 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 39.6 mt-30 -113.23 135.19 54.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.799 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.494 HD13 ' N ' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -127.39 137.08 52.67 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.613 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.494 ' N ' HD13 ' A' ' 46' ' ' LEU . 32.3 tt0 -89.97 137.59 32.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.012 0.434 . . . . 0.0 111.268 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.469 ' HB3' ' CE3' ' A' ' 34' ' ' TRP . 3.0 mm? -107.01 122.93 39.99 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.096 177.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.451 ' HD2' ' HZ3' ' A' ' 34' ' ' TRP . 37.8 Cg_exo -59.38 -4.65 2.52 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.864 2.376 . . . . 0.0 113.43 176.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.415 ' HA ' ' HB3' ' A' ' 34' ' ' TRP . . . 71.07 89.77 0.1 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.224 0.61 . . . . 0.0 112.075 177.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 22.2 ptm -162.09 127.14 3.38 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 56.53 79.0 0.19 Allowed 'General case' 0 C--O 1.234 0.268 0 O-C-N 123.328 0.392 . . . . 0.0 109.986 -173.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.725 ' HA ' ' HB2' ' A' ' 34' ' ' TRP . . . -46.5 -40.76 13.02 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.323 -171.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.49 ' HB2' ' HB1' ' A' ' 32' ' ' ALA . 16.3 t70 -125.2 94.49 4.18 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 170.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.559 ' HB ' ' HG3' ' A' ' 7' ' ' LYS . 1.3 m -63.61 131.59 94.91 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.638 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -83.13 0.34 9.62 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.689 2.259 . . . . 0.0 112.838 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.405 ' HB2' ' HD2' ' A' ' 58' ' ' PRO . 2.9 pp -146.54 161.87 36.47 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.387 -178.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 57' ' ' LEU . 39.3 Cg_endo -66.25 112.39 2.31 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.259 1.972 . . . . 0.0 111.362 175.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.3 tt -108.7 142.16 22.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.503 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.7 m -109.97 115.08 29.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.279 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.506 HG11 ' HH2' ' A' ' 34' ' ' TRP . 21.3 m -125.49 178.52 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.883 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -74.33 146.59 42.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.892 0.377 . . . . 0.0 110.905 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' A' ' 1' ' ' MET . . . -90.73 129.39 36.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.595 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -145.42 99.6 3.32 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 174.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.473 ' HB2' ' HE2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -88.79 155.02 19.81 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.924 -173.149 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 66' ' ' LEU . 4.7 mp . . . . . 0 C--O 1.248 0.979 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.4 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 22.8 ptt? . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 120.494 0.188 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -129.55 142.97 50.64 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 122.545 0.338 . . . . 0.0 110.367 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.647 HG11 HD21 ' A' ' 46' ' ' LEU . 10.7 p -151.3 138.83 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 175.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.476 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 47.3 ttm -103.7 122.45 45.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.734 0.302 . . . . 0.0 110.609 -176.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 58' ' ' PRO . 45.0 mm -96.09 128.79 46.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.5 mtp180 -97.4 123.63 41.31 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.997 0.427 . . . . 0.0 110.747 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -95.17 116.68 29.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.806 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.8 t -159.68 143.67 14.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.474 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.35 -26.63 46.8 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.79 0.329 . . . . 0.0 111.513 -175.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.5 p -64.89 -27.43 68.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.294 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 167.89 113.66 0.28 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.082 -0.58 . . . . 0.0 111.803 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -53.84 137.38 38.65 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.4 t -138.86 162.65 34.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.904 0.383 . . . . 0.0 110.705 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.592 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -145.18 139.43 27.23 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.925 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -115.05 109.35 17.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.099 0.476 . . . . 0.0 110.994 -177.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 46.6 t -84.41 97.09 4.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.075 174.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.22 -55.34 28.96 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -170.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.607 ' H ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -55.17 -32.39 62.11 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.844 0.354 . . . . 0.0 111.587 -176.353 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -96.57 -9.98 28.23 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.565 -176.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.8 t70 58.49 27.89 16.19 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.798 0.808 . . . . 0.0 109.744 -176.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.425 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 48.3 tp -91.82 110.42 21.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.928 -177.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -109.49 108.89 19.54 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 171.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.506 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 8.3 tp10 -132.59 160.23 37.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.034 0.445 . . . . 0.0 111.204 -172.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.8 mt -82.62 137.02 34.64 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.828 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 72.3 mt -78.57 101.77 4.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.237 176.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.8 m -98.14 -9.95 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.591 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.546 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 6.1 tp10 -138.43 122.61 18.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.227 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -151.82 140.24 20.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -60.28 -54.24 48.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.32 -177.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.482 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 24.2 t-20 -85.34 137.87 36.65 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.751 -174.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -50.53 -37.79 53.01 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.454 2.769 . . . . 0.0 112.551 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -78.77 -62.7 1.61 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.224 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.612 ' HG ' HD21 ' A' ' 48' ' ' LEU . 23.2 tp 176.82 -76.37 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.57 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.466 ' HE3' ' O ' ' A' ' 49' ' ' PRO . 61.3 m95 -73.02 125.65 28.12 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.775 -174.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.607 ' HA2' ' HB2' ' A' ' 50' ' ' ALA . . . 179.54 -55.07 0.09 OUTLIER Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.107 -177.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.0 -137.4 2.34 Favored Glycine 0 C--O 1.226 -0.385 0 C-N-CA 121.232 -0.509 . . . . 0.0 112.045 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.76 155.53 39.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.301 0.572 . . . . 0.0 111.751 -176.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.02 151.8 13.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.106 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.546 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 62.6 m -142.55 132.63 24.52 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.964 0.411 . . . . 0.0 110.453 178.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.592 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.2 mm? -81.5 162.84 23.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.331 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.4 -22.73 65.25 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.199 0.523 . . . . 0.0 110.833 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.506 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 27.5 t-20 -73.93 -18.77 60.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.509 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.14 -15.88 30.38 Favored Glycine 0 C--N 1.331 0.258 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.396 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 12.7 t-105 -57.83 117.33 4.16 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.602 0.239 . . . . 0.0 110.418 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -92.37 134.16 35.19 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.647 HD21 HG11 ' A' ' 3' ' ' VAL . 37.4 tp -143.13 164.87 28.98 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -111.38 141.13 45.33 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.612 HD21 ' HG ' ' A' ' 33' ' ' LEU . 16.3 tp -123.12 95.94 45.26 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.235 -175.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.466 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 28.9 Cg_endo -60.89 131.37 36.97 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.147 2.564 . . . . 0.0 112.608 -175.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.607 ' HB2' ' HA2' ' A' ' 35' ' ' GLY . . . -70.29 82.21 0.54 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.853 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 37.4 mtm -98.75 -71.36 0.69 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.955 177.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.34 128.15 6.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.99 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -95.24 -12.13 26.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.586 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -78.83 -11.34 59.99 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.45 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.8 t -60.95 119.89 49.02 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 120.924 0.392 . . . . 0.0 110.667 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -90.98 9.71 2.99 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.326 2.684 . . . . 0.0 112.865 -175.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.3 pp -122.99 150.0 58.17 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.917 -174.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 58.2 Cg_endo -72.38 97.95 0.9 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.311 2.007 . . . . 0.0 111.54 175.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.9 tt -94.92 139.68 18.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.187 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 4' ' ' MET . 41.1 m -92.06 122.09 34.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.3 175.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.0 m -116.45 170.4 6.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.422 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 1' ' ' MET . 33.7 tt0 -68.99 120.05 14.24 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.039 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.63 108.82 5.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.512 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -119.73 106.37 12.07 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 175.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -99.11 158.1 15.9 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.795 0.331 . . . . 0.0 111.278 -178.606 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.25 1.129 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 174.92 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.453 ' O ' ' HG2' ' A' ' 1' ' ' MET . 45.9 ttp . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 120.867 0.365 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.644 ' HD2' ' HB2' ' A' ' 17' ' ' ALA . 1.3 tmtp? -104.18 120.3 40.84 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -176.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.43 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 13.9 p -138.37 128.46 34.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.961 0.41 . . . . 0.0 110.101 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 51.0 ttm -103.1 110.12 21.94 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.432 HG21 HD21 ' A' ' 33' ' ' LEU . 43.4 mm -84.82 111.61 20.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.496 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 94.3 mtt180 -103.85 139.26 39.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.648 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -103.77 157.07 17.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.84 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.8 m -139.94 159.07 43.01 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -44.63 -50.19 9.9 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.091 0.472 . . . . 0.0 111.124 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.2 m -129.5 96.65 4.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.725 175.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.01 175.01 14.03 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 121.276 -0.487 . . . . 0.0 112.956 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.486 ' HB3' HD12 ' A' ' 25' ' ' ILE . 89.5 m-70 -139.17 139.09 37.46 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.5 p -134.91 133.71 39.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.886 0.374 . . . . 0.0 110.624 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.578 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -105.23 123.08 47.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.533 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -93.94 103.84 15.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.638 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.408 HG11 ' HZ3' ' A' ' 44' ' ' TRP . 49.8 t -86.39 112.13 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.114 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.644 ' HB2' ' HD2' ' A' ' 2' ' ' LYS . . . -59.91 -46.53 89.07 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -173.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -11.84 4.72 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -172.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -144.38 15.39 1.65 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 p30 42.03 29.98 0.16 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.516 0.727 . . . . 0.0 111.474 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.4 tt -88.72 117.55 27.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.372 -172.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -112.98 109.1 18.3 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 174.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.438 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 9.6 tp10 -117.29 163.24 16.63 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.034 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.0 mt -75.72 129.34 36.93 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.237 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 12' ' ' HIS . 72.4 mt -78.06 98.11 2.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.119 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.491 HG23 ' HG2' ' A' ' 27' ' ' GLU . 16.7 m -91.38 -46.37 14.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.501 -177.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.58 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 20.9 mm-40 -113.11 107.35 15.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.413 -175.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.71 142.93 50.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.619 0.247 . . . . 0.0 110.346 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -62.57 -40.87 98.22 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.122 0.487 . . . . 0.0 110.643 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -91.79 139.82 24.85 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.868 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -48.17 -38.85 33.63 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.624 2.883 . . . . 0.0 112.828 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.737 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -89.05 -61.8 1.63 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.502 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.432 HD21 HG21 ' A' ' 5' ' ' ILE . 27.4 tp -175.25 -71.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -177.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -79.33 136.19 36.93 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -170.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 165.42 -45.97 0.28 Allowed Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.397 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.16 -134.59 1.71 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.38 -0.438 . . . . 0.0 112.245 -177.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.71 165.95 21.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.292 0.568 . . . . 0.0 111.931 -175.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.8 p -146.93 167.35 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.464 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 60.7 m -142.48 123.64 14.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.785 0.326 . . . . 0.0 110.202 175.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.578 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.4 mm? -73.09 159.81 32.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.824 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.84 -16.77 52.84 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.963 0.411 . . . . 0.0 110.999 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.438 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 25.0 t-20 -75.53 -31.43 60.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.966 178.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 126.38 -20.45 6.2 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.52 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.408 ' HZ3' HG11 ' A' ' 16' ' ' VAL . 29.6 m0 -61.15 132.81 54.91 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.753 0.311 . . . . 0.0 111.555 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -104.94 137.46 42.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.803 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.407 HD21 HG11 ' A' ' 3' ' ' VAL . 48.3 tp -134.41 141.41 46.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.909 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 64' ' ' ARG . 27.2 tt0 -97.52 110.3 22.88 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 120.814 0.34 . . . . 0.0 111.042 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 3.9 mm? -93.32 144.48 28.37 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.365 176.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 48' ' ' LEU . 11.4 Cg_exo -70.83 158.63 55.02 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.42 2.08 . . . . 0.0 111.001 173.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.15 73.35 3.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.269 0.557 . . . . 0.0 110.293 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.4 mmt -95.74 -168.76 1.82 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.133 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.56 115.41 5.74 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 176.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.737 ' HB1' ' HB3' ' A' ' 32' ' ' ALA . . . -48.54 -35.8 14.06 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.583 0.552 . . . . 0.0 111.584 -174.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -119.96 86.47 2.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.18 0.514 . . . . 0.0 109.724 169.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 58.2 m -65.63 129.62 94.38 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.386 175.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.38 -34.21 40.28 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.171 2.581 . . . . 0.0 113.162 -175.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 pp -132.23 158.67 74.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.182 -176.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.496 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . 39.6 Cg_endo -66.54 105.3 0.88 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.393 2.062 . . . . 0.0 111.18 175.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.1 tt -104.56 145.39 13.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.184 -174.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 91.9 m -90.12 132.89 35.19 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.648 173.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.9 m -135.56 176.33 8.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 120.664 0.269 . . . . 0.0 111.096 -177.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.67 121.68 15.93 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.677 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.43 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . . . -90.18 110.59 21.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.518 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.533 ' HB2' ' HB3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -113.38 100.71 8.75 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 172.265 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -82.79 119.17 24.01 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 75.8 mt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.629 -0.701 . . . . 0.0 110.14 -178.181 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.446 ' HE3' HG22 ' A' ' 60' ' ' THR . 39.2 tptt -71.03 133.15 46.1 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -172.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.456 HG23 ' HA ' ' A' ' 16' ' ' VAL . 7.3 p -150.95 148.15 15.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.863 -178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.9 ttt -102.96 124.82 49.19 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.732 0.301 . . . . 0.0 110.949 -176.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.464 HG13 HD11 ' A' ' 48' ' ' LEU . 42.4 mm -109.22 128.97 64.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.732 177.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.546 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 92.7 mtt180 -101.13 118.99 38.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.09 0.471 . . . . 0.0 111.34 -176.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.437 ' HD3' ' HG ' ' A' ' 33' ' ' LEU . 9.8 mmmm -107.68 116.53 32.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.233 171.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.1 m -139.96 72.84 1.41 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.349 0.595 . . . . 0.0 109.82 175.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 54.85 -93.79 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.945 -176.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.4 t -94.48 -25.94 16.67 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.225 0.536 . . . . 0.0 110.287 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.0 112.59 4.29 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -126.43 119.92 28.45 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.438 ' OG ' ' HD2' ' A' ' 6' ' ' ARG . 16.7 p -147.57 163.1 37.66 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.584 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -139.28 141.7 37.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.372 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -114.53 104.03 11.61 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.216 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.456 ' HA ' HG23 ' A' ' 3' ' ' VAL . 47.9 t -76.1 88.19 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.629 176.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.94 -29.18 41.38 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.239 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -57.86 -38.05 75.03 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.419 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 19' ' ' LYS . 54.1 tttm -117.16 -1.81 11.79 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.472 -175.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' A' ' 19' ' ' LYS . 30.9 t70 64.71 23.73 12.8 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 122.033 0.921 . . . . 0.0 109.385 -174.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.3 tt -88.87 125.48 34.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.729 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -124.98 125.22 43.55 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 10.5 tp10 -154.44 162.26 41.25 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.893 0.378 . . . . 0.0 110.815 -176.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.406 HD23 ' HB3' ' A' ' 13' ' ' SER . 91.1 mt -79.6 144.51 33.76 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.65 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.3 mt -81.11 114.14 21.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.086 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.464 HG23 ' HG3' ' A' ' 27' ' ' GLU . 19.8 m -104.67 -26.15 3.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.488 -178.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.603 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 39.3 mt-10 -132.91 114.34 13.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.354 -176.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.561 ' SD ' ' N ' ' A' ' 28' ' ' MET . 0.6 OUTLIER -109.53 157.43 19.0 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 178.861 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.457 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 8.6 tp10 -72.32 -49.54 33.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.69 0.757 . . . . 0.0 109.428 171.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.419 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 50.8 t-20 -95.57 138.48 21.82 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.717 -175.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 30' ' ' ASN . 9.5 Cg_endo -50.29 -31.54 29.97 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.016 2.477 . . . . 0.0 111.562 173.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.92 -69.56 0.49 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.977 173.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.669 ' HB3' ' HD1' ' A' ' 34' ' ' TRP . 0.3 OUTLIER -178.43 -72.46 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.602 178.445 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.669 ' HD1' ' HB3' ' A' ' 33' ' ' LEU . 14.5 m95 -79.08 144.5 34.53 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.985 -174.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 176.83 -58.14 0.1 Allowed Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.08 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -146.47 -73.19 0.02 OUTLIER Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.242 -174.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.457 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 1.7 pptp? -132.97 167.7 19.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.169 0.509 . . . . 0.0 110.924 176.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.6 p -147.21 154.7 11.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.381 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.603 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 11.7 m -134.52 134.43 41.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.971 0.415 . . . . 0.0 110.624 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.584 HD11 ' HB3' ' A' ' 14' ' ' ALA . 2.9 mm? -87.08 169.76 12.12 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.582 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.52 -12.14 59.64 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.09 0.471 . . . . 0.0 110.884 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -80.83 -20.83 41.57 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.845 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.2 -8.92 59.26 Favored Glycine 0 C--N 1.332 0.335 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 -175.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -64.71 133.39 52.02 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 45.2 mt-30 -107.87 138.13 44.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.862 0.363 . . . . 0.0 110.465 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.434 HD11 HG11 ' A' ' 3' ' ' VAL . 3.4 tm? -138.27 132.41 31.64 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -84.07 113.33 20.96 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.464 HD11 HG13 ' A' ' 5' ' ' ILE . 18.2 tp -105.97 116.53 59.49 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.349 -173.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.419 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 3.0 Cg_exo -74.92 154.93 43.24 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.341 2.028 . . . . 0.0 111.419 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.57 74.09 5.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.294 0.568 . . . . 0.0 109.825 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.5 mmt -90.85 -54.89 3.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.997 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.463 ' O ' HG22 ' A' ' 55' ' ' THR . . . -163.21 95.08 0.84 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.237 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.489 ' HA ' ' CD1' ' A' ' 34' ' ' TRP . . . -71.48 -32.61 68.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.585 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.74 -52.93 54.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.861 -175.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.463 HG22 ' O ' ' A' ' 52' ' ' ALA . 9.8 t -28.51 120.82 0.27 Allowed Pre-proline 0 N--CA 1.477 0.897 0 O-C-N 124.224 0.952 . . . . 0.0 113.403 -169.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -85.66 10.43 3.7 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.205 2.604 . . . . 0.0 112.432 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.8 pp -131.76 153.18 81.39 Favored Pre-proline 0 C--O 1.236 0.395 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.568 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.546 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . 41.9 Cg_endo -66.63 149.9 83.89 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.826 2.35 . . . . 0.0 112.682 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.1 tt -152.03 146.93 15.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.252 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.446 HG22 ' HE3' ' A' ' 2' ' ' LYS . 17.0 m -102.02 128.27 48.54 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.315 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.415 HG11 ' HZ3' ' A' ' 34' ' ' TRP . 27.5 m -132.7 174.97 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 120.877 0.37 . . . . 0.0 111.393 -177.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -78.5 161.59 26.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.463 171.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -167.45 159.96 12.8 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.333 0.587 . . . . 0.0 112.543 -175.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -113.13 141.56 46.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.866 172.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.51 126.16 41.5 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.433 HD22 ' N ' ' A' ' 66' ' ' LEU . 2.8 mm? . . . . . 0 C--O 1.245 0.837 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.611 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -108.7 144.54 36.36 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 122.511 0.324 . . . . 0.0 110.57 -173.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.5 p -147.17 141.59 20.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.808 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.2 ttm -101.75 112.72 25.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.83 0.348 . . . . 0.0 110.268 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.465 HG13 HD11 ' A' ' 48' ' ' LEU . 41.0 mm -95.61 124.48 48.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.439 ' HB2' ' OG ' ' A' ' 13' ' ' SER . 97.4 mtt180 -97.39 118.32 33.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.148 0.499 . . . . 0.0 110.838 -175.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.464 ' NZ ' ' HB3' ' A' ' 7' ' ' LYS . 3.0 mmmp? -98.38 116.51 30.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.746 177.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.1 p -134.34 161.82 33.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.27 113.12 1.8 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.807 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.8 p 52.85 23.03 2.59 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.575 0.75 . . . . 0.0 111.688 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.85 134.84 7.84 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -133.81 117.9 17.4 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -178.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.439 ' OG ' ' HB2' ' A' ' 6' ' ' ARG . 15.3 p -135.88 161.8 34.61 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.551 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -146.24 146.24 30.69 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.66 -0.246 . . . . 0.0 110.523 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -129.7 110.25 11.63 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.94 0.4 . . . . 0.0 111.019 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.556 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 56.4 t -87.92 96.29 5.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 172.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.07 -37.88 84.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.251 -171.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.64 -22.76 66.68 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.621 0.248 . . . . 0.0 111.453 -174.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 6.4 tmtm? -119.36 -2.73 10.56 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.669 0.271 . . . . 0.0 110.586 -178.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 64.04 27.72 14.24 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.687 -177.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.556 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 54.2 tp -84.01 111.46 19.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.244 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -123.7 113.15 18.24 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.419 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 10.2 tp10 -148.18 162.83 38.66 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.839 0.352 . . . . 0.0 110.825 -173.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.7 mt -84.14 151.63 24.78 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.332 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.545 HD13 HD21 ' A' ' 33' ' ' LEU . 78.6 mt -92.2 101.21 12.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.668 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.458 HG13 ' HB2' ' A' ' 41' ' ' ALA . 16.3 m -83.87 -37.34 13.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.934 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.553 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 47.2 mt-10 -125.26 139.96 53.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.021 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.411 ' SD ' ' HA ' ' A' ' 33' ' ' LEU . 16.1 ptt? -151.2 156.74 41.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.876 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.47 ' OE1' ' HG3' ' A' ' 37' ' ' LYS . 8.8 tp10 -67.1 -37.48 83.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.079 0.466 . . . . 0.0 111.273 -176.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.416 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 45.0 t-20 -117.74 137.02 23.89 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.073 -172.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 30' ' ' ASN . 8.4 Cg_endo -47.61 -31.43 14.13 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.495 2.797 . . . . 0.0 112.099 175.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.16 -61.71 1.89 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.552 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.545 HD21 HD13 ' A' ' 25' ' ' ILE . 0.4 OUTLIER 172.42 -67.25 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.973 0.796 . . . . 0.0 110.755 175.489 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.521 ' HZ3' HG21 ' A' ' 61' ' ' VAL . 44.4 m95 -74.06 133.38 42.89 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.461 -171.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.83 -56.63 0.05 OUTLIER Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.201 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.67 -67.3 0.01 OUTLIER Glycine 0 C--N 1.334 0.446 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.524 -174.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.47 ' HG3' ' OE1' ' A' ' 29' ' ' GLU . 1.9 pptp? -134.62 168.73 18.46 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.029 0.442 . . . . 0.0 111.152 175.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 46' ' ' LEU . 14.0 p -146.97 160.67 9.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.479 -177.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.553 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 33.0 m -138.89 126.3 21.68 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.83 0.348 . . . . 0.0 110.355 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.551 HD11 ' HB3' ' A' ' 14' ' ' ALA . 2.9 mm? -78.77 159.12 28.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.168 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.458 ' HB2' HG13 ' A' ' 26' ' ' VAL . . . -65.13 -12.06 46.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.087 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.419 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 65.1 t30 -85.3 2.78 42.6 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.48 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.26 -8.79 79.07 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.197 -0.525 . . . . 0.0 113.553 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 18.0 m0 -85.52 142.83 28.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.1 0.476 . . . . 0.0 111.274 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -101.69 159.8 15.01 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.756 -176.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.404 ' O ' HG12 ' A' ' 38' ' ' VAL . 3.2 tm? -159.37 136.33 9.53 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -176.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -82.84 122.8 28.69 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 122.247 -0.283 . . . . 0.0 110.28 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.465 HD11 HG13 ' A' ' 5' ' ' ILE . 22.7 tp -115.53 112.78 43.18 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.123 -174.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.419 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 60.0 Cg_endo -68.73 158.03 59.45 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.26 1.973 . . . . 0.0 111.961 -175.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.94 76.91 3.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.093 0.473 . . . . 0.0 110.514 178.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.416 ' SD ' ' N ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -91.75 -164.8 1.23 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.627 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.416 ' N ' ' SD ' ' A' ' 51' ' ' MET . . . -83.3 109.66 17.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.743 0.306 . . . . 0.0 110.962 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.79 -7.49 54.57 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.714 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -60.86 -25.68 66.83 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.793 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.2 p -57.02 117.52 18.29 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.924 -176.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -92.14 10.88 2.41 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.145 2.563 . . . . 0.0 111.682 174.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 pp -139.5 160.85 59.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.212 -175.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -62.98 135.71 52.9 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.53 2.153 . . . . 0.0 112.726 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.9 tt -130.54 140.15 49.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.022 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.3 m -100.85 119.05 38.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.895 0.378 . . . . 0.0 110.786 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.521 HG21 ' HZ3' ' A' ' 34' ' ' TRP . 35.4 m -122.5 170.67 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.721 178.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 1' ' ' MET . 10.2 mt-10 -82.85 157.12 23.25 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 171.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -149.23 164.37 34.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.23 0.538 . . . . 0.0 111.923 -172.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.622 HH11 ' HG3' ' A' ' 64' ' ' ARG . 11.3 mmt85 -116.62 125.71 52.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.655 175.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -82.22 108.69 15.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.99 0.424 . . . . 0.0 110.354 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 78.0 mt . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.417 -0.802 . . . . 0.0 109.673 178.753 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.4 ' HB3' ' HB3' ' A' ' 63' ' ' ALA . 24.8 mmt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -88.8 114.73 25.74 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.328 -172.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 9.5 p -147.38 141.98 19.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.092 174.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.461 ' SD ' ' HB2' ' A' ' 58' ' ' PRO . 51.0 ttm -117.18 120.28 37.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.676 0.274 . . . . 0.0 110.319 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.4 mm -88.62 115.1 28.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.419 ' HG2' ' HB3' ' A' ' 58' ' ' PRO . 94.5 mtt180 -111.03 118.97 37.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.784 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.455 ' HD3' ' O ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -127.74 138.44 52.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.023 0.44 . . . . 0.0 110.986 179.036 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.63 HG22 ' H ' ' A' ' 9' ' ' ALA . 3.0 m -147.19 -179.02 6.54 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.63 ' H ' HG22 ' A' ' 8' ' ' THR . . . -49.54 107.17 0.13 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 117.826 0.285 . . . . 0.0 110.729 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.2 p 67.79 -41.02 0.42 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.787 1.235 . . . . 0.0 112.746 -177.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.69 110.78 3.14 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.318 -0.467 . . . . 0.0 112.71 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -118.42 128.88 55.04 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.6 p -143.9 155.4 44.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.877 0.37 . . . . 0.0 110.648 -178.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.515 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -128.49 115.57 18.36 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -90.37 103.91 16.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.871 -176.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.1 t -80.25 99.59 4.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.39 175.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.28 -53.85 44.87 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -172.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -11.73 31.06 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -174.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -118.3 -8.98 10.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.723 0.297 . . . . 0.0 110.526 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.4 t70 57.65 26.65 13.19 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 122.032 0.92 . . . . 0.0 109.593 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.406 ' C ' HD23 ' A' ' 21' ' ' LEU . 8.1 tt -86.98 123.54 32.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.127 -176.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -133.16 104.48 6.52 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 171.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.32 165.16 19.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.904 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.7 mt -79.69 132.99 36.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.844 0.354 . . . . 0.0 110.63 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.464 HD12 HD11 ' A' ' 33' ' ' LEU . 69.5 mt -71.37 105.33 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.776 174.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.424 HG23 ' HG2' ' A' ' 27' ' ' GLU . 10.9 m -81.42 -49.25 18.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.173 -177.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.545 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 58.1 mm-40 -106.76 140.95 38.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.916 -177.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 59.5 mtt -132.96 156.73 46.75 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.466 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 10.6 tp10 -65.35 -49.13 70.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.551 0.691 . . . . 0.0 109.336 172.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -127.43 148.34 66.02 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.877 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.05 -23.08 11.68 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.337 2.691 . . . . 0.0 113.742 -174.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -71.25 -66.44 0.62 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.696 0.284 . . . . 0.0 110.547 176.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 18.7 tp 170.2 -70.48 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.008 -175.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 46.4 m95 -76.29 153.61 35.78 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.023 -176.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' A' ' 50' ' ' ALA . . . 159.62 -33.21 0.45 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.477 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.21 -78.24 0.05 OUTLIER Glycine 0 C--O 1.226 -0.393 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.466 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -129.73 161.3 30.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.919 0.39 . . . . 0.0 110.937 178.296 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.7 m -140.01 167.59 18.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 171.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.545 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 17.7 m -135.78 125.77 25.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.9 0.381 . . . . 0.0 110.671 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.515 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.7 mm? -77.88 161.45 27.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.558 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.8 -19.69 60.03 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.187 0.518 . . . . 0.0 110.395 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -63.08 -23.25 67.36 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.407 175.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.36 12.3 57.42 Favored Glycine 0 C--N 1.332 0.36 0 N-CA-C 111.621 -0.592 . . . . 0.0 111.621 -176.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.69 ' HZ2' ' HE2' ' A' ' 65' ' ' LYS . 45.8 t-105 -106.76 140.08 40.17 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 -178.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -94.41 149.04 21.63 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.954 -177.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.523 HD21 ' HB1' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -142.9 131.81 22.88 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.194 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.578 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 42.2 tt0 -89.9 120.88 31.5 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.79 0.329 . . . . 0.0 111.205 -175.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -121.03 113.32 32.85 Favored Pre-proline 0 C--O 1.235 0.332 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.371 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.51 152.89 79.83 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.384 2.056 . . . . 0.0 111.573 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.524 ' HB2' ' HA2' ' A' ' 35' ' ' GLY . . . -71.38 75.58 0.75 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.031 0.443 . . . . 0.0 110.434 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.6 mmt -87.99 -74.37 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.389 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.99 110.03 1.85 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.545 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.2 -30.87 70.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.238 0.542 . . . . 0.0 109.628 175.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -73.36 86.77 1.5 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.447 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.438 HG21 ' HB ' ' A' ' 59' ' ' ILE . 32.1 m -139.02 109.02 7.61 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.596 177.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -83.6 14.56 2.35 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.037 2.491 . . . . 0.0 113.22 -176.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.6 pp -145.66 159.98 45.87 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.648 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.461 ' HB2' ' SD ' ' A' ' 4' ' ' MET . 37.9 Cg_endo -66.62 106.27 1.05 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.258 1.972 . . . . 0.0 111.328 175.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.438 ' HB ' HG21 ' A' ' 55' ' ' THR . 8.7 tt -89.45 146.73 5.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.113 -174.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.1 m -110.84 132.71 53.97 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.275 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.4 m -139.82 177.14 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 122.419 0.288 . . . . 0.0 110.505 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -86.01 118.17 25.31 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.224 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.523 ' HB1' HD21 ' A' ' 46' ' ' LEU . . . -70.28 109.83 4.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.945 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.578 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 1.4 tmm_? -93.59 101.73 13.9 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 174.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.69 ' HE2' ' HZ2' ' A' ' 44' ' ' TRP . 45.3 tttm -73.15 129.7 38.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.166 -176.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.457 ' N ' HD12 ' A' ' 66' ' ' LEU . 5.8 mp . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.553 -0.736 . . . . 0.0 109.485 176.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.401 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 64.6 mtt . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.409 ' HG3' ' CG2' ' A' ' 60' ' ' THR . 86.3 tttt -101.61 121.56 42.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.008 -173.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.6 p -137.4 129.52 41.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 173.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.463 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 52.9 ttm -101.06 115.06 29.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.656 -175.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.1 mm -96.28 116.36 38.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 6' ' ' ARG . 64.0 mtt85 -97.68 126.12 42.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.209 0.528 . . . . 0.0 110.853 -178.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.623 ' HD3' ' HG ' ' A' ' 33' ' ' LEU . 16.1 mmmt -119.78 115.37 23.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.006 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.2 t -135.82 -167.46 2.04 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 175.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.21 -74.11 0.04 OUTLIER 'General case' 0 C--O 1.235 0.298 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -174.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.6 p -112.11 -28.51 7.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.985 0.421 . . . . 0.0 110.795 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.02 138.69 27.2 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.6 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -141.6 121.69 13.78 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 175.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.4 p -140.45 158.87 43.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.865 0.364 . . . . 0.0 111.277 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.577 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -131.05 137.88 49.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.792 176.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.463 ' HB3' ' HB3' ' A' ' 4' ' ' MET . 40.1 t80 -119.17 104.64 10.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.956 0.407 . . . . 0.0 111.207 -177.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 59.7 t -79.83 97.37 2.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.564 174.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.13 -40.64 77.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.778 -172.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.432 ' HB2' ' HE2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -69.32 -11.96 61.25 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -171.701 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -133.98 0.47 3.18 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.777 0.322 . . . . 0.0 111.008 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 59.32 24.06 12.56 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.782 -177.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.502 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 41.9 tp -83.07 108.26 16.23 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.17 -178.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 14' ' ' ALA . 32.9 tt0 -121.87 126.72 49.36 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.443 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 10.7 tp10 -147.61 162.63 38.74 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.556 -175.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.3 mt -78.29 139.59 38.86 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.576 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.405 HG23 HG23 ' A' ' 38' ' ' VAL . 79.9 mt -82.16 104.84 11.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.852 176.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.6 m -94.84 -37.59 8.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 111.674 0.249 . . . . 0.0 111.674 -177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.601 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 34.5 tt0 -127.95 134.39 49.3 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -176.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.547 ' HG2' ' HA ' ' A' ' 33' ' ' LEU . 0.9 OUTLIER -122.87 160.87 25.19 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.516 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.465 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 11.6 tp10 -66.73 -49.06 67.21 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -106.88 142.92 26.01 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 173.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -54.91 -21.94 28.27 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.019 2.48 . . . . 0.0 113.135 -174.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.11 -71.83 0.2 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.623 0.249 . . . . 0.0 110.669 177.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.623 ' HG ' ' HD3' ' A' ' 7' ' ' LYS . 1.1 tm? -179.45 -63.23 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -178.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.422 ' HA ' HD23 ' A' ' 48' ' ' LEU . 58.1 m95 -83.57 165.28 19.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.464 -177.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 159.22 -70.39 0.24 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.718 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -147.57 -48.36 0.03 OUTLIER Glycine 0 C--N 1.33 0.198 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.138 -175.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.465 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -145.01 164.51 30.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.84 0.353 . . . . 0.0 110.315 178.607 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.405 HG23 HG23 ' A' ' 25' ' ' ILE . 6.8 p -143.41 137.24 25.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.725 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.601 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 30.5 m -112.31 116.12 29.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.81 0.338 . . . . 0.0 110.751 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.577 HD11 ' HB3' ' A' ' 14' ' ' ALA . 2.9 mm? -75.29 154.97 37.13 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.985 173.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.11 -16.5 52.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.079 0.466 . . . . 0.0 111.436 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.44 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 7.1 t30 -82.5 3.28 29.0 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.814 -178.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.25 31.77 45.79 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.731 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 19.6 t-105 -113.7 113.91 25.65 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.404 ' HB3' HD12 ' A' ' 66' ' ' LEU . 42.3 mt-30 -98.93 121.08 40.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.276 0.56 . . . . 0.0 110.807 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.6 tp -110.62 147.85 33.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.026 178.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.566 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 35.6 tt0 -84.95 115.66 22.93 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 34' ' ' TRP . 15.0 tp -112.54 116.68 48.04 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.631 -171.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.18 155.84 58.98 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.5 2.133 . . . . 0.0 112.27 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.09 79.6 5.49 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.955 0.407 . . . . 0.0 111.011 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.1 mmt -98.41 -169.16 1.76 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.122 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.37 116.79 2.62 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.971 178.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.62 -46.69 28.88 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.75 0.657 . . . . 0.0 111.722 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.488 ' HA ' ' HE2' ' A' ' 7' ' ' LYS . 30.2 m-20 -116.37 79.47 1.32 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.085 0.469 . . . . 0.0 110.269 178.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.4 m -62.98 121.88 71.53 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.688 175.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.15 2.38 6.77 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.673 2.249 . . . . 0.0 113.184 -174.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 pp -151.86 156.88 34.47 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.631 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.21 110.24 1.95 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.462 2.108 . . . . 0.0 111.008 174.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.7 tt -105.36 137.18 36.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.101 0.476 . . . . 0.0 111.003 -175.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.409 ' CG2' ' HG3' ' A' ' 2' ' ' LYS . 86.9 m -95.81 118.84 33.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.303 177.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.9 178.11 2.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.832 -177.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 1' ' ' MET . 4.0 mp0 -76.37 149.06 37.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.202 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.18 156.8 17.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.105 0.478 . . . . 0.0 111.47 -177.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.566 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -162.21 105.69 1.16 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.963 174.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -73.9 141.05 46.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.804 0.335 . . . . 0.0 111.118 -177.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 47' ' ' GLU . 70.6 mt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.818 -0.61 . . . . 0.0 109.43 175.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptt? . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 121.286 0.565 . . . . 0.0 110.005 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.425 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 23.9 tptm -94.21 110.64 22.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.277 -169.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.486 HG23 ' HA ' ' A' ' 16' ' ' VAL . 11.7 p -146.98 141.67 20.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.051 174.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 47.5 ttp -125.05 129.02 49.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.49 -177.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.9 mm -96.94 123.81 49.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.669 ' HD3' ' HB3' ' A' ' 58' ' ' PRO . 22.2 mmt85 -99.1 131.53 45.07 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.205 0.526 . . . . 0.0 111.416 -177.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -93.55 120.25 33.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.968 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.5 p -123.32 146.43 47.93 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.75 -37.66 82.58 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.028 0.442 . . . . 0.0 110.514 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.6 m -110.27 76.27 0.98 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.076 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.54 -160.05 13.53 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.434 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -138.96 146.24 40.74 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.5 m -136.9 143.82 43.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.64 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -123.84 132.32 53.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.771 0.32 . . . . 0.0 110.151 177.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -104.93 102.39 11.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.158 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.486 ' HA ' HG23 ' A' ' 3' ' ' VAL . 47.8 t -76.36 90.75 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.295 174.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.425 ' HB3' ' HG3' ' A' ' 2' ' ' LYS . . . -62.48 -32.89 73.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.143 -172.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.474 ' HB2' ' NZ ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -69.05 -1.59 7.95 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.778 -0.192 . . . . 0.0 111.487 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 19' ' ' LYS . 56.8 tttm -136.84 -1.74 2.19 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.342 176.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 56.49 29.9 16.19 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.053 0.454 . . . . 0.0 110.752 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.3 tp -98.12 117.21 31.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.874 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -109.33 125.08 51.96 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 169.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.449 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 8.0 tp10 -143.91 160.6 40.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.934 0.397 . . . . 0.0 110.767 -177.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.5 mt -76.45 134.79 39.45 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.231 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.453 HG23 HG13 ' A' ' 38' ' ' VAL . 64.5 mt -81.0 91.6 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.8 m -78.72 -32.78 16.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.79 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.577 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 8.5 tp10 -129.37 141.34 51.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.207 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.417 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -152.15 157.81 42.05 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.3 -179.587 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.485 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 6.6 tp10 -65.19 -67.03 0.47 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.776 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.45 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 56.5 t30 -90.39 130.98 39.72 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.839 -175.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.45 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 1.6 Cg_endo -40.55 -35.02 1.33 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.462 3.441 . . . . 0.0 113.567 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -67.91 -65.78 0.65 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.785 0.326 . . . . 0.0 110.535 176.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 29.6 tp 174.57 -69.21 0.01 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.161 -175.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.508 ' HE3' ' O ' ' A' ' 49' ' ' PRO . 49.1 m95 -75.26 130.9 39.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.407 -177.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 50' ' ' ALA . . . -168.09 -57.44 0.03 OUTLIER Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.293 -178.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.37 -68.02 0.07 OUTLIER Glycine 0 C--O 1.225 -0.458 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 -177.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.485 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 9.6 ptpp? -101.3 146.57 27.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.648 0.261 . . . . 0.0 110.321 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.453 HG13 HG23 ' A' ' 25' ' ' ILE . 17.2 t -147.15 153.13 12.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.577 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 43.2 m -142.8 131.21 22.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.069 0.461 . . . . 0.0 111.025 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.64 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.2 mm? -86.21 165.33 16.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.622 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.32 -20.76 65.77 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.142 0.496 . . . . 0.0 110.908 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.449 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 8.0 t30 -77.34 -9.35 58.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.47 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.62 -10.61 68.77 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 121.252 -0.499 . . . . 0.0 111.992 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 27.1 t-105 -64.64 123.38 19.15 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.478 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 43.8 mt-30 -98.62 126.96 44.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.889 0.376 . . . . 0.0 110.378 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.7 tp -123.64 139.03 54.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.538 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 21.0 tt0 -95.67 101.97 13.72 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -178.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.7 tp -101.5 104.33 33.39 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.543 -173.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.508 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 59.2 Cg_endo -70.62 136.26 30.31 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.441 2.094 . . . . 0.0 111.639 -175.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.455 ' HB2' ' HA2' ' A' ' 35' ' ' GLY . . . -64.69 80.44 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.957 0.408 . . . . 0.0 111.578 -177.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.3 mmt -86.65 -59.87 2.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.282 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.45 116.96 5.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.775 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.74 -54.77 33.45 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.617 0.573 . . . . 0.0 111.516 -174.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -103.98 91.43 3.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.985 0.421 . . . . 0.0 110.295 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.9 m -73.22 128.61 87.33 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.187 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.55 -44.09 11.96 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.403 2.069 . . . . 0.0 112.502 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.569 ' HB2' ' HD2' ' A' ' 58' ' ' PRO . 2.7 pp -132.56 165.99 32.26 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.405 -177.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.669 ' HB3' ' HD3' ' A' ' 6' ' ' ARG . 29.3 Cg_endo -60.73 110.23 0.79 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.382 2.054 . . . . 0.0 111.737 177.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.9 tt -101.63 147.81 8.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.019 -176.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 87.5 m -101.73 120.13 39.87 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.156 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.1 m -120.38 178.55 2.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.161 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.66 123.17 21.25 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.519 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.46 110.2 14.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.086 0.47 . . . . 0.0 110.782 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.415 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 3.5 tpm_? -122.14 105.16 10.01 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.203 176.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -83.58 151.28 25.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.893 0.378 . . . . 0.0 110.78 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 7.1 mp . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.331 -0.842 . . . . 0.0 109.34 174.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.748 ' SD ' ' HD3' ' A' ' 18' ' ' LYS . 24.2 ttt . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.478 ' HG3' HG21 ' A' ' 60' ' ' THR . 39.8 tttm -71.41 115.15 10.24 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.58 0.752 . . . . 0.0 110.678 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.555 HG23 ' HA ' ' A' ' 16' ' ' VAL . 8.2 p -134.24 136.31 53.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.954 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.7 ttm -104.28 116.53 32.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.967 0.413 . . . . 0.0 111.233 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.525 HG13 HD11 ' A' ' 48' ' ' LEU . 45.2 mm -91.18 115.55 30.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.507 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 74.3 mtp180 -97.46 118.78 34.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.127 0.489 . . . . 0.0 110.952 -171.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -100.03 116.59 32.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.857 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 t -149.16 -177.58 5.9 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.27 104.59 0.15 Allowed 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.386 0.429 . . . . 0.0 111.608 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.1 p 67.75 -52.96 0.51 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.005 1.322 . . . . 0.0 113.504 177.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.95 81.81 0.54 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.451 -0.404 . . . . 0.0 113.23 -174.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.411 ' HB3' HD11 ' A' ' 33' ' ' LEU . 61.2 m80 -70.84 110.42 5.59 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m -114.66 151.9 32.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.936 0.398 . . . . 0.0 111.546 -170.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.453 ' HB3' HD21 ' A' ' 40' ' ' LEU . . . -124.35 118.57 27.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.66 175.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -106.11 106.91 17.64 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.044 0.449 . . . . 0.0 110.912 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.555 ' HA ' HG23 ' A' ' 3' ' ' VAL . 29.9 t -93.71 96.51 6.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.666 176.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.82 -45.55 86.0 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.348 -173.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.748 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 49.2 pttt -63.79 -35.22 79.9 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.732 0.301 . . . . 0.0 111.054 -177.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.403 ' N ' ' HG3' ' A' ' 18' ' ' LYS . 48.0 tttm -90.42 -9.97 45.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.882 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 62.07 20.51 11.68 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.042 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 22' ' ' GLU . 4.2 tt -106.23 128.8 54.22 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -175.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.507 ' N ' HD23 ' A' ' 21' ' ' LEU . 45.3 tt0 -131.0 113.89 14.53 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 175.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 7.7 tp10 -136.4 160.36 38.99 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.941 0.401 . . . . 0.0 111.014 -175.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.2 mt -79.4 143.49 35.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.763 175.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 68.6 mt -90.0 123.13 42.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.2 m -110.59 -27.42 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -176.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.604 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 52.5 mm-40 -129.85 100.56 5.52 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.765 0.317 . . . . 0.0 110.988 -176.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.546 ' SD ' ' N ' ' A' ' 28' ' ' MET . 1.0 OUTLIER -99.97 155.37 17.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.399 -178.546 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -67.99 -53.54 25.22 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 170.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.497 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 59.3 t30 -97.42 131.16 27.77 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.042 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.497 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 2.8 Cg_endo -42.06 -39.98 6.07 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 124.185 3.257 . . . . 0.0 113.182 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.553 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -69.16 -66.39 0.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.462 177.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.411 HD11 ' HB3' ' A' ' 12' ' ' HIS . 4.5 mt 178.7 -72.63 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.255 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.594 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 41.1 m95 -72.66 140.41 47.91 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.053 -173.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.19 -23.83 0.88 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 121.278 -0.487 . . . . 0.0 112.287 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.86 -137.19 3.6 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.968 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.517 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -67.09 146.72 54.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.332 0.587 . . . . 0.0 111.941 -176.427 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.0 m -137.68 136.91 45.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 172.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.604 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 26.8 m -111.32 128.55 55.99 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.727 0.298 . . . . 0.0 110.765 -175.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . 80.6 mt -72.37 157.2 38.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.985 176.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.16 -17.74 58.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.306 0.574 . . . . 0.0 110.582 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.424 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 25.3 t-20 -69.61 -28.55 66.03 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.49 176.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.78 -18.84 26.44 Favored Glycine 0 C--N 1.331 0.269 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -175.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.721 ' HZ2' ' HD2' ' A' ' 65' ' ' LYS . 41.2 t-105 -71.0 141.51 50.99 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -114.43 146.48 40.57 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.255 0.55 . . . . 0.0 111.735 -175.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.6 tp -135.3 141.9 45.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.659 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.601 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 38.5 tt0 -92.42 105.63 17.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.187 0.518 . . . . 0.0 110.049 -178.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.525 HD11 HG13 ' A' ' 5' ' ' ILE . 18.9 tp -83.22 126.44 72.05 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.537 -174.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -51.83 145.15 32.76 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.0 2.466 . . . . 0.0 113.203 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.7 88.2 7.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.967 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 23.5 ptp -135.37 -152.39 0.46 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.439 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.54 112.47 0.6 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.656 0.265 . . . . 0.0 110.562 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.594 ' HA ' ' HB2' ' A' ' 34' ' ' TRP . . . -63.91 -27.19 68.98 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.161 -173.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -135.66 93.51 2.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.148 0.499 . . . . 0.0 110.644 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.0 p -79.67 129.84 69.78 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.672 174.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.04 -8.43 23.58 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.398 2.065 . . . . 0.0 111.936 -178.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.2 pp -138.23 158.08 71.54 Favored Pre-proline 0 C--O 1.236 0.376 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.456 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.507 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . 38.2 Cg_endo -66.19 136.13 42.89 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.437 2.091 . . . . 0.0 111.058 174.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.5 tt -136.78 144.31 32.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.877 0.37 . . . . 0.0 110.944 -174.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.478 HG21 ' HG3' ' A' ' 2' ' ' LYS . 63.7 m -98.11 130.77 44.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.145 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.41 ' O ' HG12 ' A' ' 3' ' ' VAL . 26.3 m -140.14 179.41 2.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 120.968 0.413 . . . . 0.0 111.599 -174.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -64.03 138.67 58.57 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.212 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.454 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . . . -108.37 123.41 48.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.022 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.601 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -122.89 102.04 7.79 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 175.047 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.721 ' HD2' ' HZ2' ' A' ' 44' ' ' TRP . 28.2 ttpt -65.16 145.3 56.45 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.691 -176.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.474 HD21 ' HB2' ' A' ' 47' ' ' GLU . 91.3 mt . . . . . 0 C--O 1.253 1.253 0 CA-C-O 118.821 -0.609 . . . . 0.0 109.847 175.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.671 ' SD ' ' NH1' ' A' ' 64' ' ' ARG . 59.1 mtt . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -114.32 115.33 27.21 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.99 -173.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.1 p -137.72 127.83 36.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.04 0.448 . . . . 0.0 110.002 174.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.473 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 23.2 ttt -101.71 111.87 24.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.349 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.1 mm -77.21 117.61 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -96.38 118.53 33.09 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.317 -172.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.448 ' NZ ' ' O ' ' A' ' 54' ' ' ASP . 14.3 mmmm -106.08 118.43 36.59 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.05 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 72.5 m -142.23 157.3 45.0 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.65 107.26 0.11 Allowed 'General case' 0 C--O 1.233 0.233 0 O-C-N 123.094 0.247 . . . . 0.0 110.675 178.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.5 p 66.92 -41.38 0.4 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.272 1.429 . . . . 0.0 112.916 -176.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.07 105.31 1.6 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.321 -0.466 . . . . 0.0 112.682 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -104.61 121.88 44.46 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 175.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.435 ' HB3' HD23 ' A' ' 24' ' ' LEU . 33.7 p -138.68 160.8 38.75 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.761 0.315 . . . . 0.0 110.177 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.587 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -128.0 115.81 19.07 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.408 ' HB3' ' HB3' ' A' ' 4' ' ' MET . 59.5 t80 -87.22 103.19 15.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.59 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.1 t -74.34 89.04 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.207 175.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.3 -34.61 70.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.147 -172.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.43 -12.27 59.84 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -177.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 19' ' ' LYS . 39.1 tttm -127.2 -7.82 5.9 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.484 0.183 . . . . 0.0 110.973 178.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.3 t70 67.94 17.21 9.62 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.758 0.79 . . . . 0.0 110.332 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.487 HD21 ' HG2' ' A' ' 23' ' ' GLU . 7.6 tt -88.42 134.71 33.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.192 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -134.09 111.04 10.02 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 173.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 40' ' ' LEU . 78.1 mm-40 -116.61 160.14 21.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.27 177.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.435 HD23 ' HB3' ' A' ' 13' ' ' SER . 83.1 mt -76.95 136.2 38.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.549 175.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 85.9 mt -71.96 107.26 2.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.035 175.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.0 m -94.79 -22.77 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.179 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.578 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 32.7 tt0 -142.45 142.57 32.35 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.097 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.54 ' SD ' ' N ' ' A' ' 28' ' ' MET . 1.0 OUTLIER -123.72 177.24 5.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.096 -177.005 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.511 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 8.2 tp10 -84.2 -56.79 3.47 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 168.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.421 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 35.6 t-20 -95.59 137.63 21.93 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.819 177.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 30' ' ' ASN . 5.2 Cg_endo -44.64 -22.59 0.65 Allowed 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.642 2.895 . . . . 0.0 113.076 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.22 -69.25 0.62 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.169 173.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.4 tp -177.94 -75.55 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.922 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.478 ' HE3' ' O ' ' A' ' 49' ' ' PRO . 29.4 m95 -72.11 137.42 47.03 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.659 -176.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.538 ' HA2' ' HB2' ' A' ' 50' ' ' ALA . . . -179.67 -40.45 0.07 OUTLIER Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.419 -0.895 . . . . 0.0 113.356 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.49 -71.43 0.05 OUTLIER Glycine 0 C--O 1.225 -0.419 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.959 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.511 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -120.28 164.54 16.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.0 0.429 . . . . 0.0 111.143 176.348 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 46' ' ' LEU . 14.8 p -147.34 147.02 17.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.578 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 45.7 m -121.45 133.03 55.05 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.257 0.551 . . . . 0.0 111.126 -177.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.6 mm? -92.28 155.92 17.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.886 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.57 -34.68 51.64 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.03 -1.62 57.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.881 0.372 . . . . 0.0 111.442 -171.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.94 -27.61 8.15 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.518 174.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -59.4 140.23 56.34 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.872 0.336 . . . . 0.0 110.6 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.453 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 46.2 mt-30 -122.13 144.15 49.11 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.555 HD13 ' N ' ' A' ' 47' ' ' GLU . 1.6 tm? -133.67 140.49 47.09 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -176.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.555 ' N ' HD13 ' A' ' 46' ' ' LEU . 38.0 tt0 -81.69 112.13 18.59 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.9 tp -110.97 95.18 23.08 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.27 -175.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.478 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 21.7 Cg_exo -65.46 151.28 85.43 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.782 2.321 . . . . 0.0 112.298 -175.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.538 ' HB2' ' HA2' ' A' ' 35' ' ' GLY . . . -74.74 81.34 2.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.98 0.419 . . . . 0.0 110.491 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.2 mmt -95.08 -63.72 1.14 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.201 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.448 ' HB3' HG23 ' A' ' 55' ' ' THR . . . -144.73 112.67 6.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.003 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.12 99.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.5 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.448 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . 6.7 p-10 -70.74 -54.99 9.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.395 -176.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.448 HG23 ' HB3' ' A' ' 52' ' ' ALA . 1.2 p 41.63 88.38 0.1 Allowed Pre-proline 0 N--CA 1.471 0.6 0 C-N-CA 123.11 0.564 . . . . 0.0 112.0 -177.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.55 -20.94 30.47 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.783 2.322 . . . . 0.0 112.956 -173.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.4 pp -125.97 153.93 73.79 Favored Pre-proline 0 C--O 1.236 0.35 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.63 -177.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.67 94.7 0.39 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.511 2.141 . . . . 0.0 111.693 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.7 tt -89.19 143.36 11.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.968 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 4' ' ' MET . 28.0 m -97.76 130.6 44.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.917 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.7 m -126.57 177.05 5.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 121.028 0.442 . . . . 0.0 111.194 -177.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -78.11 125.18 28.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.249 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.17 122.95 28.01 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -173.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.671 ' NH1' ' SD ' ' A' ' 1' ' ' MET . 4.6 mpt_? -118.48 100.53 7.52 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 168.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -74.78 131.8 41.09 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 82.7 mt . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.554 -0.736 . . . . 0.0 109.698 178.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.519 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 49.0 ttm . . . . . 0 N--CA 1.484 1.229 0 CA-C-O 120.773 0.32 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -109.13 133.23 53.28 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 120.803 0.335 . . . . 0.0 111.416 -176.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.561 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 14.5 p -144.0 134.25 20.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.747 174.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.5 ttp -103.54 114.02 27.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.778 0.323 . . . . 0.0 110.224 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 58' ' ' PRO . 41.4 mm -90.15 116.66 31.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.072 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -94.13 147.46 23.13 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.035 0.445 . . . . 0.0 110.198 -175.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 55' ' ' THR . 36.4 mmtm -121.3 151.58 39.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.446 -176.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.448 HG22 ' N ' ' A' ' 9' ' ' ALA . 59.9 m -159.59 164.01 34.57 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.448 ' N ' HG22 ' A' ' 8' ' ' THR . . . -39.37 -42.75 1.1 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.881 0.472 . . . . 0.0 112.002 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.6 t -146.75 -32.66 0.31 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.763 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.97 75.75 0.74 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.312 -0.471 . . . . 0.0 112.999 -177.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -68.33 138.0 55.08 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.8 p -145.08 162.8 36.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.697 0.284 . . . . 0.0 110.955 -178.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.517 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -139.61 143.88 37.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.655 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.476 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 59.7 t80 -126.37 112.44 15.66 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.0 t -85.6 123.01 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.281 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.49 -70.58 0.12 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.86 -15.88 60.0 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -172.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.802 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 57.9 tptt -101.41 -15.63 17.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.494 0.187 . . . . 0.0 110.712 -177.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 58.91 25.0 13.15 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.382 0.61 . . . . 0.0 110.188 -177.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.802 ' HB2' ' HG3' ' A' ' 19' ' ' LYS . 7.0 tt -90.96 124.33 35.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.181 -173.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -128.25 109.19 11.24 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -133.23 161.03 35.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.093 -176.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.4 mt -77.83 146.53 35.67 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.564 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 72.2 mt -88.79 112.79 24.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.707 177.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.5 m -101.5 -37.46 5.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 116.805 -0.18 . . . . 0.0 111.482 -178.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.467 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 39.1 tt0 -127.43 119.5 26.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.896 0.379 . . . . 0.0 110.642 -178.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.517 ' SD ' ' N ' ' A' ' 28' ' ' MET . 1.2 mpt? -103.43 158.13 16.55 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 9.0 tp10 -60.12 -58.7 7.42 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.132 0.492 . . . . 0.0 109.924 174.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -96.98 153.4 38.55 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.248 175.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.8 -14.87 23.92 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.711 2.274 . . . . 0.0 112.741 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.82 -69.75 0.59 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.104 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.505 ' HA ' ' HG2' ' A' ' 28' ' ' MET . 1.3 tm? -176.05 -67.89 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -178.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 56.8 m95 -84.24 160.84 20.7 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.551 -177.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 168.89 -57.59 0.2 Allowed Glycine 0 C--N 1.337 0.596 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.338 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.42 -64.12 0.02 OUTLIER Glycine 0 C--N 1.33 0.226 0 C-N-CA 121.295 -0.479 . . . . 0.0 112.118 -175.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 1.7 pptp? -131.27 168.62 17.21 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.786 0.327 . . . . 0.0 110.901 175.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.0 p -147.08 152.35 13.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.589 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 44.9 m -123.26 127.82 49.11 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 120.982 0.42 . . . . 0.0 110.856 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.517 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.4 mm? -79.38 159.69 26.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.434 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.87 -29.0 66.66 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.021 -175.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -74.87 -31.68 61.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.891 0.377 . . . . 0.0 110.466 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 128.85 -10.32 6.32 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.494 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.534 ' CE3' HD11 ' A' ' 21' ' ' LEU . 3.2 m-90 -69.9 141.98 53.06 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.142 0.471 . . . . 0.0 110.985 178.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -103.48 137.35 41.68 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.602 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 58.3 tp -130.39 141.99 50.53 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 177.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.55 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 29.8 tt0 -80.88 122.45 27.24 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.0 tp -114.28 100.18 52.32 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.886 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -58.65 150.78 67.61 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.788 2.326 . . . . 0.0 112.687 -173.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.77 90.49 0.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.547 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.3 mmt -114.64 -173.09 2.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.427 176.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.62 114.21 2.16 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.672 0.273 . . . . 0.0 110.61 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.81 -50.48 73.82 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.213 -178.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -80.39 76.87 7.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.399 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.491 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 1.4 p -116.01 98.65 51.58 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.736 173.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -77.67 -7.12 16.57 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.65 2.233 . . . . 0.0 112.492 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.458 ' O ' HD12 ' A' ' 57' ' ' LEU . 2.5 pp -102.11 149.67 36.78 Favored Pre-proline 0 C--O 1.239 0.546 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.355 -177.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 57.5 Cg_endo -71.57 92.56 0.68 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.54 2.16 . . . . 0.0 111.356 175.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.7 tt -93.62 142.29 13.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.595 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.2 m -100.8 123.11 44.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.189 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.3 m -126.44 178.5 4.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 120.834 0.35 . . . . 0.0 110.736 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.519 ' HA ' ' O ' ' A' ' 1' ' ' MET . 6.7 mp0 -69.21 149.61 48.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.397 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.561 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . . . -119.5 133.19 55.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.003 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.55 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 14.9 tpt180 -134.89 122.21 21.66 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 174.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -83.17 123.69 29.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.045 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.498 HD11 ' HB2' ' A' ' 47' ' ' GLU . 7.2 mp . . . . . 0 C--O 1.25 1.113 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.7 mmm . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -113.25 137.8 50.95 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.618 0.247 . . . . 0.0 111.111 -174.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 14.5 p -145.91 138.78 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.306 175.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 47.0 ttm -111.2 114.79 28.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.301 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 58' ' ' PRO . 47.2 mm -86.2 113.52 24.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -104.98 139.19 40.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.246 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -138.41 135.67 35.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.326 178.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.6 m -108.83 -53.8 2.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.366 0.603 . . . . 0.0 109.544 174.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -170.75 -91.03 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.576 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.5 t -76.84 -28.32 55.45 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 168.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.94 98.07 0.77 Allowed Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.798 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -107.5 121.86 45.47 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 175.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.3 p -135.17 161.04 36.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.918 0.389 . . . . 0.0 110.844 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.598 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -137.19 119.07 15.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.404 178.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -90.06 102.29 15.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.015 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.475 ' HA ' HG23 ' A' ' 3' ' ' VAL . 49.2 t -77.24 90.71 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.59 -31.54 57.11 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.184 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -52.85 -54.64 31.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.136 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.567 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 9.3 tmtt? -94.92 -5.04 45.74 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.641 -176.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.7 t70 60.07 27.32 16.75 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 122.139 0.971 . . . . 0.0 109.06 -174.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.439 ' HB2' ' HD2' ' A' ' 19' ' ' LYS . 6.9 tt -106.31 118.5 36.8 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.686 -175.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -108.05 132.54 53.45 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 172.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 10.9 tp10 -144.86 161.53 39.06 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -176.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.9 mt -78.23 140.16 38.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.427 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 77.2 mt -84.6 122.86 38.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.036 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.9 m -112.3 -35.75 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -174.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.53 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 4.7 tm-20 -129.46 123.78 32.4 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -176.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.463 ' HG2' HD12 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -124.11 140.93 52.5 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.754 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.598 ' HB2' ' HD3' ' A' ' 37' ' ' LYS . 33.0 tt0 -58.22 -36.2 72.8 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.283 0.563 . . . . 0.0 110.362 176.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -109.05 140.36 21.85 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.898 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -49.54 -34.65 34.55 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.225 2.617 . . . . 0.0 112.637 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.78 -68.93 0.5 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.304 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.521 ' HB3' ' HD1' ' A' ' 34' ' ' TRP . 21.2 tp 178.89 -68.46 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.459 -178.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.521 ' HD1' ' HB3' ' A' ' 33' ' ' LEU . 13.6 m95 -78.14 135.23 37.62 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.516 -176.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.464 ' HA2' ' HB2' ' A' ' 50' ' ' ALA . . . -172.17 -48.36 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.434 -177.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.34 -72.91 0.05 OUTLIER Glycine 0 C--O 1.226 -0.383 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -176.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.598 ' HD3' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -123.21 155.34 37.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.979 0.419 . . . . 0.0 111.004 176.456 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 46' ' ' LEU . 8.5 p -146.72 157.09 11.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.45 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 34.9 m -127.03 129.86 48.85 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.087 0.47 . . . . 0.0 111.111 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.598 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.7 mm? -81.23 163.75 22.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.086 175.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.1 -24.36 66.18 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.898 0.38 . . . . 0.0 111.432 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.407 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 2.7 t-20 -83.99 5.59 25.11 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.67 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.34 8.39 87.21 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.589 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.489 ' HE1' HD23 ' A' ' 46' ' ' LEU . 33.3 t-105 -76.65 112.33 13.09 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -88.96 115.86 26.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.992 0.425 . . . . 0.0 110.48 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.499 HD13 ' N ' ' A' ' 47' ' ' GLU . 2.3 tm? -118.9 136.27 54.14 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -176.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.499 ' N ' HD13 ' A' ' 46' ' ' LEU . 36.8 tt0 -79.8 111.85 16.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 0.0 110.366 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.5 tp -109.35 99.99 39.23 Favored Pre-proline 0 C--O 1.236 0.384 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.953 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.407 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 19.2 Cg_exo -65.36 153.33 78.74 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.612 2.208 . . . . 0.0 112.106 -174.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.464 ' HB2' ' HA2' ' A' ' 35' ' ' GLY . . . -79.53 83.76 5.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.785 0.326 . . . . 0.0 110.141 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 93.2 mmm -113.0 -79.6 0.58 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.309 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -127.84 101.12 6.21 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.493 ' HA ' ' CD1' ' A' ' 34' ' ' TRP . . . -79.14 -50.94 10.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.325 -175.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -95.25 27.07 3.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.929 -173.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.6 t -65.37 134.0 95.56 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -83.56 -1.62 10.2 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.613 2.209 . . . . 0.0 113.591 -175.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 57' ' ' LEU . 3.2 pp -120.9 149.36 50.71 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.441 0.163 . . . . 0.0 111.135 -175.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 44.1 Cg_endo -68.35 95.71 0.46 Allowed 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.305 2.003 . . . . 0.0 111.244 176.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.6 tt -89.21 142.11 13.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.849 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.4 m -101.94 123.17 45.39 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.624 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.3 m -127.69 178.0 5.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.957 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -69.54 149.93 47.68 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.547 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.487 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . . . -115.56 151.22 35.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.117 -177.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.424 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 37.5 ttt180 -153.3 121.47 6.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.616 175.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -87.19 121.31 29.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.816 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.427 HD22 ' N ' ' A' ' 66' ' ' LEU . 2.3 mm? . . . . . 0 C--O 1.248 1.026 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 172.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.644 ' SD ' ' HG2' ' A' ' 64' ' ' ARG . 59.9 mtt . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -130.52 111.76 12.57 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -169.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.556 HG11 HD11 ' A' ' 46' ' ' LEU . 7.4 p -142.09 130.45 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 171.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 46.8 ttm -101.06 112.05 24.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.0 mm -86.98 129.49 38.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -96.2 132.35 41.73 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 55' ' ' THR . 0.1 OUTLIER -107.98 116.58 32.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.368 0.604 . . . . 0.0 112.066 -166.038 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 t -177.41 131.35 0.16 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.783 171.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.55 -26.14 68.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.586 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.9 p -103.27 20.66 17.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.548 -176.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.87 49.43 0.12 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.82 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -57.4 123.74 16.51 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.492 ' HB3' HD23 ' A' ' 24' ' ' LEU . 10.7 p -151.03 162.48 40.77 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.367 -0.235 . . . . 0.0 110.367 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.439 ' HB3' HD21 ' A' ' 40' ' ' LEU . . . -145.57 136.11 24.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.233 -177.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.4 ' HD1' ' HB2' ' A' ' 22' ' ' GLU . 74.8 t80 -105.12 102.55 12.04 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 174.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.513 ' HA ' HG23 ' A' ' 3' ' ' VAL . 47.1 t -84.44 95.07 3.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.85 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.91 -26.4 64.29 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.562 -176.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.409 ' HB3' HG12 ' A' ' 16' ' ' VAL . 55.5 tptt -52.97 -39.44 63.0 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 175.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.532 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 2.6 tmtp? -116.05 -6.76 11.95 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 16' ' ' VAL . 19.1 m-20 59.69 26.01 15.05 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.614 -170.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 19' ' ' LYS . 5.1 tt -84.33 125.95 32.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.67 -176.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.458 ' N ' HD23 ' A' ' 21' ' ' LEU . 43.0 tt0 -116.22 120.46 39.04 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.463 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 7.4 tp10 -147.81 161.97 40.18 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.986 0.422 . . . . 0.0 111.184 -176.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.492 HD23 ' HB3' ' A' ' 13' ' ' SER . 96.3 mt -82.05 137.86 34.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.689 174.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.2 mt -83.05 106.33 13.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.462 HG23 ' HG3' ' A' ' 27' ' ' GLU . 16.5 m -81.96 -34.4 12.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.398 -177.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.462 ' HG3' HG23 ' A' ' 26' ' ' VAL . 48.6 mt-10 -132.83 140.16 47.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.334 -177.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.481 ' HG2' ' HA ' ' A' ' 33' ' ' LEU . 2.5 mpp? -126.15 160.0 31.39 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.51 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 14.7 tp10 -64.53 -41.63 96.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.229 0.538 . . . . 0.0 109.702 174.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -118.8 152.2 51.18 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.543 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -49.62 -33.03 29.97 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.161 2.574 . . . . 0.0 113.21 -177.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.36 -68.67 0.48 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.744 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.481 ' HA ' ' HG2' ' A' ' 28' ' ' MET . 3.7 tt -178.39 -71.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.977 0.417 . . . . 0.0 110.227 -178.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.698 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 31.7 m95 -76.65 155.72 33.21 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.27 -173.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 162.34 -42.54 0.36 Allowed Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.836 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.0 -65.61 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.51 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -144.79 167.93 21.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.793 0.33 . . . . 0.0 111.205 178.153 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.429 HG13 HD23 ' A' ' 48' ' ' LEU . 33.4 m -139.41 172.43 12.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.339 174.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.2 m -132.79 122.39 24.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.319 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.555 HD12 ' HB3' ' A' ' 44' ' ' TRP . 85.9 mt -78.17 155.99 30.12 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.159 176.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.16 -9.31 22.04 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.022 0.439 . . . . 0.0 111.308 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.463 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 28.2 t-20 -86.54 -13.13 46.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.251 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.88 -1.32 59.55 Favored Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.785 -176.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.555 ' HB3' HD12 ' A' ' 40' ' ' LEU . 15.3 t-105 -80.16 121.02 25.06 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 178.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -94.84 131.11 41.07 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.556 HD11 HG11 ' A' ' 3' ' ' VAL . 1.0 OUTLIER -122.66 132.38 54.24 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.259 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.589 ' HB3' ' HB2' ' A' ' 64' ' ' ARG . 32.2 tt0 -90.6 122.69 33.62 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.774 0.321 . . . . 0.0 110.87 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.43 HD22 ' N ' ' A' ' 48' ' ' LEU . 3.2 mm? -109.6 100.76 43.58 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -65.34 71.22 0.29 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.344 2.696 . . . . 0.0 113.469 -173.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 36.9 89.05 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.375 1.07 . . . . 0.0 113.489 175.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.485 ' HB2' ' CE3' ' A' ' 34' ' ' TRP . 25.2 mmt -129.62 -169.02 2.03 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 174.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.64 108.72 0.37 Allowed 'General case' 0 CA--C 1.532 0.273 0 O-C-N 123.098 0.249 . . . . 0.0 110.794 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.698 ' HA ' ' HB2' ' A' ' 34' ' ' TRP . . . -50.57 -37.06 37.62 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.746 -175.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -128.07 70.78 1.36 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.489 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 3.9 t -57.5 139.9 80.42 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.133 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.57 5.2 4.42 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.825 2.35 . . . . 0.0 113.352 -176.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.413 HD23 ' N ' ' A' ' 57' ' ' LEU . 2.5 pt? -152.07 147.69 20.2 Favored Pre-proline 0 C--O 1.234 0.267 0 O-C-N 122.512 -0.118 . . . . 0.0 110.966 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.99 94.33 0.28 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.622 2.215 . . . . 0.0 110.648 173.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.8 tt -96.35 150.56 4.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.08 0.467 . . . . 0.0 111.741 -172.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 90.3 m -98.93 127.75 44.93 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.14 175.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.414 ' O ' HG12 ' A' ' 3' ' ' VAL . 31.6 m -133.05 179.36 4.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 120.863 0.363 . . . . 0.0 111.02 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -55.97 108.87 0.5 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.042 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.521 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . . . -72.56 109.59 6.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.531 173.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.644 ' HG2' ' SD ' ' A' ' 1' ' ' MET . 91.7 mtt180 -132.81 135.01 45.41 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -108.53 150.58 27.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.02 0.438 . . . . 0.0 110.947 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.7 mt . . . . . 0 C--O 1.252 1.22 0 CA-C-O 118.449 -0.786 . . . . 0.0 109.659 175.02 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.64 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 121.474 0.654 . . . . 0.0 110.748 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -100.84 118.97 37.96 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.469 -175.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 11.5 p -137.8 132.58 44.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 174.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 57.9 ttp -112.23 117.6 32.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.293 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 58' ' ' PRO . 43.0 mm -87.44 119.38 34.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 176.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -96.28 125.65 40.94 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.948 0.404 . . . . 0.0 110.039 -179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 55' ' ' THR . 32.3 mmtp -85.65 115.65 23.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.596 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.6 m -159.1 134.01 8.17 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.37 -74.73 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -173.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 42.1 m -74.58 -29.24 61.25 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.918 0.39 . . . . 0.0 110.584 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.06 40.57 2.38 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.144 -0.551 . . . . 0.0 113.674 -174.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -58.81 115.56 3.17 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 172.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.7 p -138.1 151.22 47.59 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.013 0.435 . . . . 0.0 111.364 -174.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -122.5 115.74 22.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.955 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -96.22 103.61 15.52 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.949 0.404 . . . . 0.0 111.166 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.9 t -79.93 101.74 5.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.846 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.13 -37.45 83.85 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -173.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.516 ' HB2' ' NZ ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -68.21 -3.96 12.4 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -175.677 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.717 ' HD2' ' HB2' ' A' ' 21' ' ' LEU . 7.4 tmtm? -131.75 -16.73 2.92 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.038 0.447 . . . . 0.0 109.836 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.6 t70 59.23 60.97 2.19 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.89 0.853 . . . . 0.0 109.265 -170.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.717 ' HB2' ' HD2' ' A' ' 19' ' ' LYS . 7.2 tt -132.18 119.86 21.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.995 -179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -127.8 121.02 29.11 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 8.9 tp10 -130.31 162.28 29.38 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.4 mt -77.1 133.62 38.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.093 0.473 . . . . 0.0 110.857 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.474 HG23 ' HB ' ' A' ' 38' ' ' VAL . 73.9 mt -80.72 103.48 7.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.635 176.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.2 m -104.98 -1.0 9.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.976 0.417 . . . . 0.0 111.207 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.661 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 9.4 tp10 -147.61 137.85 23.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.935 -177.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 64.4 mtt -139.45 138.28 36.3 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -65.5 -45.56 83.1 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -102.07 143.65 27.02 Favored Pre-proline 0 N--CA 1.465 0.293 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 171.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.06 -21.88 67.23 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.892 2.395 . . . . 0.0 113.122 -174.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -75.24 -68.82 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.684 0.278 . . . . 0.0 110.55 178.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 3.8 tt 171.18 -60.29 0.01 OUTLIER 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.484 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 55.0 m95 -85.59 128.72 34.84 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.079 -178.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 148.1 50.55 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 -177.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 122.36 -95.22 0.54 Allowed Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 175.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.44 156.17 44.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.086 0.469 . . . . 0.0 111.039 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.474 ' HB ' HG23 ' A' ' 25' ' ' ILE . 20.4 m -125.78 149.35 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 172.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.661 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 22.6 m -109.91 121.07 44.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.084 0.468 . . . . 0.0 110.275 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . 3.1 mm? -67.01 157.03 34.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.831 177.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.71 -28.54 34.57 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -172.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -95.6 2.36 54.14 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -174.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.94 -14.49 28.94 Favored Glycine 0 N--CA 1.459 0.207 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.602 175.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -62.41 148.4 45.55 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.427 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 34.4 mt-30 -125.35 145.81 49.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.722 0.296 . . . . 0.0 110.369 177.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 52.9 tp -132.33 139.63 48.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -93.58 118.1 30.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.619 0.247 . . . . 0.0 110.891 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.449 HD22 ' N ' ' A' ' 48' ' ' LEU . 2.7 mm? -121.14 107.56 37.29 Favored Pre-proline 0 N--CA 1.465 0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.206 177.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.67 156.24 66.67 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.35 2.033 . . . . 0.0 111.017 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.56 74.25 0.78 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.006 0.431 . . . . 0.0 110.034 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 95.4 mmm -89.74 -65.2 1.04 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.878 -177.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.92 102.96 2.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.656 178.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.484 ' HA ' ' CD1' ' A' ' 34' ' ' TRP . . . -65.46 -37.65 87.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.873 -178.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.434 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . 5.3 p-10 -56.94 -69.28 0.16 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.176 -178.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.514 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 1.9 p 27.94 87.14 0.1 Allowed Pre-proline 0 N--CA 1.472 0.649 0 C-N-CA 123.837 0.855 . . . . 0.0 113.089 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -78.19 13.62 1.74 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.025 2.483 . . . . 0.0 112.829 -177.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.446 ' H ' HD23 ' A' ' 57' ' ' LEU . 2.5 pt? -141.71 153.09 64.46 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.857 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 32.0 Cg_endo -63.91 97.36 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.453 2.102 . . . . 0.0 111.419 177.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.4 tt -89.43 148.35 4.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.811 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 63.2 m -111.54 120.54 42.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.688 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.8 m -125.04 177.66 4.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.089 0.471 . . . . 0.0 111.734 -176.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.469 ' HG3' ' HG3' ' A' ' 1' ' ' MET . 40.8 tt0 -61.43 108.96 1.03 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.731 177.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . . . -74.47 123.57 24.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.484 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.7 ttm105 -138.44 102.77 4.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.876 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.427 ' C ' ' HD3' ' A' ' 65' ' ' LYS . 13.7 tmtt? -82.13 129.75 34.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.54 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 77.5 mt . . . . . 0 C--O 1.253 1.24 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.26 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.541 0.21 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.502 ' HE2' HG22 ' A' ' 60' ' ' THR . 15.4 tptm -125.3 142.65 51.38 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.596 HG11 HD21 ' A' ' 46' ' ' LEU . 12.3 p -147.62 147.07 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 116.662 -0.244 . . . . 0.0 110.78 -178.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.554 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 27.0 ttt -110.97 113.56 26.2 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 176.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.9 mm -92.41 128.43 44.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.085 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.433 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 81.1 mtp180 -97.02 118.89 34.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.067 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -121.1 124.98 46.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.534 -176.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 42.9 p -134.76 176.26 8.81 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 169.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.21 -33.43 73.46 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.893 0.378 . . . . 0.0 111.113 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.0 p -111.93 -56.58 2.37 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.315 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.58 137.48 20.28 Favored Glycine 0 C--O 1.237 0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 113.387 -174.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -128.2 118.72 23.85 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.433 ' HB3' ' HB2' ' A' ' 6' ' ' ARG . 23.1 t -142.22 162.37 35.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.739 0.304 . . . . 0.0 110.204 -176.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.568 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -140.74 134.97 31.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.277 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -118.91 107.68 13.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.222 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 37.1 t -75.85 104.51 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.35 -69.59 0.12 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -171.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -12.36 54.36 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -171.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.515 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 17.2 tppt? -100.17 -20.38 15.99 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.719 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 61.59 29.08 18.11 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.111 0.481 . . . . 0.0 110.732 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.515 ' HB2' ' HG3' ' A' ' 19' ' ' LYS . 7.4 tt -101.82 120.2 40.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.746 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -117.77 132.17 56.49 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 172.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.461 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 8.2 tp10 -147.03 165.6 29.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.419 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.422 HD12 ' N ' ' A' ' 25' ' ' ILE . 1.3 tp -86.71 140.66 29.56 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 122.988 0.515 . . . . 0.0 110.359 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 24' ' ' LEU . 79.4 mt -80.13 113.24 19.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.541 177.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.4 m -106.57 -27.52 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -177.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.49 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 4.0 tm-20 -138.17 133.32 33.14 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -177.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.447 ' SD ' ' O ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -142.59 147.0 35.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 0.0 111.082 -178.135 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -67.27 -65.0 0.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.956 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -75.36 138.37 71.44 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.17 -177.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -46.7 -26.11 4.21 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.63 2.887 . . . . 0.0 112.942 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -93.85 -68.44 0.8 Allowed 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 173.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 32.0 tp 174.44 -63.2 0.01 OUTLIER 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.553 -176.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.484 ' HZ3' HG21 ' A' ' 61' ' ' VAL . 63.9 m95 -75.47 134.82 40.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.241 -172.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.95 -13.45 5.0 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.17 -0.538 . . . . 0.0 112.041 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -168.85 -150.7 6.81 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.832 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.666 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -85.61 162.86 18.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.457 0.646 . . . . 0.0 112.696 -173.416 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 46' ' ' LEU . 8.7 p -146.7 158.82 10.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.2 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 31.4 m -133.29 128.27 35.4 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.083 0.468 . . . . 0.0 110.216 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.568 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.4 mm? -81.74 165.61 20.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.206 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.29 -19.61 63.45 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.104 0.478 . . . . 0.0 111.152 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.461 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 3.6 t-20 -83.79 -4.39 58.61 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.522 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.33 0.36 82.62 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.971 -176.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 42.2 t-105 -66.06 121.7 15.73 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -100.5 120.2 39.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.902 0.382 . . . . 0.0 110.538 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.596 HD21 HG11 ' A' ' 3' ' ' VAL . 62.7 tp -130.25 135.26 47.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.588 -178.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.666 ' HA ' ' HA ' ' A' ' 37' ' ' LYS . 30.1 tt0 -104.63 126.36 51.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.792 0.329 . . . . 0.0 110.569 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.36 136.17 64.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.909 177.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -81.66 29.72 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.908 2.406 . . . . 0.0 112.834 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 62.52 104.97 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.559 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.5 mmt -139.36 -176.66 4.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.25 178.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.57 122.58 14.43 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.274 0.359 . . . . 0.0 110.47 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.16 -38.71 90.08 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.092 0.472 . . . . 0.0 109.794 176.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -69.95 94.82 0.88 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.957 177.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.413 ' HG1' ' HE1' ' A' ' 34' ' ' TRP . 2.6 p -131.67 90.17 37.54 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.272 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -86.33 12.9 2.88 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.142 2.561 . . . . 0.0 111.868 177.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.4 ' O ' HD12 ' A' ' 57' ' ' LEU . 3.1 pp -145.84 154.87 51.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.332 -178.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.405 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . 59.7 Cg_endo -71.8 125.24 10.87 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.387 2.058 . . . . 0.0 111.429 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.9 tt -126.08 137.08 58.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 120.883 0.373 . . . . 0.0 111.045 -177.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 4' ' ' MET . 26.1 m -90.66 120.02 31.38 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.169 177.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.484 HG21 ' HZ3' ' A' ' 34' ' ' TRP . 34.3 m -128.51 176.95 6.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.392 -175.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -70.28 149.31 47.55 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.935 176.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.41 ' HB1' HD11 ' A' ' 46' ' ' LEU . . . -120.14 121.07 37.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.61 0.243 . . . . 0.0 111.412 -174.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.56 ' HB2' ' HB3' ' A' ' 47' ' ' GLU . 31.3 mmt180 -113.83 100.75 8.68 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 174.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -79.95 148.34 31.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.898 0.38 . . . . 0.0 111.157 -175.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.495 HD11 ' HB2' ' A' ' 47' ' ' GLU . 5.5 mp . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.488 -0.768 . . . . 0.0 109.228 175.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.411 ' CG ' ' HB3' ' A' ' 63' ' ' ALA . 43.6 ttm . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -108.99 133.03 53.52 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 122.504 0.322 . . . . 0.0 110.626 -173.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 14.8 p -143.4 129.17 16.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.021 0.439 . . . . 0.0 110.499 174.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 47.7 ttm -105.55 120.9 42.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.216 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 46.9 mm -96.3 122.83 48.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -96.17 149.62 21.43 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.922 0.391 . . . . 0.0 109.964 -177.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -105.6 125.32 50.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.499 -178.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.0 m -158.84 144.05 16.2 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -177.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.45 100.52 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.233 0.333 . . . . 0.0 110.654 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.8 p 68.48 -32.9 0.22 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.935 1.294 . . . . 0.0 112.923 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.12 54.05 4.82 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.699 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -69.89 118.59 12.94 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.2 t -111.72 150.05 30.77 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.54 ' HB3' HD21 ' A' ' 40' ' ' LEU . . . -124.52 131.19 53.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.167 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -110.39 103.26 11.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.117 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.571 HG12 ' HG3' ' A' ' 18' ' ' LYS . 24.4 t -88.53 104.91 15.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.025 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.07 -26.76 68.38 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -171.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.571 ' HG3' HG12 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -65.07 -20.21 66.37 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.724 0.297 . . . . 0.0 111.22 -176.29 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.532 ' HD3' HD12 ' A' ' 21' ' ' LEU . 65.0 tttp -133.67 -3.01 2.96 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.779 -178.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 60.2 30.25 19.71 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.181 0.515 . . . . 0.0 109.69 -172.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.532 HD12 ' HD3' ' A' ' 19' ' ' LYS . 5.3 tt -82.99 121.18 26.67 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -176.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.407 ' N ' HD23 ' A' ' 21' ' ' LEU . 33.7 tt0 -123.15 111.48 16.56 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 7.5 tp10 -136.74 163.82 29.71 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.739 0.304 . . . . 0.0 110.474 -176.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.9 mt -85.55 142.45 29.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.209 176.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.502 HG23 ' HB ' ' A' ' 38' ' ' VAL . 74.7 mt -87.99 115.56 28.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.312 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.4 m -104.45 -45.4 9.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.314 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.606 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 36.9 tt0 -107.65 141.13 39.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 50.1 mtt -131.58 142.91 50.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.447 -178.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -66.75 -53.3 34.64 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 171.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.511 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 65.0 t30 -100.73 129.0 28.48 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.93 175.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.511 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 8.4 Cg_endo -45.91 -26.84 3.63 Favored 'Trans proline' 0 N--CA 1.476 0.491 0 C-N-CA 124.291 3.327 . . . . 0.0 113.646 -176.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -71.6 -70.88 0.3 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.865 0.364 . . . . 0.0 110.847 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.431 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 25.8 tp 173.35 -58.52 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.217 -175.041 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.44 ' CZ3' HD12 ' A' ' 48' ' ' LEU . 47.2 m95 -92.33 157.62 16.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.315 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.48 -38.24 1.91 Allowed Glycine 0 CA--C 1.507 -0.418 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.44 -149.51 5.33 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -77.76 149.37 34.52 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.14 0.495 . . . . 0.0 111.493 -177.788 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.502 ' HB ' HG23 ' A' ' 25' ' ' ILE . 35.8 m -124.62 139.39 51.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 170.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 22.1 m -100.61 117.06 33.98 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.994 0.426 . . . . 0.0 110.53 -178.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.54 HD21 ' HB3' ' A' ' 14' ' ' ALA . 86.8 mt -65.56 152.16 44.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.989 174.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.67 -24.53 49.32 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.78 -177.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.426 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 6.2 t30 -79.27 -12.9 59.95 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.877 0.37 . . . . 0.0 111.263 -178.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.1 54.83 1.56 Allowed Glycine 0 CA--C 1.518 0.227 0 N-CA-C 111.541 -0.623 . . . . 0.0 111.541 -175.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.474 ' HB3' HD12 ' A' ' 40' ' ' LEU . 22.7 t-105 -136.62 115.83 12.55 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -93.75 120.19 33.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.892 0.377 . . . . 0.0 111.167 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.516 HD21 ' HB1' ' A' ' 63' ' ' ALA . 0.6 OUTLIER -116.82 126.41 53.02 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.788 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.582 ' HB2' HD11 ' A' ' 66' ' ' LEU . 30.4 tt0 -86.84 128.42 35.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.987 0.422 . . . . 0.0 111.464 -176.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.44 HD12 ' CZ3' ' A' ' 34' ' ' TRP . 3.6 mm? -100.02 122.47 50.5 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.811 175.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 48' ' ' LEU . 7.6 Cg_exo -74.07 39.33 0.52 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.429 2.752 . . . . 0.0 113.234 -176.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 51.6 68.33 0.82 Allowed 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 176.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.432 ' HB2' ' CE3' ' A' ' 34' ' ' TRP . 25.5 mmt -104.06 176.61 5.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.761 176.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.404 ' HB3' HG23 ' A' ' 55' ' ' THR . . . -62.75 117.3 6.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.856 0.36 . . . . 0.0 111.293 -178.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.6 -28.13 60.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.467 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -82.61 17.39 1.81 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.845 -177.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 52' ' ' ALA . 1.2 p -59.79 115.74 14.04 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.491 174.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.79 10.37 1.67 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.934 2.423 . . . . 0.0 113.381 -172.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.9 pp -143.98 159.81 51.87 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 122.327 0.251 . . . . 0.0 110.359 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.43 97.83 0.45 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.242 1.961 . . . . 0.0 110.935 175.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.1 tt -89.19 141.03 14.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.92 -175.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.3 m -107.58 127.02 53.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.398 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.15 177.18 5.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.462 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -72.1 130.65 41.41 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 176.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.587 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . . . -87.64 146.73 25.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.83 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 64' ' ' ARG . 23.5 ttp180 -145.35 113.75 6.67 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 176.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -81.73 137.72 35.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.415 -175.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.582 HD11 ' HB2' ' A' ' 47' ' ' GLU . 5.0 mp . . . . . 0 C--O 1.245 0.827 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 171.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.448 ' HG3' HG21 ' A' ' 60' ' ' THR . 39.1 ttpt -129.62 132.0 46.62 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.95 0.405 . . . . 0.0 111.301 -174.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.0 p -138.4 120.11 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 169.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.4 ttt -107.56 110.46 22.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.222 -174.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 58' ' ' PRO . 45.7 mm -85.18 128.81 38.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.159 -178.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.571 ' HB2' ' HB2' ' A' ' 13' ' ' SER . 79.5 mtp180 -96.57 131.41 43.23 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.412 ' NZ ' ' O ' ' A' ' 54' ' ' ASP . 14.2 mmmm -121.82 118.81 29.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.025 -173.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.6 p -133.65 166.85 21.65 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.59 -24.21 39.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.1 0.476 . . . . 0.0 110.178 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.6 m -75.97 -31.82 59.19 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.259 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -176.34 -168.9 37.13 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.79 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.582 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 92.6 m-70 -121.39 141.89 50.53 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.803 -0.444 . . . . 0.0 109.803 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.571 ' HB2' ' HB2' ' A' ' 6' ' ' ARG . 15.7 m -142.98 158.93 43.14 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.604 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -140.31 138.13 34.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.526 0.203 . . . . 0.0 110.831 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -111.12 103.57 12.02 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.418 HG12 ' HB3' ' A' ' 18' ' ' LYS . 41.3 t -88.24 96.32 5.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.004 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.05 -26.31 62.34 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.866 0.365 . . . . 0.0 111.533 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.418 ' HB3' HG12 ' A' ' 16' ' ' VAL . 18.2 tppt? -55.3 -26.84 42.85 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.139 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -133.5 0.24 3.3 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.372 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 57.75 28.39 15.82 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.467 0.651 . . . . 0.0 109.789 -172.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.3 tp -86.15 121.07 28.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.014 -175.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -112.72 115.82 29.14 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 173.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -139.37 161.59 37.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.955 0.407 . . . . 0.0 110.122 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.0 mt -80.46 141.63 35.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.317 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.582 ' HB ' ' HB2' ' A' ' 12' ' ' HIS . 74.6 mt -84.78 120.14 34.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.202 178.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.7 m -106.13 -27.15 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.042 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.638 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 8.0 tp10 -133.78 143.09 48.19 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.53 157.26 43.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.857 -178.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.473 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 10.8 tp10 -64.39 -37.88 89.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.842 0.353 . . . . 0.0 111.0 -177.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.485 ' OD1' ' HA3' ' A' ' 35' ' ' GLY . 12.9 m120 -125.91 148.81 64.0 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -45.63 -32.62 8.76 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.762 2.974 . . . . 0.0 113.614 -173.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -73.72 -69.71 0.42 Allowed 'General case' 0 C--O 1.234 0.284 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 176.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.41 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 3.4 tt 175.83 -66.82 0.01 OUTLIER 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.277 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -70.89 154.81 41.51 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.315 -175.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.485 ' HA3' ' OD1' ' A' ' 30' ' ' ASN . . . 128.89 0.62 6.01 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.858 -177.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 48' ' ' LEU . . . 155.43 -140.7 7.52 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.497 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -71.28 166.23 22.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.285 0.564 . . . . 0.0 112.253 -174.654 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.7 p -144.33 163.54 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.13 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.638 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 37.2 m -142.11 126.18 17.34 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.008 0.432 . . . . 0.0 110.605 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.604 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.4 mm? -78.76 168.47 19.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.46 177.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.85 -22.52 65.57 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.565 -177.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -83.42 -13.97 53.65 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.094 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.79 -4.21 53.16 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.55 -178.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 49.3 t-105 -67.65 136.59 54.62 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -122.37 137.03 55.0 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -174.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -123.62 154.01 39.91 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.23 171.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.572 ' HB3' ' HB2' ' A' ' 64' ' ' ARG . 39.1 tt0 -105.91 113.02 26.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 48' ' ' LEU . 3.3 mm? -96.07 135.15 22.9 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.403 -178.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.79 156.73 64.8 Favored 'Trans proline' 0 C--O 1.238 0.485 0 C-N-CA 122.181 1.92 . . . . 0.0 110.808 173.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.21 87.95 0.17 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.091 0.472 . . . . 0.0 110.8 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.5 mmt -104.87 179.65 4.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.628 176.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.29 125.48 23.77 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.794 177.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.0 -23.2 64.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.819 -174.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.412 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . 15.3 p-10 -74.31 -57.01 4.22 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.792 -0.185 . . . . 0.0 110.617 -177.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.4 p 33.48 81.63 0.23 Allowed Pre-proline 0 CA--C 1.537 0.458 0 O-C-N 123.809 0.693 . . . . 0.0 112.263 -178.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -76.33 -2.52 12.72 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.626 2.217 . . . . 0.0 112.21 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.431 ' O ' HD12 ' A' ' 57' ' ' LEU . 1.5 pp -128.28 157.39 74.6 Favored Pre-proline 0 C--O 1.235 0.327 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.742 -177.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 59.1 Cg_endo -72.04 98.38 0.9 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.204 1.936 . . . . 0.0 111.504 176.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.6 tt -97.38 143.77 11.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.034 -177.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.448 HG21 ' HG3' ' A' ' 2' ' ' LYS . 38.4 m -100.86 136.05 41.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.26 176.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.9 m -137.42 177.4 5.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 120.703 0.287 . . . . 0.0 110.521 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -64.34 134.82 55.39 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.586 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.94 114.02 25.69 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.48 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.572 ' HB2' ' HB3' ' A' ' 47' ' ' GLU . 2.7 mmp_? -117.58 125.85 51.52 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 172.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -97.24 146.82 24.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.57 0.224 . . . . 0.0 110.625 -178.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.3 mp . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.56 175.304 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.488 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.17 0 CA-C-O 121.304 0.573 . . . . 0.0 110.212 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -119.2 137.65 53.49 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.948 -173.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 p -149.65 128.59 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.513 174.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.405 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 53.0 ttm -102.16 111.05 23.18 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.4 mm -79.24 111.83 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -102.67 118.96 37.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.995 -176.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -86.9 128.31 35.05 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 170.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.3 p -140.41 163.32 33.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.714 -173.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.21 -22.9 66.36 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.331 0.586 . . . . 0.0 109.992 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 m -67.17 -14.73 63.18 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.386 174.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.47 -99.78 0.61 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.969 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -130.84 128.57 40.91 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.4 p -139.33 150.95 45.97 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.289 -0.264 . . . . 0.0 110.289 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.532 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -141.5 131.34 24.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.755 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -99.37 103.36 15.15 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.1 t -91.54 105.0 16.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.216 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.24 -30.04 71.26 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.822 0.344 . . . . 0.0 111.233 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -55.2 -46.71 75.89 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.964 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.691 ' HD2' ' HB2' ' A' ' 21' ' ' LEU . 4.7 tmtm? -99.6 -11.63 20.8 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -178.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 60.52 31.55 20.29 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.218 -171.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.691 ' HB2' ' HD2' ' A' ' 19' ' ' LYS . 49.1 tp -106.31 121.89 45.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.055 -174.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -107.25 108.16 19.44 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 9.0 tp10 -137.09 163.68 30.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.76 0.314 . . . . 0.0 110.675 -175.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.3 mt -80.65 137.02 36.31 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.811 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.6 mt -82.07 85.2 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.37 0.605 . . . . 0.0 109.405 175.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.448 HG23 ' HG3' ' A' ' 27' ' ' GLU . 15.8 m -73.45 -27.98 24.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.086 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.484 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 44.3 mt-10 -127.21 126.42 42.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.901 -178.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -145.08 143.47 30.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 -174.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.49 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 10.2 tp10 -58.18 -54.36 47.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.484 -177.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.416 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 21.3 t-20 -90.08 144.74 31.74 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.366 -173.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.7 -31.06 39.59 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.962 2.441 . . . . 0.0 112.35 176.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -84.4 -63.88 1.26 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.272 175.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 25.0 tp 176.94 -71.87 0.01 OUTLIER 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.603 -177.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -71.41 121.1 17.98 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.741 -176.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.416 ' HA3' ' HB2' ' A' ' 30' ' ' ASN . . . -163.03 -52.76 0.02 OUTLIER Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.011 -176.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.64 -66.64 0.02 OUTLIER Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.216 -176.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.49 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -134.05 162.02 33.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.673 0.273 . . . . 0.0 110.948 178.368 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.4 m -146.28 169.79 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 176.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.484 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 27.9 m -143.36 127.24 17.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.272 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.532 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.2 mm? -74.83 155.95 37.01 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.137 176.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.04 -18.3 33.48 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -176.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -90.98 8.87 33.11 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.654 0.264 . . . . 0.0 111.34 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.83 32.58 44.81 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.817 176.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.403 ' HZ3' ' HB2' ' A' ' 46' ' ' LEU . 24.9 t90 -107.82 116.67 32.37 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 175.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -86.83 139.99 30.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.084 0.469 . . . . 0.0 111.149 -177.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.403 ' HB2' ' HZ3' ' A' ' 44' ' ' TRP . 59.7 tp -136.29 139.68 42.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.467 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 64' ' ' ARG . 34.5 tt0 -81.37 132.96 35.35 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.0 tp -133.09 98.38 15.76 Favored Pre-proline 0 C--O 1.236 0.391 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 -177.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.27 156.34 41.02 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.877 2.385 . . . . 0.0 112.598 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.34 82.01 3.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.104 0.478 . . . . 0.0 110.264 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.5 mmt -113.58 -174.31 2.44 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.58 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.16 101.78 0.32 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.644 -177.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.05 -18.25 40.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.178 176.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -73.77 -4.75 36.53 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.388 -178.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.0 t -56.74 135.14 78.53 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.544 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -87.22 12.47 2.94 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.973 2.448 . . . . 0.0 112.872 -176.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 pp -140.19 154.06 69.66 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.186 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.26 104.59 1.58 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.402 2.068 . . . . 0.0 111.214 176.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.5 tt -88.95 140.28 16.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.148 -176.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 4' ' ' MET . 65.3 m -95.89 130.28 42.9 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.346 177.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.5 m -127.95 175.01 10.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.699 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -73.03 123.33 23.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.202 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 1' ' ' MET . . . -83.02 109.83 17.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.381 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.573 ' HB2' ' HB3' ' A' ' 47' ' ' GLU . 4.1 mpt_? -102.79 114.78 29.33 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 172.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -78.47 125.86 29.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.051 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.063 179.444 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.473 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -121.1 129.95 53.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.787 0.327 . . . . 0.0 111.77 -172.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.6 p -145.27 143.04 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.055 174.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 49.6 ttm -112.52 119.87 39.68 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.9 mm -89.58 116.04 30.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -97.58 149.1 22.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.456 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -133.93 149.29 51.28 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.928 0.394 . . . . 0.0 110.849 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.4 p -142.54 -167.86 2.6 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 171.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.35 90.45 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.5 m 74.85 -41.39 0.47 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.79 0.836 . . . . 0.0 111.683 -177.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.24 118.76 15.39 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.421 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.546 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 26.2 m80 -110.34 147.94 32.94 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.7 p -150.67 160.95 43.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.797 0.332 . . . . 0.0 110.68 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.452 ' HB3' HD21 ' A' ' 40' ' ' LEU . . . -129.62 130.92 46.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.061 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -120.23 104.85 10.41 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.985 -177.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.3 t -79.83 90.41 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 173.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.19 -48.37 54.18 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.697 -172.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.07 -23.06 66.26 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.698 0.285 . . . . 0.0 111.636 -174.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 60.6 tttm -107.86 -16.02 14.41 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.69 -178.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 19' ' ' LYS . 39.2 t70 70.01 22.17 5.87 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.726 0.774 . . . . 0.0 110.015 -175.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.444 HD23 ' N ' ' A' ' 22' ' ' GLU . 5.5 tt -83.98 123.06 29.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.222 178.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.444 ' N ' HD23 ' A' ' 21' ' ' LEU . 32.8 tt0 -134.31 116.91 15.81 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 174.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.555 ' HB3' HD13 ' A' ' 40' ' ' LEU . 7.2 tp10 -133.71 157.88 44.7 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.874 0.368 . . . . 0.0 110.219 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.9 mt -76.8 140.78 40.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.433 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' A' ' 12' ' ' HIS . 64.6 mt -83.45 114.96 24.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.806 176.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.4 m -102.23 -44.71 10.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -128.97 125.94 38.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.718 0.294 . . . . 0.0 111.034 -177.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.541 ' HG2' ' HA ' ' A' ' 33' ' ' LEU . 2.1 mpp? -111.51 167.85 10.0 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 174.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -84.86 -10.1 57.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.454 0.645 . . . . 0.0 109.38 173.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' A' ' 28' ' ' MET . 15.5 m120 -127.61 142.4 44.0 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.292 177.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -56.83 -36.93 99.05 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.79 2.327 . . . . 0.0 112.733 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.16 -70.81 0.34 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.893 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.541 ' HA ' ' HG2' ' A' ' 28' ' ' MET . 2.5 tt 178.35 -65.55 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.449 ' HB3' ' H ' ' A' ' 51' ' ' MET . 71.0 m95 -83.6 158.51 21.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.238 -174.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.88 -63.98 0.52 Allowed Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -131.84 -127.68 2.86 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.444 -0.407 . . . . 0.0 112.228 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 8.3 ptpp? -90.25 166.26 13.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.139 0.495 . . . . 0.0 111.834 -173.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 46' ' ' LEU . 9.2 p -146.69 162.18 9.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.81 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.419 ' N ' HG22 ' A' ' 38' ' ' VAL . 34.8 m -131.67 126.01 33.54 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.742 0.306 . . . . 0.0 110.414 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.555 HD13 ' HB3' ' A' ' 23' ' ' GLU . 59.8 mt -70.83 159.32 34.82 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.288 177.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.72 -24.46 57.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.13 -177.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -106.7 21.52 17.35 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.078 0.466 . . . . 0.0 111.382 -177.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.89 -33.71 6.2 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 114.774 0.67 . . . . 0.0 114.774 168.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.527 ' HB2' HD12 ' A' ' 40' ' ' LEU . 5.3 m-90 -53.9 128.51 30.43 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 117.418 0.609 . . . . 0.0 110.946 -177.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 44.1 mt-30 -103.71 138.52 40.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 110.982 -178.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.592 HD13 ' N ' ' A' ' 47' ' ' GLU . 2.8 tm? -137.72 144.56 41.77 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 37' ' ' LYS . 29.7 tt0 -111.5 129.58 56.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.889 0.376 . . . . 0.0 110.955 -177.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.405 HD22 ' N ' ' A' ' 48' ' ' LEU . 3.1 mm? -81.33 144.5 53.85 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.604 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -84.05 28.15 0.58 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.947 2.431 . . . . 0.0 112.65 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 57.73 96.0 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.094 0.557 . . . . 0.0 112.219 178.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.449 ' H ' ' HB3' ' A' ' 34' ' ' TRP . 25.6 mmt -133.49 -173.74 3.31 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.96 145.4 25.14 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 173.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.14 -28.09 64.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.974 0.416 . . . . 0.0 110.78 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -79.26 50.69 1.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.395 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.9 p -74.59 123.1 88.84 Favored Pre-proline 0 N--CA 1.453 -0.308 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 172.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.16 -7.77 19.87 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.579 2.186 . . . . 0.0 112.632 -175.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.1 pp -152.16 163.75 22.54 Favored Pre-proline 0 C--O 1.235 0.336 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.471 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.64 99.15 0.43 Allowed 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.073 1.849 . . . . 0.0 110.283 172.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.3 tt -88.05 143.49 11.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.223 0.535 . . . . 0.0 111.406 -170.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.2 m -96.06 122.51 38.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.659 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.9 m -129.78 174.3 12.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 120.956 0.408 . . . . 0.0 111.508 -175.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -63.53 126.34 27.19 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.381 177.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 1' ' ' MET . . . -90.51 109.57 20.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.697 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 30.1 tpt180 -101.47 100.41 10.86 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -79.62 133.68 36.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.805 -176.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 47' ' ' GLU . 6.4 mp . . . . . 0 C--O 1.252 1.192 0 CA-C-O 118.256 -0.878 . . . . 0.0 109.42 175.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.741 ' HG3' ' HB3' ' A' ' 63' ' ' ALA . 24.6 ptp . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -103.68 127.51 51.12 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.125 0.488 . . . . 0.0 112.024 -163.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.651 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 14.4 p -140.21 128.0 24.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.376 170.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 51.8 ttp -109.32 110.88 22.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.905 0.383 . . . . 0.0 110.465 -177.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.8 mm -84.01 131.49 33.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.423 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -96.46 121.74 38.6 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 176.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.867 ' HE2' ' HA ' ' A' ' 54' ' ' ASP . 27.1 mmmt -92.96 116.01 28.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.371 177.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.542 HG22 ' H ' ' A' ' 10' ' ' THR . 84.8 m -152.33 127.18 9.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.303 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.57 3.9 4.46 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -172.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.542 ' H ' HG22 ' A' ' 8' ' ' THR . 5.6 p -127.75 -0.5 6.06 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.736 0.272 . . . . 0.0 111.736 177.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.478 ' O ' ' HB ' ' A' ' 8' ' ' THR . . . -179.3 102.0 0.16 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.543 -177.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.587 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 64.7 m80 -81.07 143.82 32.18 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.9 t -143.13 162.31 35.89 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.554 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -145.73 122.95 11.52 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.639 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.423 ' HD1' ' HB2' ' A' ' 22' ' ' GLU . 41.9 t80 -102.35 102.73 13.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.575 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.9 t -83.78 98.27 5.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.716 175.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.35 -39.82 91.98 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.004 -173.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.469 ' NZ ' ' SD ' ' A' ' 1' ' ' MET . 0.1 OUTLIER -70.06 -5.91 30.01 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -177.167 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -130.49 10.61 5.24 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 41.58 29.59 0.11 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.677 0.791 . . . . 0.0 111.407 -175.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.64 HD21 HD21 ' A' ' 42' ' ' ASN . 52.1 tp -100.64 132.29 46.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.73 -174.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.423 ' HB2' ' HD1' ' A' ' 15' ' ' TYR . 41.0 tt0 -134.24 112.46 11.08 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 170.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -129.77 163.41 26.27 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.023 -176.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.7 mt -79.23 132.2 36.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.574 178.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.587 ' HB ' ' HB2' ' A' ' 12' ' ' HIS . 70.3 mt -77.03 98.03 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.582 175.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.2 m -88.38 -29.99 5.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.87 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.609 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 9.9 tp10 -123.25 139.56 53.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.792 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.481 ' HA ' HG22 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -150.48 147.92 28.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.225 -178.463 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -55.46 -42.82 74.81 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.703 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -131.92 144.92 55.24 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.356 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.89 -27.47 20.81 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.154 2.569 . . . . 0.0 112.784 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.57 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -64.59 -61.88 1.93 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.353 175.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.572 ' HB3' ' CD1' ' A' ' 34' ' ' TRP . 1.5 tm? 167.04 -62.82 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.469 -177.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.572 ' CD1' ' HB3' ' A' ' 33' ' ' LEU . 39.1 m95 -88.0 157.81 18.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.297 -171.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.81 -32.73 0.48 Allowed Glycine 0 C--N 1.331 0.294 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.153 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.17 -78.29 0.06 OUTLIER Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.384 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -130.21 162.29 29.24 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.269 0.557 . . . . 0.0 111.703 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.556 HG13 HG23 ' A' ' 25' ' ' ILE . 9.8 t -143.71 155.61 16.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.16 -177.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.609 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 20.1 m -134.03 127.27 31.92 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.782 0.325 . . . . 0.0 110.61 176.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.554 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.5 mm? -75.66 167.14 22.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.149 176.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.5 -21.98 64.7 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.791 0.329 . . . . 0.0 111.559 -178.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.64 HD21 HD21 ' A' ' 21' ' ' LEU . 27.4 p30 -90.81 1.26 57.08 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.627 -178.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.07 8.29 64.93 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.319 176.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.564 ' HE1' HD23 ' A' ' 46' ' ' LEU . 62.0 t-105 -76.35 117.86 18.45 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 176.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -92.53 116.49 29.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.74 0.305 . . . . 0.0 110.806 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.564 HD23 ' HE1' ' A' ' 44' ' ' TRP . 0.6 OUTLIER -115.23 134.72 54.88 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -178.221 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.622 ' HB3' ' HB2' ' A' ' 64' ' ' ARG . 31.6 tt0 -91.01 120.39 31.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.775 0.322 . . . . 0.0 110.636 -178.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.411 HD12 ' CZ3' ' A' ' 34' ' ' TRP . 3.6 mm? -110.07 106.34 58.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 175.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.8 44.33 1.53 Allowed 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.225 2.617 . . . . 0.0 113.878 -167.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 51.16 82.68 0.06 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.373 0.606 . . . . 0.0 111.848 176.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 97.0 mmm -119.16 -155.45 0.61 Allowed 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -50.12 107.77 0.18 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.828 0.347 . . . . 0.0 110.589 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.01 -34.9 77.05 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.593 -174.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.867 ' HA ' ' HE2' ' A' ' 7' ' ' LYS . 12.6 t70 -134.33 102.11 5.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.877 0.37 . . . . 0.0 110.479 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.4 p -97.14 139.98 21.8 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.08 175.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.52 7.63 3.36 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.693 2.262 . . . . 0.0 112.242 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 pp -147.4 161.01 37.63 Favored Pre-proline 0 C--O 1.236 0.374 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.89 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.28 108.26 1.33 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.017 1.811 . . . . 0.0 110.495 173.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.2 tt -88.02 137.81 20.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.15 -171.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.4 m -106.13 127.4 53.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.678 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.421 HG11 ' HH2' ' A' ' 34' ' ' TRP . 18.6 m -138.78 178.15 4.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 120.951 0.405 . . . . 0.0 111.056 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 1' ' ' MET . 41.1 tt0 -73.89 124.59 26.43 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.725 178.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.741 ' HB3' ' HG3' ' A' ' 1' ' ' MET . . . -80.74 109.96 15.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.132 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.622 ' HB2' ' HB3' ' A' ' 47' ' ' GLU . 89.5 mtt180 -110.2 137.72 47.55 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 176.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -111.65 124.39 52.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.088 -172.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.411 HD22 ' N ' ' A' ' 66' ' ' LEU . 2.9 mm? . . . . . 0 C--O 1.25 1.082 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 174.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.544 ' HB3' ' HB3' ' A' ' 63' ' ' ALA . 64.8 mtt . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -130.33 130.25 44.22 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.871 0.367 . . . . 0.0 111.722 -174.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.519 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 14.5 p -144.58 138.7 23.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 172.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 52.3 ttm -113.45 110.64 20.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.703 0.287 . . . . 0.0 110.378 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.1 mm -84.51 110.98 19.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -99.17 134.18 42.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.129 0.49 . . . . 0.0 109.725 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.559 ' HG3' ' HB ' ' A' ' 55' ' ' THR . 4.4 mmmp? -128.46 149.02 50.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.973 0.892 . . . . 0.0 113.292 -165.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.486 HG22 ' H ' ' A' ' 9' ' ' ALA . 8.7 m -136.81 174.41 10.65 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 165.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.486 ' H ' HG22 ' A' ' 8' ' ' THR . . . -57.12 -50.65 72.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.472 0.578 . . . . 0.0 110.64 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 51.7 p -101.33 -31.27 11.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.7 136.36 19.79 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.865 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.543 ' HB3' HD12 ' A' ' 25' ' ' ILE . 72.8 m80 -134.99 112.76 10.86 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 176.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.4 m -130.66 145.27 51.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.417 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.664 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -126.68 126.25 43.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.463 177.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -107.46 103.56 12.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.766 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.45 98.17 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.716 174.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.64 -46.64 77.4 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.306 -173.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.537 ' HB2' ' NZ ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -62.66 -17.09 59.82 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -174.659 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -117.48 -10.07 10.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.919 0.39 . . . . 0.0 110.205 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.2 t70 60.86 30.2 19.5 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.663 0.744 . . . . 0.0 109.511 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.5 tp -99.06 114.38 27.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.601 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -110.44 118.49 36.4 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 172.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.448 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 9.8 tp10 -134.48 158.75 43.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.993 0.425 . . . . 0.0 110.798 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.3 mt -77.19 141.19 40.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.594 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.543 HD12 ' HB3' ' A' ' 12' ' ' HIS . 71.9 mt -83.08 110.19 17.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.4 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.7 m -102.89 -23.61 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.507 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.65 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 8.0 tp10 -133.9 133.66 41.73 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.501 ' SD ' ' N ' ' A' ' 28' ' ' MET . 0.8 OUTLIER -128.74 153.01 47.79 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.391 -174.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 7.4 tp10 -66.75 -51.77 52.08 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 169.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.469 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 40.3 t30 -114.57 135.52 22.31 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.625 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.469 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 2.0 Cg_endo -38.39 -31.49 0.21 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 124.184 3.256 . . . . 0.0 113.436 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 54' ' ' ASP . . . -72.28 -69.52 0.39 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.155 174.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 3.4 tt 176.65 -71.74 0.01 OUTLIER 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.831 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.725 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 41.2 m95 -68.14 160.32 29.27 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.621 -173.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.21 -46.22 0.73 Allowed Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.598 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.63 -85.83 0.05 OUTLIER Glycine 0 C--O 1.225 -0.456 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.055 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -120.63 157.38 29.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.291 0.567 . . . . 0.0 111.743 -179.769 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 46' ' ' LEU . 9.8 p -135.23 149.04 28.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 174.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.65 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 18.7 m -125.79 126.34 44.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.013 0.435 . . . . 0.0 110.316 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.664 HD11 ' HB3' ' A' ' 14' ' ' ALA . 2.6 mm? -82.44 166.68 19.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.602 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.7 -10.09 33.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.298 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -89.19 -13.33 38.55 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.981 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.53 -13.08 56.79 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.681 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -69.56 141.8 53.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.882 0.373 . . . . 0.0 110.952 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 39.6 mt-30 -113.23 135.19 54.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.799 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.494 HD13 ' N ' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -127.39 137.08 52.67 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.494 ' N ' HD13 ' A' ' 46' ' ' LEU . 32.3 tt0 -89.97 137.59 32.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.012 0.434 . . . . 0.0 111.268 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.469 ' HB3' ' CE3' ' A' ' 34' ' ' TRP . 3.0 mm? -107.01 122.93 39.99 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.096 177.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.451 ' HD2' ' HZ3' ' A' ' 34' ' ' TRP . 37.8 Cg_exo -59.38 -4.65 2.52 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.864 2.376 . . . . 0.0 113.43 176.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.415 ' HA ' ' HB3' ' A' ' 34' ' ' TRP . . . 71.07 89.77 0.1 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.224 0.61 . . . . 0.0 112.075 177.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 22.2 ptm -162.09 127.14 3.38 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 56.53 79.0 0.19 Allowed 'General case' 0 C--O 1.234 0.268 0 O-C-N 123.328 0.392 . . . . 0.0 109.986 -173.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.725 ' HA ' ' HB2' ' A' ' 34' ' ' TRP . . . -46.5 -40.76 13.02 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.323 -171.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.49 ' HB2' ' HB1' ' A' ' 32' ' ' ALA . 16.3 t70 -125.2 94.49 4.18 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 170.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.559 ' HB ' ' HG3' ' A' ' 7' ' ' LYS . 1.3 m -63.61 131.59 94.91 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.638 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -83.13 0.34 9.62 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.689 2.259 . . . . 0.0 112.838 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.405 ' HB2' ' HD2' ' A' ' 58' ' ' PRO . 2.9 pp -146.54 161.87 36.47 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.387 -178.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 57' ' ' LEU . 39.3 Cg_endo -66.25 112.39 2.31 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.259 1.972 . . . . 0.0 111.362 175.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.3 tt -108.7 142.16 22.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.503 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.7 m -109.97 115.08 29.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.279 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.506 HG11 ' HH2' ' A' ' 34' ' ' TRP . 21.3 m -125.49 178.52 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.883 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -74.33 146.59 42.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.892 0.377 . . . . 0.0 110.905 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' A' ' 1' ' ' MET . . . -90.73 129.39 36.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.595 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -145.42 99.6 3.32 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 174.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.473 ' HB2' ' HE2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -88.79 155.02 19.81 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.924 -173.149 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 66' ' ' LEU . 4.7 mp . . . . . 0 C--O 1.248 0.979 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.4 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 22.8 ptt? . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 120.494 0.188 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -129.55 142.97 50.64 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 122.545 0.338 . . . . 0.0 110.367 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.647 HG11 HD21 ' A' ' 46' ' ' LEU . 10.7 p -151.3 138.83 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 175.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.476 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 47.3 ttm -103.7 122.45 45.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.734 0.302 . . . . 0.0 110.609 -176.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 58' ' ' PRO . 45.0 mm -96.09 128.79 46.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.5 mtp180 -97.4 123.63 41.31 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.997 0.427 . . . . 0.0 110.747 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -95.17 116.68 29.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.806 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.8 t -159.68 143.67 14.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.474 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.35 -26.63 46.8 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.79 0.329 . . . . 0.0 111.513 -175.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.5 p -64.89 -27.43 68.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.294 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 167.89 113.66 0.28 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.082 -0.58 . . . . 0.0 111.803 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -53.84 137.38 38.65 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.4 t -138.86 162.65 34.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.904 0.383 . . . . 0.0 110.705 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.592 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -145.18 139.43 27.23 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.925 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -115.05 109.35 17.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.099 0.476 . . . . 0.0 110.994 -177.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 46.6 t -84.41 97.09 4.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.075 174.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.22 -55.34 28.96 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -170.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.607 ' H ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -55.17 -32.39 62.11 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.844 0.354 . . . . 0.0 111.587 -176.353 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -96.57 -9.98 28.23 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.565 -176.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.8 t70 58.49 27.89 16.19 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.798 0.808 . . . . 0.0 109.744 -176.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.425 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 48.3 tp -91.82 110.42 21.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.928 -177.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -109.49 108.89 19.54 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 171.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.506 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 8.3 tp10 -132.59 160.23 37.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.034 0.445 . . . . 0.0 111.204 -172.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.8 mt -82.62 137.02 34.64 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.828 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 72.3 mt -78.57 101.77 4.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.237 176.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.8 m -98.14 -9.95 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.591 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.546 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 6.1 tp10 -138.43 122.61 18.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.227 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -151.82 140.24 20.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -60.28 -54.24 48.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.32 -177.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.482 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 24.2 t-20 -85.34 137.87 36.65 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.751 -174.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -50.53 -37.79 53.01 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.454 2.769 . . . . 0.0 112.551 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -78.77 -62.7 1.61 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.224 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.612 ' HG ' HD21 ' A' ' 48' ' ' LEU . 23.2 tp 176.82 -76.37 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.57 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.466 ' HE3' ' O ' ' A' ' 49' ' ' PRO . 61.3 m95 -73.02 125.65 28.12 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.775 -174.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.607 ' HA2' ' HB2' ' A' ' 50' ' ' ALA . . . 179.54 -55.07 0.09 OUTLIER Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.107 -177.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.0 -137.4 2.34 Favored Glycine 0 C--O 1.226 -0.385 0 C-N-CA 121.232 -0.509 . . . . 0.0 112.045 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.76 155.53 39.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.301 0.572 . . . . 0.0 111.751 -176.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.02 151.8 13.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.106 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.546 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 62.6 m -142.55 132.63 24.52 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.964 0.411 . . . . 0.0 110.453 178.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.592 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.2 mm? -81.5 162.84 23.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.331 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.4 -22.73 65.25 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.199 0.523 . . . . 0.0 110.833 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.506 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 27.5 t-20 -73.93 -18.77 60.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.509 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.14 -15.88 30.38 Favored Glycine 0 C--N 1.331 0.258 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.396 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 12.7 t-105 -57.83 117.33 4.16 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.602 0.239 . . . . 0.0 110.418 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -92.37 134.16 35.19 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.647 HD21 HG11 ' A' ' 3' ' ' VAL . 37.4 tp -143.13 164.87 28.98 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -111.38 141.13 45.33 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.612 HD21 ' HG ' ' A' ' 33' ' ' LEU . 16.3 tp -123.12 95.94 45.26 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.235 -175.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.466 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 28.9 Cg_endo -60.89 131.37 36.97 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.147 2.564 . . . . 0.0 112.608 -175.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.607 ' HB2' ' HA2' ' A' ' 35' ' ' GLY . . . -70.29 82.21 0.54 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.853 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 37.4 mtm -98.75 -71.36 0.69 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.955 177.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.34 128.15 6.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.99 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -95.24 -12.13 26.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.586 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -78.83 -11.34 59.99 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.45 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.8 t -60.95 119.89 49.02 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 120.924 0.392 . . . . 0.0 110.667 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -90.98 9.71 2.99 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.326 2.684 . . . . 0.0 112.865 -175.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.3 pp -122.99 150.0 58.17 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.917 -174.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 58.2 Cg_endo -72.38 97.95 0.9 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.311 2.007 . . . . 0.0 111.54 175.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.9 tt -94.92 139.68 18.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.187 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 4' ' ' MET . 41.1 m -92.06 122.09 34.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.3 175.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.0 m -116.45 170.4 6.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.422 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 1' ' ' MET . 33.7 tt0 -68.99 120.05 14.24 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.039 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.63 108.82 5.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.512 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -119.73 106.37 12.07 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 175.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -99.11 158.1 15.9 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.795 0.331 . . . . 0.0 111.278 -178.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.25 1.129 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 174.92 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.453 ' O ' ' HG2' ' A' ' 1' ' ' MET . 45.9 ttp . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 120.867 0.365 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.644 ' HD2' ' HB2' ' A' ' 17' ' ' ALA . 1.3 tmtp? -104.18 120.3 40.84 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -176.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.43 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 13.9 p -138.37 128.46 34.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.961 0.41 . . . . 0.0 110.101 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 51.0 ttm -103.1 110.12 21.94 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.432 HG21 HD21 ' A' ' 33' ' ' LEU . 43.4 mm -84.82 111.61 20.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.496 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 94.3 mtt180 -103.85 139.26 39.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.648 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -103.77 157.07 17.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.84 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.8 m -139.94 159.07 43.01 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -44.63 -50.19 9.9 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.091 0.472 . . . . 0.0 111.124 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.2 m -129.5 96.65 4.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.725 175.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.01 175.01 14.03 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 121.276 -0.487 . . . . 0.0 112.956 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.486 ' HB3' HD12 ' A' ' 25' ' ' ILE . 73.3 m80 -139.17 139.09 37.46 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.5 p -134.91 133.71 39.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.886 0.374 . . . . 0.0 110.624 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.578 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -105.23 123.08 47.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.533 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -93.94 103.84 15.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.638 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.408 HG11 ' HZ3' ' A' ' 44' ' ' TRP . 49.8 t -86.39 112.13 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.114 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.644 ' HB2' ' HD2' ' A' ' 2' ' ' LYS . . . -59.91 -46.53 89.07 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -173.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -11.84 4.72 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -172.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -144.38 15.39 1.65 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 p30 42.03 29.98 0.16 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.516 0.727 . . . . 0.0 111.474 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.4 tt -88.72 117.55 27.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.372 -172.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -112.98 109.1 18.3 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 174.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.438 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 9.6 tp10 -117.29 163.24 16.63 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.034 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.0 mt -75.72 129.34 36.93 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.237 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 12' ' ' HIS . 72.4 mt -78.06 98.11 2.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.119 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.491 HG23 ' HG2' ' A' ' 27' ' ' GLU . 16.7 m -91.38 -46.37 14.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.501 -177.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.58 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 20.9 mm-40 -113.11 107.35 15.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.413 -175.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.71 142.93 50.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.619 0.247 . . . . 0.0 110.346 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -62.57 -40.87 98.22 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.122 0.487 . . . . 0.0 110.643 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -91.79 139.82 24.85 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.868 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -48.17 -38.85 33.63 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.624 2.883 . . . . 0.0 112.828 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.737 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -89.05 -61.8 1.63 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.502 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.432 HD21 HG21 ' A' ' 5' ' ' ILE . 27.4 tp -175.25 -71.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -177.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -79.33 136.19 36.93 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -170.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 165.42 -45.97 0.28 Allowed Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.397 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.16 -134.59 1.71 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.38 -0.438 . . . . 0.0 112.245 -177.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.71 165.95 21.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.292 0.568 . . . . 0.0 111.931 -175.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.8 p -146.93 167.35 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.464 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 60.7 m -142.48 123.64 14.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.785 0.326 . . . . 0.0 110.202 175.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.578 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.4 mm? -73.09 159.81 32.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.824 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.84 -16.77 52.84 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.963 0.411 . . . . 0.0 110.999 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.438 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 25.0 t-20 -75.53 -31.43 60.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.966 178.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 126.38 -20.45 6.2 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.52 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.408 ' HZ3' HG11 ' A' ' 16' ' ' VAL . 29.6 m0 -61.15 132.81 54.91 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.753 0.311 . . . . 0.0 111.555 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -104.94 137.46 42.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.803 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.407 HD21 HG11 ' A' ' 3' ' ' VAL . 48.3 tp -134.41 141.41 46.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.909 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 64' ' ' ARG . 27.2 tt0 -97.52 110.3 22.88 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 120.814 0.34 . . . . 0.0 111.042 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 3.9 mm? -93.32 144.48 28.37 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.365 176.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 48' ' ' LEU . 11.4 Cg_exo -70.83 158.63 55.02 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.42 2.08 . . . . 0.0 111.001 173.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.15 73.35 3.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.269 0.557 . . . . 0.0 110.293 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.4 mmt -95.74 -168.76 1.82 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.133 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.56 115.41 5.74 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 176.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.737 ' HB1' ' HB3' ' A' ' 32' ' ' ALA . . . -48.54 -35.8 14.06 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.583 0.552 . . . . 0.0 111.584 -174.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -119.96 86.47 2.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.18 0.514 . . . . 0.0 109.724 169.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 58.2 m -65.63 129.62 94.38 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.386 175.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.38 -34.21 40.28 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.171 2.581 . . . . 0.0 113.162 -175.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 pp -132.23 158.67 74.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.182 -176.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.496 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . 39.6 Cg_endo -66.54 105.3 0.88 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.393 2.062 . . . . 0.0 111.18 175.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.1 tt -104.56 145.39 13.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.184 -174.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 91.9 m -90.12 132.89 35.19 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.648 173.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.9 m -135.56 176.33 8.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 120.664 0.269 . . . . 0.0 111.096 -177.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.67 121.68 15.93 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.677 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.43 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . . . -90.18 110.59 21.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.518 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.533 ' HB2' ' HB3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -113.38 100.71 8.75 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 172.265 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -82.79 119.17 24.01 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 75.8 mt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.629 -0.701 . . . . 0.0 110.14 -178.181 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.446 ' HE3' HG22 ' A' ' 60' ' ' THR . 39.2 tptt -71.03 133.15 46.1 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -172.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.456 HG23 ' HA ' ' A' ' 16' ' ' VAL . 7.3 p -150.95 148.15 15.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.863 -178.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.9 ttt -102.96 124.82 49.19 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.732 0.301 . . . . 0.0 110.949 -176.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.464 HG13 HD11 ' A' ' 48' ' ' LEU . 42.4 mm -109.22 128.97 64.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.732 177.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.546 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 92.7 mtt180 -101.13 118.99 38.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.09 0.471 . . . . 0.0 111.34 -176.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.437 ' HD3' ' HG ' ' A' ' 33' ' ' LEU . 9.8 mmmm -107.68 116.53 32.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.233 171.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.1 m -139.96 72.84 1.41 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.349 0.595 . . . . 0.0 109.82 175.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 54.85 -93.79 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.945 -176.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.4 t -94.48 -25.94 16.67 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.225 0.536 . . . . 0.0 110.287 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.0 112.59 4.29 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -126.43 119.92 28.45 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.438 ' OG ' ' HD2' ' A' ' 6' ' ' ARG . 16.7 p -147.57 163.1 37.66 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.584 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -139.28 141.7 37.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.372 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -114.53 104.03 11.61 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.216 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.456 ' HA ' HG23 ' A' ' 3' ' ' VAL . 47.9 t -76.1 88.19 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.629 176.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.94 -29.18 41.38 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.239 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -57.86 -38.05 75.03 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.419 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 19' ' ' LYS . 54.1 tttm -117.16 -1.81 11.79 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.472 -175.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' A' ' 19' ' ' LYS . 30.9 t70 64.71 23.73 12.8 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 122.033 0.921 . . . . 0.0 109.385 -174.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.3 tt -88.87 125.48 34.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.729 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -124.98 125.22 43.55 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 10.5 tp10 -154.44 162.26 41.25 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.893 0.378 . . . . 0.0 110.815 -176.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.406 HD23 ' HB3' ' A' ' 13' ' ' SER . 91.1 mt -79.6 144.51 33.76 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.65 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.3 mt -81.11 114.14 21.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.086 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.464 HG23 ' HG3' ' A' ' 27' ' ' GLU . 19.8 m -104.67 -26.15 3.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.488 -178.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.603 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 39.3 mt-10 -132.91 114.34 13.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.354 -176.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.561 ' SD ' ' N ' ' A' ' 28' ' ' MET . 0.6 OUTLIER -109.53 157.43 19.0 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 178.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.457 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 8.6 tp10 -72.32 -49.54 33.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.69 0.757 . . . . 0.0 109.428 171.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.419 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 50.8 t-20 -95.57 138.48 21.82 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.717 -175.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 30' ' ' ASN . 9.5 Cg_endo -50.29 -31.54 29.97 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.016 2.477 . . . . 0.0 111.562 173.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.92 -69.56 0.49 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.977 173.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.669 ' HB3' ' HD1' ' A' ' 34' ' ' TRP . 0.3 OUTLIER -178.43 -72.46 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.602 178.445 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.669 ' HD1' ' HB3' ' A' ' 33' ' ' LEU . 14.5 m95 -79.08 144.5 34.53 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.985 -174.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 176.83 -58.14 0.1 Allowed Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.08 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -146.47 -73.19 0.02 OUTLIER Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.242 -174.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.457 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 1.7 pptp? -132.97 167.7 19.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.169 0.509 . . . . 0.0 110.924 176.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.6 p -147.21 154.7 11.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.381 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.603 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 11.7 m -134.52 134.43 41.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.971 0.415 . . . . 0.0 110.624 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.584 HD11 ' HB3' ' A' ' 14' ' ' ALA . 2.9 mm? -87.08 169.76 12.12 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.582 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.52 -12.14 59.64 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.09 0.471 . . . . 0.0 110.884 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -80.83 -20.83 41.57 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.845 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.2 -8.92 59.26 Favored Glycine 0 C--N 1.332 0.335 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 -175.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -64.71 133.39 52.02 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 45.2 mt-30 -107.87 138.13 44.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.862 0.363 . . . . 0.0 110.465 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.434 HD11 HG11 ' A' ' 3' ' ' VAL . 3.4 tm? -138.27 132.41 31.64 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -84.07 113.33 20.96 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.464 HD11 HG13 ' A' ' 5' ' ' ILE . 18.2 tp -105.97 116.53 59.49 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.349 -173.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.419 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 3.0 Cg_exo -74.92 154.93 43.24 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.341 2.028 . . . . 0.0 111.419 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.57 74.09 5.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.294 0.568 . . . . 0.0 109.825 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.5 mmt -90.85 -54.89 3.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.997 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.463 ' O ' HG22 ' A' ' 55' ' ' THR . . . -163.21 95.08 0.84 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.237 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.489 ' HA ' ' CD1' ' A' ' 34' ' ' TRP . . . -71.48 -32.61 68.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.585 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.74 -52.93 54.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.861 -175.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.463 HG22 ' O ' ' A' ' 52' ' ' ALA . 9.8 t -28.51 120.82 0.27 Allowed Pre-proline 0 N--CA 1.477 0.897 0 O-C-N 124.224 0.952 . . . . 0.0 113.403 -169.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -85.66 10.43 3.7 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.205 2.604 . . . . 0.0 112.432 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.8 pp -131.76 153.18 81.39 Favored Pre-proline 0 C--O 1.236 0.395 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.568 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.546 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . 41.9 Cg_endo -66.63 149.9 83.89 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.826 2.35 . . . . 0.0 112.682 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.1 tt -152.03 146.93 15.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.252 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.446 HG22 ' HE3' ' A' ' 2' ' ' LYS . 17.0 m -102.02 128.27 48.54 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.315 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.415 HG11 ' HZ3' ' A' ' 34' ' ' TRP . 27.5 m -132.7 174.97 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 120.877 0.37 . . . . 0.0 111.393 -177.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -78.5 161.59 26.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.463 171.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -167.45 159.96 12.8 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.333 0.587 . . . . 0.0 112.543 -175.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -113.13 141.56 46.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.866 172.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.51 126.16 41.5 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.433 HD22 ' N ' ' A' ' 66' ' ' LEU . 2.8 mm? . . . . . 0 C--O 1.245 0.837 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.611 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -108.7 144.54 36.36 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 122.511 0.324 . . . . 0.0 110.57 -173.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.5 p -147.17 141.59 20.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.808 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.2 ttm -101.75 112.72 25.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.83 0.348 . . . . 0.0 110.268 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.465 HG13 HD11 ' A' ' 48' ' ' LEU . 41.0 mm -95.61 124.48 48.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.439 ' HB2' ' OG ' ' A' ' 13' ' ' SER . 97.4 mtt180 -97.39 118.32 33.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.148 0.499 . . . . 0.0 110.838 -175.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.464 ' NZ ' ' HB3' ' A' ' 7' ' ' LYS . 3.0 mmmp? -98.38 116.51 30.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.746 177.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.1 p -134.34 161.82 33.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.27 113.12 1.8 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.807 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.8 p 52.85 23.03 2.59 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.575 0.75 . . . . 0.0 111.688 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.85 134.84 7.84 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -133.81 117.9 17.4 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -178.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.439 ' OG ' ' HB2' ' A' ' 6' ' ' ARG . 15.3 p -135.88 161.8 34.61 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.551 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -146.24 146.24 30.69 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.66 -0.246 . . . . 0.0 110.523 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -129.7 110.25 11.63 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.94 0.4 . . . . 0.0 111.019 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.556 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 56.4 t -87.92 96.29 5.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 172.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.07 -37.88 84.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.251 -171.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.64 -22.76 66.68 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.621 0.248 . . . . 0.0 111.453 -174.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 6.4 tmtm? -119.36 -2.73 10.56 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.669 0.271 . . . . 0.0 110.586 -178.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 64.04 27.72 14.24 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.687 -177.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.556 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 54.2 tp -84.01 111.46 19.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.244 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -123.7 113.15 18.24 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.419 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 10.2 tp10 -148.18 162.83 38.66 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.839 0.352 . . . . 0.0 110.825 -173.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.7 mt -84.14 151.63 24.78 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.332 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.545 HD13 HD21 ' A' ' 33' ' ' LEU . 78.6 mt -92.2 101.21 12.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.668 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.458 HG13 ' HB2' ' A' ' 41' ' ' ALA . 16.3 m -83.87 -37.34 13.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.934 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.553 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 47.2 mt-10 -125.26 139.96 53.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.021 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.411 ' SD ' ' HA ' ' A' ' 33' ' ' LEU . 16.1 ptt? -151.2 156.74 41.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.876 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.47 ' OE1' ' HG3' ' A' ' 37' ' ' LYS . 8.8 tp10 -67.1 -37.48 83.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.079 0.466 . . . . 0.0 111.273 -176.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.416 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 45.0 t-20 -117.74 137.02 23.89 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.073 -172.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 30' ' ' ASN . 8.4 Cg_endo -47.61 -31.43 14.13 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.495 2.797 . . . . 0.0 112.099 175.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.16 -61.71 1.89 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.552 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.545 HD21 HD13 ' A' ' 25' ' ' ILE . 0.4 OUTLIER 172.42 -67.25 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.973 0.796 . . . . 0.0 110.755 175.489 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.521 ' HZ3' HG21 ' A' ' 61' ' ' VAL . 44.4 m95 -74.06 133.38 42.89 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.461 -171.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.83 -56.63 0.05 OUTLIER Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.201 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.67 -67.3 0.01 OUTLIER Glycine 0 C--N 1.334 0.446 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.524 -174.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.47 ' HG3' ' OE1' ' A' ' 29' ' ' GLU . 1.9 pptp? -134.62 168.73 18.46 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.029 0.442 . . . . 0.0 111.152 175.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 46' ' ' LEU . 14.0 p -146.97 160.67 9.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.479 -177.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.553 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 33.0 m -138.89 126.3 21.68 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.83 0.348 . . . . 0.0 110.355 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.551 HD11 ' HB3' ' A' ' 14' ' ' ALA . 2.9 mm? -78.77 159.12 28.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.168 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.458 ' HB2' HG13 ' A' ' 26' ' ' VAL . . . -65.13 -12.06 46.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.087 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.419 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 65.1 t30 -85.3 2.78 42.6 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.48 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.26 -8.79 79.07 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.197 -0.525 . . . . 0.0 113.553 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 18.0 m0 -85.52 142.83 28.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.1 0.476 . . . . 0.0 111.274 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -101.69 159.8 15.01 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.756 -176.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.404 ' O ' HG12 ' A' ' 38' ' ' VAL . 3.2 tm? -159.37 136.33 9.53 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -176.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -82.84 122.8 28.69 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 122.247 -0.283 . . . . 0.0 110.28 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.465 HD11 HG13 ' A' ' 5' ' ' ILE . 22.7 tp -115.53 112.78 43.18 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.123 -174.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.419 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 60.0 Cg_endo -68.73 158.03 59.45 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.26 1.973 . . . . 0.0 111.961 -175.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.94 76.91 3.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.093 0.473 . . . . 0.0 110.514 178.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.416 ' SD ' ' N ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -91.75 -164.8 1.23 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.627 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.416 ' N ' ' SD ' ' A' ' 51' ' ' MET . . . -83.3 109.66 17.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.743 0.306 . . . . 0.0 110.962 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.79 -7.49 54.57 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.714 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -60.86 -25.68 66.83 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.793 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.2 p -57.02 117.52 18.29 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.924 -176.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -92.14 10.88 2.41 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.145 2.563 . . . . 0.0 111.682 174.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 pp -139.5 160.85 59.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.212 -175.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -62.98 135.71 52.9 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.53 2.153 . . . . 0.0 112.726 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.9 tt -130.54 140.15 49.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.022 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.3 m -100.85 119.05 38.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.895 0.378 . . . . 0.0 110.786 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.521 HG21 ' HZ3' ' A' ' 34' ' ' TRP . 35.4 m -122.5 170.67 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.721 178.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 1' ' ' MET . 10.2 mt-10 -82.85 157.12 23.25 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 171.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -149.23 164.37 34.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.23 0.538 . . . . 0.0 111.923 -172.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.622 HH11 ' HG3' ' A' ' 64' ' ' ARG . 11.3 mmt85 -116.62 125.71 52.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.655 175.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -82.22 108.69 15.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.99 0.424 . . . . 0.0 110.354 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 78.0 mt . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.417 -0.802 . . . . 0.0 109.673 178.753 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.4 ' HB3' ' HB3' ' A' ' 63' ' ' ALA . 24.8 mmt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -88.8 114.73 25.74 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.328 -172.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 9.5 p -147.38 141.98 19.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.092 174.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.461 ' SD ' ' HB2' ' A' ' 58' ' ' PRO . 51.0 ttm -117.18 120.28 37.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.676 0.274 . . . . 0.0 110.319 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.4 mm -88.62 115.1 28.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.419 ' HG2' ' HB3' ' A' ' 58' ' ' PRO . 94.5 mtt180 -111.03 118.97 37.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.784 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.455 ' HD3' ' O ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -127.74 138.44 52.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.023 0.44 . . . . 0.0 110.986 179.036 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.63 HG22 ' H ' ' A' ' 9' ' ' ALA . 3.0 m -147.19 -179.02 6.54 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.63 ' H ' HG22 ' A' ' 8' ' ' THR . . . -49.54 107.17 0.13 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 117.826 0.285 . . . . 0.0 110.729 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.2 p 67.79 -41.02 0.42 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.787 1.235 . . . . 0.0 112.746 -177.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.69 110.78 3.14 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.318 -0.467 . . . . 0.0 112.71 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -118.42 128.88 55.04 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.6 p -143.9 155.4 44.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.877 0.37 . . . . 0.0 110.648 -178.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.515 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -128.49 115.57 18.36 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -90.37 103.91 16.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.871 -176.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.1 t -80.25 99.59 4.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.39 175.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.28 -53.85 44.87 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -172.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -11.73 31.06 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -174.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -118.3 -8.98 10.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.723 0.297 . . . . 0.0 110.526 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.4 t70 57.65 26.65 13.19 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 122.032 0.92 . . . . 0.0 109.593 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.406 ' C ' HD23 ' A' ' 21' ' ' LEU . 8.1 tt -86.98 123.54 32.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.127 -176.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -133.16 104.48 6.52 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 171.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.32 165.16 19.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.904 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.7 mt -79.69 132.99 36.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.844 0.354 . . . . 0.0 110.63 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.464 HD12 HD11 ' A' ' 33' ' ' LEU . 69.5 mt -71.37 105.33 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.776 174.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.424 HG23 ' HG2' ' A' ' 27' ' ' GLU . 10.9 m -81.42 -49.25 18.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.173 -177.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.545 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 58.1 mm-40 -106.76 140.95 38.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.916 -177.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 59.5 mtt -132.96 156.73 46.75 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.466 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 10.6 tp10 -65.35 -49.13 70.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.551 0.691 . . . . 0.0 109.336 172.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -127.43 148.34 66.02 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.877 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.05 -23.08 11.68 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.337 2.691 . . . . 0.0 113.742 -174.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -71.25 -66.44 0.62 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.696 0.284 . . . . 0.0 110.547 176.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 18.7 tp 170.2 -70.48 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.008 -175.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 46.4 m95 -76.29 153.61 35.78 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.023 -176.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' A' ' 50' ' ' ALA . . . 159.62 -33.21 0.45 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.477 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.21 -78.24 0.05 OUTLIER Glycine 0 C--O 1.226 -0.393 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.466 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -129.73 161.3 30.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.919 0.39 . . . . 0.0 110.937 178.296 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.7 m -140.01 167.59 18.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 171.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.545 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 17.7 m -135.78 125.77 25.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.9 0.381 . . . . 0.0 110.671 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.515 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.7 mm? -77.88 161.45 27.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.558 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.8 -19.69 60.03 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.187 0.518 . . . . 0.0 110.395 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -63.08 -23.25 67.36 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.407 175.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.36 12.3 57.42 Favored Glycine 0 C--N 1.332 0.36 0 N-CA-C 111.621 -0.592 . . . . 0.0 111.621 -176.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.69 ' HZ2' ' HE2' ' A' ' 65' ' ' LYS . 45.8 t-105 -106.76 140.08 40.17 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 -178.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -94.41 149.04 21.63 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.954 -177.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.523 HD21 ' HB1' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -142.9 131.81 22.88 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.194 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.578 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 42.2 tt0 -89.9 120.88 31.5 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.79 0.329 . . . . 0.0 111.205 -175.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -121.03 113.32 32.85 Favored Pre-proline 0 C--O 1.235 0.332 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.371 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.51 152.89 79.83 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.384 2.056 . . . . 0.0 111.573 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.524 ' HB2' ' HA2' ' A' ' 35' ' ' GLY . . . -71.38 75.58 0.75 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.031 0.443 . . . . 0.0 110.434 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.6 mmt -87.99 -74.37 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.389 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.99 110.03 1.85 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.545 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.2 -30.87 70.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.238 0.542 . . . . 0.0 109.628 175.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -73.36 86.77 1.5 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.447 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.438 HG21 ' HB ' ' A' ' 59' ' ' ILE . 32.1 m -139.02 109.02 7.61 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.596 177.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -83.6 14.56 2.35 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.037 2.491 . . . . 0.0 113.22 -176.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.6 pp -145.66 159.98 45.87 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.648 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.461 ' HB2' ' SD ' ' A' ' 4' ' ' MET . 37.9 Cg_endo -66.62 106.27 1.05 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.258 1.972 . . . . 0.0 111.328 175.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.438 ' HB ' HG21 ' A' ' 55' ' ' THR . 8.7 tt -89.45 146.73 5.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.113 -174.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.1 m -110.84 132.71 53.97 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.275 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.4 m -139.82 177.14 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 122.419 0.288 . . . . 0.0 110.505 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -86.01 118.17 25.31 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.224 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.523 ' HB1' HD21 ' A' ' 46' ' ' LEU . . . -70.28 109.83 4.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.945 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.578 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 1.4 tmm_? -93.59 101.73 13.9 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 174.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.69 ' HE2' ' HZ2' ' A' ' 44' ' ' TRP . 45.3 tttm -73.15 129.7 38.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.166 -176.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.457 ' N ' HD12 ' A' ' 66' ' ' LEU . 5.8 mp . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.553 -0.736 . . . . 0.0 109.485 176.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.401 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 64.6 mtt . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.409 ' HG3' ' CG2' ' A' ' 60' ' ' THR . 86.3 tttt -101.61 121.56 42.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.008 -173.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.6 p -137.4 129.52 41.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 173.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.463 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 52.9 ttm -101.06 115.06 29.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.656 -175.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.1 mm -96.28 116.36 38.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 6' ' ' ARG . 64.0 mtt85 -97.68 126.12 42.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.209 0.528 . . . . 0.0 110.853 -178.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.623 ' HD3' ' HG ' ' A' ' 33' ' ' LEU . 16.1 mmmt -119.78 115.37 23.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.006 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.2 t -135.82 -167.46 2.04 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 175.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.21 -74.11 0.04 OUTLIER 'General case' 0 C--O 1.235 0.298 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -174.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.6 p -112.11 -28.51 7.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.985 0.421 . . . . 0.0 110.795 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.02 138.69 27.2 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.6 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -141.6 121.69 13.78 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 175.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.4 p -140.45 158.87 43.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.865 0.364 . . . . 0.0 111.277 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.577 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -131.05 137.88 49.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.792 176.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.463 ' HB3' ' HB3' ' A' ' 4' ' ' MET . 40.1 t80 -119.17 104.64 10.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.956 0.407 . . . . 0.0 111.207 -177.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 59.7 t -79.83 97.37 2.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.564 174.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.13 -40.64 77.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.778 -172.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.432 ' HB2' ' HE2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -69.32 -11.96 61.25 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -171.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -133.98 0.47 3.18 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.777 0.322 . . . . 0.0 111.008 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 59.32 24.06 12.56 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.782 -177.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.502 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 41.9 tp -83.07 108.26 16.23 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.17 -178.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 14' ' ' ALA . 32.9 tt0 -121.87 126.72 49.36 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.443 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 10.7 tp10 -147.61 162.63 38.74 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.556 -175.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.3 mt -78.29 139.59 38.86 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.576 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.405 HG23 HG23 ' A' ' 38' ' ' VAL . 79.9 mt -82.16 104.84 11.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.852 176.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.6 m -94.84 -37.59 8.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 111.674 0.249 . . . . 0.0 111.674 -177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.601 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 34.5 tt0 -127.95 134.39 49.3 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -176.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.547 ' HG2' ' HA ' ' A' ' 33' ' ' LEU . 0.9 OUTLIER -122.87 160.87 25.19 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.465 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 11.6 tp10 -66.73 -49.06 67.21 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -106.88 142.92 26.01 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 173.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -54.91 -21.94 28.27 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.019 2.48 . . . . 0.0 113.135 -174.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.11 -71.83 0.2 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.623 0.249 . . . . 0.0 110.669 177.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.623 ' HG ' ' HD3' ' A' ' 7' ' ' LYS . 1.1 tm? -179.45 -63.23 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -178.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.422 ' HA ' HD23 ' A' ' 48' ' ' LEU . 58.1 m95 -83.57 165.28 19.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.464 -177.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 159.22 -70.39 0.24 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.718 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -147.57 -48.36 0.03 OUTLIER Glycine 0 C--N 1.33 0.198 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.138 -175.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.465 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -145.01 164.51 30.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.84 0.353 . . . . 0.0 110.315 178.607 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.405 HG23 HG23 ' A' ' 25' ' ' ILE . 6.8 p -143.41 137.24 25.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.725 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.601 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 30.5 m -112.31 116.12 29.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.81 0.338 . . . . 0.0 110.751 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.577 HD11 ' HB3' ' A' ' 14' ' ' ALA . 2.9 mm? -75.29 154.97 37.13 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.985 173.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.11 -16.5 52.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.079 0.466 . . . . 0.0 111.436 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.44 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 7.1 t30 -82.5 3.28 29.0 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.814 -178.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.25 31.77 45.79 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.731 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 19.6 t-105 -113.7 113.91 25.65 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.404 ' HB3' HD12 ' A' ' 66' ' ' LEU . 42.3 mt-30 -98.93 121.08 40.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.276 0.56 . . . . 0.0 110.807 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.6 tp -110.62 147.85 33.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.026 178.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.566 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 35.6 tt0 -84.95 115.66 22.93 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 34' ' ' TRP . 15.0 tp -112.54 116.68 48.04 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.631 -171.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.18 155.84 58.98 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.5 2.133 . . . . 0.0 112.27 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.09 79.6 5.49 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.955 0.407 . . . . 0.0 111.011 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.1 mmt -98.41 -169.16 1.76 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.122 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.37 116.79 2.62 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.971 178.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.62 -46.69 28.88 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.75 0.657 . . . . 0.0 111.722 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.488 ' HA ' ' HE2' ' A' ' 7' ' ' LYS . 30.2 m-20 -116.37 79.47 1.32 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.085 0.469 . . . . 0.0 110.269 178.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.4 m -62.98 121.88 71.53 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.688 175.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.15 2.38 6.77 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.673 2.249 . . . . 0.0 113.184 -174.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 pp -151.86 156.88 34.47 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.631 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.21 110.24 1.95 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.462 2.108 . . . . 0.0 111.008 174.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.7 tt -105.36 137.18 36.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.101 0.476 . . . . 0.0 111.003 -175.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.409 ' CG2' ' HG3' ' A' ' 2' ' ' LYS . 86.9 m -95.81 118.84 33.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.303 177.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.9 178.11 2.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.832 -177.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 1' ' ' MET . 4.0 mp0 -76.37 149.06 37.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.202 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.18 156.8 17.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.105 0.478 . . . . 0.0 111.47 -177.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.566 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -162.21 105.69 1.16 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.963 174.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -73.9 141.05 46.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.804 0.335 . . . . 0.0 111.118 -177.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 47' ' ' GLU . 70.6 mt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.818 -0.61 . . . . 0.0 109.43 175.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptt? . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 121.286 0.565 . . . . 0.0 110.005 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.425 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 23.9 tptm -94.21 110.64 22.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.277 -169.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.486 HG23 ' HA ' ' A' ' 16' ' ' VAL . 11.7 p -146.98 141.67 20.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.051 174.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 47.5 ttp -125.05 129.02 49.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.49 -177.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.9 mm -96.94 123.81 49.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.669 ' HD3' ' HB3' ' A' ' 58' ' ' PRO . 22.2 mmt85 -99.1 131.53 45.07 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.205 0.526 . . . . 0.0 111.416 -177.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -93.55 120.25 33.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.968 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.5 p -123.32 146.43 47.93 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.75 -37.66 82.58 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.028 0.442 . . . . 0.0 110.514 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.6 m -110.27 76.27 0.98 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.076 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.54 -160.05 13.53 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.434 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -138.96 146.24 40.74 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.5 m -136.9 143.82 43.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.64 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -123.84 132.32 53.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.771 0.32 . . . . 0.0 110.151 177.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -104.93 102.39 11.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.158 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.486 ' HA ' HG23 ' A' ' 3' ' ' VAL . 47.8 t -76.36 90.75 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.295 174.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.425 ' HB3' ' HG3' ' A' ' 2' ' ' LYS . . . -62.48 -32.89 73.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.143 -172.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.474 ' HB2' ' NZ ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -69.05 -1.59 7.95 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.778 -0.192 . . . . 0.0 111.487 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 19' ' ' LYS . 56.8 tttm -136.84 -1.74 2.19 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.342 176.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 56.49 29.9 16.19 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.053 0.454 . . . . 0.0 110.752 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.3 tp -98.12 117.21 31.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.874 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -109.33 125.08 51.96 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 169.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.449 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 8.0 tp10 -143.91 160.6 40.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.934 0.397 . . . . 0.0 110.767 -177.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.5 mt -76.45 134.79 39.45 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.231 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.453 HG23 HG13 ' A' ' 38' ' ' VAL . 64.5 mt -81.0 91.6 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.8 m -78.72 -32.78 16.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.79 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.577 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 8.5 tp10 -129.37 141.34 51.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.207 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.417 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -152.15 157.81 42.05 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.3 -179.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.485 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 6.6 tp10 -65.19 -67.03 0.47 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.776 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.45 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 56.5 t30 -90.39 130.98 39.72 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.839 -175.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.45 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 1.6 Cg_endo -40.55 -35.02 1.33 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.462 3.441 . . . . 0.0 113.567 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -67.91 -65.78 0.65 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.785 0.326 . . . . 0.0 110.535 176.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 29.6 tp 174.57 -69.21 0.01 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.161 -175.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.508 ' HE3' ' O ' ' A' ' 49' ' ' PRO . 49.1 m95 -75.26 130.9 39.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.407 -177.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 50' ' ' ALA . . . -168.09 -57.44 0.03 OUTLIER Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.293 -178.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.37 -68.02 0.07 OUTLIER Glycine 0 C--O 1.225 -0.458 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 -177.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.485 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 9.6 ptpp? -101.3 146.57 27.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.648 0.261 . . . . 0.0 110.321 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.453 HG13 HG23 ' A' ' 25' ' ' ILE . 17.2 t -147.15 153.13 12.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.577 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 43.2 m -142.8 131.21 22.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.069 0.461 . . . . 0.0 111.025 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.64 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.2 mm? -86.21 165.33 16.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.622 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.32 -20.76 65.77 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.142 0.496 . . . . 0.0 110.908 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.449 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 8.0 t30 -77.34 -9.35 58.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.47 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.62 -10.61 68.77 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 121.252 -0.499 . . . . 0.0 111.992 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 27.1 t-105 -64.64 123.38 19.15 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.478 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 43.8 mt-30 -98.62 126.96 44.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.889 0.376 . . . . 0.0 110.378 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.7 tp -123.64 139.03 54.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.538 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 21.0 tt0 -95.67 101.97 13.72 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -178.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.7 tp -101.5 104.33 33.39 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.543 -173.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.508 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 59.2 Cg_endo -70.62 136.26 30.31 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.441 2.094 . . . . 0.0 111.639 -175.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.455 ' HB2' ' HA2' ' A' ' 35' ' ' GLY . . . -64.69 80.44 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.957 0.408 . . . . 0.0 111.578 -177.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.3 mmt -86.65 -59.87 2.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.282 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.45 116.96 5.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.775 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.74 -54.77 33.45 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.617 0.573 . . . . 0.0 111.516 -174.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -103.98 91.43 3.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.985 0.421 . . . . 0.0 110.295 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.9 m -73.22 128.61 87.33 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.187 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.55 -44.09 11.96 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.403 2.069 . . . . 0.0 112.502 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.569 ' HB2' ' HD2' ' A' ' 58' ' ' PRO . 2.7 pp -132.56 165.99 32.26 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.405 -177.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.669 ' HB3' ' HD3' ' A' ' 6' ' ' ARG . 29.3 Cg_endo -60.73 110.23 0.79 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.382 2.054 . . . . 0.0 111.737 177.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.9 tt -101.63 147.81 8.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.019 -176.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 87.5 m -101.73 120.13 39.87 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.156 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.1 m -120.38 178.55 2.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.161 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.66 123.17 21.25 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.519 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.46 110.2 14.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.086 0.47 . . . . 0.0 110.782 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.415 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 3.5 tpm_? -122.14 105.16 10.01 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.203 176.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -83.58 151.28 25.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.893 0.378 . . . . 0.0 110.78 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 7.1 mp . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.331 -0.842 . . . . 0.0 109.34 174.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.748 ' SD ' ' HD3' ' A' ' 18' ' ' LYS . 24.2 ttt . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.478 ' HG3' HG21 ' A' ' 60' ' ' THR . 39.8 tttm -71.41 115.15 10.24 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.58 0.752 . . . . 0.0 110.678 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.555 HG23 ' HA ' ' A' ' 16' ' ' VAL . 8.2 p -134.24 136.31 53.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.954 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.7 ttm -104.28 116.53 32.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.967 0.413 . . . . 0.0 111.233 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.525 HG13 HD11 ' A' ' 48' ' ' LEU . 45.2 mm -91.18 115.55 30.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.507 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 74.3 mtp180 -97.46 118.78 34.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.127 0.489 . . . . 0.0 110.952 -171.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -100.03 116.59 32.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.857 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 t -149.16 -177.58 5.9 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.27 104.59 0.15 Allowed 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.386 0.429 . . . . 0.0 111.608 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.1 p 67.75 -52.96 0.51 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.005 1.322 . . . . 0.0 113.504 177.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.95 81.81 0.54 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.451 -0.404 . . . . 0.0 113.23 -174.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.411 ' HB3' HD11 ' A' ' 33' ' ' LEU . 61.2 m80 -70.84 110.42 5.59 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m -114.66 151.9 32.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.936 0.398 . . . . 0.0 111.546 -170.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.453 ' HB3' HD21 ' A' ' 40' ' ' LEU . . . -124.35 118.57 27.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.66 175.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -106.11 106.91 17.64 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.044 0.449 . . . . 0.0 110.912 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.555 ' HA ' HG23 ' A' ' 3' ' ' VAL . 29.9 t -93.71 96.51 6.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.666 176.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.82 -45.55 86.0 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.348 -173.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.748 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 49.2 pttt -63.79 -35.22 79.9 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.732 0.301 . . . . 0.0 111.054 -177.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.403 ' N ' ' HG3' ' A' ' 18' ' ' LYS . 48.0 tttm -90.42 -9.97 45.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.882 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 62.07 20.51 11.68 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.042 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 22' ' ' GLU . 4.2 tt -106.23 128.8 54.22 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -175.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.507 ' N ' HD23 ' A' ' 21' ' ' LEU . 45.3 tt0 -131.0 113.89 14.53 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 175.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 7.7 tp10 -136.4 160.36 38.99 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.941 0.401 . . . . 0.0 111.014 -175.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.2 mt -79.4 143.49 35.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.763 175.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 68.6 mt -90.0 123.13 42.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.2 m -110.59 -27.42 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -176.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.604 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 52.5 mm-40 -129.85 100.56 5.52 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.765 0.317 . . . . 0.0 110.988 -176.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.546 ' SD ' ' N ' ' A' ' 28' ' ' MET . 1.0 OUTLIER -99.97 155.37 17.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.399 -178.546 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -67.99 -53.54 25.22 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 170.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.497 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 59.3 t30 -97.42 131.16 27.77 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.042 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.497 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 2.8 Cg_endo -42.06 -39.98 6.07 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 124.185 3.257 . . . . 0.0 113.182 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.553 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -69.16 -66.39 0.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.462 177.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.411 HD11 ' HB3' ' A' ' 12' ' ' HIS . 4.5 mt 178.7 -72.63 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.255 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.594 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 41.1 m95 -72.66 140.41 47.91 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.053 -173.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.19 -23.83 0.88 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 121.278 -0.487 . . . . 0.0 112.287 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.86 -137.19 3.6 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.968 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.517 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -67.09 146.72 54.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.332 0.587 . . . . 0.0 111.941 -176.427 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.0 m -137.68 136.91 45.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 172.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.604 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 26.8 m -111.32 128.55 55.99 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.727 0.298 . . . . 0.0 110.765 -175.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . 80.6 mt -72.37 157.2 38.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.985 176.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.16 -17.74 58.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.306 0.574 . . . . 0.0 110.582 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.424 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 25.3 t-20 -69.61 -28.55 66.03 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.49 176.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.78 -18.84 26.44 Favored Glycine 0 C--N 1.331 0.269 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -175.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.721 ' HZ2' ' HD2' ' A' ' 65' ' ' LYS . 41.2 t-105 -71.0 141.51 50.99 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -114.43 146.48 40.57 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.255 0.55 . . . . 0.0 111.735 -175.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.6 tp -135.3 141.9 45.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.659 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.601 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 38.5 tt0 -92.42 105.63 17.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.187 0.518 . . . . 0.0 110.049 -178.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.525 HD11 HG13 ' A' ' 5' ' ' ILE . 18.9 tp -83.22 126.44 72.05 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.537 -174.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -51.83 145.15 32.76 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.0 2.466 . . . . 0.0 113.203 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.7 88.2 7.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.967 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 23.5 ptp -135.37 -152.39 0.46 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.439 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.54 112.47 0.6 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.656 0.265 . . . . 0.0 110.562 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.594 ' HA ' ' HB2' ' A' ' 34' ' ' TRP . . . -63.91 -27.19 68.98 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.161 -173.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -135.66 93.51 2.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.148 0.499 . . . . 0.0 110.644 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.0 p -79.67 129.84 69.78 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.672 174.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.04 -8.43 23.58 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.398 2.065 . . . . 0.0 111.936 -178.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.2 pp -138.23 158.08 71.54 Favored Pre-proline 0 C--O 1.236 0.376 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.456 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.507 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . 38.2 Cg_endo -66.19 136.13 42.89 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.437 2.091 . . . . 0.0 111.058 174.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.5 tt -136.78 144.31 32.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.877 0.37 . . . . 0.0 110.944 -174.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.478 HG21 ' HG3' ' A' ' 2' ' ' LYS . 63.7 m -98.11 130.77 44.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.145 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.41 ' O ' HG12 ' A' ' 3' ' ' VAL . 26.3 m -140.14 179.41 2.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 120.968 0.413 . . . . 0.0 111.599 -174.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -64.03 138.67 58.57 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.212 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.454 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . . . -108.37 123.41 48.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.022 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.601 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -122.89 102.04 7.79 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 175.047 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.721 ' HD2' ' HZ2' ' A' ' 44' ' ' TRP . 28.2 ttpt -65.16 145.3 56.45 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.691 -176.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.474 HD21 ' HB2' ' A' ' 47' ' ' GLU . 91.3 mt . . . . . 0 C--O 1.253 1.253 0 CA-C-O 118.821 -0.609 . . . . 0.0 109.847 175.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.671 ' SD ' ' NH1' ' A' ' 64' ' ' ARG . 59.1 mtt . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -114.32 115.33 27.21 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.99 -173.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.1 p -137.72 127.83 36.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.04 0.448 . . . . 0.0 110.002 174.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.473 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 23.2 ttt -101.71 111.87 24.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.349 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.1 mm -77.21 117.61 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -96.38 118.53 33.09 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.317 -172.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.448 ' NZ ' ' O ' ' A' ' 54' ' ' ASP . 14.3 mmmm -106.08 118.43 36.59 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.05 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 72.5 m -142.23 157.3 45.0 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.65 107.26 0.11 Allowed 'General case' 0 C--O 1.233 0.233 0 O-C-N 123.094 0.247 . . . . 0.0 110.675 178.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.5 p 66.92 -41.38 0.4 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.272 1.429 . . . . 0.0 112.916 -176.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.07 105.31 1.6 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.321 -0.466 . . . . 0.0 112.682 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -104.61 121.88 44.46 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 175.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.435 ' HB3' HD23 ' A' ' 24' ' ' LEU . 33.7 p -138.68 160.8 38.75 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.761 0.315 . . . . 0.0 110.177 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.587 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -128.0 115.81 19.07 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.408 ' HB3' ' HB3' ' A' ' 4' ' ' MET . 59.5 t80 -87.22 103.19 15.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.59 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.1 t -74.34 89.04 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.207 175.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.3 -34.61 70.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.147 -172.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.43 -12.27 59.84 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -177.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 19' ' ' LYS . 39.1 tttm -127.2 -7.82 5.9 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.484 0.183 . . . . 0.0 110.973 178.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.3 t70 67.94 17.21 9.62 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.758 0.79 . . . . 0.0 110.332 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.487 HD21 ' HG2' ' A' ' 23' ' ' GLU . 7.6 tt -88.42 134.71 33.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.192 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -134.09 111.04 10.02 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 173.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 40' ' ' LEU . 78.1 mm-40 -116.61 160.14 21.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.27 177.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.435 HD23 ' HB3' ' A' ' 13' ' ' SER . 83.1 mt -76.95 136.2 38.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.549 175.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 85.9 mt -71.96 107.26 2.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.035 175.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.0 m -94.79 -22.77 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.179 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.578 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 32.7 tt0 -142.45 142.57 32.35 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.097 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.54 ' SD ' ' N ' ' A' ' 28' ' ' MET . 1.0 OUTLIER -123.72 177.24 5.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.096 -177.005 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.511 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 8.2 tp10 -84.2 -56.79 3.47 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 168.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.421 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 35.6 t-20 -95.59 137.63 21.93 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.819 177.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 30' ' ' ASN . 5.2 Cg_endo -44.64 -22.59 0.65 Allowed 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.642 2.895 . . . . 0.0 113.076 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.22 -69.25 0.62 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.169 173.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.4 tp -177.94 -75.55 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.922 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.478 ' HE3' ' O ' ' A' ' 49' ' ' PRO . 29.4 m95 -72.11 137.42 47.03 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.659 -176.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.538 ' HA2' ' HB2' ' A' ' 50' ' ' ALA . . . -179.67 -40.45 0.07 OUTLIER Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.419 -0.895 . . . . 0.0 113.356 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.49 -71.43 0.05 OUTLIER Glycine 0 C--O 1.225 -0.419 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.959 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.511 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -120.28 164.54 16.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.0 0.429 . . . . 0.0 111.143 176.348 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 46' ' ' LEU . 14.8 p -147.34 147.02 17.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.578 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 45.7 m -121.45 133.03 55.05 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.257 0.551 . . . . 0.0 111.126 -177.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.6 mm? -92.28 155.92 17.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.886 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.57 -34.68 51.64 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -90.03 -1.62 57.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.881 0.372 . . . . 0.0 111.442 -171.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.94 -27.61 8.15 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.518 174.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -59.4 140.23 56.34 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.872 0.336 . . . . 0.0 110.6 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.453 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 46.2 mt-30 -122.13 144.15 49.11 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.555 HD13 ' N ' ' A' ' 47' ' ' GLU . 1.6 tm? -133.67 140.49 47.09 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -176.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.555 ' N ' HD13 ' A' ' 46' ' ' LEU . 38.0 tt0 -81.69 112.13 18.59 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.9 tp -110.97 95.18 23.08 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.27 -175.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.478 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 21.7 Cg_exo -65.46 151.28 85.43 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.782 2.321 . . . . 0.0 112.298 -175.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.538 ' HB2' ' HA2' ' A' ' 35' ' ' GLY . . . -74.74 81.34 2.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.98 0.419 . . . . 0.0 110.491 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.2 mmt -95.08 -63.72 1.14 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.201 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.448 ' HB3' HG23 ' A' ' 55' ' ' THR . . . -144.73 112.67 6.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.003 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.12 99.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.5 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.448 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . 6.7 p-10 -70.74 -54.99 9.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.395 -176.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.448 HG23 ' HB3' ' A' ' 52' ' ' ALA . 1.2 p 41.63 88.38 0.1 Allowed Pre-proline 0 N--CA 1.471 0.6 0 C-N-CA 123.11 0.564 . . . . 0.0 112.0 -177.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.55 -20.94 30.47 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.783 2.322 . . . . 0.0 112.956 -173.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.4 pp -125.97 153.93 73.79 Favored Pre-proline 0 C--O 1.236 0.35 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.63 -177.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.67 94.7 0.39 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.511 2.141 . . . . 0.0 111.693 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.7 tt -89.19 143.36 11.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.968 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 4' ' ' MET . 28.0 m -97.76 130.6 44.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.917 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.7 m -126.57 177.05 5.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 121.028 0.442 . . . . 0.0 111.194 -177.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -78.11 125.18 28.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.249 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.17 122.95 28.01 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -173.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.671 ' NH1' ' SD ' ' A' ' 1' ' ' MET . 4.6 mpt_? -118.48 100.53 7.52 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 168.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -74.78 131.8 41.09 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 82.7 mt . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.554 -0.736 . . . . 0.0 109.698 178.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.519 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 49.0 ttm . . . . . 0 N--CA 1.484 1.229 0 CA-C-O 120.773 0.32 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -109.13 133.23 53.28 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 120.803 0.335 . . . . 0.0 111.416 -176.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.561 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 14.5 p -144.0 134.25 20.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.747 174.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.5 ttp -103.54 114.02 27.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.778 0.323 . . . . 0.0 110.224 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 58' ' ' PRO . 41.4 mm -90.15 116.66 31.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.072 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -94.13 147.46 23.13 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.035 0.445 . . . . 0.0 110.198 -175.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 55' ' ' THR . 36.4 mmtm -121.3 151.58 39.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.446 -176.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.448 HG22 ' N ' ' A' ' 9' ' ' ALA . 59.9 m -159.59 164.01 34.57 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.448 ' N ' HG22 ' A' ' 8' ' ' THR . . . -39.37 -42.75 1.1 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.881 0.472 . . . . 0.0 112.002 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.6 t -146.75 -32.66 0.31 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.763 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.97 75.75 0.74 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.312 -0.471 . . . . 0.0 112.999 -177.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -68.33 138.0 55.08 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.8 p -145.08 162.8 36.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.697 0.284 . . . . 0.0 110.955 -178.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.517 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -139.61 143.88 37.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.655 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.476 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 59.7 t80 -126.37 112.44 15.66 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.0 t -85.6 123.01 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.281 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.49 -70.58 0.12 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.86 -15.88 60.0 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -172.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.802 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 57.9 tptt -101.41 -15.63 17.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.494 0.187 . . . . 0.0 110.712 -177.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 58.91 25.0 13.15 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.382 0.61 . . . . 0.0 110.188 -177.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.802 ' HB2' ' HG3' ' A' ' 19' ' ' LYS . 7.0 tt -90.96 124.33 35.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.181 -173.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -128.25 109.19 11.24 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -133.23 161.03 35.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.093 -176.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.4 mt -77.83 146.53 35.67 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.564 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 72.2 mt -88.79 112.79 24.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.707 177.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.5 m -101.5 -37.46 5.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 116.805 -0.18 . . . . 0.0 111.482 -178.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.467 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 39.1 tt0 -127.43 119.5 26.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.896 0.379 . . . . 0.0 110.642 -178.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.517 ' SD ' ' N ' ' A' ' 28' ' ' MET . 1.2 mpt? -103.43 158.13 16.55 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 9.0 tp10 -60.12 -58.7 7.42 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.132 0.492 . . . . 0.0 109.924 174.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.475 HD22 ' N ' ' A' ' 30' ' ' ASN . 0.9 OUTLIER -96.98 153.4 38.55 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.248 175.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.8 -14.87 23.92 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.711 2.274 . . . . 0.0 112.741 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.82 -69.75 0.59 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.104 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.505 ' HA ' ' HG2' ' A' ' 28' ' ' MET . 1.3 tm? -176.05 -67.89 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -178.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 56.8 m95 -84.24 160.84 20.7 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.551 -177.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 168.89 -57.59 0.2 Allowed Glycine 0 C--N 1.337 0.596 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.338 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.42 -64.12 0.02 OUTLIER Glycine 0 C--N 1.33 0.226 0 C-N-CA 121.295 -0.479 . . . . 0.0 112.118 -175.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 1.7 pptp? -131.27 168.62 17.21 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.786 0.327 . . . . 0.0 110.901 175.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.0 p -147.08 152.35 13.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.589 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 44.9 m -123.26 127.82 49.11 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 120.982 0.42 . . . . 0.0 110.856 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.517 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.4 mm? -79.38 159.69 26.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.434 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.87 -29.0 66.66 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.021 -175.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -74.87 -31.68 61.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.891 0.377 . . . . 0.0 110.466 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 128.85 -10.32 6.32 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.494 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.534 ' CE3' HD11 ' A' ' 21' ' ' LEU . 3.2 m-90 -69.9 141.98 53.06 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.142 0.471 . . . . 0.0 110.985 178.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -103.48 137.35 41.68 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.602 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 58.3 tp -130.39 141.99 50.53 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 177.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.55 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 29.8 tt0 -80.88 122.45 27.24 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.0 tp -114.28 100.18 52.32 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.886 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -58.65 150.78 67.61 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.788 2.326 . . . . 0.0 112.687 -173.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.77 90.49 0.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.547 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.3 mmt -114.64 -173.09 2.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.427 176.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.62 114.21 2.16 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.672 0.273 . . . . 0.0 110.61 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.81 -50.48 73.82 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.213 -178.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -80.39 76.87 7.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.399 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.491 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 1.4 p -116.01 98.65 51.58 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.736 173.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -77.67 -7.12 16.57 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.65 2.233 . . . . 0.0 112.492 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.458 ' O ' HD12 ' A' ' 57' ' ' LEU . 2.5 pp -102.11 149.67 36.78 Favored Pre-proline 0 C--O 1.239 0.546 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.355 -177.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 57.5 Cg_endo -71.57 92.56 0.68 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.54 2.16 . . . . 0.0 111.356 175.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.7 tt -93.62 142.29 13.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.595 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.2 m -100.8 123.11 44.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.189 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.3 m -126.44 178.5 4.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 120.834 0.35 . . . . 0.0 110.736 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.519 ' HA ' ' O ' ' A' ' 1' ' ' MET . 6.7 mp0 -69.21 149.61 48.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.397 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.561 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . . . -119.5 133.19 55.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.003 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.55 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 14.9 tpt180 -134.89 122.21 21.66 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 174.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -83.17 123.69 29.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.045 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.498 HD11 ' HB2' ' A' ' 47' ' ' GLU . 7.2 mp . . . . . 0 C--O 1.25 1.113 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.7 mmm . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -113.25 137.8 50.95 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.618 0.247 . . . . 0.0 111.111 -174.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 14.5 p -145.91 138.78 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.306 175.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 47.0 ttm -111.2 114.79 28.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.301 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 58' ' ' PRO . 47.2 mm -86.2 113.52 24.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -104.98 139.19 40.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.246 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -138.41 135.67 35.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.326 178.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.6 m -108.83 -53.8 2.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.366 0.603 . . . . 0.0 109.544 174.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -170.75 -91.03 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.576 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.5 t -76.84 -28.32 55.45 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 168.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.94 98.07 0.77 Allowed Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.798 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -107.5 121.86 45.47 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 175.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.3 p -135.17 161.04 36.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.918 0.389 . . . . 0.0 110.844 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.598 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -137.19 119.07 15.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.404 178.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -90.06 102.29 15.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.015 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.475 ' HA ' HG23 ' A' ' 3' ' ' VAL . 49.2 t -77.24 90.71 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.59 -31.54 57.11 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.184 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -52.85 -54.64 31.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.136 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.567 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 9.3 tmtt? -94.92 -5.04 45.74 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.641 -176.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.7 t70 60.07 27.32 16.75 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 122.139 0.971 . . . . 0.0 109.06 -174.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.439 ' HB2' ' HD2' ' A' ' 19' ' ' LYS . 6.9 tt -106.31 118.5 36.8 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.686 -175.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -108.05 132.54 53.45 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 172.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 10.9 tp10 -144.86 161.53 39.06 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -176.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.9 mt -78.23 140.16 38.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.427 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 77.2 mt -84.6 122.86 38.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.036 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.9 m -112.3 -35.75 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -174.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.53 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 4.7 tm-20 -129.46 123.78 32.4 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -176.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.463 ' HG2' HD12 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -124.11 140.93 52.5 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.598 ' HB2' ' HD3' ' A' ' 37' ' ' LYS . 33.0 tt0 -58.22 -36.2 72.8 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.283 0.563 . . . . 0.0 110.362 176.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -109.05 140.36 21.85 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.898 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -49.54 -34.65 34.55 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.225 2.617 . . . . 0.0 112.637 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.78 -68.93 0.5 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.304 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.521 ' HB3' ' HD1' ' A' ' 34' ' ' TRP . 21.2 tp 178.89 -68.46 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.459 -178.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.521 ' HD1' ' HB3' ' A' ' 33' ' ' LEU . 13.6 m95 -78.14 135.23 37.62 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.516 -176.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.464 ' HA2' ' HB2' ' A' ' 50' ' ' ALA . . . -172.17 -48.36 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.434 -177.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.34 -72.91 0.05 OUTLIER Glycine 0 C--O 1.226 -0.383 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -176.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.598 ' HD3' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -123.21 155.34 37.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.979 0.419 . . . . 0.0 111.004 176.456 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 46' ' ' LEU . 8.5 p -146.72 157.09 11.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.45 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 34.9 m -127.03 129.86 48.85 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.087 0.47 . . . . 0.0 111.111 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.598 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.7 mm? -81.23 163.75 22.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.086 175.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.1 -24.36 66.18 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.898 0.38 . . . . 0.0 111.432 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.424 HD22 HD11 ' A' ' 21' ' ' LEU . 60.4 t30 -83.99 5.59 25.11 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.67 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.34 8.39 87.21 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.589 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.489 ' HE1' HD23 ' A' ' 46' ' ' LEU . 33.3 t-105 -76.65 112.33 13.09 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -88.96 115.86 26.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.992 0.425 . . . . 0.0 110.48 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.499 HD13 ' N ' ' A' ' 47' ' ' GLU . 2.3 tm? -118.9 136.27 54.14 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -176.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.499 ' N ' HD13 ' A' ' 46' ' ' LEU . 36.8 tt0 -79.8 111.85 16.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 0.0 110.366 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.5 tp -109.35 99.99 39.23 Favored Pre-proline 0 C--O 1.236 0.384 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.953 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.407 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 19.2 Cg_exo -65.36 153.33 78.74 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.612 2.208 . . . . 0.0 112.106 -174.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.464 ' HB2' ' HA2' ' A' ' 35' ' ' GLY . . . -79.53 83.76 5.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.785 0.326 . . . . 0.0 110.141 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 93.2 mmm -113.0 -79.6 0.58 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.309 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -127.84 101.12 6.21 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.493 ' HA ' ' CD1' ' A' ' 34' ' ' TRP . . . -79.14 -50.94 10.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.325 -175.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -95.25 27.07 3.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.929 -173.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.6 t -65.37 134.0 95.56 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -83.56 -1.62 10.2 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.613 2.209 . . . . 0.0 113.591 -175.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 57' ' ' LEU . 3.2 pp -120.9 149.36 50.71 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.441 0.163 . . . . 0.0 111.135 -175.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 44.1 Cg_endo -68.35 95.71 0.46 Allowed 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.305 2.003 . . . . 0.0 111.244 176.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.6 tt -89.21 142.11 13.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.849 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.4 m -101.94 123.17 45.39 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.624 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.3 m -127.69 178.0 5.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.957 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -69.54 149.93 47.68 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.547 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.487 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . . . -115.56 151.22 35.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.117 -177.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.424 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 37.5 ttt180 -153.3 121.47 6.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.616 175.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -87.19 121.31 29.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.816 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.427 HD22 ' N ' ' A' ' 66' ' ' LEU . 2.3 mm? . . . . . 0 C--O 1.248 1.026 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 172.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.644 ' SD ' ' HG2' ' A' ' 64' ' ' ARG . 59.9 mtt . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -130.52 111.76 12.57 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -169.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.556 HG11 HD11 ' A' ' 46' ' ' LEU . 7.4 p -142.09 130.45 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 171.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 46.8 ttm -101.06 112.05 24.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.0 mm -86.98 129.49 38.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -96.2 132.35 41.73 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 55' ' ' THR . 0.1 OUTLIER -107.98 116.58 32.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.368 0.604 . . . . 0.0 112.066 -166.038 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 t -177.41 131.35 0.16 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.783 171.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.55 -26.14 68.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.586 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.9 p -103.27 20.66 17.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.548 -176.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.87 49.43 0.12 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.82 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -57.4 123.74 16.51 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.492 ' HB3' HD23 ' A' ' 24' ' ' LEU . 10.7 p -151.03 162.48 40.77 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.367 -0.235 . . . . 0.0 110.367 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.439 ' HB3' HD21 ' A' ' 40' ' ' LEU . . . -145.57 136.11 24.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.233 -177.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.4 ' HD1' ' HB2' ' A' ' 22' ' ' GLU . 74.8 t80 -105.12 102.55 12.04 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 174.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.513 ' HA ' HG23 ' A' ' 3' ' ' VAL . 47.1 t -84.44 95.07 3.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.85 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.91 -26.4 64.29 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.562 -176.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.409 ' HB3' HG12 ' A' ' 16' ' ' VAL . 55.5 tptt -52.97 -39.44 63.0 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 175.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.532 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 2.6 tmtp? -116.05 -6.76 11.95 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 16' ' ' VAL . 19.1 m-20 59.69 26.01 15.05 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.614 -170.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 19' ' ' LYS . 5.1 tt -84.33 125.95 32.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.67 -176.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.458 ' N ' HD23 ' A' ' 21' ' ' LEU . 43.0 tt0 -116.22 120.46 39.04 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.463 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 7.4 tp10 -147.81 161.97 40.18 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.986 0.422 . . . . 0.0 111.184 -176.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.492 HD23 ' HB3' ' A' ' 13' ' ' SER . 96.3 mt -82.05 137.86 34.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.689 174.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.2 mt -83.05 106.33 13.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.462 HG23 ' HG3' ' A' ' 27' ' ' GLU . 16.5 m -81.96 -34.4 12.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.398 -177.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.462 ' HG3' HG23 ' A' ' 26' ' ' VAL . 48.6 mt-10 -132.83 140.16 47.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.334 -177.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.481 ' HG2' ' HA ' ' A' ' 33' ' ' LEU . 2.5 mpp? -126.15 160.0 31.39 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.51 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 14.7 tp10 -64.53 -41.63 96.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.229 0.538 . . . . 0.0 109.702 174.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -118.8 152.2 51.18 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.543 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -49.62 -33.03 29.97 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.161 2.574 . . . . 0.0 113.21 -177.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.36 -68.67 0.48 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.744 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.481 ' HA ' ' HG2' ' A' ' 28' ' ' MET . 3.7 tt -178.39 -71.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.977 0.417 . . . . 0.0 110.227 -178.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.698 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 31.7 m95 -76.65 155.72 33.21 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.27 -173.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 162.34 -42.54 0.36 Allowed Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.836 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.0 -65.61 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.51 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -144.79 167.93 21.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.793 0.33 . . . . 0.0 111.205 178.153 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.429 HG13 HD23 ' A' ' 48' ' ' LEU . 33.4 m -139.41 172.43 12.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.339 174.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.2 m -132.79 122.39 24.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.319 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.555 HD12 ' HB3' ' A' ' 44' ' ' TRP . 85.9 mt -78.17 155.99 30.12 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.159 176.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.16 -9.31 22.04 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.022 0.439 . . . . 0.0 111.308 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.463 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 28.2 t-20 -86.54 -13.13 46.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.251 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.88 -1.32 59.55 Favored Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.785 -176.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.555 ' HB3' HD12 ' A' ' 40' ' ' LEU . 15.3 t-105 -80.16 121.02 25.06 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 178.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -94.84 131.11 41.07 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.556 HD11 HG11 ' A' ' 3' ' ' VAL . 1.0 OUTLIER -122.66 132.38 54.24 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.259 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.589 ' HB3' ' HB2' ' A' ' 64' ' ' ARG . 32.2 tt0 -90.6 122.69 33.62 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.774 0.321 . . . . 0.0 110.87 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.43 HD22 ' N ' ' A' ' 48' ' ' LEU . 3.2 mm? -109.6 100.76 43.58 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -65.34 71.22 0.29 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.344 2.696 . . . . 0.0 113.469 -173.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 36.9 89.05 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.375 1.07 . . . . 0.0 113.489 175.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.485 ' HB2' ' CE3' ' A' ' 34' ' ' TRP . 25.2 mmt -129.62 -169.02 2.03 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 174.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.64 108.72 0.37 Allowed 'General case' 0 CA--C 1.532 0.273 0 O-C-N 123.098 0.249 . . . . 0.0 110.794 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.698 ' HA ' ' HB2' ' A' ' 34' ' ' TRP . . . -50.57 -37.06 37.62 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.746 -175.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -128.07 70.78 1.36 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.489 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 3.9 t -57.5 139.9 80.42 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.133 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.57 5.2 4.42 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.825 2.35 . . . . 0.0 113.352 -176.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.413 HD23 ' N ' ' A' ' 57' ' ' LEU . 2.5 pt? -152.07 147.69 20.2 Favored Pre-proline 0 C--O 1.234 0.267 0 O-C-N 122.512 -0.118 . . . . 0.0 110.966 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.99 94.33 0.28 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.622 2.215 . . . . 0.0 110.648 173.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.8 tt -96.35 150.56 4.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.08 0.467 . . . . 0.0 111.741 -172.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 90.3 m -98.93 127.75 44.93 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.14 175.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.414 ' O ' HG12 ' A' ' 3' ' ' VAL . 31.6 m -133.05 179.36 4.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 120.863 0.363 . . . . 0.0 111.02 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -55.97 108.87 0.5 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.042 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.521 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . . . -72.56 109.59 6.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.531 173.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.644 ' HG2' ' SD ' ' A' ' 1' ' ' MET . 91.7 mtt180 -132.81 135.01 45.41 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -108.53 150.58 27.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.02 0.438 . . . . 0.0 110.947 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.7 mt . . . . . 0 C--O 1.252 1.22 0 CA-C-O 118.449 -0.786 . . . . 0.0 109.659 175.02 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.64 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 121.474 0.654 . . . . 0.0 110.748 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -100.84 118.97 37.96 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.469 -175.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 11.5 p -137.8 132.58 44.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 174.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 57.9 ttp -112.23 117.6 32.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.293 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 58' ' ' PRO . 43.0 mm -87.44 119.38 34.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 176.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -96.28 125.65 40.94 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.948 0.404 . . . . 0.0 110.039 -179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 55' ' ' THR . 32.3 mmtp -85.65 115.65 23.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.596 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.6 m -159.1 134.01 8.17 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.37 -74.73 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -173.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 42.1 m -74.58 -29.24 61.25 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.918 0.39 . . . . 0.0 110.584 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.06 40.57 2.38 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.144 -0.551 . . . . 0.0 113.674 -174.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -58.81 115.56 3.17 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 172.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.7 p -138.1 151.22 47.59 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.013 0.435 . . . . 0.0 111.364 -174.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -122.5 115.74 22.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.955 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -96.22 103.61 15.52 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.949 0.404 . . . . 0.0 111.166 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.9 t -79.93 101.74 5.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.846 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.13 -37.45 83.85 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -173.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.516 ' HB2' ' NZ ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -68.21 -3.96 12.4 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -175.677 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.717 ' HD2' ' HB2' ' A' ' 21' ' ' LEU . 7.4 tmtm? -131.75 -16.73 2.92 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.038 0.447 . . . . 0.0 109.836 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.6 t70 59.23 60.97 2.19 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.89 0.853 . . . . 0.0 109.265 -170.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.717 ' HB2' ' HD2' ' A' ' 19' ' ' LYS . 7.2 tt -132.18 119.86 21.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.995 -179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -127.8 121.02 29.11 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 8.9 tp10 -130.31 162.28 29.38 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.4 mt -77.1 133.62 38.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.093 0.473 . . . . 0.0 110.857 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.474 HG23 ' HB ' ' A' ' 38' ' ' VAL . 73.9 mt -80.72 103.48 7.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.635 176.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.2 m -104.98 -1.0 9.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.976 0.417 . . . . 0.0 111.207 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.661 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 9.4 tp10 -147.61 137.85 23.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.935 -177.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 64.4 mtt -139.45 138.28 36.3 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -65.5 -45.56 83.1 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.07 143.65 27.02 Favored Pre-proline 0 N--CA 1.465 0.293 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 171.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.06 -21.88 67.23 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.892 2.395 . . . . 0.0 113.122 -174.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -75.24 -68.82 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.684 0.278 . . . . 0.0 110.55 178.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 3.8 tt 171.18 -60.29 0.01 OUTLIER 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.484 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 55.0 m95 -85.59 128.72 34.84 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.079 -178.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 148.1 50.55 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 -177.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 122.36 -95.22 0.54 Allowed Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 175.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.44 156.17 44.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.086 0.469 . . . . 0.0 111.039 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.474 ' HB ' HG23 ' A' ' 25' ' ' ILE . 20.4 m -125.78 149.35 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 172.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.661 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 22.6 m -109.91 121.07 44.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.084 0.468 . . . . 0.0 110.275 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . 3.1 mm? -67.01 157.03 34.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.831 177.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.71 -28.54 34.57 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -172.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -95.6 2.36 54.14 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -174.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.94 -14.49 28.94 Favored Glycine 0 N--CA 1.459 0.207 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.602 175.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -62.41 148.4 45.55 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.427 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 34.4 mt-30 -125.35 145.81 49.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.722 0.296 . . . . 0.0 110.369 177.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 52.9 tp -132.33 139.63 48.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -93.58 118.1 30.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.619 0.247 . . . . 0.0 110.891 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.449 HD22 ' N ' ' A' ' 48' ' ' LEU . 2.7 mm? -121.14 107.56 37.29 Favored Pre-proline 0 N--CA 1.465 0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.206 177.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.67 156.24 66.67 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.35 2.033 . . . . 0.0 111.017 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.56 74.25 0.78 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.006 0.431 . . . . 0.0 110.034 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 95.4 mmm -89.74 -65.2 1.04 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.878 -177.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.92 102.96 2.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.656 178.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.484 ' HA ' ' CD1' ' A' ' 34' ' ' TRP . . . -65.46 -37.65 87.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.873 -178.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.434 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . 5.3 p-10 -56.94 -69.28 0.16 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.176 -178.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.514 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 1.9 p 27.94 87.14 0.1 Allowed Pre-proline 0 N--CA 1.472 0.649 0 C-N-CA 123.837 0.855 . . . . 0.0 113.089 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -78.19 13.62 1.74 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.025 2.483 . . . . 0.0 112.829 -177.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.446 ' H ' HD23 ' A' ' 57' ' ' LEU . 2.5 pt? -141.71 153.09 64.46 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.857 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 32.0 Cg_endo -63.91 97.36 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.453 2.102 . . . . 0.0 111.419 177.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.4 tt -89.43 148.35 4.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.811 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 63.2 m -111.54 120.54 42.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.688 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.8 m -125.04 177.66 4.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.089 0.471 . . . . 0.0 111.734 -176.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.469 ' HG3' ' HG3' ' A' ' 1' ' ' MET . 40.8 tt0 -61.43 108.96 1.03 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.731 177.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . . . -74.47 123.57 24.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.484 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.7 ttm105 -138.44 102.77 4.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.876 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.427 ' C ' ' HD3' ' A' ' 65' ' ' LYS . 13.7 tmtt? -82.13 129.75 34.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.54 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 77.5 mt . . . . . 0 C--O 1.253 1.24 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.26 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.541 0.21 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.502 ' HE2' HG22 ' A' ' 60' ' ' THR . 15.4 tptm -125.3 142.65 51.38 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.596 HG11 HD21 ' A' ' 46' ' ' LEU . 12.3 p -147.62 147.07 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 116.662 -0.244 . . . . 0.0 110.78 -178.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.554 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 27.0 ttt -110.97 113.56 26.2 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 176.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.9 mm -92.41 128.43 44.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.085 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.433 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 81.1 mtp180 -97.02 118.89 34.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.067 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -121.1 124.98 46.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.534 -176.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 42.9 p -134.76 176.26 8.81 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 169.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.21 -33.43 73.46 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.893 0.378 . . . . 0.0 111.113 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.0 p -111.93 -56.58 2.37 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.315 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.58 137.48 20.28 Favored Glycine 0 C--O 1.237 0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 113.387 -174.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -128.2 118.72 23.85 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.433 ' HB3' ' HB2' ' A' ' 6' ' ' ARG . 23.1 t -142.22 162.37 35.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.739 0.304 . . . . 0.0 110.204 -176.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.568 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -140.74 134.97 31.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.277 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -118.91 107.68 13.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.222 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 37.1 t -75.85 104.51 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.35 -69.59 0.12 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -171.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -12.36 54.36 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -171.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.515 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 17.2 tppt? -100.17 -20.38 15.99 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.719 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 61.59 29.08 18.11 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.111 0.481 . . . . 0.0 110.732 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.515 ' HB2' ' HG3' ' A' ' 19' ' ' LYS . 7.4 tt -101.82 120.2 40.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.746 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -117.77 132.17 56.49 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 172.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.461 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 8.2 tp10 -147.03 165.6 29.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.419 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.422 HD12 ' N ' ' A' ' 25' ' ' ILE . 1.3 tp -86.71 140.66 29.56 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 122.988 0.515 . . . . 0.0 110.359 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 24' ' ' LEU . 79.4 mt -80.13 113.24 19.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.541 177.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.4 m -106.57 -27.52 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -177.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.49 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 4.0 tm-20 -138.17 133.32 33.14 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -177.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.447 ' SD ' ' O ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -142.59 147.0 35.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 0.0 111.082 -178.135 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -67.27 -65.0 0.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.956 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -75.36 138.37 71.44 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.17 -177.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -46.7 -26.11 4.21 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.63 2.887 . . . . 0.0 112.942 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -93.85 -68.44 0.8 Allowed 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 173.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 32.0 tp 174.44 -63.2 0.01 OUTLIER 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.553 -176.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.484 ' HZ3' HG21 ' A' ' 61' ' ' VAL . 63.9 m95 -75.47 134.82 40.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.241 -172.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.95 -13.45 5.0 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.17 -0.538 . . . . 0.0 112.041 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -168.85 -150.7 6.81 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.832 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.666 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -85.61 162.86 18.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.457 0.646 . . . . 0.0 112.696 -173.416 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 46' ' ' LEU . 8.7 p -146.7 158.82 10.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.2 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 31.4 m -133.29 128.27 35.4 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.083 0.468 . . . . 0.0 110.216 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.568 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.4 mm? -81.74 165.61 20.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.206 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.29 -19.61 63.45 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.104 0.478 . . . . 0.0 111.152 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.461 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 61.8 t30 -83.79 -4.39 58.61 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.522 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.33 0.36 82.62 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.971 -176.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 42.2 t-105 -66.06 121.7 15.73 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -100.5 120.2 39.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.902 0.382 . . . . 0.0 110.538 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.596 HD21 HG11 ' A' ' 3' ' ' VAL . 62.7 tp -130.25 135.26 47.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.588 -178.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.666 ' HA ' ' HA ' ' A' ' 37' ' ' LYS . 30.1 tt0 -104.63 126.36 51.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.792 0.329 . . . . 0.0 110.569 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.36 136.17 64.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.909 177.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -81.66 29.72 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.908 2.406 . . . . 0.0 112.834 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 62.52 104.97 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.559 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.5 mmt -139.36 -176.66 4.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.25 178.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.57 122.58 14.43 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.274 0.359 . . . . 0.0 110.47 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.16 -38.71 90.08 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.092 0.472 . . . . 0.0 109.794 176.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -69.95 94.82 0.88 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.957 177.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.413 ' HG1' ' HE1' ' A' ' 34' ' ' TRP . 2.6 p -131.67 90.17 37.54 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.272 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -86.33 12.9 2.88 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.142 2.561 . . . . 0.0 111.868 177.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.4 ' O ' HD12 ' A' ' 57' ' ' LEU . 3.1 pp -145.84 154.87 51.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.332 -178.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.405 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . 59.7 Cg_endo -71.8 125.24 10.87 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.387 2.058 . . . . 0.0 111.429 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.9 tt -126.08 137.08 58.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 120.883 0.373 . . . . 0.0 111.045 -177.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 4' ' ' MET . 26.1 m -90.66 120.02 31.38 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.169 177.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.484 HG21 ' HZ3' ' A' ' 34' ' ' TRP . 34.3 m -128.51 176.95 6.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.392 -175.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -70.28 149.31 47.55 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.935 176.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.41 ' HB1' HD11 ' A' ' 46' ' ' LEU . . . -120.14 121.07 37.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.61 0.243 . . . . 0.0 111.412 -174.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.56 ' HB2' ' HB3' ' A' ' 47' ' ' GLU . 31.3 mmt180 -113.83 100.75 8.68 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 174.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -79.95 148.34 31.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.898 0.38 . . . . 0.0 111.157 -175.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.495 HD11 ' HB2' ' A' ' 47' ' ' GLU . 5.5 mp . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.488 -0.768 . . . . 0.0 109.228 175.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.411 ' CG ' ' HB3' ' A' ' 63' ' ' ALA . 43.6 ttm . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -108.99 133.03 53.52 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 122.504 0.322 . . . . 0.0 110.626 -173.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 14.8 p -143.4 129.17 16.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.021 0.439 . . . . 0.0 110.499 174.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 47.7 ttm -105.55 120.9 42.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.216 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 46.9 mm -96.3 122.83 48.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -96.17 149.62 21.43 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.922 0.391 . . . . 0.0 109.964 -177.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -105.6 125.32 50.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.499 -178.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.0 m -158.84 144.05 16.2 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -177.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.45 100.52 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.233 0.333 . . . . 0.0 110.654 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.8 p 68.48 -32.9 0.22 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.935 1.294 . . . . 0.0 112.923 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.12 54.05 4.82 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.699 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -69.89 118.59 12.94 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.2 t -111.72 150.05 30.77 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.54 ' HB3' HD21 ' A' ' 40' ' ' LEU . . . -124.52 131.19 53.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.167 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -110.39 103.26 11.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.117 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.571 HG12 ' HG3' ' A' ' 18' ' ' LYS . 24.4 t -88.53 104.91 15.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.025 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.07 -26.76 68.38 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -171.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.571 ' HG3' HG12 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -65.07 -20.21 66.37 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.724 0.297 . . . . 0.0 111.22 -176.29 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.532 ' HD3' HD12 ' A' ' 21' ' ' LEU . 65.0 tttp -133.67 -3.01 2.96 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.779 -178.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 60.2 30.25 19.71 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.181 0.515 . . . . 0.0 109.69 -172.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.532 HD12 ' HD3' ' A' ' 19' ' ' LYS . 5.3 tt -82.99 121.18 26.67 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -176.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.407 ' N ' HD23 ' A' ' 21' ' ' LEU . 33.7 tt0 -123.15 111.48 16.56 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 7.5 tp10 -136.74 163.82 29.71 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.739 0.304 . . . . 0.0 110.474 -176.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.9 mt -85.55 142.45 29.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.209 176.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.502 HG23 ' HB ' ' A' ' 38' ' ' VAL . 74.7 mt -87.99 115.56 28.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.312 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.4 m -104.45 -45.4 9.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.314 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.606 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 36.9 tt0 -107.65 141.13 39.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 50.1 mtt -131.58 142.91 50.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.447 -178.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -66.75 -53.3 34.64 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 171.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.511 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 65.0 t30 -100.73 129.0 28.48 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.93 175.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.511 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 8.4 Cg_endo -45.91 -26.84 3.63 Favored 'Trans proline' 0 N--CA 1.476 0.491 0 C-N-CA 124.291 3.327 . . . . 0.0 113.646 -176.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -71.6 -70.88 0.3 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.865 0.364 . . . . 0.0 110.847 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.431 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 25.8 tp 173.35 -58.52 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.217 -175.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.44 ' CZ3' HD12 ' A' ' 48' ' ' LEU . 47.2 m95 -92.33 157.62 16.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.315 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.48 -38.24 1.91 Allowed Glycine 0 CA--C 1.507 -0.418 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.44 -149.51 5.33 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -77.76 149.37 34.52 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.14 0.495 . . . . 0.0 111.493 -177.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.502 ' HB ' HG23 ' A' ' 25' ' ' ILE . 35.8 m -124.62 139.39 51.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 170.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 22.1 m -100.61 117.06 33.98 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.994 0.426 . . . . 0.0 110.53 -178.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.54 HD21 ' HB3' ' A' ' 14' ' ' ALA . 86.8 mt -65.56 152.16 44.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.989 174.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.67 -24.53 49.32 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.78 -177.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.426 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 6.2 t30 -79.27 -12.9 59.95 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.877 0.37 . . . . 0.0 111.263 -178.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.1 54.83 1.56 Allowed Glycine 0 CA--C 1.518 0.227 0 N-CA-C 111.541 -0.623 . . . . 0.0 111.541 -175.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.474 ' HB3' HD12 ' A' ' 40' ' ' LEU . 22.7 t-105 -136.62 115.83 12.55 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -93.75 120.19 33.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.892 0.377 . . . . 0.0 111.167 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.516 HD21 ' HB1' ' A' ' 63' ' ' ALA . 0.6 OUTLIER -116.82 126.41 53.02 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.582 ' HB2' HD11 ' A' ' 66' ' ' LEU . 30.4 tt0 -86.84 128.42 35.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.987 0.422 . . . . 0.0 111.464 -176.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.44 HD12 ' CZ3' ' A' ' 34' ' ' TRP . 3.6 mm? -100.02 122.47 50.5 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.811 175.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 48' ' ' LEU . 7.6 Cg_exo -74.07 39.33 0.52 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.429 2.752 . . . . 0.0 113.234 -176.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 51.6 68.33 0.82 Allowed 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 176.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.432 ' HB2' ' CE3' ' A' ' 34' ' ' TRP . 25.5 mmt -104.06 176.61 5.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.761 176.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.404 ' HB3' HG23 ' A' ' 55' ' ' THR . . . -62.75 117.3 6.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.856 0.36 . . . . 0.0 111.293 -178.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.6 -28.13 60.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.467 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -82.61 17.39 1.81 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.845 -177.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 52' ' ' ALA . 1.2 p -59.79 115.74 14.04 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.491 174.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.79 10.37 1.67 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.934 2.423 . . . . 0.0 113.381 -172.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.9 pp -143.98 159.81 51.87 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 122.327 0.251 . . . . 0.0 110.359 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.43 97.83 0.45 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.242 1.961 . . . . 0.0 110.935 175.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.1 tt -89.19 141.03 14.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.92 -175.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.3 m -107.58 127.02 53.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.398 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.15 177.18 5.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.462 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -72.1 130.65 41.41 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 176.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.587 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . . . -87.64 146.73 25.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.83 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 64' ' ' ARG . 23.5 ttp180 -145.35 113.75 6.67 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 176.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -81.73 137.72 35.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.415 -175.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.582 HD11 ' HB2' ' A' ' 47' ' ' GLU . 5.0 mp . . . . . 0 C--O 1.245 0.827 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 171.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.448 ' HG3' HG21 ' A' ' 60' ' ' THR . 39.1 ttpt -129.62 132.0 46.62 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.95 0.405 . . . . 0.0 111.301 -174.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.0 p -138.4 120.11 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 169.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.4 ttt -107.56 110.46 22.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.222 -174.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 58' ' ' PRO . 45.7 mm -85.18 128.81 38.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.159 -178.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.571 ' HB2' ' HB2' ' A' ' 13' ' ' SER . 79.5 mtp180 -96.57 131.41 43.23 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.412 ' NZ ' ' O ' ' A' ' 54' ' ' ASP . 14.2 mmmm -121.82 118.81 29.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.025 -173.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.6 p -133.65 166.85 21.65 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.59 -24.21 39.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.1 0.476 . . . . 0.0 110.178 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.6 m -75.97 -31.82 59.19 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.259 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -176.34 -168.9 37.13 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.79 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.582 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 48.7 m80 -121.39 141.89 50.53 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.803 -0.444 . . . . 0.0 109.803 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.571 ' HB2' ' HB2' ' A' ' 6' ' ' ARG . 15.7 m -142.98 158.93 43.14 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.604 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -140.31 138.13 34.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.526 0.203 . . . . 0.0 110.831 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -111.12 103.57 12.02 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.418 HG12 ' HB3' ' A' ' 18' ' ' LYS . 41.3 t -88.24 96.32 5.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.004 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.05 -26.31 62.34 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.866 0.365 . . . . 0.0 111.533 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.418 ' HB3' HG12 ' A' ' 16' ' ' VAL . 18.2 tppt? -55.3 -26.84 42.85 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.139 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -133.5 0.24 3.3 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.372 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 57.75 28.39 15.82 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.467 0.651 . . . . 0.0 109.789 -172.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.3 tp -86.15 121.07 28.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.014 -175.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -112.72 115.82 29.14 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 173.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -139.37 161.59 37.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.955 0.407 . . . . 0.0 110.122 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.0 mt -80.46 141.63 35.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.317 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.582 ' HB ' ' HB2' ' A' ' 12' ' ' HIS . 74.6 mt -84.78 120.14 34.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.202 178.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.7 m -106.13 -27.15 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.042 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.638 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 8.0 tp10 -133.78 143.09 48.19 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.53 157.26 43.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.857 -178.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.473 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 10.8 tp10 -64.39 -37.88 89.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.842 0.353 . . . . 0.0 111.0 -177.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.485 ' OD1' ' HA3' ' A' ' 35' ' ' GLY . 12.9 m120 -125.91 148.81 64.0 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -45.63 -32.62 8.76 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.762 2.974 . . . . 0.0 113.614 -173.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -73.72 -69.71 0.42 Allowed 'General case' 0 C--O 1.234 0.284 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 176.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.41 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 3.4 tt 175.83 -66.82 0.01 OUTLIER 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.277 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -70.89 154.81 41.51 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.315 -175.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.485 ' HA3' ' OD1' ' A' ' 30' ' ' ASN . . . 128.89 0.62 6.01 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.858 -177.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 48' ' ' LEU . . . 155.43 -140.7 7.52 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.497 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -71.28 166.23 22.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.285 0.564 . . . . 0.0 112.253 -174.654 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.7 p -144.33 163.54 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.13 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.638 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 37.2 m -142.11 126.18 17.34 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.008 0.432 . . . . 0.0 110.605 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.604 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.4 mm? -78.76 168.47 19.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.46 177.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.85 -22.52 65.57 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.565 -177.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -83.42 -13.97 53.65 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.094 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.79 -4.21 53.16 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.55 -178.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 49.3 t-105 -67.65 136.59 54.62 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -122.37 137.03 55.0 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -174.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -123.62 154.01 39.91 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.23 171.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.572 ' HB3' ' HB2' ' A' ' 64' ' ' ARG . 39.1 tt0 -105.91 113.02 26.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 48' ' ' LEU . 3.3 mm? -96.07 135.15 22.9 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.403 -178.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.79 156.73 64.8 Favored 'Trans proline' 0 C--O 1.238 0.485 0 C-N-CA 122.181 1.92 . . . . 0.0 110.808 173.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.21 87.95 0.17 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.091 0.472 . . . . 0.0 110.8 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.5 mmt -104.87 179.65 4.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.628 176.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.29 125.48 23.77 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.794 177.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.0 -23.2 64.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.819 -174.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.412 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . 15.3 p-10 -74.31 -57.01 4.22 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.792 -0.185 . . . . 0.0 110.617 -177.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.4 p 33.48 81.63 0.23 Allowed Pre-proline 0 CA--C 1.537 0.458 0 O-C-N 123.809 0.693 . . . . 0.0 112.263 -178.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -76.33 -2.52 12.72 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.626 2.217 . . . . 0.0 112.21 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.431 ' O ' HD12 ' A' ' 57' ' ' LEU . 1.5 pp -128.28 157.39 74.6 Favored Pre-proline 0 C--O 1.235 0.327 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.742 -177.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 59.1 Cg_endo -72.04 98.38 0.9 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.204 1.936 . . . . 0.0 111.504 176.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.6 tt -97.38 143.77 11.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.034 -177.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.448 HG21 ' HG3' ' A' ' 2' ' ' LYS . 38.4 m -100.86 136.05 41.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.26 176.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.9 m -137.42 177.4 5.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 120.703 0.287 . . . . 0.0 110.521 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -64.34 134.82 55.39 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.586 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.94 114.02 25.69 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.48 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.572 ' HB2' ' HB3' ' A' ' 47' ' ' GLU . 2.7 mmp_? -117.58 125.85 51.52 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 172.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -97.24 146.82 24.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.57 0.224 . . . . 0.0 110.625 -178.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.3 mp . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.56 175.304 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.488 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.17 0 CA-C-O 121.304 0.573 . . . . 0.0 110.212 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -119.2 137.65 53.49 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.948 -173.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 p -149.65 128.59 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.513 174.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.405 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 53.0 ttm -102.16 111.05 23.18 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.4 mm -79.24 111.83 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -102.67 118.96 37.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.995 -176.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -86.9 128.31 35.05 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 170.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.3 p -140.41 163.32 33.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.714 -173.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.21 -22.9 66.36 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.331 0.586 . . . . 0.0 109.992 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 m -67.17 -14.73 63.18 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.386 174.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.47 -99.78 0.61 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.969 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -130.84 128.57 40.91 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.4 p -139.33 150.95 45.97 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.289 -0.264 . . . . 0.0 110.289 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.532 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -141.5 131.34 24.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.755 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -99.37 103.36 15.15 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.1 t -91.54 105.0 16.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.216 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.24 -30.04 71.26 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.822 0.344 . . . . 0.0 111.233 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -55.2 -46.71 75.89 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.964 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.691 ' HD2' ' HB2' ' A' ' 21' ' ' LEU . 4.7 tmtm? -99.6 -11.63 20.8 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -178.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 60.52 31.55 20.29 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.218 -171.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.691 ' HB2' ' HD2' ' A' ' 19' ' ' LYS . 49.1 tp -106.31 121.89 45.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.055 -174.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -107.25 108.16 19.44 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 9.0 tp10 -137.09 163.68 30.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.76 0.314 . . . . 0.0 110.675 -175.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.3 mt -80.65 137.02 36.31 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.811 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.6 mt -82.07 85.2 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.37 0.605 . . . . 0.0 109.405 175.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.448 HG23 ' HG3' ' A' ' 27' ' ' GLU . 15.8 m -73.45 -27.98 24.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.086 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.484 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 44.3 mt-10 -127.21 126.42 42.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.901 -178.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -145.08 143.47 30.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 -174.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.49 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 10.2 tp10 -58.18 -54.36 47.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.484 -177.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.416 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 21.3 t-20 -90.08 144.74 31.74 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.366 -173.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.7 -31.06 39.59 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.962 2.441 . . . . 0.0 112.35 176.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -84.4 -63.88 1.26 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.272 175.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 25.0 tp 176.94 -71.87 0.01 OUTLIER 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.603 -177.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -71.41 121.1 17.98 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.741 -176.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.416 ' HA3' ' HB2' ' A' ' 30' ' ' ASN . . . -163.03 -52.76 0.02 OUTLIER Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.011 -176.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.64 -66.64 0.02 OUTLIER Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.216 -176.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.49 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -134.05 162.02 33.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.673 0.273 . . . . 0.0 110.948 178.368 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.4 m -146.28 169.79 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 176.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.484 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 27.9 m -143.36 127.24 17.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.272 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.532 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.2 mm? -74.83 155.95 37.01 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.137 176.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.04 -18.3 33.48 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -176.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.676 HD22 HD11 ' A' ' 21' ' ' LEU . 91.4 m-20 -90.98 8.87 33.11 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.654 0.264 . . . . 0.0 111.34 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.83 32.58 44.81 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.817 176.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.403 ' HZ3' ' HB2' ' A' ' 46' ' ' LEU . 24.9 t90 -107.82 116.67 32.37 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 175.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -86.83 139.99 30.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.084 0.469 . . . . 0.0 111.149 -177.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.403 ' HB2' ' HZ3' ' A' ' 44' ' ' TRP . 59.7 tp -136.29 139.68 42.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.467 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 64' ' ' ARG . 34.5 tt0 -81.37 132.96 35.35 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.0 tp -133.09 98.38 15.76 Favored Pre-proline 0 C--O 1.236 0.391 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 -177.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.27 156.34 41.02 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.877 2.385 . . . . 0.0 112.598 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.34 82.01 3.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.104 0.478 . . . . 0.0 110.264 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.5 mmt -113.58 -174.31 2.44 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.58 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.16 101.78 0.32 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.644 -177.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.05 -18.25 40.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.178 176.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -73.77 -4.75 36.53 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.388 -178.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.0 t -56.74 135.14 78.53 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.544 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -87.22 12.47 2.94 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.973 2.448 . . . . 0.0 112.872 -176.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 pp -140.19 154.06 69.66 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.186 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.26 104.59 1.58 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.402 2.068 . . . . 0.0 111.214 176.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.5 tt -88.95 140.28 16.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.148 -176.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 4' ' ' MET . 65.3 m -95.89 130.28 42.9 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.346 177.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.5 m -127.95 175.01 10.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.699 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -73.03 123.33 23.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.202 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 1' ' ' MET . . . -83.02 109.83 17.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.381 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.573 ' HB2' ' HB3' ' A' ' 47' ' ' GLU . 4.1 mpt_? -102.79 114.78 29.33 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 172.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -78.47 125.86 29.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.051 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.063 179.444 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.473 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -121.1 129.95 53.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.787 0.327 . . . . 0.0 111.77 -172.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.6 p -145.27 143.04 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.055 174.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 49.6 ttm -112.52 119.87 39.68 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.9 mm -89.58 116.04 30.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -97.58 149.1 22.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.456 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -133.93 149.29 51.28 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.928 0.394 . . . . 0.0 110.849 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.4 p -142.54 -167.86 2.6 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 171.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.35 90.45 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.5 m 74.85 -41.39 0.47 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.79 0.836 . . . . 0.0 111.683 -177.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.24 118.76 15.39 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.421 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.546 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 26.2 m80 -110.34 147.94 32.94 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.7 p -150.67 160.95 43.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.797 0.332 . . . . 0.0 110.68 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.452 ' HB3' HD21 ' A' ' 40' ' ' LEU . . . -129.62 130.92 46.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.061 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -120.23 104.85 10.41 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.985 -177.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.3 t -79.83 90.41 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 173.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.19 -48.37 54.18 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.697 -172.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.07 -23.06 66.26 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.698 0.285 . . . . 0.0 111.636 -174.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 60.6 tttm -107.86 -16.02 14.41 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.69 -178.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 19' ' ' LYS . 39.2 t70 70.01 22.17 5.87 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.726 0.774 . . . . 0.0 110.015 -175.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.444 HD23 ' N ' ' A' ' 22' ' ' GLU . 5.5 tt -83.98 123.06 29.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.222 178.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.444 ' N ' HD23 ' A' ' 21' ' ' LEU . 32.8 tt0 -134.31 116.91 15.81 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 174.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.555 ' HB3' HD13 ' A' ' 40' ' ' LEU . 7.2 tp10 -133.71 157.88 44.7 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.874 0.368 . . . . 0.0 110.219 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.9 mt -76.8 140.78 40.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.433 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' A' ' 12' ' ' HIS . 64.6 mt -83.45 114.96 24.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.806 176.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.4 m -102.23 -44.71 10.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -128.97 125.94 38.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.718 0.294 . . . . 0.0 111.034 -177.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.541 ' HG2' ' HA ' ' A' ' 33' ' ' LEU . 2.1 mpp? -111.51 167.85 10.0 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 174.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -84.86 -10.1 57.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.454 0.645 . . . . 0.0 109.38 173.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' A' ' 28' ' ' MET . 15.5 m120 -127.61 142.4 44.0 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.292 177.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -56.83 -36.93 99.05 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.79 2.327 . . . . 0.0 112.733 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.16 -70.81 0.34 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.893 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.541 ' HA ' ' HG2' ' A' ' 28' ' ' MET . 2.5 tt 178.35 -65.55 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.449 ' HB3' ' H ' ' A' ' 51' ' ' MET . 71.0 m95 -83.6 158.51 21.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.238 -174.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.88 -63.98 0.52 Allowed Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -131.84 -127.68 2.86 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.444 -0.407 . . . . 0.0 112.228 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 8.3 ptpp? -90.25 166.26 13.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.139 0.495 . . . . 0.0 111.834 -173.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 46' ' ' LEU . 9.2 p -146.69 162.18 9.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.81 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.419 ' N ' HG22 ' A' ' 38' ' ' VAL . 34.8 m -131.67 126.01 33.54 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.742 0.306 . . . . 0.0 110.414 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.555 HD13 ' HB3' ' A' ' 23' ' ' GLU . 59.8 mt -70.83 159.32 34.82 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.288 177.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.72 -24.46 57.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.13 -177.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -106.7 21.52 17.35 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.078 0.466 . . . . 0.0 111.382 -177.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.89 -33.71 6.2 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 114.774 0.67 . . . . 0.0 114.774 168.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.527 ' HB2' HD12 ' A' ' 40' ' ' LEU . 5.3 m-90 -53.9 128.51 30.43 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 117.418 0.609 . . . . 0.0 110.946 -177.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 44.1 mt-30 -103.71 138.52 40.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 110.982 -178.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.592 HD13 ' N ' ' A' ' 47' ' ' GLU . 2.8 tm? -137.72 144.56 41.77 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 37' ' ' LYS . 29.7 tt0 -111.5 129.58 56.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.889 0.376 . . . . 0.0 110.955 -177.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.405 HD22 ' N ' ' A' ' 48' ' ' LEU . 3.1 mm? -81.33 144.5 53.85 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.604 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -84.05 28.15 0.58 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.947 2.431 . . . . 0.0 112.65 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 57.73 96.0 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.094 0.557 . . . . 0.0 112.219 178.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.449 ' H ' ' HB3' ' A' ' 34' ' ' TRP . 25.6 mmt -133.49 -173.74 3.31 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.96 145.4 25.14 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 173.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.14 -28.09 64.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.974 0.416 . . . . 0.0 110.78 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -79.26 50.69 1.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.395 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.9 p -74.59 123.1 88.84 Favored Pre-proline 0 N--CA 1.453 -0.308 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 172.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.16 -7.77 19.87 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.579 2.186 . . . . 0.0 112.632 -175.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.1 pp -152.16 163.75 22.54 Favored Pre-proline 0 C--O 1.235 0.336 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.471 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.64 99.15 0.43 Allowed 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.073 1.849 . . . . 0.0 110.283 172.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.3 tt -88.05 143.49 11.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.223 0.535 . . . . 0.0 111.406 -170.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.2 m -96.06 122.51 38.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.659 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.9 m -129.78 174.3 12.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 120.956 0.408 . . . . 0.0 111.508 -175.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -63.53 126.34 27.19 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.381 177.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 1' ' ' MET . . . -90.51 109.57 20.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.697 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 30.1 tpt180 -101.47 100.41 10.86 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -79.62 133.68 36.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.805 -176.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 47' ' ' GLU . 6.4 mp . . . . . 0 C--O 1.252 1.192 0 CA-C-O 118.256 -0.878 . . . . 0.0 109.42 175.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.741 ' HG3' ' HB3' ' A' ' 63' ' ' ALA . 24.6 ptp . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -103.68 127.51 51.12 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.125 0.488 . . . . 0.0 112.024 -163.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.651 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 14.4 p -140.21 128.0 24.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.376 170.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 51.8 ttp -109.32 110.88 22.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.905 0.383 . . . . 0.0 110.465 -177.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.8 mm -84.01 131.49 33.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.423 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -96.46 121.74 38.6 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 176.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.867 ' HE2' ' HA ' ' A' ' 54' ' ' ASP . 27.1 mmmt -92.96 116.01 28.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.371 177.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.542 HG22 ' H ' ' A' ' 10' ' ' THR . 84.8 m -152.33 127.18 9.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.303 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.57 3.9 4.46 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -172.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.542 ' H ' HG22 ' A' ' 8' ' ' THR . 5.6 p -127.75 -0.5 6.06 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.736 0.272 . . . . 0.0 111.736 177.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.478 ' O ' ' HB ' ' A' ' 8' ' ' THR . . . -179.3 102.0 0.16 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.543 -177.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.587 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 64.7 m80 -81.07 143.82 32.18 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.9 t -143.13 162.31 35.89 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.554 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -145.73 122.95 11.52 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.639 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.423 ' HD1' ' HB2' ' A' ' 22' ' ' GLU . 41.9 t80 -102.35 102.73 13.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.575 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.9 t -83.78 98.27 5.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.716 175.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.35 -39.82 91.98 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.004 -173.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.469 ' NZ ' ' SD ' ' A' ' 1' ' ' MET . 0.1 OUTLIER -70.06 -5.91 30.01 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -177.167 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -130.49 10.61 5.24 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 41.58 29.59 0.11 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.677 0.791 . . . . 0.0 111.407 -175.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.64 HD21 HD21 ' A' ' 42' ' ' ASN . 52.1 tp -100.64 132.29 46.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.73 -174.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.423 ' HB2' ' HD1' ' A' ' 15' ' ' TYR . 41.0 tt0 -134.24 112.46 11.08 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 170.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -129.77 163.41 26.27 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.023 -176.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.7 mt -79.23 132.2 36.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.574 178.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.587 ' HB ' ' HB2' ' A' ' 12' ' ' HIS . 70.3 mt -77.03 98.03 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.582 175.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.2 m -88.38 -29.99 5.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.87 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.609 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 9.9 tp10 -123.25 139.56 53.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.792 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.481 ' HA ' HG22 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -150.48 147.92 28.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.225 -178.463 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -55.46 -42.82 74.81 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.703 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -131.92 144.92 55.24 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.356 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.89 -27.47 20.81 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.154 2.569 . . . . 0.0 112.784 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.57 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -64.59 -61.88 1.93 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.353 175.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.572 ' HB3' ' CD1' ' A' ' 34' ' ' TRP . 1.5 tm? 167.04 -62.82 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.469 -177.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.572 ' CD1' ' HB3' ' A' ' 33' ' ' LEU . 39.1 m95 -88.0 157.81 18.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.297 -171.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.81 -32.73 0.48 Allowed Glycine 0 C--N 1.331 0.294 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.153 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.17 -78.29 0.06 OUTLIER Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.384 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -130.21 162.29 29.24 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.269 0.557 . . . . 0.0 111.703 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.556 HG13 HG23 ' A' ' 25' ' ' ILE . 9.8 t -143.71 155.61 16.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.16 -177.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.609 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 20.1 m -134.03 127.27 31.92 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.782 0.325 . . . . 0.0 110.61 176.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.554 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.5 mm? -75.66 167.14 22.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.149 176.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.5 -21.98 64.7 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.791 0.329 . . . . 0.0 111.559 -178.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.64 HD21 HD21 ' A' ' 21' ' ' LEU . 27.4 p30 -90.81 1.26 57.08 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.627 -178.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.07 8.29 64.93 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.319 176.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.564 ' HE1' HD23 ' A' ' 46' ' ' LEU . 62.0 t-105 -76.35 117.86 18.45 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 176.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -92.53 116.49 29.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.74 0.305 . . . . 0.0 110.806 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.564 HD23 ' HE1' ' A' ' 44' ' ' TRP . 0.6 OUTLIER -115.23 134.72 54.88 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -178.221 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.622 ' HB3' ' HB2' ' A' ' 64' ' ' ARG . 31.6 tt0 -91.01 120.39 31.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.775 0.322 . . . . 0.0 110.636 -178.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.411 HD12 ' CZ3' ' A' ' 34' ' ' TRP . 3.6 mm? -110.07 106.34 58.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 175.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.8 44.33 1.53 Allowed 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.225 2.617 . . . . 0.0 113.878 -167.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 51.16 82.68 0.06 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.373 0.606 . . . . 0.0 111.848 176.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 97.0 mmm -119.16 -155.45 0.61 Allowed 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -50.12 107.77 0.18 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.828 0.347 . . . . 0.0 110.589 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.01 -34.9 77.05 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.593 -174.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.867 ' HA ' ' HE2' ' A' ' 7' ' ' LYS . 12.6 t70 -134.33 102.11 5.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.877 0.37 . . . . 0.0 110.479 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.4 p -97.14 139.98 21.8 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.08 175.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.52 7.63 3.36 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.693 2.262 . . . . 0.0 112.242 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 pp -147.4 161.01 37.63 Favored Pre-proline 0 C--O 1.236 0.374 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.89 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.28 108.26 1.33 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.017 1.811 . . . . 0.0 110.495 173.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.2 tt -88.02 137.81 20.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.15 -171.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.4 m -106.13 127.4 53.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.678 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.421 HG11 ' HH2' ' A' ' 34' ' ' TRP . 18.6 m -138.78 178.15 4.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 120.951 0.405 . . . . 0.0 111.056 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 1' ' ' MET . 41.1 tt0 -73.89 124.59 26.43 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.725 178.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.741 ' HB3' ' HG3' ' A' ' 1' ' ' MET . . . -80.74 109.96 15.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.132 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.622 ' HB2' ' HB3' ' A' ' 47' ' ' GLU . 89.5 mtt180 -110.2 137.72 47.55 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 176.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -111.65 124.39 52.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.088 -172.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.411 HD22 ' N ' ' A' ' 66' ' ' LEU . 2.9 mm? . . . . . 0 C--O 1.25 1.082 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 174.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.544 ' HB3' ' HB3' ' A' ' 63' ' ' ALA . 64.8 mtt . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -130.33 130.25 44.22 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.871 0.367 . . . . 0.0 111.722 -174.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.519 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 14.5 p -144.58 138.7 23.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 172.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 52.3 ttm -113.45 110.64 20.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.703 0.287 . . . . 0.0 110.378 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.1 mm -84.51 110.98 19.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -99.17 134.18 42.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.129 0.49 . . . . 0.0 109.725 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.559 ' HG3' ' HB ' ' A' ' 55' ' ' THR . 4.4 mmmp? -128.46 149.02 50.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.973 0.892 . . . . 0.0 113.292 -165.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.486 HG22 ' H ' ' A' ' 9' ' ' ALA . 8.7 m -136.81 174.41 10.65 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 165.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.486 ' H ' HG22 ' A' ' 8' ' ' THR . . . -57.12 -50.65 72.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.472 0.578 . . . . 0.0 110.64 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 51.7 p -101.33 -31.27 11.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.7 136.36 19.79 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.865 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.543 ' HB3' HD12 ' A' ' 25' ' ' ILE . 72.8 m80 -134.99 112.76 10.86 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 176.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.4 m -130.66 145.27 51.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.417 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.664 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -126.68 126.25 43.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.463 177.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -107.46 103.56 12.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.766 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.45 98.17 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.716 174.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.64 -46.64 77.4 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.306 -173.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.537 ' HB2' ' NZ ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -62.66 -17.09 59.82 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -174.659 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -117.48 -10.07 10.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.919 0.39 . . . . 0.0 110.205 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.2 t70 60.86 30.2 19.5 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.663 0.744 . . . . 0.0 109.511 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.5 tp -99.06 114.38 27.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.601 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -110.44 118.49 36.4 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 172.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.448 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 9.8 tp10 -134.48 158.75 43.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.993 0.425 . . . . 0.0 110.798 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.3 mt -77.19 141.19 40.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.594 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.543 HD12 ' HB3' ' A' ' 12' ' ' HIS . 71.9 mt -83.08 110.19 17.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.4 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.7 m -102.89 -23.61 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.507 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.65 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 8.0 tp10 -133.9 133.66 41.73 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.501 ' SD ' ' N ' ' A' ' 28' ' ' MET . 0.8 OUTLIER -128.74 153.01 47.79 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.391 -174.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 7.4 tp10 -66.75 -51.77 52.08 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 169.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.469 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 40.3 t30 -114.57 135.52 22.31 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.625 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.469 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 2.0 Cg_endo -38.39 -31.49 0.21 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 124.184 3.256 . . . . 0.0 113.436 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 54' ' ' ASP . . . -72.28 -69.52 0.39 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.155 174.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 3.4 tt 176.65 -71.74 0.01 OUTLIER 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.831 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.725 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 41.2 m95 -68.14 160.32 29.27 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.621 -173.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.21 -46.22 0.73 Allowed Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.598 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.63 -85.83 0.05 OUTLIER Glycine 0 C--O 1.225 -0.456 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.055 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -120.63 157.38 29.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.291 0.567 . . . . 0.0 111.743 -179.769 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 46' ' ' LEU . 9.8 p -135.23 149.04 28.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 174.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.65 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 18.7 m -125.79 126.34 44.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.013 0.435 . . . . 0.0 110.316 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.664 HD11 ' HB3' ' A' ' 14' ' ' ALA . 2.6 mm? -82.44 166.68 19.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.602 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.7 -10.09 33.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.298 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -89.19 -13.33 38.55 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.981 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.53 -13.08 56.79 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.681 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -69.56 141.8 53.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.882 0.373 . . . . 0.0 110.952 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 39.6 mt-30 -113.23 135.19 54.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.799 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.494 HD13 ' N ' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -127.39 137.08 52.67 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.494 ' N ' HD13 ' A' ' 46' ' ' LEU . 32.3 tt0 -89.97 137.59 32.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.012 0.434 . . . . 0.0 111.268 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.469 ' HB3' ' CE3' ' A' ' 34' ' ' TRP . 3.0 mm? -107.01 122.93 39.99 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.096 177.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.451 ' HD2' ' HZ3' ' A' ' 34' ' ' TRP . 37.8 Cg_exo -59.38 -4.65 2.52 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.864 2.376 . . . . 0.0 113.43 176.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.415 ' HA ' ' HB3' ' A' ' 34' ' ' TRP . . . 71.07 89.77 0.1 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.224 0.61 . . . . 0.0 112.075 177.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 22.2 ptm -162.09 127.14 3.38 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 56.53 79.0 0.19 Allowed 'General case' 0 C--O 1.234 0.268 0 O-C-N 123.328 0.392 . . . . 0.0 109.986 -173.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.725 ' HA ' ' HB2' ' A' ' 34' ' ' TRP . . . -46.5 -40.76 13.02 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.323 -171.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.49 ' HB2' ' HB1' ' A' ' 32' ' ' ALA . 16.3 t70 -125.2 94.49 4.18 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 170.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.559 ' HB ' ' HG3' ' A' ' 7' ' ' LYS . 1.3 m -63.61 131.59 94.91 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.638 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -83.13 0.34 9.62 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.689 2.259 . . . . 0.0 112.838 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.405 ' HB2' ' HD2' ' A' ' 58' ' ' PRO . 2.9 pp -146.54 161.87 36.47 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.387 -178.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 57' ' ' LEU . 39.3 Cg_endo -66.25 112.39 2.31 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.259 1.972 . . . . 0.0 111.362 175.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.3 tt -108.7 142.16 22.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.503 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.7 m -109.97 115.08 29.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.279 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.506 HG11 ' HH2' ' A' ' 34' ' ' TRP . 21.3 m -125.49 178.52 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.883 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -74.33 146.59 42.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.892 0.377 . . . . 0.0 110.905 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' A' ' 1' ' ' MET . . . -90.73 129.39 36.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.595 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -145.42 99.6 3.32 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 174.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.473 ' HB2' ' HE2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -88.79 155.02 19.81 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.924 -173.149 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 66' ' ' LEU . 4.7 mp . . . . . 0 C--O 1.248 0.979 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.4 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 22.8 ptt? . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 120.494 0.188 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -129.55 142.97 50.64 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 122.545 0.338 . . . . 0.0 110.367 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.647 HG11 HD21 ' A' ' 46' ' ' LEU . 10.7 p -151.3 138.83 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 175.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.476 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 47.3 ttm -103.7 122.45 45.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.734 0.302 . . . . 0.0 110.609 -176.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 58' ' ' PRO . 45.0 mm -96.09 128.79 46.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.5 mtp180 -97.4 123.63 41.31 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.997 0.427 . . . . 0.0 110.747 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -95.17 116.68 29.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.806 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.8 t -159.68 143.67 14.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.474 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.35 -26.63 46.8 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.79 0.329 . . . . 0.0 111.513 -175.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.5 p -64.89 -27.43 68.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.294 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 167.89 113.66 0.28 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.082 -0.58 . . . . 0.0 111.803 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -53.84 137.38 38.65 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.4 t -138.86 162.65 34.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.904 0.383 . . . . 0.0 110.705 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.592 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -145.18 139.43 27.23 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.925 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -115.05 109.35 17.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.099 0.476 . . . . 0.0 110.994 -177.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 46.6 t -84.41 97.09 4.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.075 174.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.22 -55.34 28.96 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -170.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.607 ' H ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -55.17 -32.39 62.11 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.844 0.354 . . . . 0.0 111.587 -176.353 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -96.57 -9.98 28.23 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.565 -176.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.8 t70 58.49 27.89 16.19 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.798 0.808 . . . . 0.0 109.744 -176.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.425 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 48.3 tp -91.82 110.42 21.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.928 -177.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -109.49 108.89 19.54 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 171.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.506 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 8.3 tp10 -132.59 160.23 37.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.034 0.445 . . . . 0.0 111.204 -172.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.8 mt -82.62 137.02 34.64 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.828 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 72.3 mt -78.57 101.77 4.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.237 176.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.8 m -98.14 -9.95 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.591 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.546 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 6.1 tp10 -138.43 122.61 18.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.227 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -151.82 140.24 20.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -60.28 -54.24 48.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.32 -177.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.482 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 24.2 t-20 -85.34 137.87 36.65 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.751 -174.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -50.53 -37.79 53.01 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.454 2.769 . . . . 0.0 112.551 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -78.77 -62.7 1.61 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.224 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.612 ' HG ' HD21 ' A' ' 48' ' ' LEU . 23.2 tp 176.82 -76.37 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.57 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.466 ' HE3' ' O ' ' A' ' 49' ' ' PRO . 61.3 m95 -73.02 125.65 28.12 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.775 -174.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.607 ' HA2' ' HB2' ' A' ' 50' ' ' ALA . . . 179.54 -55.07 0.09 OUTLIER Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.107 -177.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.0 -137.4 2.34 Favored Glycine 0 C--O 1.226 -0.385 0 C-N-CA 121.232 -0.509 . . . . 0.0 112.045 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.76 155.53 39.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.301 0.572 . . . . 0.0 111.751 -176.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.02 151.8 13.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.106 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.546 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 62.6 m -142.55 132.63 24.52 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.964 0.411 . . . . 0.0 110.453 178.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.592 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.2 mm? -81.5 162.84 23.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.331 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.4 -22.73 65.25 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.199 0.523 . . . . 0.0 110.833 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.506 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 27.5 t-20 -73.93 -18.77 60.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.509 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.14 -15.88 30.38 Favored Glycine 0 C--N 1.331 0.258 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.396 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 12.7 t-105 -57.83 117.33 4.16 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.602 0.239 . . . . 0.0 110.418 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -92.37 134.16 35.19 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.647 HD21 HG11 ' A' ' 3' ' ' VAL . 37.4 tp -143.13 164.87 28.98 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -111.38 141.13 45.33 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.612 HD21 ' HG ' ' A' ' 33' ' ' LEU . 16.3 tp -123.12 95.94 45.26 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.235 -175.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.466 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 28.9 Cg_endo -60.89 131.37 36.97 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.147 2.564 . . . . 0.0 112.608 -175.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.607 ' HB2' ' HA2' ' A' ' 35' ' ' GLY . . . -70.29 82.21 0.54 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.853 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 37.4 mtm -98.75 -71.36 0.69 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.955 177.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.34 128.15 6.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.99 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -95.24 -12.13 26.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.586 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -78.83 -11.34 59.99 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.45 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.8 t -60.95 119.89 49.02 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 120.924 0.392 . . . . 0.0 110.667 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -90.98 9.71 2.99 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.326 2.684 . . . . 0.0 112.865 -175.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.3 pp -122.99 150.0 58.17 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.917 -174.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 58.2 Cg_endo -72.38 97.95 0.9 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.311 2.007 . . . . 0.0 111.54 175.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.9 tt -94.92 139.68 18.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.187 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 4' ' ' MET . 41.1 m -92.06 122.09 34.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.3 175.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.0 m -116.45 170.4 6.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.422 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 1' ' ' MET . 33.7 tt0 -68.99 120.05 14.24 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.039 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.63 108.82 5.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.512 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -119.73 106.37 12.07 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 175.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -99.11 158.1 15.9 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.795 0.331 . . . . 0.0 111.278 -178.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.25 1.129 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 174.92 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.453 ' O ' ' HG2' ' A' ' 1' ' ' MET . 45.9 ttp . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 120.867 0.365 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.644 ' HD2' ' HB2' ' A' ' 17' ' ' ALA . 1.3 tmtp? -104.18 120.3 40.84 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -176.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.43 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 13.9 p -138.37 128.46 34.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.961 0.41 . . . . 0.0 110.101 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 51.0 ttm -103.1 110.12 21.94 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.432 HG21 HD21 ' A' ' 33' ' ' LEU . 43.4 mm -84.82 111.61 20.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.496 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 94.3 mtt180 -103.85 139.26 39.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.648 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -103.77 157.07 17.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.84 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.8 m -139.94 159.07 43.01 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -44.63 -50.19 9.9 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.091 0.472 . . . . 0.0 111.124 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.2 m -129.5 96.65 4.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.725 175.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.01 175.01 14.03 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 121.276 -0.487 . . . . 0.0 112.956 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.486 ' HB3' HD12 ' A' ' 25' ' ' ILE . 73.3 m80 -139.17 139.09 37.46 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.5 p -134.91 133.71 39.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.886 0.374 . . . . 0.0 110.624 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.578 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -105.23 123.08 47.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.533 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -93.94 103.84 15.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.638 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.408 HG11 ' HZ3' ' A' ' 44' ' ' TRP . 49.8 t -86.39 112.13 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.114 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.644 ' HB2' ' HD2' ' A' ' 2' ' ' LYS . . . -59.91 -46.53 89.07 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -173.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -11.84 4.72 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -172.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -144.38 15.39 1.65 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 p30 42.03 29.98 0.16 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.516 0.727 . . . . 0.0 111.474 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.4 tt -88.72 117.55 27.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.372 -172.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -112.98 109.1 18.3 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 174.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.438 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 9.6 tp10 -117.29 163.24 16.63 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.034 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.0 mt -75.72 129.34 36.93 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.237 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 12' ' ' HIS . 72.4 mt -78.06 98.11 2.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.119 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.491 HG23 ' HG2' ' A' ' 27' ' ' GLU . 16.7 m -91.38 -46.37 14.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.501 -177.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.58 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 20.9 mm-40 -113.11 107.35 15.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.413 -175.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.71 142.93 50.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.619 0.247 . . . . 0.0 110.346 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -62.57 -40.87 98.22 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.122 0.487 . . . . 0.0 110.643 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -91.79 139.82 24.85 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.868 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -48.17 -38.85 33.63 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.624 2.883 . . . . 0.0 112.828 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.737 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -89.05 -61.8 1.63 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.502 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.432 HD21 HG21 ' A' ' 5' ' ' ILE . 27.4 tp -175.25 -71.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -177.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -79.33 136.19 36.93 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -170.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 165.42 -45.97 0.28 Allowed Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.397 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.16 -134.59 1.71 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.38 -0.438 . . . . 0.0 112.245 -177.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.71 165.95 21.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.292 0.568 . . . . 0.0 111.931 -175.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.8 p -146.93 167.35 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.464 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 60.7 m -142.48 123.64 14.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.785 0.326 . . . . 0.0 110.202 175.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.578 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.4 mm? -73.09 159.81 32.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.824 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.84 -16.77 52.84 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.963 0.411 . . . . 0.0 110.999 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.438 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 25.0 t-20 -75.53 -31.43 60.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.966 178.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 126.38 -20.45 6.2 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.52 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.408 ' HZ3' HG11 ' A' ' 16' ' ' VAL . 29.6 m0 -61.15 132.81 54.91 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.753 0.311 . . . . 0.0 111.555 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -104.94 137.46 42.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.803 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.407 HD21 HG11 ' A' ' 3' ' ' VAL . 48.3 tp -134.41 141.41 46.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.909 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 64' ' ' ARG . 27.2 tt0 -97.52 110.3 22.88 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 120.814 0.34 . . . . 0.0 111.042 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 3.9 mm? -93.32 144.48 28.37 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.365 176.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 48' ' ' LEU . 11.4 Cg_exo -70.83 158.63 55.02 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.42 2.08 . . . . 0.0 111.001 173.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.15 73.35 3.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.269 0.557 . . . . 0.0 110.293 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.4 mmt -95.74 -168.76 1.82 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.133 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.56 115.41 5.74 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 176.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.737 ' HB1' ' HB3' ' A' ' 32' ' ' ALA . . . -48.54 -35.8 14.06 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.583 0.552 . . . . 0.0 111.584 -174.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -119.96 86.47 2.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.18 0.514 . . . . 0.0 109.724 169.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 58.2 m -65.63 129.62 94.38 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.386 175.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.38 -34.21 40.28 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.171 2.581 . . . . 0.0 113.162 -175.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 pp -132.23 158.67 74.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.182 -176.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.496 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . 39.6 Cg_endo -66.54 105.3 0.88 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.393 2.062 . . . . 0.0 111.18 175.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.1 tt -104.56 145.39 13.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.184 -174.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 91.9 m -90.12 132.89 35.19 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.648 173.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.9 m -135.56 176.33 8.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 120.664 0.269 . . . . 0.0 111.096 -177.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.67 121.68 15.93 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.677 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.43 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . . . -90.18 110.59 21.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.518 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.533 ' HB2' ' HB3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -113.38 100.71 8.75 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 172.265 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -82.79 119.17 24.01 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 75.8 mt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.629 -0.701 . . . . 0.0 110.14 -178.181 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.446 ' HE3' HG22 ' A' ' 60' ' ' THR . 39.2 tptt -71.03 133.15 46.1 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -172.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.456 HG23 ' HA ' ' A' ' 16' ' ' VAL . 7.3 p -150.95 148.15 15.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.863 -178.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.9 ttt -102.96 124.82 49.19 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.732 0.301 . . . . 0.0 110.949 -176.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.464 HG13 HD11 ' A' ' 48' ' ' LEU . 42.4 mm -109.22 128.97 64.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.732 177.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.546 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 92.7 mtt180 -101.13 118.99 38.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.09 0.471 . . . . 0.0 111.34 -176.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.437 ' HD3' ' HG ' ' A' ' 33' ' ' LEU . 9.8 mmmm -107.68 116.53 32.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.233 171.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.1 m -139.96 72.84 1.41 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.349 0.595 . . . . 0.0 109.82 175.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 54.85 -93.79 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.945 -176.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.4 t -94.48 -25.94 16.67 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.225 0.536 . . . . 0.0 110.287 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.0 112.59 4.29 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -126.43 119.92 28.45 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.438 ' OG ' ' HD2' ' A' ' 6' ' ' ARG . 16.7 p -147.57 163.1 37.66 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.584 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -139.28 141.7 37.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.372 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -114.53 104.03 11.61 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.216 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.456 ' HA ' HG23 ' A' ' 3' ' ' VAL . 47.9 t -76.1 88.19 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.629 176.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.94 -29.18 41.38 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.239 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -57.86 -38.05 75.03 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.419 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 19' ' ' LYS . 54.1 tttm -117.16 -1.81 11.79 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.472 -175.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' A' ' 19' ' ' LYS . 30.9 t70 64.71 23.73 12.8 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 122.033 0.921 . . . . 0.0 109.385 -174.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.3 tt -88.87 125.48 34.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.729 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -124.98 125.22 43.55 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 10.5 tp10 -154.44 162.26 41.25 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.893 0.378 . . . . 0.0 110.815 -176.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.406 HD23 ' HB3' ' A' ' 13' ' ' SER . 91.1 mt -79.6 144.51 33.76 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.65 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.3 mt -81.11 114.14 21.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.086 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.464 HG23 ' HG3' ' A' ' 27' ' ' GLU . 19.8 m -104.67 -26.15 3.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.488 -178.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.603 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 39.3 mt-10 -132.91 114.34 13.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.354 -176.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.561 ' SD ' ' N ' ' A' ' 28' ' ' MET . 0.6 OUTLIER -109.53 157.43 19.0 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 178.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.457 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 8.6 tp10 -72.32 -49.54 33.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.69 0.757 . . . . 0.0 109.428 171.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.419 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 50.8 t-20 -95.57 138.48 21.82 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.717 -175.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 30' ' ' ASN . 9.5 Cg_endo -50.29 -31.54 29.97 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.016 2.477 . . . . 0.0 111.562 173.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.92 -69.56 0.49 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.977 173.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.669 ' HB3' ' HD1' ' A' ' 34' ' ' TRP . 0.3 OUTLIER -178.43 -72.46 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.602 178.445 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.669 ' HD1' ' HB3' ' A' ' 33' ' ' LEU . 14.5 m95 -79.08 144.5 34.53 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.985 -174.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 176.83 -58.14 0.1 Allowed Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.08 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -146.47 -73.19 0.02 OUTLIER Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.242 -174.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.457 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 1.7 pptp? -132.97 167.7 19.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.169 0.509 . . . . 0.0 110.924 176.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.6 p -147.21 154.7 11.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.381 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.603 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 11.7 m -134.52 134.43 41.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.971 0.415 . . . . 0.0 110.624 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.584 HD11 ' HB3' ' A' ' 14' ' ' ALA . 2.9 mm? -87.08 169.76 12.12 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.582 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.52 -12.14 59.64 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.09 0.471 . . . . 0.0 110.884 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -80.83 -20.83 41.57 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.845 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.2 -8.92 59.26 Favored Glycine 0 C--N 1.332 0.335 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 -175.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -64.71 133.39 52.02 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 45.2 mt-30 -107.87 138.13 44.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.862 0.363 . . . . 0.0 110.465 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.434 HD11 HG11 ' A' ' 3' ' ' VAL . 3.4 tm? -138.27 132.41 31.64 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -84.07 113.33 20.96 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.464 HD11 HG13 ' A' ' 5' ' ' ILE . 18.2 tp -105.97 116.53 59.49 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.349 -173.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.419 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 3.0 Cg_exo -74.92 154.93 43.24 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.341 2.028 . . . . 0.0 111.419 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.57 74.09 5.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.294 0.568 . . . . 0.0 109.825 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.5 mmt -90.85 -54.89 3.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.997 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.463 ' O ' HG22 ' A' ' 55' ' ' THR . . . -163.21 95.08 0.84 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.237 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.489 ' HA ' ' CD1' ' A' ' 34' ' ' TRP . . . -71.48 -32.61 68.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.585 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.74 -52.93 54.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.861 -175.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.463 HG22 ' O ' ' A' ' 52' ' ' ALA . 9.8 t -28.51 120.82 0.27 Allowed Pre-proline 0 N--CA 1.477 0.897 0 O-C-N 124.224 0.952 . . . . 0.0 113.403 -169.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -85.66 10.43 3.7 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.205 2.604 . . . . 0.0 112.432 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.8 pp -131.76 153.18 81.39 Favored Pre-proline 0 C--O 1.236 0.395 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.568 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.546 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . 41.9 Cg_endo -66.63 149.9 83.89 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.826 2.35 . . . . 0.0 112.682 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.1 tt -152.03 146.93 15.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.252 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.446 HG22 ' HE3' ' A' ' 2' ' ' LYS . 17.0 m -102.02 128.27 48.54 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.315 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.415 HG11 ' HZ3' ' A' ' 34' ' ' TRP . 27.5 m -132.7 174.97 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 120.877 0.37 . . . . 0.0 111.393 -177.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -78.5 161.59 26.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.463 171.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -167.45 159.96 12.8 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.333 0.587 . . . . 0.0 112.543 -175.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -113.13 141.56 46.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.866 172.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.51 126.16 41.5 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.433 HD22 ' N ' ' A' ' 66' ' ' LEU . 2.8 mm? . . . . . 0 C--O 1.245 0.837 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.611 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -108.7 144.54 36.36 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 122.511 0.324 . . . . 0.0 110.57 -173.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.5 p -147.17 141.59 20.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.808 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.2 ttm -101.75 112.72 25.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.83 0.348 . . . . 0.0 110.268 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.465 HG13 HD11 ' A' ' 48' ' ' LEU . 41.0 mm -95.61 124.48 48.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.439 ' HB2' ' OG ' ' A' ' 13' ' ' SER . 97.4 mtt180 -97.39 118.32 33.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.148 0.499 . . . . 0.0 110.838 -175.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.464 ' NZ ' ' HB3' ' A' ' 7' ' ' LYS . 3.0 mmmp? -98.38 116.51 30.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.746 177.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.1 p -134.34 161.82 33.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.27 113.12 1.8 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.807 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.8 p 52.85 23.03 2.59 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.575 0.75 . . . . 0.0 111.688 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.85 134.84 7.84 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -133.81 117.9 17.4 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -178.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.439 ' OG ' ' HB2' ' A' ' 6' ' ' ARG . 15.3 p -135.88 161.8 34.61 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.551 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -146.24 146.24 30.69 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.66 -0.246 . . . . 0.0 110.523 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -129.7 110.25 11.63 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.94 0.4 . . . . 0.0 111.019 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.556 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 56.4 t -87.92 96.29 5.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 172.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.07 -37.88 84.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.251 -171.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.64 -22.76 66.68 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.621 0.248 . . . . 0.0 111.453 -174.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 6.4 tmtm? -119.36 -2.73 10.56 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.669 0.271 . . . . 0.0 110.586 -178.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 64.04 27.72 14.24 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.687 -177.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.556 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 54.2 tp -84.01 111.46 19.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.244 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -123.7 113.15 18.24 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.419 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 10.2 tp10 -148.18 162.83 38.66 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.839 0.352 . . . . 0.0 110.825 -173.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.7 mt -84.14 151.63 24.78 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.332 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.545 HD13 HD21 ' A' ' 33' ' ' LEU . 78.6 mt -92.2 101.21 12.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.668 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.458 HG13 ' HB2' ' A' ' 41' ' ' ALA . 16.3 m -83.87 -37.34 13.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.934 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.553 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 47.2 mt-10 -125.26 139.96 53.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.021 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.411 ' SD ' ' HA ' ' A' ' 33' ' ' LEU . 16.1 ptt? -151.2 156.74 41.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.876 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.47 ' OE1' ' HG3' ' A' ' 37' ' ' LYS . 8.8 tp10 -67.1 -37.48 83.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.079 0.466 . . . . 0.0 111.273 -176.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.416 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 45.0 t-20 -117.74 137.02 23.89 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.073 -172.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 30' ' ' ASN . 8.4 Cg_endo -47.61 -31.43 14.13 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.495 2.797 . . . . 0.0 112.099 175.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.16 -61.71 1.89 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.552 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.545 HD21 HD13 ' A' ' 25' ' ' ILE . 0.4 OUTLIER 172.42 -67.25 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.973 0.796 . . . . 0.0 110.755 175.489 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.521 ' HZ3' HG21 ' A' ' 61' ' ' VAL . 44.4 m95 -74.06 133.38 42.89 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.461 -171.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.83 -56.63 0.05 OUTLIER Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.201 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.67 -67.3 0.01 OUTLIER Glycine 0 C--N 1.334 0.446 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.524 -174.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.47 ' HG3' ' OE1' ' A' ' 29' ' ' GLU . 1.9 pptp? -134.62 168.73 18.46 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.029 0.442 . . . . 0.0 111.152 175.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 46' ' ' LEU . 14.0 p -146.97 160.67 9.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.479 -177.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.553 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 33.0 m -138.89 126.3 21.68 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.83 0.348 . . . . 0.0 110.355 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.551 HD11 ' HB3' ' A' ' 14' ' ' ALA . 2.9 mm? -78.77 159.12 28.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.168 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.458 ' HB2' HG13 ' A' ' 26' ' ' VAL . . . -65.13 -12.06 46.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.087 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.419 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 65.1 t30 -85.3 2.78 42.6 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.48 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.26 -8.79 79.07 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.197 -0.525 . . . . 0.0 113.553 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 18.0 m0 -85.52 142.83 28.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.1 0.476 . . . . 0.0 111.274 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -101.69 159.8 15.01 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.756 -176.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.404 ' O ' HG12 ' A' ' 38' ' ' VAL . 3.2 tm? -159.37 136.33 9.53 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -176.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -82.84 122.8 28.69 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 122.247 -0.283 . . . . 0.0 110.28 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.465 HD11 HG13 ' A' ' 5' ' ' ILE . 22.7 tp -115.53 112.78 43.18 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.123 -174.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.419 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 60.0 Cg_endo -68.73 158.03 59.45 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.26 1.973 . . . . 0.0 111.961 -175.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.94 76.91 3.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.093 0.473 . . . . 0.0 110.514 178.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.416 ' SD ' ' N ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -91.75 -164.8 1.23 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.627 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.416 ' N ' ' SD ' ' A' ' 51' ' ' MET . . . -83.3 109.66 17.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.743 0.306 . . . . 0.0 110.962 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.79 -7.49 54.57 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.714 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -60.86 -25.68 66.83 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.793 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.2 p -57.02 117.52 18.29 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.924 -176.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -92.14 10.88 2.41 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.145 2.563 . . . . 0.0 111.682 174.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 pp -139.5 160.85 59.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.212 -175.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -62.98 135.71 52.9 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.53 2.153 . . . . 0.0 112.726 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.9 tt -130.54 140.15 49.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.022 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.3 m -100.85 119.05 38.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.895 0.378 . . . . 0.0 110.786 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.521 HG21 ' HZ3' ' A' ' 34' ' ' TRP . 35.4 m -122.5 170.67 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.721 178.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 1' ' ' MET . 10.2 mt-10 -82.85 157.12 23.25 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 171.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -149.23 164.37 34.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.23 0.538 . . . . 0.0 111.923 -172.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.622 HH11 ' HG3' ' A' ' 64' ' ' ARG . 11.3 mmt85 -116.62 125.71 52.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.655 175.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -82.22 108.69 15.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.99 0.424 . . . . 0.0 110.354 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 78.0 mt . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.417 -0.802 . . . . 0.0 109.673 178.753 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.4 ' HB3' ' HB3' ' A' ' 63' ' ' ALA . 24.8 mmt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -88.8 114.73 25.74 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.328 -172.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 9.5 p -147.38 141.98 19.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.092 174.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.461 ' SD ' ' HB2' ' A' ' 58' ' ' PRO . 51.0 ttm -117.18 120.28 37.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.676 0.274 . . . . 0.0 110.319 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.4 mm -88.62 115.1 28.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.419 ' HG2' ' HB3' ' A' ' 58' ' ' PRO . 94.5 mtt180 -111.03 118.97 37.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.784 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.455 ' HD3' ' O ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -127.74 138.44 52.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.023 0.44 . . . . 0.0 110.986 179.036 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.63 HG22 ' H ' ' A' ' 9' ' ' ALA . 3.0 m -147.19 -179.02 6.54 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.63 ' H ' HG22 ' A' ' 8' ' ' THR . . . -49.54 107.17 0.13 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 117.826 0.285 . . . . 0.0 110.729 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.2 p 67.79 -41.02 0.42 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.787 1.235 . . . . 0.0 112.746 -177.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.69 110.78 3.14 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.318 -0.467 . . . . 0.0 112.71 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -118.42 128.88 55.04 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.6 p -143.9 155.4 44.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.877 0.37 . . . . 0.0 110.648 -178.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.515 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -128.49 115.57 18.36 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -90.37 103.91 16.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.871 -176.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.1 t -80.25 99.59 4.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.39 175.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.28 -53.85 44.87 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -172.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -11.73 31.06 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -174.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -118.3 -8.98 10.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.723 0.297 . . . . 0.0 110.526 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.4 t70 57.65 26.65 13.19 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 122.032 0.92 . . . . 0.0 109.593 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.406 ' C ' HD23 ' A' ' 21' ' ' LEU . 8.1 tt -86.98 123.54 32.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.127 -176.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -133.16 104.48 6.52 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 171.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.32 165.16 19.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.904 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.7 mt -79.69 132.99 36.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.844 0.354 . . . . 0.0 110.63 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.464 HD12 HD11 ' A' ' 33' ' ' LEU . 69.5 mt -71.37 105.33 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.776 174.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.424 HG23 ' HG2' ' A' ' 27' ' ' GLU . 10.9 m -81.42 -49.25 18.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.173 -177.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.545 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 58.1 mm-40 -106.76 140.95 38.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.916 -177.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 59.5 mtt -132.96 156.73 46.75 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.466 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 10.6 tp10 -65.35 -49.13 70.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.551 0.691 . . . . 0.0 109.336 172.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -127.43 148.34 66.02 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.877 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.05 -23.08 11.68 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.337 2.691 . . . . 0.0 113.742 -174.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -71.25 -66.44 0.62 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.696 0.284 . . . . 0.0 110.547 176.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 18.7 tp 170.2 -70.48 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.008 -175.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 46.4 m95 -76.29 153.61 35.78 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.023 -176.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' A' ' 50' ' ' ALA . . . 159.62 -33.21 0.45 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.477 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.21 -78.24 0.05 OUTLIER Glycine 0 C--O 1.226 -0.393 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.466 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -129.73 161.3 30.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.919 0.39 . . . . 0.0 110.937 178.296 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.7 m -140.01 167.59 18.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 171.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.545 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 17.7 m -135.78 125.77 25.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.9 0.381 . . . . 0.0 110.671 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.515 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.7 mm? -77.88 161.45 27.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.558 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.8 -19.69 60.03 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.187 0.518 . . . . 0.0 110.395 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -63.08 -23.25 67.36 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.407 175.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.36 12.3 57.42 Favored Glycine 0 C--N 1.332 0.36 0 N-CA-C 111.621 -0.592 . . . . 0.0 111.621 -176.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.69 ' HZ2' ' HE2' ' A' ' 65' ' ' LYS . 45.8 t-105 -106.76 140.08 40.17 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 -178.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -94.41 149.04 21.63 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.954 -177.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.523 HD21 ' HB1' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -142.9 131.81 22.88 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.194 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.578 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 42.2 tt0 -89.9 120.88 31.5 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.79 0.329 . . . . 0.0 111.205 -175.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -121.03 113.32 32.85 Favored Pre-proline 0 C--O 1.235 0.332 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.371 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.51 152.89 79.83 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.384 2.056 . . . . 0.0 111.573 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.524 ' HB2' ' HA2' ' A' ' 35' ' ' GLY . . . -71.38 75.58 0.75 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.031 0.443 . . . . 0.0 110.434 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.6 mmt -87.99 -74.37 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.389 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.99 110.03 1.85 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.545 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.2 -30.87 70.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.238 0.542 . . . . 0.0 109.628 175.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -73.36 86.77 1.5 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.447 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.438 HG21 ' HB ' ' A' ' 59' ' ' ILE . 32.1 m -139.02 109.02 7.61 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.596 177.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -83.6 14.56 2.35 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.037 2.491 . . . . 0.0 113.22 -176.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.6 pp -145.66 159.98 45.87 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.648 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.461 ' HB2' ' SD ' ' A' ' 4' ' ' MET . 37.9 Cg_endo -66.62 106.27 1.05 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.258 1.972 . . . . 0.0 111.328 175.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.438 ' HB ' HG21 ' A' ' 55' ' ' THR . 8.7 tt -89.45 146.73 5.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.113 -174.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.1 m -110.84 132.71 53.97 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.275 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.4 m -139.82 177.14 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 122.419 0.288 . . . . 0.0 110.505 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -86.01 118.17 25.31 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.224 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.523 ' HB1' HD21 ' A' ' 46' ' ' LEU . . . -70.28 109.83 4.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.945 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.578 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 1.4 tmm_? -93.59 101.73 13.9 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 174.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.69 ' HE2' ' HZ2' ' A' ' 44' ' ' TRP . 45.3 tttm -73.15 129.7 38.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.166 -176.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.457 ' N ' HD12 ' A' ' 66' ' ' LEU . 5.8 mp . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.553 -0.736 . . . . 0.0 109.485 176.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.401 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 64.6 mtt . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.409 ' HG3' ' CG2' ' A' ' 60' ' ' THR . 86.3 tttt -101.61 121.56 42.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.008 -173.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.6 p -137.4 129.52 41.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 173.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.463 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 52.9 ttm -101.06 115.06 29.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.656 -175.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.1 mm -96.28 116.36 38.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 6' ' ' ARG . 64.0 mtt85 -97.68 126.12 42.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.209 0.528 . . . . 0.0 110.853 -178.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.623 ' HD3' ' HG ' ' A' ' 33' ' ' LEU . 16.1 mmmt -119.78 115.37 23.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.006 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.2 t -135.82 -167.46 2.04 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 175.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.21 -74.11 0.04 OUTLIER 'General case' 0 C--O 1.235 0.298 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -174.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.6 p -112.11 -28.51 7.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.985 0.421 . . . . 0.0 110.795 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.02 138.69 27.2 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.6 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -141.6 121.69 13.78 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 175.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.4 p -140.45 158.87 43.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.865 0.364 . . . . 0.0 111.277 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.577 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -131.05 137.88 49.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.792 176.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.463 ' HB3' ' HB3' ' A' ' 4' ' ' MET . 40.1 t80 -119.17 104.64 10.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.956 0.407 . . . . 0.0 111.207 -177.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 59.7 t -79.83 97.37 2.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.564 174.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.13 -40.64 77.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.778 -172.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.432 ' HB2' ' HE2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -69.32 -11.96 61.25 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -171.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -133.98 0.47 3.18 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.777 0.322 . . . . 0.0 111.008 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 59.32 24.06 12.56 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.782 -177.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.502 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 41.9 tp -83.07 108.26 16.23 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.17 -178.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 14' ' ' ALA . 32.9 tt0 -121.87 126.72 49.36 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.443 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 10.7 tp10 -147.61 162.63 38.74 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.556 -175.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.3 mt -78.29 139.59 38.86 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.576 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.405 HG23 HG23 ' A' ' 38' ' ' VAL . 79.9 mt -82.16 104.84 11.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.852 176.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.6 m -94.84 -37.59 8.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 111.674 0.249 . . . . 0.0 111.674 -177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.601 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 34.5 tt0 -127.95 134.39 49.3 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -176.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.547 ' HG2' ' HA ' ' A' ' 33' ' ' LEU . 0.9 OUTLIER -122.87 160.87 25.19 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.465 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 11.6 tp10 -66.73 -49.06 67.21 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -106.88 142.92 26.01 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 173.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -54.91 -21.94 28.27 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.019 2.48 . . . . 0.0 113.135 -174.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.11 -71.83 0.2 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.623 0.249 . . . . 0.0 110.669 177.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.623 ' HG ' ' HD3' ' A' ' 7' ' ' LYS . 1.1 tm? -179.45 -63.23 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -178.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.422 ' HA ' HD23 ' A' ' 48' ' ' LEU . 58.1 m95 -83.57 165.28 19.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.464 -177.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 159.22 -70.39 0.24 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.718 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -147.57 -48.36 0.03 OUTLIER Glycine 0 C--N 1.33 0.198 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.138 -175.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.465 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -145.01 164.51 30.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.84 0.353 . . . . 0.0 110.315 178.607 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.405 HG23 HG23 ' A' ' 25' ' ' ILE . 6.8 p -143.41 137.24 25.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.725 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.601 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 30.5 m -112.31 116.12 29.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.81 0.338 . . . . 0.0 110.751 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.577 HD11 ' HB3' ' A' ' 14' ' ' ALA . 2.9 mm? -75.29 154.97 37.13 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.985 173.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.11 -16.5 52.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.079 0.466 . . . . 0.0 111.436 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.44 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 7.1 t30 -82.5 3.28 29.0 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.814 -178.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.25 31.77 45.79 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.731 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 19.6 t-105 -113.7 113.91 25.65 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.404 ' HB3' HD12 ' A' ' 66' ' ' LEU . 42.3 mt-30 -98.93 121.08 40.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.276 0.56 . . . . 0.0 110.807 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.6 tp -110.62 147.85 33.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.026 178.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.566 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 35.6 tt0 -84.95 115.66 22.93 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 34' ' ' TRP . 15.0 tp -112.54 116.68 48.04 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.631 -171.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.18 155.84 58.98 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.5 2.133 . . . . 0.0 112.27 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.09 79.6 5.49 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.955 0.407 . . . . 0.0 111.011 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.1 mmt -98.41 -169.16 1.76 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.122 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.37 116.79 2.62 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.971 178.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.62 -46.69 28.88 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.75 0.657 . . . . 0.0 111.722 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.488 ' HA ' ' HE2' ' A' ' 7' ' ' LYS . 30.2 m-20 -116.37 79.47 1.32 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.085 0.469 . . . . 0.0 110.269 178.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.4 m -62.98 121.88 71.53 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.688 175.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.15 2.38 6.77 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.673 2.249 . . . . 0.0 113.184 -174.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 pp -151.86 156.88 34.47 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.631 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.21 110.24 1.95 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.462 2.108 . . . . 0.0 111.008 174.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.7 tt -105.36 137.18 36.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.101 0.476 . . . . 0.0 111.003 -175.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.409 ' CG2' ' HG3' ' A' ' 2' ' ' LYS . 86.9 m -95.81 118.84 33.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.303 177.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.9 178.11 2.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.832 -177.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 1' ' ' MET . 4.0 mp0 -76.37 149.06 37.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.202 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.18 156.8 17.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.105 0.478 . . . . 0.0 111.47 -177.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.566 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -162.21 105.69 1.16 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.963 174.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -73.9 141.05 46.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.804 0.335 . . . . 0.0 111.118 -177.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 47' ' ' GLU . 70.6 mt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.818 -0.61 . . . . 0.0 109.43 175.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptt? . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 121.286 0.565 . . . . 0.0 110.005 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.425 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 23.9 tptm -94.21 110.64 22.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.277 -169.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.486 HG23 ' HA ' ' A' ' 16' ' ' VAL . 11.7 p -146.98 141.67 20.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.051 174.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 47.5 ttp -125.05 129.02 49.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.49 -177.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.9 mm -96.94 123.81 49.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.669 ' HD3' ' HB3' ' A' ' 58' ' ' PRO . 22.2 mmt85 -99.1 131.53 45.07 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.205 0.526 . . . . 0.0 111.416 -177.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -93.55 120.25 33.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.968 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.5 p -123.32 146.43 47.93 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.75 -37.66 82.58 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.028 0.442 . . . . 0.0 110.514 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.6 m -110.27 76.27 0.98 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.076 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.54 -160.05 13.53 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.434 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -138.96 146.24 40.74 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.5 m -136.9 143.82 43.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.64 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -123.84 132.32 53.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.771 0.32 . . . . 0.0 110.151 177.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -104.93 102.39 11.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.158 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.486 ' HA ' HG23 ' A' ' 3' ' ' VAL . 47.8 t -76.36 90.75 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.295 174.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.425 ' HB3' ' HG3' ' A' ' 2' ' ' LYS . . . -62.48 -32.89 73.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.143 -172.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.474 ' HB2' ' NZ ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -69.05 -1.59 7.95 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.778 -0.192 . . . . 0.0 111.487 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 19' ' ' LYS . 56.8 tttm -136.84 -1.74 2.19 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.342 176.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 56.49 29.9 16.19 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.053 0.454 . . . . 0.0 110.752 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.3 tp -98.12 117.21 31.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.874 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -109.33 125.08 51.96 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 169.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.449 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 8.0 tp10 -143.91 160.6 40.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.934 0.397 . . . . 0.0 110.767 -177.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.5 mt -76.45 134.79 39.45 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.231 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.453 HG23 HG13 ' A' ' 38' ' ' VAL . 64.5 mt -81.0 91.6 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.8 m -78.72 -32.78 16.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.79 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.577 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 8.5 tp10 -129.37 141.34 51.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.207 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.417 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -152.15 157.81 42.05 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.3 -179.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.485 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 6.6 tp10 -65.19 -67.03 0.47 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.776 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.45 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 56.5 t30 -90.39 130.98 39.72 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.839 -175.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.45 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 1.6 Cg_endo -40.55 -35.02 1.33 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.462 3.441 . . . . 0.0 113.567 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -67.91 -65.78 0.65 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.785 0.326 . . . . 0.0 110.535 176.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 29.6 tp 174.57 -69.21 0.01 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.161 -175.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.508 ' HE3' ' O ' ' A' ' 49' ' ' PRO . 49.1 m95 -75.26 130.9 39.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.407 -177.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 50' ' ' ALA . . . -168.09 -57.44 0.03 OUTLIER Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.293 -178.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.37 -68.02 0.07 OUTLIER Glycine 0 C--O 1.225 -0.458 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 -177.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.485 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 9.6 ptpp? -101.3 146.57 27.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.648 0.261 . . . . 0.0 110.321 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.453 HG13 HG23 ' A' ' 25' ' ' ILE . 17.2 t -147.15 153.13 12.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.577 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 43.2 m -142.8 131.21 22.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.069 0.461 . . . . 0.0 111.025 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.64 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.2 mm? -86.21 165.33 16.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.622 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.32 -20.76 65.77 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.142 0.496 . . . . 0.0 110.908 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.449 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 8.0 t30 -77.34 -9.35 58.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.47 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.62 -10.61 68.77 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 121.252 -0.499 . . . . 0.0 111.992 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 27.1 t-105 -64.64 123.38 19.15 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.478 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 43.8 mt-30 -98.62 126.96 44.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.889 0.376 . . . . 0.0 110.378 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.7 tp -123.64 139.03 54.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.538 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 21.0 tt0 -95.67 101.97 13.72 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -178.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.7 tp -101.5 104.33 33.39 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.543 -173.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.508 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 59.2 Cg_endo -70.62 136.26 30.31 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.441 2.094 . . . . 0.0 111.639 -175.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.455 ' HB2' ' HA2' ' A' ' 35' ' ' GLY . . . -64.69 80.44 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.957 0.408 . . . . 0.0 111.578 -177.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.3 mmt -86.65 -59.87 2.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.282 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.45 116.96 5.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.775 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.74 -54.77 33.45 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.617 0.573 . . . . 0.0 111.516 -174.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -103.98 91.43 3.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.985 0.421 . . . . 0.0 110.295 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.9 m -73.22 128.61 87.33 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.187 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.55 -44.09 11.96 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.403 2.069 . . . . 0.0 112.502 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.569 ' HB2' ' HD2' ' A' ' 58' ' ' PRO . 2.7 pp -132.56 165.99 32.26 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.405 -177.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.669 ' HB3' ' HD3' ' A' ' 6' ' ' ARG . 29.3 Cg_endo -60.73 110.23 0.79 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.382 2.054 . . . . 0.0 111.737 177.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.9 tt -101.63 147.81 8.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.019 -176.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 87.5 m -101.73 120.13 39.87 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.156 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.1 m -120.38 178.55 2.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.161 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.66 123.17 21.25 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.519 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.46 110.2 14.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.086 0.47 . . . . 0.0 110.782 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.415 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 3.5 tpm_? -122.14 105.16 10.01 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.203 176.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -83.58 151.28 25.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.893 0.378 . . . . 0.0 110.78 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 7.1 mp . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.331 -0.842 . . . . 0.0 109.34 174.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.748 ' SD ' ' HD3' ' A' ' 18' ' ' LYS . 24.2 ttt . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.478 ' HG3' HG21 ' A' ' 60' ' ' THR . 39.8 tttm -71.41 115.15 10.24 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.58 0.752 . . . . 0.0 110.678 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.555 HG23 ' HA ' ' A' ' 16' ' ' VAL . 8.2 p -134.24 136.31 53.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.954 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.7 ttm -104.28 116.53 32.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.967 0.413 . . . . 0.0 111.233 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.525 HG13 HD11 ' A' ' 48' ' ' LEU . 45.2 mm -91.18 115.55 30.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.507 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 74.3 mtp180 -97.46 118.78 34.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.127 0.489 . . . . 0.0 110.952 -171.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -100.03 116.59 32.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.857 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 t -149.16 -177.58 5.9 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.27 104.59 0.15 Allowed 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.386 0.429 . . . . 0.0 111.608 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.1 p 67.75 -52.96 0.51 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.005 1.322 . . . . 0.0 113.504 177.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.95 81.81 0.54 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.451 -0.404 . . . . 0.0 113.23 -174.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.411 ' HB3' HD11 ' A' ' 33' ' ' LEU . 61.2 m80 -70.84 110.42 5.59 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m -114.66 151.9 32.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.936 0.398 . . . . 0.0 111.546 -170.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.453 ' HB3' HD21 ' A' ' 40' ' ' LEU . . . -124.35 118.57 27.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.66 175.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -106.11 106.91 17.64 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.044 0.449 . . . . 0.0 110.912 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.555 ' HA ' HG23 ' A' ' 3' ' ' VAL . 29.9 t -93.71 96.51 6.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.666 176.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.82 -45.55 86.0 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.348 -173.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.748 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 49.2 pttt -63.79 -35.22 79.9 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.732 0.301 . . . . 0.0 111.054 -177.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.403 ' N ' ' HG3' ' A' ' 18' ' ' LYS . 48.0 tttm -90.42 -9.97 45.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.882 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 62.07 20.51 11.68 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.042 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 22' ' ' GLU . 4.2 tt -106.23 128.8 54.22 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -175.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.507 ' N ' HD23 ' A' ' 21' ' ' LEU . 45.3 tt0 -131.0 113.89 14.53 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 175.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 7.7 tp10 -136.4 160.36 38.99 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.941 0.401 . . . . 0.0 111.014 -175.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.2 mt -79.4 143.49 35.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.763 175.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 68.6 mt -90.0 123.13 42.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.2 m -110.59 -27.42 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -176.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.604 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 52.5 mm-40 -129.85 100.56 5.52 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.765 0.317 . . . . 0.0 110.988 -176.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.546 ' SD ' ' N ' ' A' ' 28' ' ' MET . 1.0 OUTLIER -99.97 155.37 17.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.399 -178.546 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -67.99 -53.54 25.22 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 170.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.497 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 59.3 t30 -97.42 131.16 27.77 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.042 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.497 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 2.8 Cg_endo -42.06 -39.98 6.07 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 124.185 3.257 . . . . 0.0 113.182 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.553 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -69.16 -66.39 0.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.462 177.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.411 HD11 ' HB3' ' A' ' 12' ' ' HIS . 4.5 mt 178.7 -72.63 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.255 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.594 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 41.1 m95 -72.66 140.41 47.91 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.053 -173.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.19 -23.83 0.88 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 121.278 -0.487 . . . . 0.0 112.287 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.86 -137.19 3.6 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.968 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.517 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -67.09 146.72 54.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.332 0.587 . . . . 0.0 111.941 -176.427 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.0 m -137.68 136.91 45.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 172.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.604 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 26.8 m -111.32 128.55 55.99 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.727 0.298 . . . . 0.0 110.765 -175.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . 80.6 mt -72.37 157.2 38.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.985 176.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.16 -17.74 58.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.306 0.574 . . . . 0.0 110.582 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.424 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 25.3 t-20 -69.61 -28.55 66.03 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.49 176.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.78 -18.84 26.44 Favored Glycine 0 C--N 1.331 0.269 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -175.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.721 ' HZ2' ' HD2' ' A' ' 65' ' ' LYS . 41.2 t-105 -71.0 141.51 50.99 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -114.43 146.48 40.57 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.255 0.55 . . . . 0.0 111.735 -175.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.6 tp -135.3 141.9 45.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.659 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.601 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 38.5 tt0 -92.42 105.63 17.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.187 0.518 . . . . 0.0 110.049 -178.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.525 HD11 HG13 ' A' ' 5' ' ' ILE . 18.9 tp -83.22 126.44 72.05 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.537 -174.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -51.83 145.15 32.76 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.0 2.466 . . . . 0.0 113.203 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.7 88.2 7.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.967 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 23.5 ptp -135.37 -152.39 0.46 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.439 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.54 112.47 0.6 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.656 0.265 . . . . 0.0 110.562 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.594 ' HA ' ' HB2' ' A' ' 34' ' ' TRP . . . -63.91 -27.19 68.98 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.161 -173.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -135.66 93.51 2.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.148 0.499 . . . . 0.0 110.644 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.0 p -79.67 129.84 69.78 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.672 174.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.04 -8.43 23.58 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.398 2.065 . . . . 0.0 111.936 -178.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.2 pp -138.23 158.08 71.54 Favored Pre-proline 0 C--O 1.236 0.376 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.456 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.507 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . 38.2 Cg_endo -66.19 136.13 42.89 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.437 2.091 . . . . 0.0 111.058 174.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.5 tt -136.78 144.31 32.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.877 0.37 . . . . 0.0 110.944 -174.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.478 HG21 ' HG3' ' A' ' 2' ' ' LYS . 63.7 m -98.11 130.77 44.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.145 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.41 ' O ' HG12 ' A' ' 3' ' ' VAL . 26.3 m -140.14 179.41 2.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 120.968 0.413 . . . . 0.0 111.599 -174.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -64.03 138.67 58.57 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.212 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.454 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . . . -108.37 123.41 48.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.022 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.601 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -122.89 102.04 7.79 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 175.047 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.721 ' HD2' ' HZ2' ' A' ' 44' ' ' TRP . 28.2 ttpt -65.16 145.3 56.45 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.691 -176.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.474 HD21 ' HB2' ' A' ' 47' ' ' GLU . 91.3 mt . . . . . 0 C--O 1.253 1.253 0 CA-C-O 118.821 -0.609 . . . . 0.0 109.847 175.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.671 ' SD ' ' NH1' ' A' ' 64' ' ' ARG . 59.1 mtt . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -114.32 115.33 27.21 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.99 -173.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.1 p -137.72 127.83 36.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.04 0.448 . . . . 0.0 110.002 174.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.473 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 23.2 ttt -101.71 111.87 24.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.349 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.1 mm -77.21 117.61 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -96.38 118.53 33.09 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.317 -172.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.448 ' NZ ' ' O ' ' A' ' 54' ' ' ASP . 14.3 mmmm -106.08 118.43 36.59 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.05 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 72.5 m -142.23 157.3 45.0 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.65 107.26 0.11 Allowed 'General case' 0 C--O 1.233 0.233 0 O-C-N 123.094 0.247 . . . . 0.0 110.675 178.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.5 p 66.92 -41.38 0.4 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.272 1.429 . . . . 0.0 112.916 -176.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.07 105.31 1.6 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.321 -0.466 . . . . 0.0 112.682 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -104.61 121.88 44.46 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 175.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.435 ' HB3' HD23 ' A' ' 24' ' ' LEU . 33.7 p -138.68 160.8 38.75 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.761 0.315 . . . . 0.0 110.177 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.587 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -128.0 115.81 19.07 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.408 ' HB3' ' HB3' ' A' ' 4' ' ' MET . 59.5 t80 -87.22 103.19 15.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.59 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.1 t -74.34 89.04 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.207 175.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.3 -34.61 70.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.147 -172.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.43 -12.27 59.84 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -177.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 19' ' ' LYS . 39.1 tttm -127.2 -7.82 5.9 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.484 0.183 . . . . 0.0 110.973 178.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.3 t70 67.94 17.21 9.62 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.758 0.79 . . . . 0.0 110.332 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.487 HD21 ' HG2' ' A' ' 23' ' ' GLU . 7.6 tt -88.42 134.71 33.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.192 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -134.09 111.04 10.02 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 173.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 40' ' ' LEU . 78.1 mm-40 -116.61 160.14 21.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.27 177.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.435 HD23 ' HB3' ' A' ' 13' ' ' SER . 83.1 mt -76.95 136.2 38.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.549 175.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 85.9 mt -71.96 107.26 2.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.035 175.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.0 m -94.79 -22.77 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.179 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.578 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 32.7 tt0 -142.45 142.57 32.35 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.097 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.54 ' SD ' ' N ' ' A' ' 28' ' ' MET . 1.0 OUTLIER -123.72 177.24 5.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.096 -177.005 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.511 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 8.2 tp10 -84.2 -56.79 3.47 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 168.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.421 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 35.6 t-20 -95.59 137.63 21.93 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.819 177.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 30' ' ' ASN . 5.2 Cg_endo -44.64 -22.59 0.65 Allowed 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.642 2.895 . . . . 0.0 113.076 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.22 -69.25 0.62 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.169 173.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.4 tp -177.94 -75.55 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.922 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.478 ' HE3' ' O ' ' A' ' 49' ' ' PRO . 29.4 m95 -72.11 137.42 47.03 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.659 -176.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.538 ' HA2' ' HB2' ' A' ' 50' ' ' ALA . . . -179.67 -40.45 0.07 OUTLIER Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.419 -0.895 . . . . 0.0 113.356 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.49 -71.43 0.05 OUTLIER Glycine 0 C--O 1.225 -0.419 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.959 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.511 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -120.28 164.54 16.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.0 0.429 . . . . 0.0 111.143 176.348 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 46' ' ' LEU . 14.8 p -147.34 147.02 17.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.578 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 45.7 m -121.45 133.03 55.05 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.257 0.551 . . . . 0.0 111.126 -177.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.6 mm? -92.28 155.92 17.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.886 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.57 -34.68 51.64 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -90.03 -1.62 57.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.881 0.372 . . . . 0.0 111.442 -171.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.94 -27.61 8.15 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.518 174.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -59.4 140.23 56.34 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.872 0.336 . . . . 0.0 110.6 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.453 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 46.2 mt-30 -122.13 144.15 49.11 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.555 HD13 ' N ' ' A' ' 47' ' ' GLU . 1.6 tm? -133.67 140.49 47.09 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -176.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.555 ' N ' HD13 ' A' ' 46' ' ' LEU . 38.0 tt0 -81.69 112.13 18.59 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.9 tp -110.97 95.18 23.08 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.27 -175.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.478 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 21.7 Cg_exo -65.46 151.28 85.43 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.782 2.321 . . . . 0.0 112.298 -175.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.538 ' HB2' ' HA2' ' A' ' 35' ' ' GLY . . . -74.74 81.34 2.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.98 0.419 . . . . 0.0 110.491 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.2 mmt -95.08 -63.72 1.14 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.201 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.448 ' HB3' HG23 ' A' ' 55' ' ' THR . . . -144.73 112.67 6.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.003 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.12 99.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.5 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.448 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . 6.7 p-10 -70.74 -54.99 9.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.395 -176.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.448 HG23 ' HB3' ' A' ' 52' ' ' ALA . 1.2 p 41.63 88.38 0.1 Allowed Pre-proline 0 N--CA 1.471 0.6 0 C-N-CA 123.11 0.564 . . . . 0.0 112.0 -177.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.55 -20.94 30.47 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.783 2.322 . . . . 0.0 112.956 -173.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.4 pp -125.97 153.93 73.79 Favored Pre-proline 0 C--O 1.236 0.35 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.63 -177.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.67 94.7 0.39 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.511 2.141 . . . . 0.0 111.693 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.7 tt -89.19 143.36 11.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.968 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 4' ' ' MET . 28.0 m -97.76 130.6 44.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.917 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.7 m -126.57 177.05 5.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 121.028 0.442 . . . . 0.0 111.194 -177.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -78.11 125.18 28.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.249 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.17 122.95 28.01 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -173.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.671 ' NH1' ' SD ' ' A' ' 1' ' ' MET . 4.6 mpt_? -118.48 100.53 7.52 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 168.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -74.78 131.8 41.09 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 82.7 mt . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.554 -0.736 . . . . 0.0 109.698 178.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.519 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 49.0 ttm . . . . . 0 N--CA 1.484 1.229 0 CA-C-O 120.773 0.32 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -109.13 133.23 53.28 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 120.803 0.335 . . . . 0.0 111.416 -176.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.561 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 14.5 p -144.0 134.25 20.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.747 174.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.5 ttp -103.54 114.02 27.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.778 0.323 . . . . 0.0 110.224 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 58' ' ' PRO . 41.4 mm -90.15 116.66 31.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.072 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -94.13 147.46 23.13 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.035 0.445 . . . . 0.0 110.198 -175.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 55' ' ' THR . 36.4 mmtm -121.3 151.58 39.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.446 -176.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.448 HG22 ' N ' ' A' ' 9' ' ' ALA . 59.9 m -159.59 164.01 34.57 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.448 ' N ' HG22 ' A' ' 8' ' ' THR . . . -39.37 -42.75 1.1 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.881 0.472 . . . . 0.0 112.002 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.6 t -146.75 -32.66 0.31 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.763 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.97 75.75 0.74 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.312 -0.471 . . . . 0.0 112.999 -177.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -68.33 138.0 55.08 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.8 p -145.08 162.8 36.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.697 0.284 . . . . 0.0 110.955 -178.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.517 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -139.61 143.88 37.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.655 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.476 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 59.7 t80 -126.37 112.44 15.66 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.0 t -85.6 123.01 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.281 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.49 -70.58 0.12 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.86 -15.88 60.0 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -172.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.802 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 57.9 tptt -101.41 -15.63 17.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.494 0.187 . . . . 0.0 110.712 -177.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 58.91 25.0 13.15 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.382 0.61 . . . . 0.0 110.188 -177.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.802 ' HB2' ' HG3' ' A' ' 19' ' ' LYS . 7.0 tt -90.96 124.33 35.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.181 -173.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -128.25 109.19 11.24 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -133.23 161.03 35.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.093 -176.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.4 mt -77.83 146.53 35.67 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.564 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 72.2 mt -88.79 112.79 24.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.707 177.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.5 m -101.5 -37.46 5.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 116.805 -0.18 . . . . 0.0 111.482 -178.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.467 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 39.1 tt0 -127.43 119.5 26.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.896 0.379 . . . . 0.0 110.642 -178.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.517 ' SD ' ' N ' ' A' ' 28' ' ' MET . 1.2 mpt? -103.43 158.13 16.55 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 9.0 tp10 -60.12 -58.7 7.42 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.132 0.492 . . . . 0.0 109.924 174.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.475 HD22 ' N ' ' A' ' 30' ' ' ASN . 0.9 OUTLIER -96.98 153.4 38.55 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.248 175.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.8 -14.87 23.92 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.711 2.274 . . . . 0.0 112.741 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.82 -69.75 0.59 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.104 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.505 ' HA ' ' HG2' ' A' ' 28' ' ' MET . 1.3 tm? -176.05 -67.89 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -178.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 56.8 m95 -84.24 160.84 20.7 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.551 -177.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 168.89 -57.59 0.2 Allowed Glycine 0 C--N 1.337 0.596 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.338 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.42 -64.12 0.02 OUTLIER Glycine 0 C--N 1.33 0.226 0 C-N-CA 121.295 -0.479 . . . . 0.0 112.118 -175.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 1.7 pptp? -131.27 168.62 17.21 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.786 0.327 . . . . 0.0 110.901 175.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.0 p -147.08 152.35 13.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.589 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 44.9 m -123.26 127.82 49.11 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 120.982 0.42 . . . . 0.0 110.856 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.517 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.4 mm? -79.38 159.69 26.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.434 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.87 -29.0 66.66 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.021 -175.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -74.87 -31.68 61.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.891 0.377 . . . . 0.0 110.466 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 128.85 -10.32 6.32 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.494 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.534 ' CE3' HD11 ' A' ' 21' ' ' LEU . 3.2 m-90 -69.9 141.98 53.06 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.142 0.471 . . . . 0.0 110.985 178.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -103.48 137.35 41.68 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.602 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 58.3 tp -130.39 141.99 50.53 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 177.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.55 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 29.8 tt0 -80.88 122.45 27.24 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.0 tp -114.28 100.18 52.32 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.886 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -58.65 150.78 67.61 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.788 2.326 . . . . 0.0 112.687 -173.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.77 90.49 0.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.547 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.3 mmt -114.64 -173.09 2.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.427 176.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.62 114.21 2.16 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.672 0.273 . . . . 0.0 110.61 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.81 -50.48 73.82 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.213 -178.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -80.39 76.87 7.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.399 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.491 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 1.4 p -116.01 98.65 51.58 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.736 173.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -77.67 -7.12 16.57 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.65 2.233 . . . . 0.0 112.492 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.458 ' O ' HD12 ' A' ' 57' ' ' LEU . 2.5 pp -102.11 149.67 36.78 Favored Pre-proline 0 C--O 1.239 0.546 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.355 -177.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 57.5 Cg_endo -71.57 92.56 0.68 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.54 2.16 . . . . 0.0 111.356 175.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.7 tt -93.62 142.29 13.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.595 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.2 m -100.8 123.11 44.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.189 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.3 m -126.44 178.5 4.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 120.834 0.35 . . . . 0.0 110.736 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.519 ' HA ' ' O ' ' A' ' 1' ' ' MET . 6.7 mp0 -69.21 149.61 48.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.397 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.561 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . . . -119.5 133.19 55.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.003 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.55 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 14.9 tpt180 -134.89 122.21 21.66 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 174.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -83.17 123.69 29.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.045 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.498 HD11 ' HB2' ' A' ' 47' ' ' GLU . 7.2 mp . . . . . 0 C--O 1.25 1.113 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.7 mmm . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -113.25 137.8 50.95 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.618 0.247 . . . . 0.0 111.111 -174.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 14.5 p -145.91 138.78 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.306 175.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 47.0 ttm -111.2 114.79 28.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.301 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 58' ' ' PRO . 47.2 mm -86.2 113.52 24.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -104.98 139.19 40.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.246 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -138.41 135.67 35.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.326 178.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.6 m -108.83 -53.8 2.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.366 0.603 . . . . 0.0 109.544 174.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -170.75 -91.03 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.576 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.5 t -76.84 -28.32 55.45 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 168.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.94 98.07 0.77 Allowed Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.798 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -107.5 121.86 45.47 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 175.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.3 p -135.17 161.04 36.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.918 0.389 . . . . 0.0 110.844 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.598 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -137.19 119.07 15.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.404 178.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -90.06 102.29 15.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.015 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.475 ' HA ' HG23 ' A' ' 3' ' ' VAL . 49.2 t -77.24 90.71 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.59 -31.54 57.11 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.184 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -52.85 -54.64 31.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.136 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.567 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 9.3 tmtt? -94.92 -5.04 45.74 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.641 -176.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.7 t70 60.07 27.32 16.75 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 122.139 0.971 . . . . 0.0 109.06 -174.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.439 ' HB2' ' HD2' ' A' ' 19' ' ' LYS . 6.9 tt -106.31 118.5 36.8 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.686 -175.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -108.05 132.54 53.45 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 172.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 10.9 tp10 -144.86 161.53 39.06 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -176.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.9 mt -78.23 140.16 38.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.427 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 77.2 mt -84.6 122.86 38.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.036 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.9 m -112.3 -35.75 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -174.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.53 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 4.7 tm-20 -129.46 123.78 32.4 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -176.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.463 ' HG2' HD12 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -124.11 140.93 52.5 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.598 ' HB2' ' HD3' ' A' ' 37' ' ' LYS . 33.0 tt0 -58.22 -36.2 72.8 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.283 0.563 . . . . 0.0 110.362 176.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -109.05 140.36 21.85 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.898 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -49.54 -34.65 34.55 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.225 2.617 . . . . 0.0 112.637 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.78 -68.93 0.5 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.304 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.521 ' HB3' ' HD1' ' A' ' 34' ' ' TRP . 21.2 tp 178.89 -68.46 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.459 -178.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.521 ' HD1' ' HB3' ' A' ' 33' ' ' LEU . 13.6 m95 -78.14 135.23 37.62 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.516 -176.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.464 ' HA2' ' HB2' ' A' ' 50' ' ' ALA . . . -172.17 -48.36 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.434 -177.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.34 -72.91 0.05 OUTLIER Glycine 0 C--O 1.226 -0.383 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -176.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.598 ' HD3' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -123.21 155.34 37.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.979 0.419 . . . . 0.0 111.004 176.456 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 46' ' ' LEU . 8.5 p -146.72 157.09 11.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.45 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 34.9 m -127.03 129.86 48.85 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.087 0.47 . . . . 0.0 111.111 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.598 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.7 mm? -81.23 163.75 22.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.086 175.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.1 -24.36 66.18 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.898 0.38 . . . . 0.0 111.432 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.424 HD22 HD11 ' A' ' 21' ' ' LEU . 60.4 t30 -83.99 5.59 25.11 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.67 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.34 8.39 87.21 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.589 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.489 ' HE1' HD23 ' A' ' 46' ' ' LEU . 33.3 t-105 -76.65 112.33 13.09 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -88.96 115.86 26.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.992 0.425 . . . . 0.0 110.48 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.499 HD13 ' N ' ' A' ' 47' ' ' GLU . 2.3 tm? -118.9 136.27 54.14 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -176.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.499 ' N ' HD13 ' A' ' 46' ' ' LEU . 36.8 tt0 -79.8 111.85 16.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 0.0 110.366 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.5 tp -109.35 99.99 39.23 Favored Pre-proline 0 C--O 1.236 0.384 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.953 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.407 ' O ' ' HE3' ' A' ' 34' ' ' TRP . 19.2 Cg_exo -65.36 153.33 78.74 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.612 2.208 . . . . 0.0 112.106 -174.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.464 ' HB2' ' HA2' ' A' ' 35' ' ' GLY . . . -79.53 83.76 5.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.785 0.326 . . . . 0.0 110.141 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 93.2 mmm -113.0 -79.6 0.58 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.309 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -127.84 101.12 6.21 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.493 ' HA ' ' CD1' ' A' ' 34' ' ' TRP . . . -79.14 -50.94 10.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.325 -175.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -95.25 27.07 3.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.929 -173.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.6 t -65.37 134.0 95.56 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -83.56 -1.62 10.2 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.613 2.209 . . . . 0.0 113.591 -175.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 57' ' ' LEU . 3.2 pp -120.9 149.36 50.71 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.441 0.163 . . . . 0.0 111.135 -175.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 44.1 Cg_endo -68.35 95.71 0.46 Allowed 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.305 2.003 . . . . 0.0 111.244 176.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.6 tt -89.21 142.11 13.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.849 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.4 m -101.94 123.17 45.39 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.624 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.3 m -127.69 178.0 5.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.957 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -69.54 149.93 47.68 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.547 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.487 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . . . -115.56 151.22 35.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.117 -177.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.424 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 37.5 ttt180 -153.3 121.47 6.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.616 175.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -87.19 121.31 29.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.816 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.427 HD22 ' N ' ' A' ' 66' ' ' LEU . 2.3 mm? . . . . . 0 C--O 1.248 1.026 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 172.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.644 ' SD ' ' HG2' ' A' ' 64' ' ' ARG . 59.9 mtt . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -130.52 111.76 12.57 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -169.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.556 HG11 HD11 ' A' ' 46' ' ' LEU . 7.4 p -142.09 130.45 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 171.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 46.8 ttm -101.06 112.05 24.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.0 mm -86.98 129.49 38.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -96.2 132.35 41.73 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 55' ' ' THR . 0.1 OUTLIER -107.98 116.58 32.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.368 0.604 . . . . 0.0 112.066 -166.038 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 t -177.41 131.35 0.16 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.783 171.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.55 -26.14 68.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.586 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.9 p -103.27 20.66 17.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.548 -176.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.87 49.43 0.12 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.82 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -57.4 123.74 16.51 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.492 ' HB3' HD23 ' A' ' 24' ' ' LEU . 10.7 p -151.03 162.48 40.77 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.367 -0.235 . . . . 0.0 110.367 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.439 ' HB3' HD21 ' A' ' 40' ' ' LEU . . . -145.57 136.11 24.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.233 -177.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.4 ' HD1' ' HB2' ' A' ' 22' ' ' GLU . 74.8 t80 -105.12 102.55 12.04 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 174.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.513 ' HA ' HG23 ' A' ' 3' ' ' VAL . 47.1 t -84.44 95.07 3.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.85 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.91 -26.4 64.29 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.562 -176.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.409 ' HB3' HG12 ' A' ' 16' ' ' VAL . 55.5 tptt -52.97 -39.44 63.0 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 175.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.532 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 2.6 tmtp? -116.05 -6.76 11.95 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 16' ' ' VAL . 19.1 m-20 59.69 26.01 15.05 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.614 -170.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 19' ' ' LYS . 5.1 tt -84.33 125.95 32.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.67 -176.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.458 ' N ' HD23 ' A' ' 21' ' ' LEU . 43.0 tt0 -116.22 120.46 39.04 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.463 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 7.4 tp10 -147.81 161.97 40.18 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.986 0.422 . . . . 0.0 111.184 -176.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.492 HD23 ' HB3' ' A' ' 13' ' ' SER . 96.3 mt -82.05 137.86 34.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.689 174.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.2 mt -83.05 106.33 13.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.462 HG23 ' HG3' ' A' ' 27' ' ' GLU . 16.5 m -81.96 -34.4 12.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.398 -177.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.462 ' HG3' HG23 ' A' ' 26' ' ' VAL . 48.6 mt-10 -132.83 140.16 47.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.334 -177.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.481 ' HG2' ' HA ' ' A' ' 33' ' ' LEU . 2.5 mpp? -126.15 160.0 31.39 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.51 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 14.7 tp10 -64.53 -41.63 96.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.229 0.538 . . . . 0.0 109.702 174.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -118.8 152.2 51.18 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.543 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -49.62 -33.03 29.97 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.161 2.574 . . . . 0.0 113.21 -177.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.36 -68.67 0.48 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.744 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.481 ' HA ' ' HG2' ' A' ' 28' ' ' MET . 3.7 tt -178.39 -71.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.977 0.417 . . . . 0.0 110.227 -178.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.698 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 31.7 m95 -76.65 155.72 33.21 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.27 -173.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 162.34 -42.54 0.36 Allowed Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.836 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.0 -65.61 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.51 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -144.79 167.93 21.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.793 0.33 . . . . 0.0 111.205 178.153 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.429 HG13 HD23 ' A' ' 48' ' ' LEU . 33.4 m -139.41 172.43 12.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.339 174.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.2 m -132.79 122.39 24.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.319 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.555 HD12 ' HB3' ' A' ' 44' ' ' TRP . 85.9 mt -78.17 155.99 30.12 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.159 176.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.16 -9.31 22.04 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.022 0.439 . . . . 0.0 111.308 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.463 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 28.2 t-20 -86.54 -13.13 46.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.251 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.88 -1.32 59.55 Favored Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.785 -176.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.555 ' HB3' HD12 ' A' ' 40' ' ' LEU . 15.3 t-105 -80.16 121.02 25.06 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 178.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -94.84 131.11 41.07 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.556 HD11 HG11 ' A' ' 3' ' ' VAL . 1.0 OUTLIER -122.66 132.38 54.24 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.259 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.589 ' HB3' ' HB2' ' A' ' 64' ' ' ARG . 32.2 tt0 -90.6 122.69 33.62 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.774 0.321 . . . . 0.0 110.87 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.43 HD22 ' N ' ' A' ' 48' ' ' LEU . 3.2 mm? -109.6 100.76 43.58 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -65.34 71.22 0.29 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.344 2.696 . . . . 0.0 113.469 -173.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 36.9 89.05 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.375 1.07 . . . . 0.0 113.489 175.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.485 ' HB2' ' CE3' ' A' ' 34' ' ' TRP . 25.2 mmt -129.62 -169.02 2.03 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 174.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.64 108.72 0.37 Allowed 'General case' 0 CA--C 1.532 0.273 0 O-C-N 123.098 0.249 . . . . 0.0 110.794 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.698 ' HA ' ' HB2' ' A' ' 34' ' ' TRP . . . -50.57 -37.06 37.62 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.746 -175.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -128.07 70.78 1.36 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.489 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 3.9 t -57.5 139.9 80.42 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.133 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.57 5.2 4.42 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.825 2.35 . . . . 0.0 113.352 -176.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.413 HD23 ' N ' ' A' ' 57' ' ' LEU . 2.5 pt? -152.07 147.69 20.2 Favored Pre-proline 0 C--O 1.234 0.267 0 O-C-N 122.512 -0.118 . . . . 0.0 110.966 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.99 94.33 0.28 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.622 2.215 . . . . 0.0 110.648 173.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.8 tt -96.35 150.56 4.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.08 0.467 . . . . 0.0 111.741 -172.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 90.3 m -98.93 127.75 44.93 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.14 175.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.414 ' O ' HG12 ' A' ' 3' ' ' VAL . 31.6 m -133.05 179.36 4.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 120.863 0.363 . . . . 0.0 111.02 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -55.97 108.87 0.5 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.042 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.521 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . . . -72.56 109.59 6.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.531 173.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.644 ' HG2' ' SD ' ' A' ' 1' ' ' MET . 91.7 mtt180 -132.81 135.01 45.41 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -108.53 150.58 27.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.02 0.438 . . . . 0.0 110.947 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.7 mt . . . . . 0 C--O 1.252 1.22 0 CA-C-O 118.449 -0.786 . . . . 0.0 109.659 175.02 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.64 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 121.474 0.654 . . . . 0.0 110.748 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -100.84 118.97 37.96 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.469 -175.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 11.5 p -137.8 132.58 44.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 174.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 57.9 ttp -112.23 117.6 32.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.293 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 58' ' ' PRO . 43.0 mm -87.44 119.38 34.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 176.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -96.28 125.65 40.94 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.948 0.404 . . . . 0.0 110.039 -179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 55' ' ' THR . 32.3 mmtp -85.65 115.65 23.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.596 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.6 m -159.1 134.01 8.17 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.37 -74.73 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -173.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 42.1 m -74.58 -29.24 61.25 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.918 0.39 . . . . 0.0 110.584 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.06 40.57 2.38 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.144 -0.551 . . . . 0.0 113.674 -174.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -58.81 115.56 3.17 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 172.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.7 p -138.1 151.22 47.59 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.013 0.435 . . . . 0.0 111.364 -174.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -122.5 115.74 22.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.955 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -96.22 103.61 15.52 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.949 0.404 . . . . 0.0 111.166 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.9 t -79.93 101.74 5.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.846 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.13 -37.45 83.85 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -173.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.516 ' HB2' ' NZ ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -68.21 -3.96 12.4 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -175.677 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.717 ' HD2' ' HB2' ' A' ' 21' ' ' LEU . 7.4 tmtm? -131.75 -16.73 2.92 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.038 0.447 . . . . 0.0 109.836 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.6 t70 59.23 60.97 2.19 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.89 0.853 . . . . 0.0 109.265 -170.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.717 ' HB2' ' HD2' ' A' ' 19' ' ' LYS . 7.2 tt -132.18 119.86 21.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.995 -179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -127.8 121.02 29.11 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 8.9 tp10 -130.31 162.28 29.38 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.4 mt -77.1 133.62 38.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.093 0.473 . . . . 0.0 110.857 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.474 HG23 ' HB ' ' A' ' 38' ' ' VAL . 73.9 mt -80.72 103.48 7.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.635 176.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.2 m -104.98 -1.0 9.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.976 0.417 . . . . 0.0 111.207 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.661 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 9.4 tp10 -147.61 137.85 23.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.935 -177.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 64.4 mtt -139.45 138.28 36.3 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -65.5 -45.56 83.1 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.07 143.65 27.02 Favored Pre-proline 0 N--CA 1.465 0.293 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 171.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.06 -21.88 67.23 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.892 2.395 . . . . 0.0 113.122 -174.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -75.24 -68.82 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.684 0.278 . . . . 0.0 110.55 178.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 3.8 tt 171.18 -60.29 0.01 OUTLIER 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.484 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 55.0 m95 -85.59 128.72 34.84 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.079 -178.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 148.1 50.55 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 -177.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 122.36 -95.22 0.54 Allowed Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 175.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.44 156.17 44.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.086 0.469 . . . . 0.0 111.039 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.474 ' HB ' HG23 ' A' ' 25' ' ' ILE . 20.4 m -125.78 149.35 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 172.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.661 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 22.6 m -109.91 121.07 44.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.084 0.468 . . . . 0.0 110.275 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . 3.1 mm? -67.01 157.03 34.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.831 177.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.71 -28.54 34.57 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -172.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -95.6 2.36 54.14 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -174.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.94 -14.49 28.94 Favored Glycine 0 N--CA 1.459 0.207 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.602 175.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -62.41 148.4 45.55 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.427 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 34.4 mt-30 -125.35 145.81 49.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.722 0.296 . . . . 0.0 110.369 177.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 52.9 tp -132.33 139.63 48.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -93.58 118.1 30.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.619 0.247 . . . . 0.0 110.891 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.449 HD22 ' N ' ' A' ' 48' ' ' LEU . 2.7 mm? -121.14 107.56 37.29 Favored Pre-proline 0 N--CA 1.465 0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.206 177.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.67 156.24 66.67 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.35 2.033 . . . . 0.0 111.017 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.56 74.25 0.78 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.006 0.431 . . . . 0.0 110.034 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 95.4 mmm -89.74 -65.2 1.04 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.878 -177.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.92 102.96 2.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.656 178.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.484 ' HA ' ' CD1' ' A' ' 34' ' ' TRP . . . -65.46 -37.65 87.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.873 -178.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.434 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . 5.3 p-10 -56.94 -69.28 0.16 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.176 -178.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.514 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 1.9 p 27.94 87.14 0.1 Allowed Pre-proline 0 N--CA 1.472 0.649 0 C-N-CA 123.837 0.855 . . . . 0.0 113.089 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -78.19 13.62 1.74 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.025 2.483 . . . . 0.0 112.829 -177.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.446 ' H ' HD23 ' A' ' 57' ' ' LEU . 2.5 pt? -141.71 153.09 64.46 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.857 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 32.0 Cg_endo -63.91 97.36 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.453 2.102 . . . . 0.0 111.419 177.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.4 tt -89.43 148.35 4.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.811 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 63.2 m -111.54 120.54 42.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.688 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.8 m -125.04 177.66 4.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.089 0.471 . . . . 0.0 111.734 -176.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.469 ' HG3' ' HG3' ' A' ' 1' ' ' MET . 40.8 tt0 -61.43 108.96 1.03 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.731 177.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . . . -74.47 123.57 24.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.484 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.7 ttm105 -138.44 102.77 4.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.876 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.427 ' C ' ' HD3' ' A' ' 65' ' ' LYS . 13.7 tmtt? -82.13 129.75 34.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.54 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 77.5 mt . . . . . 0 C--O 1.253 1.24 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.26 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.541 0.21 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.502 ' HE2' HG22 ' A' ' 60' ' ' THR . 15.4 tptm -125.3 142.65 51.38 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.596 HG11 HD21 ' A' ' 46' ' ' LEU . 12.3 p -147.62 147.07 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 116.662 -0.244 . . . . 0.0 110.78 -178.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.554 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 27.0 ttt -110.97 113.56 26.2 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 176.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.9 mm -92.41 128.43 44.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.085 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.433 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 81.1 mtp180 -97.02 118.89 34.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.067 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -121.1 124.98 46.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.534 -176.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 42.9 p -134.76 176.26 8.81 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 169.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.21 -33.43 73.46 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.893 0.378 . . . . 0.0 111.113 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.0 p -111.93 -56.58 2.37 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.315 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.58 137.48 20.28 Favored Glycine 0 C--O 1.237 0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 113.387 -174.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -128.2 118.72 23.85 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.433 ' HB3' ' HB2' ' A' ' 6' ' ' ARG . 23.1 t -142.22 162.37 35.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.739 0.304 . . . . 0.0 110.204 -176.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.568 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -140.74 134.97 31.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.277 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -118.91 107.68 13.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.222 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 37.1 t -75.85 104.51 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.35 -69.59 0.12 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -171.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -12.36 54.36 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -171.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.515 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 17.2 tppt? -100.17 -20.38 15.99 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.719 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 61.59 29.08 18.11 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.111 0.481 . . . . 0.0 110.732 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.515 ' HB2' ' HG3' ' A' ' 19' ' ' LYS . 7.4 tt -101.82 120.2 40.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.746 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -117.77 132.17 56.49 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 172.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.461 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 8.2 tp10 -147.03 165.6 29.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.419 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.422 HD12 ' N ' ' A' ' 25' ' ' ILE . 1.3 tp -86.71 140.66 29.56 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 122.988 0.515 . . . . 0.0 110.359 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 24' ' ' LEU . 79.4 mt -80.13 113.24 19.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.541 177.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.4 m -106.57 -27.52 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -177.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.49 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 4.0 tm-20 -138.17 133.32 33.14 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -177.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.447 ' SD ' ' O ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -142.59 147.0 35.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 0.0 111.082 -178.135 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -67.27 -65.0 0.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.956 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -75.36 138.37 71.44 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.17 -177.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -46.7 -26.11 4.21 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.63 2.887 . . . . 0.0 112.942 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -93.85 -68.44 0.8 Allowed 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 173.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 32.0 tp 174.44 -63.2 0.01 OUTLIER 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.553 -176.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.484 ' HZ3' HG21 ' A' ' 61' ' ' VAL . 63.9 m95 -75.47 134.82 40.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.241 -172.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.95 -13.45 5.0 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.17 -0.538 . . . . 0.0 112.041 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -168.85 -150.7 6.81 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.832 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.666 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -85.61 162.86 18.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.457 0.646 . . . . 0.0 112.696 -173.416 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 46' ' ' LEU . 8.7 p -146.7 158.82 10.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.2 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 31.4 m -133.29 128.27 35.4 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.083 0.468 . . . . 0.0 110.216 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.568 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.4 mm? -81.74 165.61 20.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.206 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.29 -19.61 63.45 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.104 0.478 . . . . 0.0 111.152 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.461 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 61.8 t30 -83.79 -4.39 58.61 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.522 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.33 0.36 82.62 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.971 -176.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 42.2 t-105 -66.06 121.7 15.73 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -100.5 120.2 39.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.902 0.382 . . . . 0.0 110.538 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.596 HD21 HG11 ' A' ' 3' ' ' VAL . 62.7 tp -130.25 135.26 47.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.588 -178.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.666 ' HA ' ' HA ' ' A' ' 37' ' ' LYS . 30.1 tt0 -104.63 126.36 51.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.792 0.329 . . . . 0.0 110.569 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.36 136.17 64.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.909 177.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -81.66 29.72 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.908 2.406 . . . . 0.0 112.834 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 62.52 104.97 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.559 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.5 mmt -139.36 -176.66 4.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.25 178.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.57 122.58 14.43 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.274 0.359 . . . . 0.0 110.47 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.16 -38.71 90.08 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.092 0.472 . . . . 0.0 109.794 176.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -69.95 94.82 0.88 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.957 177.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.413 ' HG1' ' HE1' ' A' ' 34' ' ' TRP . 2.6 p -131.67 90.17 37.54 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.272 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -86.33 12.9 2.88 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.142 2.561 . . . . 0.0 111.868 177.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.4 ' O ' HD12 ' A' ' 57' ' ' LEU . 3.1 pp -145.84 154.87 51.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.332 -178.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.405 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . 59.7 Cg_endo -71.8 125.24 10.87 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.387 2.058 . . . . 0.0 111.429 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.9 tt -126.08 137.08 58.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 120.883 0.373 . . . . 0.0 111.045 -177.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 4' ' ' MET . 26.1 m -90.66 120.02 31.38 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.169 177.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.484 HG21 ' HZ3' ' A' ' 34' ' ' TRP . 34.3 m -128.51 176.95 6.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.392 -175.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -70.28 149.31 47.55 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.935 176.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.41 ' HB1' HD11 ' A' ' 46' ' ' LEU . . . -120.14 121.07 37.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.61 0.243 . . . . 0.0 111.412 -174.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.56 ' HB2' ' HB3' ' A' ' 47' ' ' GLU . 31.3 mmt180 -113.83 100.75 8.68 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 174.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -79.95 148.34 31.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.898 0.38 . . . . 0.0 111.157 -175.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.495 HD11 ' HB2' ' A' ' 47' ' ' GLU . 5.5 mp . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.488 -0.768 . . . . 0.0 109.228 175.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.411 ' CG ' ' HB3' ' A' ' 63' ' ' ALA . 43.6 ttm . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -108.99 133.03 53.52 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 122.504 0.322 . . . . 0.0 110.626 -173.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 14.8 p -143.4 129.17 16.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.021 0.439 . . . . 0.0 110.499 174.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 47.7 ttm -105.55 120.9 42.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.216 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 46.9 mm -96.3 122.83 48.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -96.17 149.62 21.43 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.922 0.391 . . . . 0.0 109.964 -177.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -105.6 125.32 50.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.499 -178.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.0 m -158.84 144.05 16.2 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -177.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.45 100.52 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.233 0.333 . . . . 0.0 110.654 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.8 p 68.48 -32.9 0.22 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.935 1.294 . . . . 0.0 112.923 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.12 54.05 4.82 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.699 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -69.89 118.59 12.94 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.2 t -111.72 150.05 30.77 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.54 ' HB3' HD21 ' A' ' 40' ' ' LEU . . . -124.52 131.19 53.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.167 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -110.39 103.26 11.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.117 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.571 HG12 ' HG3' ' A' ' 18' ' ' LYS . 24.4 t -88.53 104.91 15.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.025 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.07 -26.76 68.38 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -171.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.571 ' HG3' HG12 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -65.07 -20.21 66.37 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.724 0.297 . . . . 0.0 111.22 -176.29 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.532 ' HD3' HD12 ' A' ' 21' ' ' LEU . 65.0 tttp -133.67 -3.01 2.96 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.779 -178.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 60.2 30.25 19.71 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.181 0.515 . . . . 0.0 109.69 -172.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.532 HD12 ' HD3' ' A' ' 19' ' ' LYS . 5.3 tt -82.99 121.18 26.67 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -176.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.407 ' N ' HD23 ' A' ' 21' ' ' LEU . 33.7 tt0 -123.15 111.48 16.56 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 7.5 tp10 -136.74 163.82 29.71 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.739 0.304 . . . . 0.0 110.474 -176.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.9 mt -85.55 142.45 29.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.209 176.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.502 HG23 ' HB ' ' A' ' 38' ' ' VAL . 74.7 mt -87.99 115.56 28.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.312 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.4 m -104.45 -45.4 9.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.314 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.606 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 36.9 tt0 -107.65 141.13 39.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 50.1 mtt -131.58 142.91 50.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.447 -178.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -66.75 -53.3 34.64 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 171.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.511 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 65.0 t30 -100.73 129.0 28.48 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.93 175.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.511 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 8.4 Cg_endo -45.91 -26.84 3.63 Favored 'Trans proline' 0 N--CA 1.476 0.491 0 C-N-CA 124.291 3.327 . . . . 0.0 113.646 -176.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -71.6 -70.88 0.3 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.865 0.364 . . . . 0.0 110.847 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.431 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 25.8 tp 173.35 -58.52 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.217 -175.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.44 ' CZ3' HD12 ' A' ' 48' ' ' LEU . 47.2 m95 -92.33 157.62 16.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.315 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.48 -38.24 1.91 Allowed Glycine 0 CA--C 1.507 -0.418 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.44 -149.51 5.33 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -77.76 149.37 34.52 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.14 0.495 . . . . 0.0 111.493 -177.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.502 ' HB ' HG23 ' A' ' 25' ' ' ILE . 35.8 m -124.62 139.39 51.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 170.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 22.1 m -100.61 117.06 33.98 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.994 0.426 . . . . 0.0 110.53 -178.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.54 HD21 ' HB3' ' A' ' 14' ' ' ALA . 86.8 mt -65.56 152.16 44.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.989 174.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.67 -24.53 49.32 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.78 -177.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.426 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 6.2 t30 -79.27 -12.9 59.95 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.877 0.37 . . . . 0.0 111.263 -178.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.1 54.83 1.56 Allowed Glycine 0 CA--C 1.518 0.227 0 N-CA-C 111.541 -0.623 . . . . 0.0 111.541 -175.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.474 ' HB3' HD12 ' A' ' 40' ' ' LEU . 22.7 t-105 -136.62 115.83 12.55 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -93.75 120.19 33.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.892 0.377 . . . . 0.0 111.167 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.516 HD21 ' HB1' ' A' ' 63' ' ' ALA . 0.6 OUTLIER -116.82 126.41 53.02 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.582 ' HB2' HD11 ' A' ' 66' ' ' LEU . 30.4 tt0 -86.84 128.42 35.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.987 0.422 . . . . 0.0 111.464 -176.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.44 HD12 ' CZ3' ' A' ' 34' ' ' TRP . 3.6 mm? -100.02 122.47 50.5 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.811 175.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 48' ' ' LEU . 7.6 Cg_exo -74.07 39.33 0.52 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.429 2.752 . . . . 0.0 113.234 -176.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 51.6 68.33 0.82 Allowed 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 176.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.432 ' HB2' ' CE3' ' A' ' 34' ' ' TRP . 25.5 mmt -104.06 176.61 5.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.761 176.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.404 ' HB3' HG23 ' A' ' 55' ' ' THR . . . -62.75 117.3 6.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.856 0.36 . . . . 0.0 111.293 -178.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.6 -28.13 60.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.467 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -82.61 17.39 1.81 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.845 -177.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 52' ' ' ALA . 1.2 p -59.79 115.74 14.04 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.491 174.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.79 10.37 1.67 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.934 2.423 . . . . 0.0 113.381 -172.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.9 pp -143.98 159.81 51.87 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 122.327 0.251 . . . . 0.0 110.359 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.43 97.83 0.45 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.242 1.961 . . . . 0.0 110.935 175.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.1 tt -89.19 141.03 14.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.92 -175.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.3 m -107.58 127.02 53.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.398 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.15 177.18 5.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.462 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -72.1 130.65 41.41 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 176.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.587 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . . . -87.64 146.73 25.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.83 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 64' ' ' ARG . 23.5 ttp180 -145.35 113.75 6.67 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 176.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -81.73 137.72 35.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.415 -175.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.582 HD11 ' HB2' ' A' ' 47' ' ' GLU . 5.0 mp . . . . . 0 C--O 1.245 0.827 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 171.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.448 ' HG3' HG21 ' A' ' 60' ' ' THR . 39.1 ttpt -129.62 132.0 46.62 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.95 0.405 . . . . 0.0 111.301 -174.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.0 p -138.4 120.11 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 169.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.4 ttt -107.56 110.46 22.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.222 -174.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 58' ' ' PRO . 45.7 mm -85.18 128.81 38.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.159 -178.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.571 ' HB2' ' HB2' ' A' ' 13' ' ' SER . 79.5 mtp180 -96.57 131.41 43.23 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.412 ' NZ ' ' O ' ' A' ' 54' ' ' ASP . 14.2 mmmm -121.82 118.81 29.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.025 -173.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.6 p -133.65 166.85 21.65 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.59 -24.21 39.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.1 0.476 . . . . 0.0 110.178 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.6 m -75.97 -31.82 59.19 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.259 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -176.34 -168.9 37.13 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.79 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.582 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 48.7 m80 -121.39 141.89 50.53 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.803 -0.444 . . . . 0.0 109.803 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.571 ' HB2' ' HB2' ' A' ' 6' ' ' ARG . 15.7 m -142.98 158.93 43.14 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.604 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -140.31 138.13 34.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.526 0.203 . . . . 0.0 110.831 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -111.12 103.57 12.02 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.418 HG12 ' HB3' ' A' ' 18' ' ' LYS . 41.3 t -88.24 96.32 5.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.004 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.05 -26.31 62.34 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.866 0.365 . . . . 0.0 111.533 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.418 ' HB3' HG12 ' A' ' 16' ' ' VAL . 18.2 tppt? -55.3 -26.84 42.85 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.139 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -133.5 0.24 3.3 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.372 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 57.75 28.39 15.82 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.467 0.651 . . . . 0.0 109.789 -172.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.3 tp -86.15 121.07 28.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.014 -175.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -112.72 115.82 29.14 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 173.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -139.37 161.59 37.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.955 0.407 . . . . 0.0 110.122 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.0 mt -80.46 141.63 35.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.317 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.582 ' HB ' ' HB2' ' A' ' 12' ' ' HIS . 74.6 mt -84.78 120.14 34.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.202 178.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.7 m -106.13 -27.15 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.042 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.638 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 8.0 tp10 -133.78 143.09 48.19 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.53 157.26 43.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.857 -178.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.473 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 10.8 tp10 -64.39 -37.88 89.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.842 0.353 . . . . 0.0 111.0 -177.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.485 ' OD1' ' HA3' ' A' ' 35' ' ' GLY . 12.9 m120 -125.91 148.81 64.0 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -45.63 -32.62 8.76 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.762 2.974 . . . . 0.0 113.614 -173.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -73.72 -69.71 0.42 Allowed 'General case' 0 C--O 1.234 0.284 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 176.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.41 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 3.4 tt 175.83 -66.82 0.01 OUTLIER 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.277 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -70.89 154.81 41.51 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.315 -175.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.485 ' HA3' ' OD1' ' A' ' 30' ' ' ASN . . . 128.89 0.62 6.01 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.858 -177.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 48' ' ' LEU . . . 155.43 -140.7 7.52 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.497 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -71.28 166.23 22.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.285 0.564 . . . . 0.0 112.253 -174.654 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.7 p -144.33 163.54 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.13 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.638 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 37.2 m -142.11 126.18 17.34 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.008 0.432 . . . . 0.0 110.605 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.604 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.4 mm? -78.76 168.47 19.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.46 177.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.85 -22.52 65.57 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.565 -177.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -83.42 -13.97 53.65 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.094 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.79 -4.21 53.16 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.55 -178.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 49.3 t-105 -67.65 136.59 54.62 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -122.37 137.03 55.0 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -174.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -123.62 154.01 39.91 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.23 171.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.572 ' HB3' ' HB2' ' A' ' 64' ' ' ARG . 39.1 tt0 -105.91 113.02 26.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 48' ' ' LEU . 3.3 mm? -96.07 135.15 22.9 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.403 -178.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.79 156.73 64.8 Favored 'Trans proline' 0 C--O 1.238 0.485 0 C-N-CA 122.181 1.92 . . . . 0.0 110.808 173.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.21 87.95 0.17 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.091 0.472 . . . . 0.0 110.8 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.5 mmt -104.87 179.65 4.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.628 176.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.29 125.48 23.77 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.794 177.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.0 -23.2 64.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.819 -174.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.412 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . 15.3 p-10 -74.31 -57.01 4.22 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.792 -0.185 . . . . 0.0 110.617 -177.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.4 p 33.48 81.63 0.23 Allowed Pre-proline 0 CA--C 1.537 0.458 0 O-C-N 123.809 0.693 . . . . 0.0 112.263 -178.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -76.33 -2.52 12.72 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.626 2.217 . . . . 0.0 112.21 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.431 ' O ' HD12 ' A' ' 57' ' ' LEU . 1.5 pp -128.28 157.39 74.6 Favored Pre-proline 0 C--O 1.235 0.327 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.742 -177.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 59.1 Cg_endo -72.04 98.38 0.9 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.204 1.936 . . . . 0.0 111.504 176.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.6 tt -97.38 143.77 11.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.034 -177.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.448 HG21 ' HG3' ' A' ' 2' ' ' LYS . 38.4 m -100.86 136.05 41.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.26 176.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.9 m -137.42 177.4 5.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 120.703 0.287 . . . . 0.0 110.521 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -64.34 134.82 55.39 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.586 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.94 114.02 25.69 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.48 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.572 ' HB2' ' HB3' ' A' ' 47' ' ' GLU . 2.7 mmp_? -117.58 125.85 51.52 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 172.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -97.24 146.82 24.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.57 0.224 . . . . 0.0 110.625 -178.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.3 mp . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.56 175.304 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.488 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.17 0 CA-C-O 121.304 0.573 . . . . 0.0 110.212 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -119.2 137.65 53.49 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.948 -173.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 p -149.65 128.59 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.513 174.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.405 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 53.0 ttm -102.16 111.05 23.18 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.4 mm -79.24 111.83 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -102.67 118.96 37.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.995 -176.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -86.9 128.31 35.05 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 170.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.3 p -140.41 163.32 33.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.714 -173.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.21 -22.9 66.36 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.331 0.586 . . . . 0.0 109.992 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 m -67.17 -14.73 63.18 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.386 174.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.47 -99.78 0.61 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.969 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -130.84 128.57 40.91 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.4 p -139.33 150.95 45.97 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.289 -0.264 . . . . 0.0 110.289 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.532 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -141.5 131.34 24.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.755 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -99.37 103.36 15.15 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.1 t -91.54 105.0 16.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.216 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.24 -30.04 71.26 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.822 0.344 . . . . 0.0 111.233 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -55.2 -46.71 75.89 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.964 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.691 ' HD2' ' HB2' ' A' ' 21' ' ' LEU . 4.7 tmtm? -99.6 -11.63 20.8 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -178.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 60.52 31.55 20.29 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.218 -171.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.691 ' HB2' ' HD2' ' A' ' 19' ' ' LYS . 49.1 tp -106.31 121.89 45.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.055 -174.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -107.25 108.16 19.44 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 9.0 tp10 -137.09 163.68 30.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.76 0.314 . . . . 0.0 110.675 -175.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.3 mt -80.65 137.02 36.31 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.811 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.6 mt -82.07 85.2 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.37 0.605 . . . . 0.0 109.405 175.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.448 HG23 ' HG3' ' A' ' 27' ' ' GLU . 15.8 m -73.45 -27.98 24.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.086 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.484 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 44.3 mt-10 -127.21 126.42 42.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.901 -178.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -145.08 143.47 30.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 -174.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.49 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 10.2 tp10 -58.18 -54.36 47.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.484 -177.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.416 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 21.3 t-20 -90.08 144.74 31.74 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.366 -173.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.7 -31.06 39.59 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.962 2.441 . . . . 0.0 112.35 176.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -84.4 -63.88 1.26 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.272 175.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 25.0 tp 176.94 -71.87 0.01 OUTLIER 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.603 -177.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -71.41 121.1 17.98 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.741 -176.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.416 ' HA3' ' HB2' ' A' ' 30' ' ' ASN . . . -163.03 -52.76 0.02 OUTLIER Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.011 -176.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.64 -66.64 0.02 OUTLIER Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.216 -176.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.49 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -134.05 162.02 33.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.673 0.273 . . . . 0.0 110.948 178.368 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.4 m -146.28 169.79 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 176.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.484 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 27.9 m -143.36 127.24 17.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.272 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.532 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.2 mm? -74.83 155.95 37.01 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.137 176.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.04 -18.3 33.48 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -176.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.676 HD22 HD11 ' A' ' 21' ' ' LEU . 91.4 m-20 -90.98 8.87 33.11 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.654 0.264 . . . . 0.0 111.34 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.83 32.58 44.81 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.817 176.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.403 ' HZ3' ' HB2' ' A' ' 46' ' ' LEU . 24.9 t90 -107.82 116.67 32.37 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 175.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -86.83 139.99 30.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.084 0.469 . . . . 0.0 111.149 -177.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.403 ' HB2' ' HZ3' ' A' ' 44' ' ' TRP . 59.7 tp -136.29 139.68 42.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.467 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 64' ' ' ARG . 34.5 tt0 -81.37 132.96 35.35 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.0 tp -133.09 98.38 15.76 Favored Pre-proline 0 C--O 1.236 0.391 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 -177.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.27 156.34 41.02 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.877 2.385 . . . . 0.0 112.598 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.34 82.01 3.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.104 0.478 . . . . 0.0 110.264 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.5 mmt -113.58 -174.31 2.44 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.58 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.16 101.78 0.32 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.644 -177.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.05 -18.25 40.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.178 176.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -73.77 -4.75 36.53 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.388 -178.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.0 t -56.74 135.14 78.53 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.544 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -87.22 12.47 2.94 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.973 2.448 . . . . 0.0 112.872 -176.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 pp -140.19 154.06 69.66 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.186 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.26 104.59 1.58 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.402 2.068 . . . . 0.0 111.214 176.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.5 tt -88.95 140.28 16.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.148 -176.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 4' ' ' MET . 65.3 m -95.89 130.28 42.9 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.346 177.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.5 m -127.95 175.01 10.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.699 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -73.03 123.33 23.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.202 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 1' ' ' MET . . . -83.02 109.83 17.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.381 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.573 ' HB2' ' HB3' ' A' ' 47' ' ' GLU . 4.1 mpt_? -102.79 114.78 29.33 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 172.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -78.47 125.86 29.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.051 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.063 179.444 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.473 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -121.1 129.95 53.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.787 0.327 . . . . 0.0 111.77 -172.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.6 p -145.27 143.04 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.055 174.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 49.6 ttm -112.52 119.87 39.68 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.9 mm -89.58 116.04 30.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -97.58 149.1 22.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.456 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -133.93 149.29 51.28 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.928 0.394 . . . . 0.0 110.849 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.4 p -142.54 -167.86 2.6 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 171.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.35 90.45 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.5 m 74.85 -41.39 0.47 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.79 0.836 . . . . 0.0 111.683 -177.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.24 118.76 15.39 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.421 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.546 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 26.2 m80 -110.34 147.94 32.94 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.7 p -150.67 160.95 43.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.797 0.332 . . . . 0.0 110.68 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.452 ' HB3' HD21 ' A' ' 40' ' ' LEU . . . -129.62 130.92 46.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.061 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -120.23 104.85 10.41 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.985 -177.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.3 t -79.83 90.41 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 173.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.19 -48.37 54.18 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.697 -172.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.07 -23.06 66.26 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.698 0.285 . . . . 0.0 111.636 -174.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 60.6 tttm -107.86 -16.02 14.41 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.69 -178.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 19' ' ' LYS . 39.2 t70 70.01 22.17 5.87 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.726 0.774 . . . . 0.0 110.015 -175.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.444 HD23 ' N ' ' A' ' 22' ' ' GLU . 5.5 tt -83.98 123.06 29.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.222 178.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.444 ' N ' HD23 ' A' ' 21' ' ' LEU . 32.8 tt0 -134.31 116.91 15.81 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 174.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.555 ' HB3' HD13 ' A' ' 40' ' ' LEU . 7.2 tp10 -133.71 157.88 44.7 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.874 0.368 . . . . 0.0 110.219 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.9 mt -76.8 140.78 40.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.433 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' A' ' 12' ' ' HIS . 64.6 mt -83.45 114.96 24.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.806 176.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.4 m -102.23 -44.71 10.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -128.97 125.94 38.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.718 0.294 . . . . 0.0 111.034 -177.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.541 ' HG2' ' HA ' ' A' ' 33' ' ' LEU . 2.1 mpp? -111.51 167.85 10.0 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 174.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -84.86 -10.1 57.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.454 0.645 . . . . 0.0 109.38 173.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' A' ' 28' ' ' MET . 15.5 m120 -127.61 142.4 44.0 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.292 177.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -56.83 -36.93 99.05 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.79 2.327 . . . . 0.0 112.733 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.16 -70.81 0.34 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.893 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.541 ' HA ' ' HG2' ' A' ' 28' ' ' MET . 2.5 tt 178.35 -65.55 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.449 ' HB3' ' H ' ' A' ' 51' ' ' MET . 71.0 m95 -83.6 158.51 21.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.238 -174.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.88 -63.98 0.52 Allowed Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -131.84 -127.68 2.86 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.444 -0.407 . . . . 0.0 112.228 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 8.3 ptpp? -90.25 166.26 13.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.139 0.495 . . . . 0.0 111.834 -173.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 46' ' ' LEU . 9.2 p -146.69 162.18 9.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.81 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.419 ' N ' HG22 ' A' ' 38' ' ' VAL . 34.8 m -131.67 126.01 33.54 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.742 0.306 . . . . 0.0 110.414 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.555 HD13 ' HB3' ' A' ' 23' ' ' GLU . 59.8 mt -70.83 159.32 34.82 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.288 177.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.72 -24.46 57.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.13 -177.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -106.7 21.52 17.35 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.078 0.466 . . . . 0.0 111.382 -177.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.89 -33.71 6.2 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 114.774 0.67 . . . . 0.0 114.774 168.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.527 ' HB2' HD12 ' A' ' 40' ' ' LEU . 5.3 m-90 -53.9 128.51 30.43 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 117.418 0.609 . . . . 0.0 110.946 -177.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 44.1 mt-30 -103.71 138.52 40.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 110.982 -178.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.592 HD13 ' N ' ' A' ' 47' ' ' GLU . 2.8 tm? -137.72 144.56 41.77 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 37' ' ' LYS . 29.7 tt0 -111.5 129.58 56.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.889 0.376 . . . . 0.0 110.955 -177.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.405 HD22 ' N ' ' A' ' 48' ' ' LEU . 3.1 mm? -81.33 144.5 53.85 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.604 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -84.05 28.15 0.58 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.947 2.431 . . . . 0.0 112.65 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 57.73 96.0 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.094 0.557 . . . . 0.0 112.219 178.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.449 ' H ' ' HB3' ' A' ' 34' ' ' TRP . 25.6 mmt -133.49 -173.74 3.31 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.96 145.4 25.14 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 173.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.14 -28.09 64.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.974 0.416 . . . . 0.0 110.78 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -79.26 50.69 1.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.395 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.9 p -74.59 123.1 88.84 Favored Pre-proline 0 N--CA 1.453 -0.308 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 172.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.16 -7.77 19.87 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.579 2.186 . . . . 0.0 112.632 -175.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.1 pp -152.16 163.75 22.54 Favored Pre-proline 0 C--O 1.235 0.336 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.471 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.64 99.15 0.43 Allowed 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.073 1.849 . . . . 0.0 110.283 172.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.3 tt -88.05 143.49 11.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.223 0.535 . . . . 0.0 111.406 -170.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.2 m -96.06 122.51 38.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.659 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.9 m -129.78 174.3 12.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 120.956 0.408 . . . . 0.0 111.508 -175.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -63.53 126.34 27.19 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.381 177.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 1' ' ' MET . . . -90.51 109.57 20.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.697 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' A' ' 47' ' ' GLU . 30.1 tpt180 -101.47 100.41 10.86 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -79.62 133.68 36.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.805 -176.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 47' ' ' GLU . 6.4 mp . . . . . 0 C--O 1.252 1.192 0 CA-C-O 118.256 -0.878 . . . . 0.0 109.42 175.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.741 ' HG3' ' HB3' ' A' ' 63' ' ' ALA . 24.6 ptp . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -103.68 127.51 51.12 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.125 0.488 . . . . 0.0 112.024 -163.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.651 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 14.4 p -140.21 128.0 24.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.376 170.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 51.8 ttp -109.32 110.88 22.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.905 0.383 . . . . 0.0 110.465 -177.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.8 mm -84.01 131.49 33.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.423 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -96.46 121.74 38.6 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 176.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.867 ' HE2' ' HA ' ' A' ' 54' ' ' ASP . 27.1 mmmt -92.96 116.01 28.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.371 177.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.542 HG22 ' H ' ' A' ' 10' ' ' THR . 84.8 m -152.33 127.18 9.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.303 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.57 3.9 4.46 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -172.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.542 ' H ' HG22 ' A' ' 8' ' ' THR . 5.6 p -127.75 -0.5 6.06 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.736 0.272 . . . . 0.0 111.736 177.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.478 ' O ' ' HB ' ' A' ' 8' ' ' THR . . . -179.3 102.0 0.16 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.543 -177.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.587 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 64.7 m80 -81.07 143.82 32.18 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.9 t -143.13 162.31 35.89 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.554 ' HB3' HD11 ' A' ' 40' ' ' LEU . . . -145.73 122.95 11.52 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.639 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.423 ' HD1' ' HB2' ' A' ' 22' ' ' GLU . 41.9 t80 -102.35 102.73 13.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.575 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.9 t -83.78 98.27 5.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.716 175.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.35 -39.82 91.98 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.004 -173.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.469 ' NZ ' ' SD ' ' A' ' 1' ' ' MET . 0.1 OUTLIER -70.06 -5.91 30.01 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -177.167 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -130.49 10.61 5.24 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 41.58 29.59 0.11 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.677 0.791 . . . . 0.0 111.407 -175.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.64 HD21 HD21 ' A' ' 42' ' ' ASN . 52.1 tp -100.64 132.29 46.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.73 -174.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.423 ' HB2' ' HD1' ' A' ' 15' ' ' TYR . 41.0 tt0 -134.24 112.46 11.08 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 170.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -129.77 163.41 26.27 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.023 -176.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.7 mt -79.23 132.2 36.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.574 178.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.587 ' HB ' ' HB2' ' A' ' 12' ' ' HIS . 70.3 mt -77.03 98.03 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.582 175.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.2 m -88.38 -29.99 5.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.87 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.609 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 9.9 tp10 -123.25 139.56 53.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.792 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.481 ' HA ' HG22 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -150.48 147.92 28.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.225 -178.463 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -55.46 -42.82 74.81 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.703 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -131.92 144.92 55.24 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.356 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.89 -27.47 20.81 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.154 2.569 . . . . 0.0 112.784 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.57 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . -64.59 -61.88 1.93 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.353 175.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.572 ' HB3' ' CD1' ' A' ' 34' ' ' TRP . 1.5 tm? 167.04 -62.82 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.469 -177.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.572 ' CD1' ' HB3' ' A' ' 33' ' ' LEU . 39.1 m95 -88.0 157.81 18.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.297 -171.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.81 -32.73 0.48 Allowed Glycine 0 C--N 1.331 0.294 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.153 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.17 -78.29 0.06 OUTLIER Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.384 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -130.21 162.29 29.24 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.269 0.557 . . . . 0.0 111.703 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.556 HG13 HG23 ' A' ' 25' ' ' ILE . 9.8 t -143.71 155.61 16.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.16 -177.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.609 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 20.1 m -134.03 127.27 31.92 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.782 0.325 . . . . 0.0 110.61 176.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.554 HD11 ' HB3' ' A' ' 14' ' ' ALA . 3.5 mm? -75.66 167.14 22.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.149 176.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.5 -21.98 64.7 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.791 0.329 . . . . 0.0 111.559 -178.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.64 HD21 HD21 ' A' ' 21' ' ' LEU . 27.4 p30 -90.81 1.26 57.08 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.627 -178.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.07 8.29 64.93 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.319 176.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.564 ' HE1' HD23 ' A' ' 46' ' ' LEU . 62.0 t-105 -76.35 117.86 18.45 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 176.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -92.53 116.49 29.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.74 0.305 . . . . 0.0 110.806 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.564 HD23 ' HE1' ' A' ' 44' ' ' TRP . 0.6 OUTLIER -115.23 134.72 54.88 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -178.221 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.622 ' HB3' ' HB2' ' A' ' 64' ' ' ARG . 31.6 tt0 -91.01 120.39 31.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.775 0.322 . . . . 0.0 110.636 -178.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.411 HD12 ' CZ3' ' A' ' 34' ' ' TRP . 3.6 mm? -110.07 106.34 58.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 175.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.8 44.33 1.53 Allowed 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.225 2.617 . . . . 0.0 113.878 -167.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 51.16 82.68 0.06 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.373 0.606 . . . . 0.0 111.848 176.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 97.0 mmm -119.16 -155.45 0.61 Allowed 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -50.12 107.77 0.18 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.828 0.347 . . . . 0.0 110.589 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.01 -34.9 77.05 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.593 -174.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.867 ' HA ' ' HE2' ' A' ' 7' ' ' LYS . 12.6 t70 -134.33 102.11 5.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.877 0.37 . . . . 0.0 110.479 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.4 p -97.14 139.98 21.8 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.08 175.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.52 7.63 3.36 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.693 2.262 . . . . 0.0 112.242 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 pp -147.4 161.01 37.63 Favored Pre-proline 0 C--O 1.236 0.374 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.89 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.28 108.26 1.33 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.017 1.811 . . . . 0.0 110.495 173.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.2 tt -88.02 137.81 20.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.15 -171.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.4 m -106.13 127.4 53.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.678 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.421 HG11 ' HH2' ' A' ' 34' ' ' TRP . 18.6 m -138.78 178.15 4.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 120.951 0.405 . . . . 0.0 111.056 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 1' ' ' MET . 41.1 tt0 -73.89 124.59 26.43 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.725 178.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.741 ' HB3' ' HG3' ' A' ' 1' ' ' MET . . . -80.74 109.96 15.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.132 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.622 ' HB2' ' HB3' ' A' ' 47' ' ' GLU . 89.5 mtt180 -110.2 137.72 47.55 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 176.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -111.65 124.39 52.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.088 -172.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.411 HD22 ' N ' ' A' ' 66' ' ' LEU . 2.9 mm? . . . . . 0 C--O 1.25 1.082 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 174.45 . . . . . . . . 1 1 . 1 stop_ save_